<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
  <head>
    <meta content="text/html; charset=windows-1252"
      http-equiv="Content-Type">
    <title>Tooth Remineralization -- Calcium Phosphate Remineralization
      Patents</title>
  </head>
  <body>
    <div align="left">
      <blockquote>
        <div><big><big><b><img alt="" src="0logo.gif" height="82"
                  width="124"></b></big></big><b><br>
            <a href="../index.htm">rexresearch.com</a></b><br>
          <hr size="2" width="100%"></div>
      </blockquote>
    </div>
    <div align="left"><big><big> </big></big>
      <blockquote>
        <div align="center"><big><big><b><br>
                Tooth Remineralization Patents</b></big></big><br>
          <br>
        </div>
        <b> </b><b><br>
        </b>
        <hr size="2" width="100%">
        <div align="center"><br>
          <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
          <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
          <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
          <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
          <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
          <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
          <hr size="2" width="100%"><b><br>
          </b>
          <div align="left"><b> </b><b>A. <a href="#ingred">Key
                Ingredients in Patents</a></b><br>
            <b> </b><br>
            <b> </b><b>B. <a href="#patabstr">List of Patents</a></b><b><a
                href="#patabstr"> / Abstracts</a></b><br>
            <b> </b><br>
            <b> </b><b>C. <a href="#excerpts">Excerpts of Select
                Patents</a></b><br>
          </div>
          <br>
          <hr size="2" width="100%"><a name="ingred"></a><br>
          <div align="center">
            <div align="left"><b>SUMMARY OF KEY INGREDIENTS</b> --<br>
              <br>
              <b>Dentifrice for dental remineralization</b><br>
              <b> </b><b>US4177258</b><br>
              <b>A</b>n<b> antinucleating agent such as ethylenediamine
                tetramethylenephosphonic acid</b> or water soluble salt
              thereof, the pH&nbsp; abou<b>t 6.8-7.5.</b><br>
              <br>
              <b>TOOTHPASTE COMPOSITION</b><br>
              <b> </b><b>KR840001942 &nbsp;&nbsp;&nbsp; &nbsp; </b><br>
              &nbsp;<b>5-35% synthetic hydroxyapatite </b>powder, <b>30-35%










                abrasive material that contains calcium phosphate or
                calcium pyrophosphate</b>,<b> 0.1-20% NaCl, 0.003-3%
                MgCl2, and 30-35% water by weight. </b><br>
              <br>
              <b>Prophylactic dental paste comprising dicalcium
                phosphate and method of using it for cleaning, polishing
                and remineralizing teeth.</b><br>
              <b> </b><b>EP0040938</b><br>
              <b>6</b><b>0 percent by weight of dicalcium phosphate</b>,
              (which may be anhydrous dicalcium phosphate, dicalcium
              phosphate dihydrate or a mixture of the two)<br>
              <br>
              <b>MEANS &amp; METHOD FOR THE REMINERALIZATION &amp;
                PROPHYLAXY OF DENTAL ENAMEL
                DEMINERALIZATION&nbsp;&nbsp;&nbsp; </b><br>
              <b> BG92020</b><br>
              <b>0.4 to 10 collagen</b><br>
              <br>
              <b>DENTIFRICE COMPOSITION</b><br>
              <b> </b><b>JP7223930</b><br>
              <b>Tricalcium phosphate, a mixture (molar ratio of Ca/P:
                1.30-1.67 of tetracalcium phosphate with calcium primary
                phosphate (anhydride or monohydrate), a mixture (molar
                ratio of Ca/P: 1.30-1.67) of tetracalcium phosphate with
                secondary calcium phosphate (anhydride or monohydrate),
                a mixture (molar ratio of Ca/P: 1.30-1.50) of tricalcium
                phosphate with calcium primary phosphate, etc</b>.,<br>
              <br>
              <b>Artificial saliva and its preparing method</b><br>
              <b> </b><b>CN1130066</b><br>
              <b>Sodium chloride, potassium chloride, calcium chloride,
                magnesium chloride, acidic and alkaline sodium phosphate</b><br>
              <br>
              <b>DENTIFRICE COMPOSITION</b><br>
              <b> </b><b>JP9040539</b><br>
              <br>
              <b>Hydroxyapatite) and 0.05-10wt.% carbamide peroxide --</b>
              a <b>synergistic effect is exhibited by mixing both</b>,
              A mixture of more than two species<b> of tricalcium
                phosphate, calcium hydrogen phosphate, calcium
                dihydrogen phosphate, octacalcium phosphate and calcium
                pyrophosphate can be used instead of hydroxyapatite as
                the calcium compound.</b><br>
              <br>
              <b>Dentifrice for the mineralization and remineralization
                of teeth</b><br>
              <b> </b><b>US6372198</b><br>
              <b> </b><b>Coenzyme Q10</b><b>, selenium, and bromine</b><br>
              <br>
              <b>COMPOSITION FOR CARIES PREVENTION</b><br>
              <b> </b><b>CA2485836 </b><br>
              <b> </b><b>0.01 to 10% by weight of sodium
                carboxymethylcellulose having the etherification degree
                of 0.7 to 1.0 is used in a composition blended with a
                casein phosphopeptide - amorphous calcium phosphate
                complex (CPP - ACP</b>)<br>
              <br>
              <b>Methods for treating dental conditions using tissue
                scaffolds</b><br>
              <b> </b><b>US2007248933</b><br>
              <b> </b><b>TGF-beta supergene family</b>, that promotes
              regeneration and differentiation of healthy dental tissue
              in vivo<br>
              <br>
              <b>Calcium phosphate complex and salts in oral delivery
                systems</b><br>
              <b> </b><b>CN101415398</b><br>
              <b>Phosphopeptide o r phosphoprotein stabilized calcium
                phosphate</b><br>
              <br>
              <b>ORAL COMPOSITION FOR STABILIZATION, (RE)CALCIFICATION
                AND (RE)MINERALIZATION OF TOOTH ENAMEL AND DENTINE</b><br>
              <b> </b><b>US2008152598</b><br>
              <b> Calcium form of zeolite</b> <br>
              <br>
              <b>ORAL CARE PRODUCTS COMPRISING BUFFER SYSTEMS FOR
                IMPROVED MINERALIZATION/REMINERALIZATION BENEFITS.</b><br>
              <b> </b><b>MX2009008303</b><br>
              <b> </b><b>Calcium salt, a phosphate salt, a sodium salt
                and a potassium salt. For example, the molar ratio of
                the sodium salt to the potassium salt ranges from about
                3 to about 4</b>.<br>
              <br>
              <b>DENTAL PROPHYLACTIC PASTE</b><br>
              <b> </b><b>WO2011031606 </b><br>
              <b>Water soluble silicate</b><br>
              <br>
              <b>COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH
                HEALTH AND APPEARANCE.</b><br>
              <b> </b><b>MX2010014220 </b><br>
              Surface-active<b> organophosphate</b> compounds, an
              antimicrobial agent preferably selected from quaternary
              ammonium compounds and polyvalent metal salts, an
              anticalculus agent.<br>
              <br>
              <b>CALCIUM PEROXYPHOSPHATES AND USE THEREOF IN DENTAL
                COMPOSITIONS</b><br>
              <b> </b><b>US2011142768</b><br>
              <b>Calcium peroxymonophosphate or calcium
                diperoxymonophosphate</b> <br>
              <br>
              <b>NOVEL TYPE OF ANION-CONTAINING CALCIUM PHOSPHATE
                COMPOUND FOR DENTAL REMINERALIZATION</b><br>
              <b> </b><b>US2012129135</b><br>
              The anion-containing calcium phosphate compound has the
              following formula: <b>(Ca+2)x(anion-a)y(PO4-3)z wherein
                2x=(a*y+3z); a is an integer of 1 to 3; and each of x, y
                and z is not 0.</b><br>
              <b> </b><b> </b><br>
              <b>Dentifrice compositions</b><br>
              <b> </b><b>US4327079</b><br>
              <b>0.1 to 20% by weight of NaCl and/or KCl and 0.003 to 3%
                by weight of MgCl2</b><br>
              <b> </b><br>
              <b>DENTAL FORMULATION</b><br>
              <b> </b><b>WO9319728</b><br>
              <b> </b><b>Water soluble phosphate, particularly a
                pyrophosphate or tripolyphosphate</b>, to inhibit
              demineralization <br>
              <br>
              <b>TOOTH-PASTE</b><br>
              <b> </b><b>SK280006</b><br>
              <b>Combination of silicilic acids and dicalcium phosphate
                dihydrate (brushite )</b><br>
              <br>
              <b>TOOTH PASTE COMPOSITION</b><br>
              <b> </b><b>JP9124451</b><br>
              A natural<b> zeolite such as gismondine, garronite,
                analcime or wirakite or a synthetic zeolite such as
                stilbite or Ca-mordenite) and (B) hydroxyapatite</b>. ,<b>
                preferably 5-30%, </b>based on the whole amount of the
              composition.<br>
              <p class="printAbstract" lang="en"><b>REMINERALIZATION
                  MATERIAL FOR ORGANOMINERAL TISSUES<br>
                </b><b>BG103544</b><b><br>
                  Zn2+ ions</b> is preferred in presence of quantities
                less than 1%, better closer to 0.2%<br>
              </p>
              <p class="printAbstract" lang="en"><b>CHEWING GUM WITH
                  DENTAL HEALTH BENEFITS EMPLOYING CALCIUM LACTATE</b><br>
              </p>
              <b> </b><b>WO0042861</b><br>
              <b>Calcium lactate.</b><br>
              <b> </b><br>
              <b>REMINERALIZATION PROMOTERS</b><br>
              <b> </b><b>WO2005003753</b><br>
              <b>Starch phosphate, maltodextrin phosphate, reducing
                maltodextrin phosphate, oligosaccharide phosphate</b>, <br>
              <br>
              <b>Oral and dental care product</b><br>
              <b> </b><b>US2007154411</b><br>
              <b>Proteins, protein hydrolysates and protein hydrolysate
                derivatives</b><br>
              <br>
              <b>Formulation of dual eicosanoid system and cytokine
                system inhibitors for use in the prevention and
                treatment of oral diseases and conditions</b><br>
              <b> </b><b>US2006079467</b><br>
              <b> </b><b>Free-B-Ring flavonoids and flavans</b>
              isolated from a single plant or multiple plants,
              preferably in the<b> Scutellaria, Oroxylum, Acacia or
                Uncaria genus</b> of plants<br>
              <br>
              <b>CALCIUM BINDING PEPTIDES</b><br>
              <b>WO2007038683</b><br>
              <b> </b><b>Aspartic acid, glutamic acid, asparagine,
                alanine and glutamine</b>, and Y and Z are amino acids
              selected from<b> alanine, serine, threonine,
                phosphoserine, phosphothreonine</b>, and their
              derivatives. These compounds <b>have the property of
                binding tightly and specifically to calcified surface</b><b>.</b><br>
              <b> </b><br>
              <b>MATERIAL FOR FILLING ROOT CANALS OF TEETH</b><br>
              <b> </b><b>RU2197939</b><br>
              <b>Zeolite</b> at the quantity of 10-70% and <b>contains
                calcium being 1.5-45 mg</b> higher/g enriched zeolite <br>
              <br>
              <b>Dental cleaning formulation and manufacturing process</b><br>
              <b> </b><b>US6602490</b><br>
              <b>Potassium Citrate and Disodium Edetate.</b><br>
              <br>
              <b>METHOD FOR MINERALIZATION OF ROOT TOOTH TISSUE</b><br>
              <b> </b><b>EA200801499</b><br>
              <b>Sodium hydrogen carbonate; 0.01% Myramistin solution
                for suppressing the activity of pathogenic microflora
                and for enhancing focal defense reactions; calcium
                glycerophosphate and nanocrystalline calcium
                hydroxyappatite as remineralizing components</b><br>
              <br>
              <b>BIOACTIVE GLASS COMPOSITION</b><br>
              <b> </b><b>JP2008120681</b><br>
              <b>Silica-based bioactive glass</b><br>
              <br>
              <b>GEL FOR REMINERALIZATION OF TOOTH TISSUES</b><br>
              <b> </b><b>EA200800988</b><br>
              <b>Calcium glycerophosphate 0.1-3.0,</b> a source of<b>
                magnesium ions 0.01-0.50, guar gum 0.03-0.30 </b>as
              active components, <b>Magnesium chloride, magnesium
                sulfate or magnesium nitrate</b> is used as a source of
              magnesium ions.<br>
              <br>
              <b>Method for in-vitro induction of remineralization of
                dentin</b><br>
              <b> </b><b>CN102172334</b><br>
              <b>Agar gel CaCl2 solution mineralization system
                containing phosphate</b> can induce the deposition and
              growth of strip nano crystals<br>
              <br>
              <hr size="2" width="100%"><b><a name="patabstr"></a><br>
              </b>
              <div align="center"><b>PATENTS ABSTRACTS</b><br>
              </div>
              <div align="left"><br>
                <b>PROCESSES AND COMPOSITIONS FOR REMINERALIZATION OF
                  DENTAL ENAMEL</b><br>
                <b> </b><b>GB1452125</b><br>
                <b> </b><br>
                <b> </b>Remineralizing teeth PROCTER &amp; GAMBLE CO 12
                Oot 1973 [13 Oct 1972] 47800/73 Heading A5B A pack for
                remineralizing teeth comprises (A) a cation in
                water-soluble form which cation is capable of forming an
                insoluble preciptate and (B) an anion in water-soluble
                form which is capable of forming with the cation an
                insoluble precipitate adapted to remineralize subsurface
                dental enamel, one of both of components (A) and (B)
                containing a flavouring agent, the components being
                compatible with the oral environment and being such as
                to have a pH from 3 to 10 in solution. In use, the two
                components are applied sequentially to the tooth, the
                remineralizing precipitate being thereby formed in situ.
                Cations specified are calcium, indium, barium,
                lanthanium, manganese, lead, tin, zinc, zirconium, iron,
                titanium, vanadium, cadmium, magnesium, aluminium,
                strontium, cesium, samarium, praseodymium, neodymium,
                nickel, lithium (with phosphate), molybdenum, vanadium,
                tungsten. Anions specified are fluoride, phosphate,
                fluorophosphate, silicofluoride, molybdate, sulphate,
                tungstate, 8-hydroxyquinolate, tartrate, sorbate,
                carbonate, iodate, stearate, hydroxide, palmitate,
                myristate, laurate, oxalate, decyl sulphonate, lauryl
                sulphonate, myristyl sulphonate, cetyl sulphonate,
                octadecyl sulphonate, silicate, hexadecyl sulphonate,
                aluminate. Physical forms of the two components
                specified are: mouthwashes, toothpastes, beverages,
                candy drops, foods, toothpowders, chewing gum,
                toothpaste in which one component is encapsulated and a
                multilayer lozenge.<br>
                <br>
              </div>
            </div>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Process and composition for the remineralization and
              prevention of demineralization of animal teeth including
              humans</b><br>
            <b> </b><b>US4397837</b><br>
            <b> </b><br>
            <b> </b>Compositions for the remineralization and
            prevention of demineralization of the teeth of animals
            including humans in the form of two phases, one phase
            containing a water-soluble calcium compound and the other
            phase containing a water-soluble phosphate and optionally a
            water-soluble fluorine compound. The concentration of
            calcium and phosphate (PO4) ions is about 50 to 35,000 ppm
            and 50 to 40,000 ppm respectively, and the amount of
            fluorine compound is about 0.01 to 5.0%, all by weight of
            the total composition. The compositions may also contain at
            least one of a conventional flavoring substance, aroma
            substance, surfactant, astringent, polishing agent,
            thickener and preservative.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left">&nbsp;<br>
            <b>Processes and compositions for remineralization of dental
              enamel</b><br>
            <b> </b><b>US4083955</b><br>
            <br>
            Two compositions containing respectively a cation and an
            anion, such as calcium ion and phosphate ion, are
            sequentially applied to dental enamel resulting in
            remineralization of subsurface dental enamel.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Stable solution for dental remineralization</b><br>
            <b> </b><b>US4183915</b><br>
            <b> </b><br>
            An aqueous solution useful for remineralizing subsurface
            carious lesions of dental enamel which solution contains
            sources of calcium ions and phosphate ions as well as
            fluoride ions and further includes as an agent to stabilize
            the solution against precipitation, an antinucleating agent
            such as ethylenediamine tetramethylenephosphonic acid or
            water soluble salt thereof, the pH of the solution being
            about 5-9, preferably close to physiological conditions,
            such as about 6.8-7.5.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left">&nbsp;<br>
            <b>Dentifrice for dental remineralization</b><br>
            <b> </b><b>US4177258</b><br>
            <b> </b><br>
            A dentifrice useful for remineralizing subsurface carious
            lesions of dental enamel which contains sources of calcium
            ions and phosphate ions as well as fluoride ions and further
            includes as agent to stabilize against precipitation of the
            calcium and phosphate ions, an<b> antinucleating agent such
              as ethylenediamine tetramethylenephosphonic acid</b> or
            water soluble salt thereof, the pH of the dentifrice being
            about 5-9, preferably close to physiological conditions,
            such as abou<b>t 6.8-7.5.</b><br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>TOOTHPASTE COMPOSITION</b><br>
            <b> </b><b>KR840001942 &nbsp;&nbsp;&nbsp; &nbsp; </b><br>
            <b> </b><br>
            A dentifrice includes synthetic hydroxyapatite powder. This
            compsn. was found effective in removing plaque from teeth
            surfaces and in the remineralization of the enamel. The
            toothpaste consists of <b>5-35% synthetic hydroxyapatite </b>powder,






            <b>30-35% abrasive material that contains calcium phosphate
              or calcium pyrophosphate</b>, 20-35% filler that contains
            a glycerine or sorbitol group,<b> 0.1-20% NaCl, 0.003-3%
              MgCl2, and 30-35% water by weight. </b>The compositon
            should be either neutral or alkali.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Prophylactic dental paste comprising dicalcium phosphate
              and method of using it for cleaning, polishing and
              remineralizing teeth.</b><br>
            <b> </b><b>EP0040938</b><br>
            <b> </b><br>
            A prophylactic dental paste for professional use containing
            at least<b> 60 percent by weight of dicalcium phosphate</b>,
            (which may be anhydrous dicalcium phosphate, dicalcium
            phosphate dihydrate or a mixture of the two) not only
            satisfactorily cleans the tooth surface but provides a tooth
            with higher luster or polish. The use of the prophylatic
            dental paste of the invention, in which the dicalcium
            phosphate has the same calcium to phosphorus atom ratio
            found in the tooth, aids in remineralization of the cleaned
            tooth surface.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>DENTAL REMINERALIZATION COMPOSITION</b><br>
            <b> </b><b>CA1165953</b><br>
            <b> </b><br>
            An aqueous composition useful for remineralizing subsurface
            carious lesion, of dental enamel which comprises an aqueous
            solution which contains sources of calcium ions and
            phosphate ions as well as fluoride ions and further includes
            as an antinucleating agent, to stabilize the solution
            against precipitation, 2-phosphono-butane-tricarboxylic acid
            1,2,4 or water soluble salt thereof, the pH of the solution
            being about 5-9, preferably close to physiological
            conditions, such as about 6.8-7.5.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Anticariogenic remineralizing dentifrice</b><br>
            <b> </b><b>US4460565</b><br>
            <b> </b><br>
            <b> </b>A dentifrice containing two or more fluorine
            compounds, at least one soluble salt producing phosphate
            ions, and at least one substance providing calcium ions, and
            as a result thereof having good remineralization properties.
            Preferred compositions contain as the fluorine compounds a
            fluoride and a monofluorophosphate, as phosphate compounds a
            cyclic metaphosphate and a linear phosphate, and as calcium
            compound a calcium salt of an organic acid.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Method of making a clear, stable aqueous
              mouthwash solution and the solution made by that method
              for the enhancement of cells of the oral cavity and the
              remineralization of teeth&nbsp;&nbsp; &nbsp;</b><br>
            <b> </b><b>US4606912</b><br>
            <br>
            A solutions for optimizing the environmental conditions
            within the human oral cavity is disclosed which enhances the
            functioning of cells of the oral cavity and promotes
            remineralization of teeth. These solutions are effective in
            treating and preventing caries and periodontal disease and
            reducing mouth odor and are easily and safely used by the
            lay population. A method of making the solutions which
            totally prevents the formation of calcium phosphate
            crystals, for example hydroxyapatite, is disclosed.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>MEANS &amp; METHOD FOR THE REMINERALIZATION &amp;
              PROPHYLAXY OF DENTAL ENAMEL
              DEMINERALIZATION&nbsp;&nbsp;&nbsp; </b><br>
            <b> BG92020</b><br>
            <b> </b><br>
            The means and the method are used in dentistry for the
            prophylaxy and treatment of initial forms of dental caries.
            The means contains water soluble calcium and phosphate salts
            having constant ion activity in suitable gel form which is
            indifferent and does not affect the oral cavity mucous
            membrane and teeth and does not stimulate the development of
            dental scale. By the method, lasting and more stable
            penetration of the phosphate-calcium ions and filling of the
            enamel cracks is achieved. By it, a two-stage gel system is
            used consisting of phosphate anionic gel and calcium
            cationic gel which are applied successively in such a manner
            that calcium phosphates participating in the
            remineralization of the enamel precipitate on the dental
            surface. The gels contain from 5 to 15% methylcellulose.
            Water soluble phosphate salts are contained in the phosphate
            anionic gel in concentrations, in %: from <b>0.4 to 10
              collagen</b>; 0.2-1 biologically active substance; 0.01 to
            1 fluoride additives, and other microelements up to 0.2. The
            cationic gel contains in %: from 0.5 to 12 calcium soluble
            salts, 0.1-1 collagen, 0.01-1 biologically active substances
            and 0.01-2 microelements.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>DENTIFRICE COMPOSITION</b><br>
            <b> </b><b>JP7223930</b><br>
            <b> </b><br>
            PURPOSE:To obtain a dentifrice composition having pH of
            nearly neutrality and capable of efficiently removing dental
            plaque an promoting remineralization of the tooth surface
            and making the tooth surface glossy by blending calcium salt
            powder having ability capable of converting to
            hydroxyapatite in the presence of saliva in oral cavity.
            CONSTITUTION:This dentifrice composition contains calcium
            salt powder (especially <b>octacalcium phosphate</b>)
            capable of converting to hydroxyapatite by contacting with
            water (especially saliva in oral cavity) and it has <b>pH
              5-8</b>. As the calcium salt powder, <b>tricalcium
              phosphate, a mixture (molar ratio of Ca/P: 1.30-1.67 of
              tetracalcium phosphate with calcium primary phosphate
              (anhydride or monohydrate), a mixture (molar ratio of
              Ca/P: 1.30-1.67) of tetracalcium phosphate with secondary
              calcium phosphate (anhydride or monohydrate), a mixture
              (molar ratio of Ca/P: 1.30-1.50) of tricalcium phosphate
              with calcium primary phosphate, etc</b>., is preferably
            used. This composition can not only remove a contaminant
            such as dental plaque, but repair also damage by promotion
            of remineralization of the toot surface.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Artificial saliva and its preparing method</b><br>
            <b> </b><b>CN1130066</b><br>
            <b> </b><br>
            An artificial saliva is prepared by mixing and compounding
            of sodium fluoride, <b>sodium chloride, potassium chloride,
              calcium chloride, magnesium chloride, acidic and alkaline
              sodium phosphate</b>, antiseptic and sterilized distilled
            water, its pH value being 0.4-6.0. This invention features
            that it changes symptoms of xerostomia patient, and promotes
            remission of oral mucosa hyperemia and heals erosive
            surface, while it prevents dental caries, promotes
            remineralization of decalcified teeth during radiactive
            therapy and stops the occurrence of intensified dental
            caries after radiactive therapy.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>DENTIFRICE COMPOSITION</b><br>
            <b> </b><b>JP9040539</b><br>
            <br>
            PROBLEM TO BE SOLVED: To obtain a dentifrice composition
            having an action removing pigmentation of teeth and also
            promoting remineralization of the surface of the teeth.
            SOLUTION: This composition contains 0.1-90wt.% a calcium
            compound (e.g.;<b> hydroxyapatite) and 0.05-10wt.% carbamide
              peroxide</b>. Hydroxyapatite has an action performing
            remineralization of the surface enamel of teeth, carbamide
            peroxide has an action removing pigmentation of teeth and a
            <b>synergistic effect is exhibited by mixing both</b>, then
            a whitening and a removing action of pigmentation of the
            teeth are exceedingly increased and simultaneously a
            mineralization effect of the surface of the teeth is
            reserved. A mixture of more than two species<b> of
              tricalcium phosphate, calcium hydrogen phosphate, calcium
              dihydrogen phosphate, octacalcium phosphate and calcium
              pyrophosphate can be used instead of hydroxyapatite as the
              calcium compound.</b><br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Chewing gum compositions and the use thereof for
              remineralization of lesions in teeth</b><br>
            <b> </b><b>US5645853</b><br>
            <b> </b><br>
            This invention relates to chewing gum compositions and
            methods utilizing same which are useful to remineralize
            subsurface dental enamel. More specifically, this invention
            relates to stable, single-part chewing gum compositions
            containing calcium and phosphate salts which when applied to
            lesions in dental enamel result in remineralization of
            subsurface dental enamel and/or mineralization of tubules in
            dentin thereby counteracting caries and/or hypersensitivity.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Processes and compositions for the remineralization of
              teeth</b><br>
            <b> </b><b>US5817296</b><br>
            <b> </b><br>
            The present invention relates to remineralization, without
            demineralization, by applying to the teeth a composition
            which is present in either one or in two phases and which
            does not react to any large extent until introduced into the
            oral cavity and upon such introduction does not rapidly
            precipitate. One phase systems contain at least one
            water-soluble calcium compound, at least one other
            water-soluble, non-toxic compound containing a divalent
            metal different from calcium, and at least one water-soluble
            inorganic phosphate compound. If desired at least one
            water-soluble fluorine compound may be added to the system.
            In two phase systems one phase contains the calcium and the
            divalent metal compounds and the other the phosphate and
            optionally, the fluoride compound. In this way the ions
            which effect remineralization can be absorbed by the dental
            enamel and their subsequent, but controlled, reaction causes
            rehardening of demineralized areas in the dental enamel.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Chewing gum products and the use thereof for
              remineralizing subsurface dental lesions</b><br>
            <b> </b><b>US5958380</b><br>
            <b> </b><br>
            This invention relates to a stable, single-part chewing gum
            product and methods of using same to effect remineralization
            of subsurface lesions in teeth and/or mineralization of
            exposed dentinal tubules. The chewing gum product contains a
            water-soluble cationic portion, a water-soluble anionic
            portion and a stabilizing component which substantially
            inhibits reaction between the cationic and anionic portions
            during storage of the chewing gum product but which allows
            the cationic and anionic portions to be simultaneously
            released at a substantially equal rate from the product when
            the product is chewed in the presence of saliva and/or
            water. The cationic portion is composed of at least one
            water-soluble calcium salt, and the anionic portion contains
            at least one water-soluble phosphate and, optionally, at
            least one water-soluble fluoride salt. The stabilizing
            component may be at least one water-soluble divalent metal
            salt other than calcium salt, the divalent metal salt being
            disposed in the cationic portion of the product.
            Alternatively, the stabilizing component may be a
            desiccating agent or an encapsulating coating, wherein the
            encapsulating coating is disposed on particles of one or
            both of the cationic and anionic portions.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Processes and compositions for the remineralization of
              teeth</b><br>
            <b> </b><b>US5833957</b><br>
            <b> </b><br>
            The present invention relates to remineralization, without
            demineralization, by applying to the teeth a composition
            which is present in either one or in two phases and which
            does not react to any large extent until introduced into the
            oral cavity and upon such introduction does not rapidly
            precipitate. One phase systems contain at least one
            water-soluble calcium compound, at least one other
            water-soluble, non-toxic compound containing a divalent
            metal different from calcium, and at least one water-soluble
            inorganic phosphate compound. If desired at least one
            water-soluble fluorine compound may be added to the system.
            In two phase systems one phase contains the calcium and the
            divalent metal compounds and the other the phosphate and
            optionally, the fluoride compound. In this way the ions
            which effect remineralization can be absorbed by the dental
            enamel and their subsequent, but controlled, reaction causes
            rehardening of demineralized areas in the dental enamel.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>PROCESSES AND COMPOSITIONS FOR REMINERALIZATION AND
              PREVENTION OF DEMINERALIZATION OF DENTAL ENAMEL.</b><br>
            <b> </b><b>MX9709490</b><br>
            <b> </b><br>
            The present invention relates to the problems of
            remineralization, without demineralization of dental enamel
            by applying to the teeth a composition which is present in
            two phases which do not react with one another until
            introduced into the oral cavity. One phase contains at least
            one water-soluble calcium compound and the other contains at
            least one water-soluble inorganic phosphate and at least one
            water-soluble fluorine compound. In this way the ions which
            effect remineralization can be absorbed by the dental enamel
            and their subsequent reaction causes rehardening of
            demineralized areas in the dental enamel.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>COMPOSITION AND METHOD FOR REMINERALIZATION OF TEETH.</b><br>
            <b> </b><b>MX9801062</b><br>
            <br>
            This invention relates to non-aqeuous compositions and
            method utilizing same which are useful to remineralize
            subsurface dental enamel. More specifically, this invention
            relates to stable, single-part compositions containing
            calcium and phosphate salts which may be in a hydrophilic,
            non-aqueous vehicle and which when applied to lesions in
            dental enamel result in remineralization of subsurface
            dental enamel and/or mineralization of tubules in dentin
            thereby counteracting caries and/or hypersensitivity.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>REMINERALIZING PRODUCTS AND METHODS FOR TEETH.</b><br>
            <b> </b><b>MX9801063</b><br>
            <b> </b><br>
            Products and methods are provided for the remineralization
            of lesions formed in the subsurfaces of teeth and/or
            mineralization of tubules in exposed dentin of teeth,
            wherein the products generally contain at least one
            water-soluble calcium salt, at least one divalent metal salt
            other than calcium salt, at least one water-soluble
            phosphate salt, and, optionally, at least one water-soluble
            fluoride salt. The water-soluble salts are then mixed to
            form an aqueous mixed solution having a pH of from about 4.5
            to about 7.0. Cations released by the divalent metal salt
            stabilize the aqueous solution such that phosphate and
            calcium ions released by the salts do not react to any large
            extent until the product is introduced into the oral cavity
            and, upon introduction into the oral cavity, the ions do not
            rapidly precipitate. This gives the cations and anions
            sufficient time to diffuse through the tooth surface to the
            lesion(s) and/or tubules where the ions form a precipitate,
            thereby remineralizing the lesion(s) and/or mineralizing the
            tubule(s).<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Two-part oral products and methods of using same to
              remineralize teeth</b><br>
            <b> </b><b>US5858333</b><br>
            <b> </b><br>
            A two-part oral product capable of remineralizing subsurface
            lesions and/or mineralizing exposed dentinal tubules in
            teeth is composed of cationic and anionic discrete parts.
            The cationic discrete part contains at least one
            water-soluble calcium salt and, preferably, at least one
            non-toxic, water-soluble salt of a divalent metal other than
            calcium, and a first pharmaceutically acceptable carrier.
            The anionic discrete part contains at least one
            water-soluble phosphate salt and, preferably, at least one
            water-soluble fluoride salt, and a second pharmaceutically
            carrier. Preferably, one of the carriers is an aqueous
            carrier and the other of the carriers is a non-aqueous
            carrier. The cationic and anionic parts are simultaneously
            released from the product upon mixing of the product with
            water and/or saliva to form the mixed aqueous solution. In
            this way, calcium ions released by the calcium salt and
            phosphate ions released by the phosphate salt are
            simultaneously delivered to the tooth surfaces by the
            solution. To effect subsurface remineralization and/or
            mineralization, the parts are mixed together to form the
            mixed aqueous solution, and the solution is then promptly
            applied to the teeth for a period of time sufficient to
            allow calcium ions and phosphate ions to diffuse through the
            tooth surface to the subsurface, where the ions react to
            form an insoluble precipitate onto the lesion and/or tubule,
            thereby remineralizing such lesion and/or mineralizing such
            tubule.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>SOLID PRODUCTS AND METHODS FOR THE REMINERALIZATION OF
              TEETH</b><br>
            <b> </b><b>WO9934772</b><br>
            <b> </b><br>
            Solid products for remineralizing subsurface lesions and/or
            mineralizing exposed tubules in dentin containing an anionic
            component composed of at least one phosphate salt and a
            cationic component composed of at least one calcium salt.
            The cationic components and the anionic components are mixed
            in a carrier component and then coated on an insoluble,
            solid substrate. Subsurface lesions and/or exposed dentin
            tubules in a tooth are remineralized by the rapid and
            simultaneous release of the calcium and phosphate salts into
            water and/or saliva such that the subsurface lesions and
            dentin tubules are permeated by the calcium and phosphate
            ions. The calcium and phosphate ions precipitate as
            water-insoluble calcium phosphate in the subsurface lesions
            or dentin tubules. The products may be in the form of dental
            floss, tooth picks, dental adhesives, and implants.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>IMPROVED PRODUCTS AND METHODS FOR THE REMINERALIZATION OF
              TEETH</b><br>
            <b> </b><b>KR20000036009</b><br>
            <b> </b><br>
            PURPOSE: Improved products and methods for remineralizing
            subsurface lesions in teeth and for mineralizing exposed
            tubules in dentin are provided to prevent demineralization
            thereof. CONSTITUTION: A liquid product for remineralizing
            subsurface lesions and/or for mineralizing exposed dentin
            tubules in teeth, comprises: (a) a cationic component
            comprising at least one partially water-soluble calcium
            salt; (b) an anionic component comprising at least one
            water-soluble phosphate salt and at least one water-soluble
            fluoride salt; and (c) a separating means disposed to
            separate the components (a) and (b), wherein the components
            (a) and (b) have a pH in water such that a mixed aqueous
            composition formed by mixing the components (a) and (b) with
            water and/or saliva has a pH of from about 4.0 to about
            10.0; further wherein the product contains an amount of the
            calcium salt such that in the mixed aqueous composition a
            first portion of the calcium salt exists as dissolved
            calcium cations and a second portion of the calcium salt
            exists as undissolved calcium salt, the aqueous composition
            further comprising dissolved phosphate anions released by
            the phosphate salt and dissolved fluoride anions released by
            the fluoride salt.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Processes for the remineralization and mineralization of
              teeth</b><br>
            <b> </b><b>US6036944</b><br>
            <br>
            A method for remineralizing one or more subsurface lesions
            in a tooth and/or mineralizing one or more exposed dentinal
            tubules in the tooth involves dispensing effective amounts
            of at least one water-soluble calcium salt, at least one
            water-soluble non-toxic divalent metal compound wherein the
            divalent metal is other than calcium, at least one
            water-soluble phosphate salt and, optionally, a
            water-soluble fluoride salt; mixing the salts and compound
            to form a non-carbonated mixture having a pH in water such
            that a non-carbonated aqueous solution containing the
            mixture has a pH of from 4.5 to about 7.0; and then applying
            the non-carbonated mixture as the non-carbonated aqueous
            solution to a surface of the tooth for a sufficient period
            of time to allow sufficient amounts of calcium, phosphate
            and, if present, fluoride, ions in the solution to diffuse
            into the subsurface of the tooth where the diffused ions
            then react to form an insoluble precipitate onto the lesions
            and/or exposed tubules, thereby remineralizing the lesions
            and/or mineralizing the tubules.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Products and methods for the remineralization and
              prevention of demineralization of teeth</b><br>
            <b> </b><b>US6485708</b><br>
            <b> </b><br>
            Improved one-part and two-part liquid products such as,
            e.g., mouthwashes, mouthrinses, toothpastes, gels and the
            like, for remineralizing subsurface lesions and/or
            mineralizing exposed dentin tubules in teeth contain a
            cationic component, an anionic component and a separating
            means for separating the cationic and anionic components.
            The anionic component contains water-soluble phosphate and
            fluoride salts, while the cationic component contains at
            least one partially water-soluble calcium salt and
            preferably at least one water-soluble salt of a divalent
            metal other than calcium. The tooth is treated with a mixed
            aqueous composition formed by mixing the cationic and
            anionic components with water and/or saliva. The mixed
            aqueous composition has a pH of from about 4.0 to about 10.0
            and, in addition to dissolved calcium cations and dissolved
            phosphate and fluoride anions, contains a quantity of
            undissolved calcium salt. The use of the partially
            water-soluble calcium salt delays precipitation of the
            cations and anions in the aqueous composition until after
            the ions have diffused through the tooth surface to the
            subsurface and/or dentin so as to effect remineralization
            and/or mineralization, respectively.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Remineralization of teeth</b><br>
            <b> </b><b>US6214321</b><br>
            <b> </b><br>
            An oral product and method is provided for remineralizing
            teeth. The product includes a first composition containing a
            water soluble calcium phosphate salt or monolithic
            combination of calcium and phosphate salts in a carrier with
            the first composition having a pH less than 7, and a second
            composition containing an alkaline material and a fluoride
            ion source in a carrier to achieve a pH greater than 7.5.
            The first and second compositions are separated from one
            another prior to use. When combined upon application to
            teeth, the first and second compositions generate
            hydroxyapatite depositing same on dental enamel.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dentifrice for the mineralization and remineralization of
              teeth</b><br>
            <b> </b><b>US6372198</b><br>
            <b> </b><br>
            Dentifrice compositions for mineralizing and remineralizing
            a surface or subsurface of at least one tooth, are
            described. The compositions primarily include at least one
            water soluble calcium salt, at least one water soluble
            phosphate salt, and at least one antioxidant, such as<b>
              coenzyme Q10</b>. Additionally, at least one water soluble
            non-toxic divalent metal compound, wherein the metal is
            other than calcium, such as magnesium, may also be added.
            Furthermore, at least one selenium-containing material, as
            well as at least one bromine-containing material, may also
            be added to the composition. The respective materials are
            then mixed and formed into a paste and applied to the tooth
            surface for a sufficient period of time to allow sufficient
            amounts of calcium and phosphate ions in the mixture to
            diffuse through the tooth surface, where the diffused ions
            react together to form an insoluble precipitate on the
            surface or subsurface of the tooth. The <b>co-enzyme Q10,
              selenium, and bromine </b>are believed to contribute to
            the overall health of the oval cavity, especially gum
            tissues.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Products and methods for the remineralization and
              prevention of demineralization of teeth</b><br>
            <b> </b><b>US2001051136</b><br>
            <b> </b><br>
            Improved solid products for remineralizing subsurface
            lesions and/or mineralizing exposed tubules in dentin
            contain an anionic component, a cationic component and a
            separating component for separating the anionic and cationic
            components in the product. The anionic component contains at
            least one water-soluble phosphate salt and the cationic
            component contains at least one partially water-soluble
            calcium salt. To remineralize subsurface lesions and/or
            mineralize exposed dentin tubules in a tooth, the anionic
            and cationic components are mixed with water and/or saliva
            to form a mixed aqueous composition having a pH of from
            greater than about 4.0 to about 10.0, which is then applied
            to the tooth.; Because of the partial water-solubility of
            the calcium salt, the calcium cations and the phosphate
            anions in the mixed aqueous composition remain soluble for a
            period of time sufficient to allow the cations and anions to
            diffuse through the surface of the tooth to the subsurface
            and/or dentin, where the diffused cations and anions react
            to form an insoluble precipitate on the lesion for
            remineralization thereof and/or on the exposed tubule for
            mineralization thereof. The products may be in the form of
            chewing gums, lozenges, candies, edible food products, and
            the like.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Composition for remineralization of a tooth</b><br>
            <b> </b><b>US2002044912</b><br>
            <b> </b><br>
            A composition for remineralization of a tooth, adapting to a
            tooth surface demineralized due to dental caries and forming
            a compound within the tooth to gradually release a phosphate
            ion and a calcium ion therein, is comprised of a solution A
            to be first applied to a tooth surface, containing 1 to 30%
            by weight of a calcium salt, with the remainder being a
            volatile solvent; and a solution B that is an aqueous
            solution containing 1 to 30% by weight of a phosphate and
            preferably a fluoride in an amount of 0.0001 to 5% by
            weight, where at least one of the solution A and the
            solution B preferably further contains a surfactant in an
            amount of 0.0005 to 1 % by weight.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left">&nbsp;<br>
            <b>ANTI-CARIOUS CANDIES AND CONFECTIONS</b><br>
            <b> </b><b>WO02058582</b><br>
            <b> </b><br>
            <b> </b>Composition and kit used for growing apatite on
            dental material, e.g. remineralization of carious defects,
            uses gelatin gel containing phosphate ions, gel free from
            phosphate ions and medium containing calcium ions<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dental Composition </b><br>
            <b> </b><b>DE10223157 </b><br>
            <b> </b><br>
            comprising (a) a first gel comprising gelatin and phosphate
            ions, (b) a second gel free from phosphate ions and (c) a
            medium containing calcium ions is claimed. Independent
            claims are also included for the following: (1) Kit
            comprising components (a), (b) and (c); (2) Use of (i) gel
            (a), (ii) gel (b) as coating on (a) and (iii) medium (c) for
            growing apatite on dental material.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>THERAPEUTIC AND PROPHYLACTIC TOPICAL-DESTINATION FACILITY
              IN THE FORM OF SELF-STICKING FILM FOR REMINERALIZATION OF
              SOLID DENTAL TISSUES</b><br>
            <b> </b><b>RU2238078 </b><br>
            <br>
            FIELD: stomatology. ^ SUBSTANCE: invention relates to
            facility appropriate to prevent and to treat caries and
            hyperesthesia as well as remineralization of solid dental
            tissues. Facility is made in the form of biocompatible
            polymer film composed of hydrophilic and hydrophobic layers,
            the former including fluoride ions, calcium compounds, and
            phosphorus-containing compounds as well as antimicrobial and
            auxiliary substances. ^ EFFECT: achieved strictly controlled
            and simultaneous supply of calcium, phosphate, and fluoride
            ions. ^ 14 cl,<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>COMPOSITION FOR CARIES PREVENTION</b><br>
            <b> </b><b>CA2485836 </b><br>
            <b> </b><br>
            To obtain a composition for caries prevention, which has
            effects for efficiently suppressing demineralization and
            promoting remineralization and stability in keeping for a
            long time, <b>0.01 to 10% by weight of sodium
              carboxymethylcellulose having the etherification degree of
              0.7 to 1.0 is used in a composition blended with a casein
              phosphopeptide - amorphous calcium phosphate complex (CPP
              - ACP</b>) and / or a casein phosphopeptide - amorphous
            calcium fluoride phosphate complex (CPP - ACFP), a sodium
            carboxymethylcellulose, a viscosity regulator and water.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dental releasing materials</b><br>
            <b> </b><b>US2007123604</b><br>
            <b> </b><br>
            The present invention relates to methods and compositions of
            dental materials containing nano-sized calcium phosphate and
            other fillers that release calcium, phosphate and fluoride.
            This invention further relates to dental compositions for
            restorations, stress-bearing applications, artificial
            crowns, anterior and posterior tooth fillings, adhesives,
            cavity liners, cements, bases, orthodontic devices,
            prostheses, and sealants utilizing high stress-bearing
            materials that release materials for the remineralization of
            decayed tooth structures.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Composite material, useful e.g. as neo- and /or
              remineralization component in the production of cleaning
              composition and care of the teeth, comprises highly
              water-soluble calcium salts and ampholytic polymer
              component</b><br>
            <b> </b><b>DE102005052370</b><br>
            <b> </b><br>
            Composite material comprises high water-soluble calcium
            salts, where the calcium salts in the form of single
            crystallite or particle and majority of the calcium salts
            are crystallite form with an average particle diameter of
            less than 1000 nm, preferably 300 nm; and ampholytic polymer
            component, which exhibits an isoelectric point of 5-7.4.
            Independent claims are included for: (1) a procedure for the
            preparation of the composite material comprising
            precipitating aqueous solution of water-soluble calcium salt
            and aqueous solution of water-soluble phosphate- and/or
            fluoride salt in the presence of polymer component; (2) a
            mouth-, dental care and -cleaning agent with a content of
            composite material; (3) a sweet comprising a content of
            composite material; and (4) a composite for the induction or
            promotion of new formation of bone fabric with the composite
            material. - ACTIVITY : Osteopathic. <br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dental whitening compositions</b><br>
            <b> </b><b>US2006115437</b><br>
            <b> </b><br>
            A whitening system has a de-sensitizing effect as well as
            re-mineralizing capability. The system may be a
            one-component or a two-component composition. The system may
            also be an unfoamed, a foamed or a foamable composition. For
            a one-component system, a sparingly soluble calcium
            phosphate salt may be in dry particle form with at least one
            gelling agent, wherein the salt is capable of sustained
            release of both calcium and phosphate ions into saliva upon
            exposure of the particle thereto and providing a
            hydroxyapatite remineralization. In a two component system,
            a first component has at least one peroxide compound, at
            least one source of phosphate and at least one gelling
            agent; and a second component has at least one source of
            calcium, strontium and/or mixtures thereof. The second
            component may also contain at least one gelling agent, and
            the composition maybe present as a foam or is foamable. The
            composition may be packed in a two-compartment syringe, or
            be present in a carrier or coated onto a substrate.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Process for treating teeth</b><br>
            <b> </b><b>US2006216247</b><br>
            <b> </b><br>
            An acidic solution is applied to the tooth surface in the
            oral cavity and has the ingredients thymol, eucalyptol and
            menthol. It kills bacteria in the mouth and makes the
            environment acidic. The acidity in the oral cavity causes
            demineralization to occur, releasing calcium and phosphate
            through open pores in the tooth surface. The acidic solution
            is removed from the oral cavity after a predetermined amount
            of time. The non-acidic mouthwash is applied to the tooth
            surface subsequent to the removal of the acidic solution. It
            has sodium fluoride and works to neutralize acidic
            conditions in the oral cavity allowing remineralization to
            occur. Calcium and phosphate ions fill the open pores in the
            tooth surface, hardening the enamel. After a predetermined
            amount of time the user removes the non-acidic solution<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>CALCIUM PHOSPHATE SALTS IN ORAL COMPOSITIONS SUITABLE AS
              A TOOTH REMINERALIZING AGENT</b><br>
            <b> </b><b>WO2007092763 </b><br>
            <b> </b><br>
            The present invention is generally directed to an oral
            composition comprising a calcium phosphate salt and a
            combination of acids having differing solubilities in the
            oral cavity, for tooth mineralization or remineralization.
            The presence of a combination of acids in the oral
            composition acts to maximize the release of calcium and
            phosphate ions from the oral composition over an extended
            period of time, in order to promote the precipitation of
            enamel-like crystals on the surfaces of the teeth, or in
            subsurface regions therein<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Methods for treating dental conditions using tissue
              scaffolds</b><br>
            <b> </b><b>US2007248933</b><br>
            <b> </b><br>
            The invention provides methods, apparatus and kits for
            regenerating dental tissue in vivo that are useful for
            treating a variety of dental conditions, exemplified by
            treatment of caries. The invention uses tissue scaffold
            wafers, preferably made of PGA, PLLA, PDLLA or PLGA
            dimensioned to fit into a hole of corresponding sized
            drilled into the tooth of subject to expose dental pulp in
            vivo. In certain embodiments the tissue scaffold wafer
            further comprises calcium phosphate and fluoride. The tissue
            scaffold wafer may be secured into the hole with a hydrogel,
            a cement or other suitable material. Either the wafer or the
            hydrogel or both contain a morphogenic agent, such as a
            member encoded by the <b>TGF-beta supergene family</b>,
            that promotes regeneration and differentiation of healthy
            dental tissue in vivo, which in turn leads to
            remineralization of dentin and enamel. The tissue scaffold
            may further include an antibiotic or anti-inflammatory
            agent.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Calcium phosphate complex and salts in oral delivery
              systems</b><br>
            <b> </b><b>CN101415398</b><br>
            <b> </b><br>
            The present invention relates to oral delivery systems, such
            as confectioner y and chewing gum compositions, and methods
            for remineralizing tooth enamel in mammals. In particular,
            the oral delivery systems include a <b>phosphopeptide o r
              phosphoprotein stabilized calcium phosphate</b> or calcium
            fluoride phosphate complex and a salt selected from calcium
            salts, phosphate salts and combinations thereof. The
            delivery systems promote remineralization of tooth enamel of
            consumers.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dental Whitening Compositions</b><br>
            <b> </b><b>US2008050408</b><br>
            <b> </b><br>
            Dental whitening system has a de-sensitizing effect as well
            as re-mineralizing capability. The system may be a
            one-component or a two-component composition. The system may
            also be an unfoamed, a foamed or a foamable composition. For
            a one-component system, a sparingly soluble calcium
            phosphate salt may be in dry particle form with at least one
            gelling agent, wherein the salt is capable of sustained
            release of both calcium and phosphate ions into saliva upon
            exposure of the particle thereto and providing a
            hydroxyapatite remineralization. In a two component system,
            a first component has at least one peroxide compound, at
            least one source of phosphate and at least one gelling
            agent; and a second component has at least one source of
            calcium, <b>strontium</b> and/or mixtures thereof. The
            second component may also contain at least one gelling
            agent, and the composition maybe present as a foam or is
            foamable. The composition may be packed in a two-compartment
            syringe, or be present in a carrier or coated onto a
            substrate.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>ORAL COMPOSITION FOR STABILIZATION, (RE)CALCIFICATION AND
              (RE)MINERALIZATION OF TOOTH ENAMEL AND DENTINE</b><br>
            <b> </b><b>US2008152598</b><br>
            <b> </b><br>
            An oral composition for the stabilization, recalcification
            and remineralization of dental enamel, providing efficient
            protection from tooth decay. The oral composition uses the
            calcium form of zeolite, phosphate salts soluble in water,
            and matrix proteins of teeth. The efficiency of this
            solution is based on the adjustment of pH in the mouth
            cavity to the required value while at the same time
            incorporating the calcium ions from the<b> calcium form of
              zeolite</b> into the dental enamel and dentin in the
            presence of matrix proteins of the teeth. Calcium and
            phosphate ions stabilizes the crystal structure of calcium
            hydroxyapatite in tooth enamel and dentin.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Recalcification Promoter And Composition For Oral Cavity</b><br>
            <b> </b><b>US2010129298</b><br>
            <b> </b><br>
            It is intended to provide a remineralization promoter for
            tooth enamel and a composition for an oral cavity, which can
            highly effectively promote the remineralization of tooth
            enamel and strongly inhibit dental caries. The
            remineralization promoter for tooth enamel and the
            composition for an oral cavity are characterized by
            containing amorphous hydroxyapatite and/or amorphized
            hydroxyapatite showing two peaks at 2[theta]=31 to 35 DEG in
            X-ray diffraction. The amorphized hydroxyapatite is obtained
            by reacting calcium salt with phosphate in an aqueous
            solution and drying the reaction solution at a temperature
            of 10 to 70 DEG C.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>TOOTH FLUORIDATING AND REMINERALIZING COMPOSITIONS AND
              METHODS, BASED ON NANOAGGREGATE FORMATION&nbsp;&nbsp;
              &nbsp;</b><br>
            <b> </b><b>WO2008147997</b><br>
            <b> </b><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>CALCIUM PHOSPHATE COMPLEX AND SALTS IN ORAL DELIVERY
              SYSTEMS.</b><br>
            <b> </b><b>MX2008012524</b><br>
            <b> </b><br>
            The present invention relates to oral delivery systems, such
            as confectionery and chewing gum compositions, and methods
            for remineralizing tooth enamel in mammals. In particular,
            the oral delivery systems include a phosphopeptide or
            phosphoprotein stabilized calcium phosphate or calcium
            fluoride phosphate complex and a salt selected from calcium
            salts, phosphate salts and combinations thereof. The
            delivery systems promote remineralization of tooth enamel of
            consumers.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Preparation method of inorganic calcium phosphate
              salt/biodegradable polymer fiber film composite material</b><br>
            <b> </b><b>CN101507841</b><br>
            <b> </b><br>
            The invention discloses a method for preparing composite
            material from inorganic calcium phosphate salt/biodegradable
            polymer fiber membrane. The method comprises the steps of
            superposing more than two inorganic calcium phosphate
            salt/biodegradable polymer fiber membranes to form a
            multilayer composite fiber membrane and hot press molding on
            the multilayer composite fiber membrane, wherein the
            orientation degree of fibers in the inorganic calcium
            phosphate salt/biodegradable polymer fiber membranes is more
            than 80 percent, and the included angle of the fiber
            orientation of adjacent layers of the multilayer composite
            fiber membrane is between 0 and 90 degrees. The method has
            the advantages of high adaptability, simple process, low
            cost and good repeatability.; The prepared composite
            material has biological activity and remineralization
            performance, high mechanical properties and direction
            controlability.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>FUNCTIONALIZED CALCIUM PHOSPHATE HYBRID SYSTEMS FOR THE
              REMINERALIZATION OF TEETH AND A METHOD FOR PRODUCING THE
              SAME</b><br>
            <b> </b><b>US2010291164</b><br>
            <b> </b><br>
            A dental remineralizing system, including a functionalized
            calcium-containing complex having an organic surfactant
            component mechanochemically attached to a distressed calcium
            phosphate component and blended with the comestible
            material.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>ORAL CARE PRODUCTS COMPRISING BUFFER SYSTEMS FOR IMPROVED
              MINERALIZATION/REMINERALIZATION BENEFITS.</b><br>
            <b> </b><b>MX2009008303</b><br>
            <b> </b><br>
            Oral products for the improved
            mineralization/remineralization of teeth are provided. In an
            embodiment, the present disclosure provides an oral product
            comprising a <b>calcium salt, a phosphate salt, a sodium
              salt and a potassium salt. For example, the molar ratio of
              the sodium salt to the potassium salt ranges from about 3
              to about 4</b>.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>ANTICARIOUS CHEWING GUM, CANDY, GEL, TOOTHPASTE, AND
              DENTIFRICE</b><br>
            <b> </b><b>JP2010047575</b><br>
            <b> </b><br>
            PROBLEM TO BE SOLVED: To provide an anticarious delivery
            vehicle releasing calcium phosphate ions which diffuse into
            partially demineralized tooth enamel or dentin, leading to
            remineralization and repair of caries lesions, dental
            plaque, open dentinal tubules and exposed dentin without the
            use of fluoride. ; SOLUTION: The chewing gums, candies,
            confectioneries, toothpastes, dentifrices and gel include
            non-toxic sparingly soluble calcium compounds and phosphate
            compounds as additives and release calcium ions and
            phosphate ions into the oral cavity gradually and
            persistently for a period not less than 5 minutes. ; C<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>DENTAL PROPHYLACTIC PASTE</b><br>
            <b> </b><b>WO2011031606 </b><br>
            <b> </b><br>
            A dental prophylactic paste having excellent flowability
            during the manufacturing process, minimal to no splattering
            during use, and remineralization characteristics is
            provided. The prophylactic paste includes at least one water
            soluble calcium salt; a water soluble phosphate salt, a <b>water





              soluble silicate</b>; and a moisture retention agent. The
            paste has a splatter rating of less than 3. The splatter
            rating of the paste refers to the tendency of the paste to
            splatter during a dental cleaning procedure. The lower the
            splatter rating, the less the paste has a tendency to
            splatter. A paste having a splatter rating of less than 3 is
            considered to have good handability.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH
              HEALTH AND APPEARANCE.</b><br>
            <b> </b><b>MX2010014220 </b><br>
            <b> </b><br>
            Disclosed are oral care compositions comprising selected
            surface-active<b> organophosphate</b> compounds and methods
            of use to provide protection of teeth from erosion caused by
            the action of chemicals, such as harsh abrasives and acids.
            The surface-active organophosphate compounds are substantive
            to teeth, the phosphate groups binding the calcium in teeth
            and thus preventing loss of calcium from dissolution when
            contacted with acids. The organophosphate compound may also
            deposit a protective surface coating that prevents contact
            of teeth with erosive challenges. Selected organophosphate
            compounds contain one or more phosphate groups and are
            combined in the oral care composition with one or more of a
            fluoride ion agent, an antimicrobial agent preferably
            selected from quaternary ammonium compounds and polyvalent
            metal salts, an anticalculus agent and additional
            surfactant, to provide benefits including superior
            anti-erosion, anticaries, antiplaque and anti-staining as
            demonstrated by enhanced fluoride uptake, remineralization,
            resistance to acid demineralization and antimicrobial
            activities, resulting in improved overall tooth health,
            structural integrity and appearance.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>CALCIUM PEROXYPHOSPHATES AND USE THEREOF IN DENTAL
              COMPOSITIONS</b><br>
            <b> </b><b>US2011142768 &nbsp;</b><br>
            <b> </b><br>
            Calcium peroxyphosphate compounds and dental compositions
            comprising these compounds that combine both whitening/stain
            removal of teeth with remineralization are disclosed. The
            calcium peroxyphosphate compounds are capable of releasing,
            in an aqueous environment, whitening and remineralization
            effective amounts of calcium ion, phosphate ion, and active
            oxygen. Preferred compounds are <b>calcium
              peroxymonophosphate or calcium diperoxymonophosphate</b>
            compounds. These compounds may be used in humans and other
            animals, including other mammals.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Method for in-vitro induction of remineralization of
              dentin</b><br>
            <b> </b><b>CN102172334 &nbsp;</b><br>
            <b> </b><br>
            The invention discloses a method for induction of
            remineralization of tissue of tooth, which comprises the
            following steps: preparing a dental film; preparing a dentin
            remineralization inducing mineralization system solution;
            and remineralizing the dentin. In the invention, the micro
            environment of the calcification of the tissue of the tooth
            in a gel matrix is stimulated, a calcium phosphate ion
            dispersing hydrogel system is constructed, and the
            biomimetic mineralization of the dentin is induced in vitro.
            The surface deposits are qualitatively characterized by
            constructing an agar gel mineralization system on the
            surface of the acid-corroded dentin in vitro and by suing a
            scanning electron microscope (SEM) and a micro-Fourier
            transform infrared spectrometer (FTIR). Results show an agar
            gel CaCl2 solution mineralization system containing
            phosphate can induce the deposition and growth of strip nano
            crystals on the surface of acid-corroded dentin surface, and
            that the deposited apatite crystals are densely arranged in
            an interlaced shape. The method is simple, convenient, quick
            and low in cost, and is an effective technical method for
            the biomimetic mineralization of the dentin.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Calcium phosphate complex and salts in oral delivery
              systems</b><br>
            <b> </b><b>AU2011202746</b><br>
            <b> </b><br>
            <b> </b>The present invention relates to oral delivery
            systems, such as confectionery and chewing gum compositions,
            and methods for remineralizing tooth enamel in mammals. In
            particular, the oral 5 delivery systems include a
            phosphopeptide or phosphoprotein stabilized calcium
            phosphate or calcium fluoride phosphate complex and a salt
            selected from calcium salts, phosphate salts and
            combinations thereof. The delivery systems promote
            remineralization of tooth enamel of consumers. <br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>SOLID-STATE METHOD FOR PRODUCING FUNCTIONALIZED
              CALCIUM PHOSPHATE HYBRID ORGANIC/INORGANIC CHEMICAL
              SYSTEMS FOR DENTAL REMINERALIZATION APPLICATIONS</b><br>
            <b> </b><b>US2012114718 </b><br>
            <br>
            A method of repairing weakened teeth, including combining a
            first predetermined amount of an inorganic calcium source
            with a second predetermined amount of an organic material to
            define a mixture, placing the mixture in a milling vessel
            operationally connected to a planetary mill, introducing
            milling media into the milling vessel, milling the mixture
            to impart sufficient kinetic energy to break down the
            organic and inorganic materials into substantially smaller
            intermediate particles and fuse the intermediate particles
            together to yield functionalized molecules having both
            organic and inorganic chemical characteristics, combining a
            functionalized calcium phosphate/organic compound with a
            fluoridated formulation to define a hybrid system, and
            applying the hybrid system to the weakened teeth.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>NOVEL TYPE OF ANION-CONTAINING CALCIUM PHOSPHATE COMPOUND
              FOR DENTAL REMINERALIZATION</b><br>
            <b> </b><b>US2012129135</b><br>
            <b> </b><br>
            The invention provides an anion-containing calcium phosphate
            compound, composition and dental patch comprising the same
            and their use in remineralizing teeth. The anion-containing
            calcium phosphate compound has the following formula: <b>(Ca+2)x(anion-a)y(PO4-3)z











              wherein 2x=(a*y+3z); a is an integer of 1 to 3; and each
              of x, y and z is not 0.</b><br>
            <b> </b><b> </b><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>MINERAL TRIOXIDE AGGREGATE (MTA) COMPOSITION AND USE</b><br>
            <b> </b><b>US2012156308 &nbsp;</b><br>
            <b> </b><br>
            The present application discloses a fast-setting mineral
            trioxide aggregate (MTA) with fluoride release for practical
            treatment of diseases in teeth and bone, e.g. for caries
            treatment and/or prevention. The cariostatic MTA contain
            calcia-silica-alumina cement with moderately increased
            tricalcium aluminate content allowing high calcium hydroxide
            release. The MTA composition support remineralization and
            biomineralization, and it is suitable for stimulation of
            hard tissue regeneration. MTA embodiments contain
            superplasticizerand nanosilicate for improved mechanical
            properties. The MTA compositions include optional
            radiocontrast and nano-enriched leachable fluorine, nitrate,
            strontium, and phosphate. The fast-setting MTA paste
            exhibits flow-to-clay-like consistency, which allows new
            practical applications including cavity lining, temporary
            restoration, bonding, and cementations in one MTA
            embodiment. The high calcium hydroxide and high fluoride
            release are suitable for caries prevention and treatment,
            and per se inhibition of dental symptoms.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>A novel type of dual anion-containing calcium phosphate
              compound for dental remineralization</b><br>
            <b> </b><b>TW201221145</b><br>
            <b> </b><br>
            The invention provides an anion-containing calcium phosphate
            compound, composition and dental patch comprising the same
            and their use in remineralizing teeth. The anion-containing
            calcium phosphate compound has the following formula:
            (Ca&lt;SP&gt;+2&lt;/SP&gt;)x (anion&lt;SP&gt;-a&lt;/SP&gt;)y
            (PO4&lt;SP&gt;-3&lt;/SP&gt;)z wherein 2x = (a*y + 3z); a is
            an integer of 1 to 3; and each of x, y and z is not 0.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>ANTIMICROBIAL COMPOSITIONS FOR TOOTH FLUORIDATION AND
              REMINERALIZATION</b><br>
            <b> </b><b>WO2012119155</b><br>
            <b> </b><br>
            Compositions and methods for delivering, in an oral
            environment, <b>chlorhexidine</b> in combination with
            beneficial ions selected from calcium, phosphate, fluoride,
            <b>silver</b>, and carbonate ions are described. These
            compositions and methods may involve the formation of
            chlorhexidine compounds either prior to use or in situ.
            Representative compounds include chlorhexidine fluoride
            (ChxF), chlorhexidine phosphate (ChxP), chlorhexidine
            calcium fluoride (ChxCF), chlorhexidine phosphate fluoride
            (ChxPF), chlorhexidine calcium phosphate (ChxCP),
            chlorhexidine calcium phosphate fluoride (ChxCPF),
            chlorhexidine silver calcium phosphate fluoride (ChxACPF) or
            the compositions or methods which will form these noble
            chlorhexidine compounds when applied to the tooth. Two or
            more of these chlorhexidine compounds may be formed as an
            aggregate, or one or more of these chlorhexidine compounds
            may be formed as an aggregate with calcium fluoride (CaF2).<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Mouth-and dental-care prepns - contg hydroxyl-apatite
              and/or disinfectants</b><br>
            <b> </b><b>DE2134862</b><br>
            <b> </b><br>
            Mouth- and tooth-care preparations (e.g. toothpastes, tooth
            powders, chewing tablets, pastilles, chewing gums, gum
            ointments, mouthwashes, gargles) contg. finely divided
            hydroxylapatite and/or an orally tolerable mucous membrane
            promoting disinfectant, and pref. also contg. an osmotically
            acting inorganic salt combination and a local anaesthetic. -
            The hydroxylapatite has a favourable and lasting effect on
            dental hypersensitivity and hyperaesthesia, due to
            remineralization of the dentine with effective blocking of
            dentine capillaries, inhibiting transmission of the pain
            reflex to the pulpa. The disinfectant-contg. compositions
            have a favourable effect on mouth odour due to elimination
            of putrefactive bacteria from the mucosa. <br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>STABLE COMPOSITION FOR TOOTH REMINERALIZATION</b><br>
            <b> </b><b>JP55053212</b><br>
            <b> </b><br>
            An aqueous solution useful for remineralizing subsurface
            carious lesions of dental enamel which solution contains
            sources of calcium ions and phosphate ions as well as
            fluoride ions and further includes as an agent to stabilize
            the solution against precipitation, an antinucleating agent
            such as ethylenediamine tetramethylenephosphonic acid or
            water soluble salt thereof, the pH of the solution being
            about 5-9, preferably close to physiological conditions,
            such as about 6.8-7.5.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Dentifrice compositions</b><br>
            <b> </b><b>US4327079</b><br>
            <b> </b><br>
            A dentifrice composition containing synthetic hydroxyapatite
            powder which is neutral or weakly alkaline or contains <b>0.1





              to 20% by weight of NaCl and/or KCl and 0.003 to 3% by
              weight of MgCl2</b>. The dentifrice composition is very
            effective in fortifying a surface of a tooth, promoting
            remineralization of the surface of the tooth and eliminating
            plaque from the tooth.<br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>REMINERALIZATION OF TOOTH</b><br>
            <b> </b><b>JP3048613</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">PURPOSE: To
            enable the teeth to be remineralized by applying a
            nonastringent composition for oral cavity in the form of
            dentifrice or mouthwash containing each specified amount of
            xylitol and fluoride ion feed compound(s) to a demineralized
            portion of tooth structure. CONSTITUTION: Remineralization
            of a demineralized portion of tooth structure is
            accomplished by applying, to the above portion, a
            nonastringent composition for oral cavity in the form of
            dentifrice or mouthwash containing 10-20wt.% of xylitol and
            such an amount of at least one fluoride ion feed compound as
            to be enough to feed a total of 150-1,800ppm of fluoride ion
            so that sodium fluoride feeds a majority of such fluoride
            ion.</p>
          <div align="left"><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><b>&nbsp; </b><br>
            <b> </b><b>COMPOSITION FOR REMINERALIZATION OF
              DEMINERALIZED TOOTH PART</b><br>
            <b> </b><b>RU2092153</b><br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>DENTAL FORMULATION</b><br>
            <b> </b><b>WO9319728</b><br>
            <b> </b><br>
            This invention concerns inhibiting tooth enamel
            demineralization by using a <b>water soluble phosphate,
              particularly a pyrophosphate or tripolyphosphate</b>, to
            inhibit demineralization while not negatively impacting
            remineralization.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>TOOTH-PASTE</b><br>
            <b> </b><b>SK280006</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">Proposed is a
            toothpaste with the usual components and containing as the
            polishing agent a combination of silicilic acids and
            dicalcium phosphate dihydrate (brushite), this toothpaste
            having a particularly effective restoring action on the
            tooth surface. This action is due to controlled
            remineralization in, in particular, enamel scratches and
            Tomes' pits. This action can be reinforced by the addition
            of magnesium ions and/or fluorophosphate ions.</p>
          <div align="left"><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>TOOTH PASTE COMPOSITION</b><br>
            <b> </b><b>JP9124451</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">PROBLEM TO BE
            SOLVED: To obtain the subject composition capable of
            adsorbing off halitosis- causing substances to prevent the
            halitosis, and excellent in the dental caries- preventing
            effect due to the remineralization of tooth surfaces by
            simultaneously using a zeolite and synthetic hydroxyapatite.
            SOLUTION: This tooth paste composition contains (A) a
            zeolite (e.g. a natural<b> zeolite such as gismondine,
              garronite, analcime or wirakite or a synthetic zeolite
              such as stilbite or Ca-mordenite) and (B) hydroxyapatite</b>.
            The component A is preferably a zeolite of the formula:
            (MI,MII1/2 )m (Alm Sin O2(m+n) ).-xH2 O, (n&gt;=m) (MI, MII
            are those each subjected to an ion exchange treatment using
            a monovalent and/or divalent cation excluding Li&lt;+&gt;
            and K&lt;+&gt; , especially preferably Ca&lt;2+&gt; ). The
            component A is preferably compounded in an amount of
            1.0-50.0%,<b> preferably 5-30%, </b>based on the whole
            amount of the composition.</p>
          <div align="left"><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><b>&nbsp; </b><br>
            <b> </b><b>IMPROVED PRODUCTS AND METHODS FOR THE
              REMINERALIZATION AND PREVENTION OF DEMINERALIZATION OF
              TEETH</b><br>
            <b> </b><b>WO9813012</b><br>
            <br>
            Improved one-part and two-part liquid products such as,
            e.g., mouthwashes, mouthrinses, toothpastes, gels and the
            like, for remineralizing subsurface lesions and/or
            mineralizing exposed dentin tubules in teeth contain a
            cationic component, an anionic component and a separating
            means for separating the cationic and anionic components.
            The anionic component contains water-soluble phosphate and
            fluoride salts, while the cationic component contains at
            least one partially water-soluble calcium salt and
            preferably at least one water-soluble salt of a divalent
            metal other than calcium. The tooth is treated with a mixed
            aqueous composition formed by mixing the cationic and
            anionic components with water and/or saliva. The mixed
            aqueous composition has a pH of from about 4.0 to about 10.0
            and, in addition to dissolved calcium cations and dissolved
            phosphate and fluoride anions, contains a quantity of
            undissolved calcium salt. The use of the partially
            water-soluble calcium salt delays precipitation of the
            cations and anions in the aqueous composition until after
            the ions have diffused through the tooth surface to the
            subsurface and/or dentin so as to effect remineralization
            and/or mineralization, respectively. <br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><b>&nbsp;</b><br>
            <b> </b><b>REMINERALIZATION MATERIAL FOR ORGANOMINERAL
              TISSUES</b><br>
            <b> </b><b>BG103544</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">The material
            can be appled for primary filling in the treatment of caries
            in particular deep ones. It remineralizes the dentine with a
            composition very close to the original one having high
            microhardness. It can also be applied as an ingredient of a
            promedicament for teeth such as tooth pastes, elixirs,
            cotton threads and powders. The material includes a mixture
            of cation and anion exchange resins, charged with Ca2+, F-
            and PO43- ions, in appr. mole ratio of 2:1:1. Material where
            the resins also have a charge of <b>Zn2+ ions</b> is
            preferred in presence of quantities less than 1%, better
            closer to 0.2%, of the dry weight of the resin. Resins are
            suitable the base of which is of laterally cross linked
            polystyrene with 2 to 14% divinylbenzene. <br>
            <br>
          </p>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Bioactive glass compositions and methods of
              treatment using bioactive glass</b><br>
            <b> </b><b>US6244871</b><br>
            <b> </b><br>
            A novel silica based bioactive glass composition that can be
            used in conjunction with a delivery agent such as a
            toothpaste, gel, etc. having a particle size range &lt;90
            mum which will form a rapid and continuous reaction with
            body fluids due to the immediate and long term ionic release
            of Ca and P from the core silica particles, to produce a
            stable crystalline hydroxy carbonate apatite layer deposited
            onto and into the dentin tubules for the immediate and long
            term reduction of dentin hypersensitivity and tooth surface
            remineralization.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>CHEWING GUM WITH DENTAL HEALTH BENEFITS
              EMPLOYING CALCIUM LACTATE</b><br>
            <b> </b><b>WO0042861</b><br>
            <b> </b><br>
            A chewing gum and method for the remineralization of tooth
            enamel is provided. The chewing gum comprises an insoluble
            base portion, a water soluble portion, a flavor, and a
            therapeutically effective amount of <b> calcium lactate.</b><br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>CHEWING GUM WITH DENTAL BENEFITS INCLUDING
              CALCIUM IN A FOOD GRADE ACID</b><br>
            <b> </b><b>WO0062762</b><br>
          </div>
          <p class="printAbstract" align="left">Methods and chewing gums
            for the remineralization of tooth enamel are provided. To
            this end a sugar free chewing gum comprising an insoluble
            portion, a water soluble portion, a flavor, calcium
            carbonate, and a food grade acid is provided as well as
            methods of using same.<br>
            <br>
          </p>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Prophylactic mouthwash solution, especially for
              use together with an abrasive powder, comprises an
              antimicrobial or bacteriostatic and tooth-remineralizing
              agent</b><br>
            <b> </b><b>DE10026716</b><br>
            <b> </b><br>
            Prophylactic mouthwash solution comprises an agent (I) that
            has antimicrobial or bacteriostatic activity and contributes
            to the remineralization of teeth.<br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><b>&nbsp;</b><br>
            <b> </b><b>DENTIN DESENSITIZING TOOTH CARE AGENT PROVIDING
              INTENSIVE REMINERALIZATION AND ANTI-CARIES ACTION</b><br>
            <b> </b><b>RU2005106291</b><br>
            <b> </b><br>
            FIELD: stomatology. ^ SUBSTANCE: claimed composition
            contains salts releasing fluoride ions and potassium ions
            and pH 8-9.9, wherein pH level is buffered with phosphate
            salt. ^ EFFECT: tooth care agent of improved effect.<br>
            <b> </b><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>REMINERALIZATION PROMOTERS</b><br>
            <b> </b><b>WO2005003753</b><br>
            <b> </b><br>
            Substances or compositions having a function of keeping
            metal ions such as Ca ion in a soluble state and a function
            of promoting remineralization and repairing tooth decay at
            the early stage are utilized in foods, drinks, seasonings,
            taste improving agents, oral hygiene products, detergents,
            metal suppliers, metal absorption promoters, cosmetics,
            feeds and fertilizers. A remineralization promoter that is a
            composition containing at least one member selected from the
            group consisting of <b>starch phosphate, maltodextrin
              phosphate, reducing maltodextrin phosphate,
              oligosaccharide phosphate</b>, reducing oligosaccharide
            phosphate, organic acids and saccharides and having a
            function of exerting a calcipexis ratio of 5% or higher,
            preferably 10% or higher, in a specific remineralization
            test reaction; and foods, drinks, seasonings, taste
            improving agents, oral hygiene products, detergents, metal
            suppliers, metal absorption promoters, cosmetics, feeds or
            fertilizers characterized by containing the above-described
            remineralization promoter.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Oral and dental care product</b><br>
            <b> </b><b>US2007154411</b><br>
            <b> </b><br>
            <b> </b>The invention relates to oral and dental hygiene
            products comprising a) a composite material consisting of
            calcium salts which are slightly soluble in water, in the
            form of nanoparticulate primary particles having a length of
            from 5 to 150 nm and a cross section of from 2 to 50 nm and
            protein components selected from <b>proteins, protein
              hydrolysates and protein hydrolysate derivatives</b>, and
            b) 10 to 35% by weight of a cleaning agent mixture, the
            cleaning agent mixture comprising from 0.01 to 5% by weight
            of aluminum oxide polishing agent. The oral and dental
            hygiene products ensure a thorough cleaning of the teeth
            with simultaneous and long-lasting remineralization of the
            tooth surface.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Chewable mass for the remineralization of tooth
              enamel</b><br>
            <b> </b><b>US2007116799</b><br>
            <b> </b><br>
            A method of producing chewable mass for remineralization of
            tooth enamel, including the steps of preparing an aqueous
            solution of at least one acidifying agent suitable as a
            foodstuff, adding a reactive calcium source to the aqueous
            solution, adding the solution to a thickener, wherein
            phosphoric acid is added during at least one of the
            preceding steps, thoroughly mixing all of the components to
            form a mass, and forming and drying the mass. The chewable
            mass has a calcium content of between 30 and 190 mMol/kg of
            finished product. <br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Induced remineralisation of human tooth enamel</b><br>
            <b> </b><b>US2005220724</b><br>
            <b> </b><br>
            The present application relates to the induced
            remineralization of human tooth enamel and in particular to
            the building up of apatite on tooth material.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Formulation of dual eicosanoid system and
              cytokine system inhibitors for use in the prevention and
              treatment of oral diseases and conditions</b><br>
            <b> </b><b>US2006079467</b><br>
            <b> </b><br>
            The present invention provides a novel composition of matter
            comprised of a mixture of two specific classes of compounds-<b>Free-B-Ring











              flavonoids and flavans</b>-for use in the prevention and
            treatment of diseases and conditions associated with mouth,
            gums and teeth. This composition of matter simultaneously
            inhibits cyclooxygenase (COX) and lipoxygenase (LOX)
            enzymatic activity and reduces cytokine production at the
            mRNA level in normal, aged and damaged periodontal cells and
            tissues. This invention further provides a method for the
            prevention and treatment of diseases and conditions of the
            mouth, gums and teeth. The method for preventing and
            treating diseases and conditions of the mouth, teeth and
            gums is comprised of administering to a host in need thereof
            a therapeutically effective amount of a composition
            comprising a mixture of Free-B-Ring flavonoids and flavans
            synthesized and/or isolated from a single plant or multiple
            plants, preferably in the<b> Scutellaria, Oroxylum, Acacia
              or Uncaria genus</b> of plants and pharmaceutically and/or
            cosmetically acceptable carriers. Finally the present
            invention provides a method for the prevention and treatment
            of diseases and conditions of the mouth, teeth or gums,
            including but not limited to periodontal diseases, such as
            gingivitis, periodontitis, pulpitis, periodontal conditions
            caused by the physical implantation of oral dentures,
            trauma, injuries, bruxism, neoplastic and other degenerative
            processes; material alba, pellicles, dental plagues,
            calculus, and stains. Use of the composition described
            herein also affords the benefit of maintaining optimum
            saliva production and pH, minimizing bacterial growth,
            reducing the formation of pellicles and plague, inhibiting
            tooth decalcification and tooth caries (decay), promoting
            remineralization, which yields healthy gums, whitening
            teeth, maintaining healthy oral hygiene and reducing oral
            malodour (halitosis).<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Induced Remineralisation of Human Dental Enamel</b><br>
            <b> </b><b>US2007218017</b><br>
            <b> </b><br>
            The present application relates to the induced
            remineralization of human tooth enamel and in particular to
            the building up of apatite on tooth material.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Oral and dental hygiene product</b><br>
            <b> </b><b>US2006222602</b><br>
            <b> </b><br>
            An oral and dental hygiene product comprising a) a composite
            material containing poorly water-soluble calcium salts in
            the form of nanoparticulate primary particles which are
            between 5 and 150 nm long and have a cross-section of
            between 2 and 50 nm, and protein constituents selected from
            proteins, protein hydrolysates and protein hydrolysate
            derivatives, and b) between 0.1 and 9 wt. % of a cleaning
            agent, in relation to the total weight of the product. The
            inventive oral and dental hygiene product ensures an
            effective and long-lasting remineralization of the surface
            of the tooth, and a protective cleaning action of the
            cleaning or polishing agent.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>CALCIUM BINDING PEPTIDES</b><br>
            <b>WO2007038683</b><br>
            <b> </b><br>
            <b> </b>Disclosed herein are a class of compounds
            comprising peptides of the sequence (X-Y-Z)n, wherein X is
            an amino acid selected from<b> aspartic acid, glutamic acid,
              asparagine, alanine and glutamine</b>, and Y and Z are
            amino acids selected from<b> alanine, serine, threonine,
              phosphoserine, phosphothreonine</b>, and their
            derivatives. These compounds <b>have the property of
              binding tightly and specifically to calcified surfaces</b>,
            making them useful for a variety of applications including
            remineralization of tooth and bone surfaces, diagnosis of
            bone and tooth defects, treatment of bone and tooth defects,
            and analysis of the presence and location of calcified
            deposits both in vitro and in vivo and in industrial,
            synthetic, medical, dental, and research applications where
            identification, localization, or manipulation of
            calcification is desirable.<br>
            <b> </b><br>
            <b> </b></div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>MOUTH AND TEETH CLEANING AND/OR REMINERALIZATION METHOD</b><br>
            <b> </b><b>WO2007101511</b><br>
            <b> </b><br>
            The invention relates to a method for cleaning the mouth and
            teeth, remineralizing or neomineralizing the dental
            material, and/or reducing the sensitivity of teeth to pain.
            Said method is characterized in that the teeth are treated
            with an electric tooth brushing apparatus, preferably an
            untrasonic toothbrush, and an oral care product and/or a
            dentifrice comprising calcium salts that are difficult to
            dissolve in water and/or the composite materials thereof.
            Also disclosed is a kit that is used in the inventive
            method. <br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Products and methods for the remineralization
              and prevention of demineralization of teeth</b><br>
            <b> </b><b>US6451290 </b><br>
            <br>
            Improved solid products for remineralizing subsurface
            lesions and/or mineralizing exposed tubules in dentin
            contain an anionic component, a cationic component and a
            separating component for separating the anionic and cationic
            components in the product. The anionic component contains at
            least one water-soluble phosphate salt and the cationic
            component contains at least one partially water-soluble
            calcium salt. To remineralize subsurface lesions and/or
            mineralize exposed dentin tubules in a tooth, the anionic
            and cationic components are mixed with water and/or saliva
            to form a mixed aqueous composition having a pH of from
            greater than about 4.0 to about 10.0, which is then applied
            to the tooth.; Because of the partial water-solubility of
            the calcium salt, the calcium cations and the phosphate
            anions in the mixed aqueous composition remain soluble for a
            period of time sufficient to allow the cations and anions to
            diffuse through the surface of the tooth to the subsurface
            and/or dentin, where the diffused cations and anions react
            to form an insoluble precipitate on the lesion for
            remineralization thereof and/or on the exposed tubule for
            mineralization thereof. The products may be in the form of
            chewing gums, lozenges, candies, edible food products, and
            the like.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Composition for remineralization of a tooth</b><br>
            <b> </b><b>AU5435001</b><br>
            <br>
            A composition for remineralization of a tooth, adapting to a
            tooth surface demineralized due to dental caries and forming
            a compound within the tooth to gradually release a phosphate
            ion and a calcium ion therein, is comprised of a solution A
            to be first applied to a tooth surface, containing 1 to 30%
            by weight of a calcium salt, with the remainder being a
            volatile solvent; and a solution B that is an aqueous
            solution containing 1 to 30% by weight of a phosphate and
            preferably a fluoride in an amount of 0.0001 to 5% by
            weight, where at least one of the solution A and the
            solution B preferably further contains a surfactant in an
            amount of 0.0005 to 1 % by weight.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>MATERIAL FOR FILLING ROOT CANALS OF TEETH</b><br>
            <b> </b><b>RU2197939</b><br>
            <br>
            FIELD: medicine, therapeutic stomatology. SUBSTANCE: method
            deals with treating teeth in case of chronic granulating and
            granulomatous periodontitis. Material for filling root
            canals of teeth consists of powder mixed upon liquid and
            contains inorganic components in its powder part -
            mineralizers of dental tissue, roentgenocontrast filler. It
            contains enriched ion-exchange natural mineral named <b>zeolite</b>
            at the quantity of 10-70% against powder weight, zeolite is
            enriched with calcium ions and <b>contains calcium being
              1.5-45 mg</b> higher/g enriched zeolite against in zeolite
            before enrichment. Filling material causes no inflammations,
            allergic reactions and has no destructive impact upon
            periodontium tissues. It provides, also, optimization of
            reparative osteogenesis, remineralization of dental tissues
            and prolongs duration of filling and tooth functionality.
            EFFECT: higher efficiency of filling process<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Dental cleaning formulation and manufacturing process</b><br>
            <b> </b><b>US6602490</b><br>
            <br>
            A dental hygiene preparation of very low toxicity, but with
            good remineralization properties and effectiveness in
            removing food particles and plaques from the tooth surfaces
            is particularly indicated for use by elderly patients and
            those with compromised immune systems. The preparation uses
            a nonfermentable sweetener in lieu of Sodium Fluoride,
            Sodium Monofluorophasphate or Stannous Fluoride as a
            caries-preventive agent in combination with <b>Potassium
              Citrate and Disodium Edetate.</b><br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Oral compositions for treating tooth hypersensitivity</b><br>
            <b> </b><b>US2007258916</b><br>
            <b> </b><br>
            Oral Compositions for Treating Tooth Hypersensitivity
            Disclosed herein are oral compositions for decreasing tooth
            hypersensitivity. In one aspect, the compositions induce
            remineralization of dentine using bioactive glass, thereby
            reducing tooth sensitivity.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>METHOD FOR MINERALIZATION OF ROOT TOOTH TISSUE</b><br>
            <b> </b><b>EA200801499</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">The present
            invention relates to medicine, namely, dentistry, and may be
            used in the treatment of caries of a tooth root. The object
            of the invention is to improve the efficiency of
            remineralization of hard tooth tissues for the purpose of
            reducing treatment periods of progressive and/or rapidly
            progressive supragingival carious stains without dentine
            defects on the vestibular and/or oral surface of a tooth
            root. The method consists in the subsequent use, in the
            course of the medical treatment of demineralization of
            tissues of a tooth root for the purpose of cleaning a tooth
            root and for Ph normalization, of the following substances:
            <b>sodium hydrogen carbonate; 0.01% Myramistin solution for
              suppressing the activity of pathogenic microflora and for
              enhancing focal defense reactions; calcium
              glycerophosphate and nanocrystalline calcium
              hydroxyappatite as remineralizing components</b>, and
            finally a fluorinated photocurable dentine cylant
            (desensitizer) is applied for providing a long-term contact
            of the above medicaments with complex cavity of a tooth root
            and for reducing dentine sensitivity of exposed tooth roots.
            The affected surface of a tooth root is exposed to
            medicaments during 3 procedures for 2.5 minutes at one day
            interval.</p>
          <div align="left"><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>BIOACTIVE GLASS COMPOSITION</b><br>
            <b> </b><b>JP2008120681</b><br>
            <br>
            PROBLEM TO BE SOLVED: To provide a composition which is
            easily applicable and immediately adheres to a tooth
            structure, and chemically and physically interacting with
            the tooth structure. ; SOLUTION: A novel <b>silica-based
              bioactive glass</b> composition that can be used in
            conjunction with a delivery agent such as a toothpaste and
            gel has a particle size range of smaller than 90 [mu]m, and
            forms a rapid and continuous reaction with body fluids by
            virtue of the immediate and long-term ionic release of Ca
            and P from the core silica particles, to produce a stable
            crystalline hydroxy carbonate apatite layer deposited onto
            and into the dentin tubules for the immediate and long-term
            recovery-from dentin hypersensitivity and tooth surface
            remineralization.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>GEL FOR REMINERALIZATION OF TOOTH TISSUES</b><br>
            <b> </b><b>EA200800988</b><br>
            <br>
            The inventive technical result is aimed at practical
            realization of an effective remineralization composition
            using available components. A patient can use the
            composition without any assistance for prophylaxis of
            caries, for treating non-carious lesions, including dental
            hyperesthesia and improving tooth appearance (color and
            brightness). The inventive result is achieved by using a gel
            which comprises in wt.%: xylitol 2-25, <b>calcium
              glycerophosphate 0.1-3.0,</b> a source of<b> magnesium
              ions 0.01-0.50, guar gum 0.03-0.30 </b>as active
            components as also inert components used for preparing tooth
            gels. <b>Magnesium chloride, magnesium sulfate or magnesium
              nitrate</b> is used as a source of magnesium ions.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>STOMATOLOGICAL LACQUER</b><br>
            <b> </b><b>WO2010134833</b><br>
            <br>
            A stomatological lacquer can be used for the prophylaxis and
            treatment of caries, hyperaesthesia, and accelerated
            remineralization of tooth dentine and enamel. Said lacquer
            comprises copal dissolved in a mixture of organic solvents,
            specifically - in one part of isopropyl alcohol and two
            parts of ethyl acetate and chlorobutanol, and also
            fluorinating, remineralizing and antiseptic components in
            the following ratios (% by mass): copal - 9.0 - 15.0;
            aminofluoride - 0.5 - 6.0; sodium fluoride - 0.1 - 1.0;
            alcoholic colloid (gel) of nano-sized hydroxyapatite - 0.2 -
            5.0; chlorobutanol - 0.2 - 6.0; isoamyl acetate - 3.0 -
            15.0; solvents - up to 100. Furthermore, the alcoholic
            colloid comprises not less than 0.2 and not more than 20% of
            nano-sized hydroxyapatite.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>ORAL COMPOSITION FOR IMPROVING REMINERALIZATION</b><br>
            <b> </b><b>KR20110090216</b><br>
            <br>
            PURPOSE: An oral composition for promoting remineralization
            is provided to enhance tooth strength without irritation to
            human oral cavity mucous. CONSTITUTION: An oral composition
            for promoting remineralization contains 0.005-1.0 weight
            parts of pearl powder. The diameter of the pearl powder
            particle is 0.05-0.30 mm. The composition is manufactured in
            the form of toothbrush, oral cleaning agent, mouth rinse, or
            chewing gum. The oral composition enhances the strength of
            teeth.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>TOOTHBRUSH WITH REACTIVE COMPOSITION FOR REMINERALIZATION
              OF TEETH</b><br>
            <b> </b><b>WO2012015422</b><br>
            <br>
            A toothbrush having brush means and a means to support the
            brush means; and a one or two part therapeutic tooth
            treatment composition which becomes activated when wet
            incorporated on the brush means or within the toothbrush
            means to support the brush means in a manner such that the
            composition remains inactive during storage and is only
            activated when contacted with water or saliva; and a method
            comprising brushing a tooth with the toothbrush so that the
            brush means become wet with saliva, optionally wetting the
            brush means with water immediately prior to brushing a
            tooth, and the composition becomes activated to form a
            therapeutic composition to provide remineralization,
            whitening, and/or fluoridation.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>Method for in-vitro induction of remineralization of
              dentin</b><br>
            <b> </b><b>CN102172334</b><br>
            <br>
            The invention discloses a method for induction of
            remineralization of tissue of tooth, which comprises the
            following steps: preparing a dental film; preparing a dentin
            remineralization inducing mineralization system solution;
            and remineralizing the dentin. In the invention, the micro
            environment of the calcification of the tissue of the tooth
            in a gel matrix is stimulated, a calcium phosphate ion
            dispersing hydrogel system is constructed, and the
            biomimetic mineralization of the dentin is induced in vitro.
            The surface deposits are qualitatively characterized by
            constructing an agar gel mineralization system on the
            surface of the acid-corroded dentin in vitro and by suing a
            scanning electron microscope (SEM) and a micro-Fourier
            transform infrared spectrometer (FTIR). Results show an <b>agar




              gel CaCl2 solution mineralization system containing
              phosphate</b> can induce the deposition and growth of
            strip nano crystals on the surface of acid-corroded dentin
            surface, and that the deposited apatite crystals are densely
            arranged in an interlaced shape. The method is simple,
            convenient, quick and low in cost, and is an effective
            technical method for the biomimetic mineralization of the
            dentin.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>DUAL ACTION DENTIFRICE COMPOSITIONS TO PREVENT
              HYPERSENSITIVITY AND PROMOTE REMINERALIZATION.</b><br>
            <b> </b><b>MX2011009421</b><br>
            <br>
            The invention encompasses combinations of bioactive glass
            composition and potassium salts that are useful in
            conjunction with delivery agent such as, for example,
            toothpastes, mouthwashes, and oral gels. In certain
            embodiments, the compositions of the invention form a rapid
            and continuous reaction with body fluids (e.g., saliva) to
            promote the immediate and long- term release of Ca and P
            ions to produce a stable crystalline layer deposited onto
            and into the dentin tubules for the immediate and long term
            reduction of dentin hypersensitivity and tooth surface
            remineralization.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b>COMPOSITIONS, METHODS AND KITS FOR REMINERALIZATION AND
              INHIBITION OF DENTAL CARIES IN TEETH</b><br>
            <b> </b><b>WO2012078980</b><br>
            <br>
            Methods, compositions and kits are provided for enhancing
            remineralization of a tooth or bone containing
            hydroxyapatite and inhibiting caries progression or loss of
            hydroxyapatite using a bisphosphonate or pyrophosphonate.
            The tooth or tooth surface contains a trauma or defect, for
            example the tooth contains a caries that is identified using
            a detectable probe. The bisphosphonate or pyrophosphonate is
            contacted to the tooth and/or oral cavity and binds to the
            hydroxyapatite material in the tooth or bone and prevents
            loss of hydroxyapatite material or strengthens the
            hydroxyapatite. The amount and extent of enhanced
            remineralization or of inhibition of caries progression and
            loss of hydroxyapatite are determined by techniques
            including photography, light microscopy and fluorescence
            microscopy.<br>
            <br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Dental care chewing gum</b><br>
            <b> </b><b>CN102524504</b><br>
          </div>
          <p class="printAbstract" align="left" lang="en">The invention
            relates to a chewing gum, in particular to a chewing gum
            capable of whitening, protecting and repairing teeth. The
            chewing gum comprises a dental care element, and is
            characterized in that: the dental care element consists of
            peroxide carrying oxygen-containing free radicals, fluoride
            containing soluble fluorine, and a gel containing
            remineralizing components. The chewing gum can clean an oral
            cavity, effectively removes dental plaque, promotes
            remineralization of enamel, prevents tooth decay, has a
            repairing effect on fine decayed tooth gaps and holes which
            have been present, and removes various color spots formed to
            whiten teeth, so that the teeth are repaired and cared
            gradually in the process of chewing the chewing gum.</p>
          <div align="left"><br>
          </div>
          <hr align="left" size="2" width="100%">
          <div align="left"><br>
            <b> </b><b>Remineralising dental care agent</b><br>
            <b> </b><b>EP2286786</b><br>
            <br>
            Tooth care agent (I) comprises an active agent complex of
            hydroxyapatite, fluoride and xylitol to increase
            remineralization activity of hydroxyapatite and fluoride.<br>
          </div>
          <br>
          <hr size="2" width="100%"><a name="excerpts"></a><b><br>
          </b>
          <div align="center"><b>PATENT EXCERPTS</b><br>
          </div>
          <br>
          <div align="left"><b>US4177258</b><br>
            <b> </b><br>
            This invention relates to a dentifrice which is effective to
            remineralize various lesions in dental enamel.<br>
            <br>
            It is known that dental caries begin with lesions of
            so-called "white spots," which are demineralized areas below
            the surface of intact dental enamel. If unchecked, surface
            enamel above a sub-surface lesion eventually collapses,
            leading to cavitation and subsequent loss of tooth
            structure.<br>
            <br>
            In accordance with certain of its aspects, this invention
            relates to a remineralizing dentifrice comprising an aqueous
            humectant vehicle having dissolved therein at least 50 ppm
            of calcium ions and at least 50 ppm of phosphate ions, the
            ratio of calcium to phosphate ions being from about 0.01 to
            about 100:1, the amount of calcium ions and phosphate ions
            being insufficient to precipitate and sufficient to effect
            remineralization of dental enamel; said dentifrice further
            comprising a gelling agent, a compound which provides
            fluoride anticaries agent and an antinucleating agent
            selected from the group of acids and orally acceptable
            water-soluble salts thereof consisting of: <br>
            <br>
            diamine tetramethylenephosphonic acids of the formula (M2 O3
            PH2 C)2 N(CH2 PO3 M2)2 wherein n is an integer from 1 to 10;
            phosphonoacetic acid or salt thereof of the formula M2 O3
            PCH2 COOM; <br>
            peroxydiphosphate of the formula M4 P2 O8 ; <br>
            an oligomer ##STR1## in which M is hydrogen or an orally
            acceptable cation; R1, R2, R3, and R4 are independently
            hydrogen, methyl or ethyl; Y is at least one hydrophilic
            member of the group consisting of COOM, --CONH2 and CH2 OH;
            X is at least one hydrophobic member of the group consisting
            of --CN, --COOR, --COOR5 OR, --CONHR and COONHR5 COR; R is
            C1-8 alkyl; R5 is C1-4 alkylene a is 0-7 and a+b is about
            4-15;<br>
            <br>
            said dentifrice having a pH of about 5 to about 9.<br>
            <br>
            The antinucleating properties of the agents employed in the
            present invention appear to be effective to prevent
            precipitate formation from the calcium and phosphate ions in
            the dentifrice particularly with the fluoride ions also
            present... an antinucleating agent (e.g., a diphosphonate)
            can in sufficient quantity at a physiological pH completely
            absorb onto a spherical nucleated particle of hydroxyapatite
            as it forms and entirely block crystal growth. In this way,
            the formation of large insoluble crystals of apatite is
            prevented and coated small hydroxyapatite crystals of higher
            water solubility are attained.<br>
            <br>
            It has been found that not all antinucleating agents can
            successfully stabilize calcium ions and phosphate ions
            against precipitating to form large insoluble apatite
            crystals. For instance, such insoluble crystals from which
            it is sought to use antinucleating agents such as sodium
            hexametaphosphate, sodium pyrophosphate, sodium phytate and
            mellitic acid as well as disodium
            phosphonoethane-1,2-dicarboxylate,
            1,1-diphosphonopropane-2,3-dicarboxylic acid monohydrate,
            3-amino-1-hydroxypropane-1,1-diphosphonic acid and
            imino-diacetic-N-methylene phosphonic acid. On the other
            hand, the antinucleating agents of the present invention
            successfully stabilize the calcium ions and phosphate ions
            against precipitation as large insoluble apatite crystals at
            a pH between about 5 and about 9. Preferably, the pH is
            about 6.8 to about 7.5, which approximates usual human
            physiological conditions and is optimum for effecting
            remineralization. Desirably, the antinucleating agent of the
            invention is present in amount of about 10 to 5000 ppm
            (1.times.10@-5 M to 1.times.10@-2 M) of the dentifrice,
            preferably about 250 to 2500 ppm (5.times.10@-5 M to
            5.times. 10@-2 M), such as about 2250 ppm (5.times.10@-3 M).<br>
            <br>
            The antinucleating agent of the invention is desirably a
            diamine tetramethylenephosphonic acid of the formula (M2 O3
            PH2 C)2 --N(CH2)n --(CH2 PO3 M2)2...<br>
            <br>
            The polyamine polyphosphonic compounds which are most
            preferred are ethylenediamine tetra (methylenephosphonic
            acid), (hereinafter EDITEMPA) and its water-soluble orally
            acceptable salts, (e.g., sodium, potassium, and ammonium and
            other pharmaceutically acceptable salts; most preferably the
            tri-, tetra- or penta-sodium salts) <br>
            <br>
            The desirable oligomer antinucleating agents and methods for
            their preparation are described in U.S. Pat. Nos. 3,646,099
            and 3,859,260 ....<br>
            <br>
            These oligomers are anionic and of relatively low and
            accurately regulated degree of polymerization, (in contrast
            to the conventional free radical redox polymerization
            conducted with an oxidative initiator such as hydrogen,
            alkyl, or acyl peroxides, persulfates or hydroperoxides in
            relatively large amounts and a reductive activator such as
            NaHSO3, Na2 S2 O4 or sodium formaldehyde sulfoxylate in
            relatively low amounts generally added subsequently to the
            polymerization medium) are prepared by a reductive
            polymerization in which a much larger amount of a bisulfite
            salt, e.g. NaHSO3 (sodium bisulfite, sodium acid sulfite), a
            reducing agent, is the initiator charged initially with the
            monomer, and an oxidizing agent is added in smaller amounts
            as the activator during the polymerizing or oligomerizing
            process...<br>
            <br>
            The oligomerization is carried out in water in the presence
            of a relatively large amount of the bisulfite reducing
            initiator, expressed in mols of monomer/gram formula weight
            (gFW) of reducing initiator is about 4 to 15, this ratio
            determining the degree of oligomerization.<br>
            <br>
            The reductive initiator is preferably a water soluble
            bisulfite salt (M in the formula), especially alkali metal,
            such as sodium or potassium, but bisulfite salts containing
            other orally acceptable cations of the type referred to
            above may be employed.<br>
            <br>
            In practice, enough oxidative activator is used to effect
            100% conversion of the monomers to oligomers. The amount of
            such activator, expressed as gFW activator/gFw initiator may
            range from 0.0001 to 0.1 but usually is from about 0.0001 to
            0.1. Examples of these oxidative activators are ammonium,
            sodium potassium persulfate, hydrogen peroxide and other
            water soluble oxidants commonly employed in the
            polymerization art.<br>
            <br>
            Following completion of the oligomerization reaction, any
            free carboxylic acids groups in the oligomer molecules may,
            if desired be partially or completely neutralized,
            preferably at least 60%, by treating the aqueous oligomer
            solution with a suitable base to convert such groups to
            their salts with orally acceptable cations as referred to
            above. These aqueous oligomer solutions have a highly
            desirable low viscosity, and low molecular weight range
            depending on the monomer units in the oligomer.<br>
            <br>
            It will be understood that the oligomer formula above is not
            intended to depict the actual structure of the oligomer
            molecule, the bracketed units of which formula are randomly
            distributed in the molecule with the --SO3 M group being
            normally bonded to a terminal carbon atom in the oligomer
            chain devoid of X and or Y substituents. In the oligomers
            preferred for use herein, a is zero, Y is --COOM, R1 -R4 are
            H, and M is alkali metal, e.g. sodium, b being about 10, as
            derived from acrylic acid. An oligomer of the formula above
            in the form of its sodium salt, with a molecular weight of
            about 1,000, containing about 10 acrylic acid monomeric
            units, is commercially available under the trade name ND-2
            (a product of UniRoyal).<br>
            <br>
            The effective antinucleating agents render the
            remineralizing dentifrice stable at normally occurring
            temperatures, e.g., about 15 DEG C.-40 DEG C. The
            remineralizing agents can diffuse effectively through an
            intact enamel surface in order to act on subsurface lesions.<br>
            <br>
            The stability provided by the effective antinucleating
            agents prevents spontaneous precipitation on enamel surfaces
            and thereby permits diffusion of the remineralizing
            components to subsurface lesions.<br>
            <br>
            One or more sources of each calcium ions and phosphate ions
            may be employed. When the source is normally insoluble such
            as a calcium phosphate, it is solubilized during preparation
            of the solution, by maintaining an acid pH of about 6 or
            less (e.g., about 2.5 to 6) during preparation of the
            remineralizing solution, particularly before the effective
            antinucleating agent is added.<br>
            <br>
            The normally insoluble sources of calcium and phosphate ions
            may be a single compound such as tricalcium phosphate (which
            substantially corresponds to hydroxyapatite, Ca5 (PO4)3 OH
            or 3Ca3 (PO4)2 .multidot.Ca(OH)2, bone meal or dicalcium
            phosphate (dihydrate or anhydrous). When dissolved,
            particularly in the presence of fluoride ions, formation of
            hydroxyapatite, fluorohydroxyapatite and fluorapatite
            occurs.<br>
            <br>
            Examples of other normally water-soluble or normally
            water-insoluble (but soluble at pH of about 6 or less)
            sources of calcium ion, but not phosphate ion, which can be
            used in the remineralizing dentifrice of the invention
            include calcium salts with acetate, gluconate, nitrate,
            stearate, lactate, formate, molybdate, tungstate, sulfate,
            alkyl sulfonate (e.g. lauryl sulfonate), oleate, tartrate,
            sorbate, iodate, silicate, aluminate, benzoate, citrate,
            fumarate, butyrate, isobutyrate, malate, maleate,
            propionate, valerate and the like. Mixtures of such calcium
            sources with each other or with calcium phosphate may be
            employed.<br>
            <br>
            Examples of sources of phosphate ions, but not calcium ion,
            which can be used in the remineralizing dentifrice of the
            invention include the normally water-soluble or normally
            water-insoluble (but soluble at pH of about 6 or less) salts
            including alkali metal (e.g. sodium and potassium),
            ammonium, magnesium, barium and strontium orthophosphates
            and acid orthophosphates, metaphosphates, pyrophosphates, as
            well as glycerophosphates, fructose-6-phosphate,
            sorbitol-6-phosphate, glucose-1-phosphate,
            glucose-6-phosphate and the like. Mixtures of such phosphate
            sources with each other or with calcium phosphate may be
            employed.<br>
            <br>
            Tricalcium phosphate or the other sources of calcium and
            phosphate which together form hydroxyapatite when dissolved
            are employed with the mole ratio of calcium ion to phosphate
            ion being&nbsp; preferably about 1.2 to about 2:1, e.g.,
            about 1.4 to about 1.7:1. A ratio of calcium to phosphate of
            1.67:1 corresponds to the ratio of calcium to phosphate in
            dental enamel. The amount of calcium ion and phosphate ion
            in the dentifrice is sufficient to effect remineralization,
            there being typically at least about 500 ppm of each of
            calcium ion and phosphate ion. The maximum amount of calcium
            ion and phosphate ion desirable is that which would not
            result in precipitate formation. This could vary depending
            on the ion sources and the pH conditions. Typically, about
            35,000 ppm of calcium ion and about 40,000 ppm of phosphate
            can be employed and precipitation still avoided.<br>
            <br>
            In the prior art it has been difficult to maintain the
            solubility of calcium phosphate, particularly in the
            presence of a fluoride source. As previously indicated, this
            is overcome in the present invention when the effective
            antinucleating agents are employed. Examples of fluoride ion
            sources (including complex fluoride ions) include alkali
            metal (e.g., sodium potassium and lithium) ammonium,
            alkaline earth metal (e.g., calcium, barium, strontium,
            magnesium), aluminum, zinc, stannous, indium, zirconium,
            copper, nickel, palladium and organonitrogen such as
            alkylamine (e.g., hexylamine) compounds with fluoride ion
            sources. Sources of fluoride ions include fluoride,
            fluorophosphate (including monofluorophosphate,
            difluorophosphate and polyfluorophosphate), silicofluoride,
            fluorozirconate, fluoroborate and fluorostannite. Typical
            compounds are sodium fluoride, zinc fluoride, stannous
            fluoride and sodium monofluorophosphate. Sodium fluoride and
            sodium monofluorophosphate are preferred. The fluoride
            source compound is desirably present in amount to provide
            about 1 ppm to 10,000 ppm(0.0001%- 1%)fluoride to the
            remineralizing dentifrice e.g., about 1 ppm to 1000 ppm
            (0.0001-0.76%)sodium monofluorophosphate, preferably about 5
            ppm fluoride. The amount of the compound employed should not
            be sufficient to result in precipitate formation. For
            instance, in the case of a fluoride source of low
            solubility, such as calcium fluoride, the amount of the
            compound employed should not exceed 1500 ppm.<br>
            <br>
            The stable remineralizing dentifrice may be made by first
            preparing a stock solution of soluble calcium ions from a
            solution of a water-soluble salt such as calcium chloride
            and phosphate ions from a solution of a water salt such as
            sodium dihydrogen phosphate; one or both of the calcium or
            phosphate solutions preferably containing antinucleating
            agent such as EDITEMPA, prior to forming the stock solution
            in order to prevent spontaneous precipitation. A preferred
            final concentration of calcium ions and phosphate ions in
            the stock solution is about 1.5 mM and 0.9 mM respectively.
            A water-soluble salt such as sodium fluoride, stannous
            fluoride or sodium monofluorophosphate is then added to the
            stock solution and the pH adjusted, typically to about 5 to
            9, typically about 6 to 7, for instance with sodium
            hydroxide.<br>
            <br>
            The stock solution is then mixed into a dentifrice
            containing an aqueous humectant vehicle and a gelling agent
            typically in about equal amounts in order to dissolve the
            calcium and phosphate ions in the dentifrice.<br>
            <br>
            Alternatively, an insoluble calcium phosphate source such as
            hydroxyapatite or dicalcium phosphate can be solubilized in
            clear solution by reducing the pH to about 2-4, typically
            about 2.8-3.8 with acids such as phosphoric acid,
            hydrochloric acid and the like. After the antinucleating
            agent and fluoride are added and the pH raised typically to
            about 6 to 7, the thus formed solution is mixed into a
            dentifrice containing an aqueous humectant vehicle in
            typically about equal amounts, thereby dissolving calcium
            and phosphate ions therein.<br>
            <br>
            The dentifrice can be maintained for a long period of time,
            remaining effective when brought into contact with dental
            material to remineralize sub-surface lesions.<br>
            <br>
            The dentifrice typically contains about 10-50% of a dentally
            acceptable water-insoluble polishing material. Preferably
            the polishing material does not include calcium and
            phosphate moieties. Insoluble polishing materials containing
            calcium and phosphate moieties, such as dicalcium phosphate,
            would not provide calcium ions and phosphate ions in the
            amounts provided by the solubilized material in the
            dentifrice of the invention. Desirable polishing agents
            include hydrated alumina, silica (colloidal, precipitated or
            crystalline), dolomite, bentonite, melamineformaldehyde
            resin, urea formaldehyde resin and the like. Hydrated
            alumina and silica are preferred. The dental cream also
            generally contains humectant such as glycerine, sorbitol,
            propylene glycol or polyethylene glycol 400 and gelling
            agent such as sodium carboxymethyl cellulose or Irish Moss.
            Also, surface active agent flavoring and/or sweetening
            material, antibacterial agent, antibacterial preservative,
            (e.g. sodium benzoate or methyl-4-hydroxy benzote), silicone
            material, chlorophyll compound or ammoniated material may be
            present.<br>
            <br>
            The following examples illustrate the invention but do not
            limit it. All parts, amounts and proportions are by weight
            unless otherwise noted.<br>
            <br>
            EXAMPLE 1<br>
            <br>
            A stock solution of hydroxyapatite (tricalcium phosphate) is
            prepared by adding a solution containing calcium chloride to
            a solution of sodium dihydrogen phosphate to a final
            concentration of 1.5 mM calcium ions and 0.9 mM phosphate
            ions; the sodium dihydrogen phosphate solution containing
            EDITEMPA to provide the stock solution with 1.times.10@-5 M
            thereof and phosphoric acid to provide the stock solution
            with a pH of about 3.<br>
            <br>
            The pH is raised to 7 with 1 N potassium hydroxide. Sodium
            monofluorophosphate is then added to a concentration of 5
            ppm fluoride in the stock solution following which sodium
            chloride is added to give an electrolyte concentration of 50
            mM and additional water is added to 1 liter.<br>
            <br>
            The solution thus formed is added in 1:1 ratio to the
            following dental cream formulation:<br>
            <br>
            PARTS<br>
            <br>
            Glycerine 10.00<br>
            Sorbitol (70%) 17.00<br>
            Water 23.70<br>
            Sodium Benzoate 0.50<br>
            Sodium Saccharin 0.20<br>
            Sodium Carboxymethyl<br>
            Cellulose 1.10<br>
            Precipitated Silica 45.00<br>
            Sodium Lauryl Sulfate 1.50<br>
            Flavor 1.00<br>
            <br>
            The dental cream remains stable upon storage and the calcium
            ions and phosphate ions remain dissolved therein.<br>
            <br>
            EXAMPLE 2<br>
            <br>
            Similar dental creams to that of Example 1 are prepared in
            which the solution containing calcium ions and phosphate
            ions contains each of PAA (concentration 5.times.10@-3 M);
            PODP (concentration 5.times.10@-4); and UniRoyal Oligomer
            ND-2 (concentration 5.times.10@-4 M). The dental creams are
            stable upon storage and the calcium ions and phosphate ions
            remain dissolved therein.<br>
            <br>
            EXAMPLE 3<br>
            <br>
            A stock solution of hydroxyapatite (tricalcium phosphate) is
            prepared by adding hydroxyapatite to water to a final
            concentration of 1.5 mM calcium ions and 0.9 mM phosphate
            ions. 0.25 grams of sodium benzoate (from 0.05% solution
            thereof) are then added to the solution to minimize
            bacterial growth.<br>
            <br>
            Phosphoric acid is then added to 500 ml of the stock
            solution to produce a clear solution at pH 3, after which
            the pH is raised to 6 with 1 N potassium hydroxide. Next
            EDITEMPA is added and mixed into the solution to a
            concentration of 1.times.10@-5 M thereof, following which
            additional potassium hydroxide is added to produce a pH of
            7. Sodium monofluorophosphate is then added to a
            concentration of 5 ppm fluoride in the stock solution
            following which sodium chloride is added to give an
            electrolyte concentration of 50 mM and additional water is
            added to 1 liter.<br>
            <br>
            The solution thus formed is added in 1:1 ratio to the dental
            cream formulation set forth in Example 1. The dental cream
            remains stable upon storage and the calcium ions and
            phosphate ions remain dissolved therein.<br>
            <br>
            EXAMPLE 4<br>
            <br>
            A similar dental cream to that of Example 3 is prepared in
            which dicalcium phosphate dihydrate is solubilized in the
            stock solution in place of hydroxyapatite to give a
            concentration of 60 ppm of calcium ions and 400 ppm of
            phosphate ions in the stock solution. The dental cream
            remains stable upon storage and the calcium ions and
            phosphate ions remain dissolved therein.<br>
          </div>
          <br>
          <hr size="2" width="100%"><br>
          <div align="left"><b>EP0040938</b><br>
            <b> </b><br>
            [0001] This invention relates to a new composition for
            cleaning and polishing teeth by dental prophylaxis and more
            specifically to a dental prophylactic paste comprising
            dicalcium phosphate dihydrate...<br>
            <br>
            SUMMARY OF THE INVENTION<br>
            <br>
            [0007] These and other advantages are achieved by a
            prophylactic dental paste comprising greater than about 70
            percent by weight of dicalcium phosphate, based on the total
            weight of the paste. There is also provided a prophylaxis
            method comprising applying to a tooth surface a dental
            prophylactic paste containing at least about 60 percent by
            weight dicalcium phosphate, based on the total weight of the
            paste.<br>
            <br>
            [0008] The term "dicalcium phosphate" as it is used in the
            specification and claims shall mean dicalcium phosphate
            dihydrate, anhydrous dicalcium phosphate and mixtures
            thereof.<br>
            <br>
            [0009] Dicalcium phosphate, and particularly dicalcium
            phosphate dihydrate, is commonly used as a polishing agent
            in dentifrices to clean teeth with a toothbrush. Broadly
            described, dicalcium phosphate dihydrate is prepared by the
            addition of a lime slurry to phosphoric acid under
            conditions such that dicalcium phosphate dihydrate is
            precipitated. In many cases, the dicalcium phosphate also
            contains other ingredients to inhibit spontaneous hydrolysis
            and/or dehydration. Stabilizing agents such as alkali metal
            pyrophosphate and trimagnesium phosphate are added to the
            dicalcium phosphate dihydrate during its preparation to
            stabilize the dicalcium phosphate dihydrate. Processes for
            preparing dicalcium phosphate stabilized against spontaneous
            hydrolysis and/or dehydration have been disclosed in U.S.
            2,287,699, U.S. 3,012,852 and U.S. 4,193,973.<br>
            <br>
            [0010] As is known to those skilled in the art, anhydrous
            dicalcium phosphate can be prepared in accordance with the
            teachings in U.S. 3,647,371 by adding lime to aqueous
            phosphoric acid while the reaction temperature is maintained
            sufficiently high to insure production of dicalcium
            phosphate substantially free from its water of
            crystallization.<br>
            <br>
            [0011] The dicalcium phosphate useful in the prophylactic
            dental paste of the present invention can be dicalcium
            phosphate dihydrate or anhydrous dicalcium phosphate or
            mixtures of the two. However, as is known to those skilled
            in the art, anhydrous dicalcium phosphate frequently has a
            radioactive dentine abrasivity (RDA), as determined
            according to the method of Grabenstetter et al, JOURNAL OF
            DENTAL RESEARCH, Vol. 37, page 1060 (1958) of from about
            1,000 to 1,400. Hence, the use of anhydrous dicalcium
            phosphate with such high abrasivi- ties should be avoided in
            the prophylactic dental paste of the present invention to
            avoid loss of hard tooth structure due-to abrasion. The
            dicalcium phosphate in the prophylactic dental paste should
            have an RDA of less than 1,000. and it is preferred that the
            paste have an RDA of less than about 750. As is known to
            those skilled in the art, anhydrous dicalcium phosphate
            having an RDA value of about 50 to about 150 has been
            prepared according to the teachings of U.S. 3,647,371 and
            such anhydrous dicalcium phosphate is suitable for use in
            the paste of the present invention. On the other hand,
            dicalcium phosphate dihydrate has an RDA value of less than
            500 and its use is preferred in the paste of the present
            invention. However, as will occur to those skilled in the
            art in view of the present disclosure, a mixture of
            dicalcium phosphate dihydrate and anhydrous dicalcium
            phosphate can be used, particularly if the anhydrous
            dicalcium phosphate has an RDA value of less than 750, as
            the dicalcium phosphate for the paste of the present
            invention, and a mixture of dicalcium phosphate dihydrate
            and anhydrous dicalcium phosphate can be used if higher
            abrasivity is required provided that the RDA value of the
            prophylactic dental paste is less than 1,000 and preferably
            less than 750.<br>
            <br>
            [0012] The prophylactic dental paste of the present
            invention should contain at least about 60 percent by weight
            of dicalcium phosphate, preferably greater than 70 percent
            by weight dicalcium phosphate, to insure that there is
            adequate polishing agent for the dental prophylaxis to
            remove stains and other dental debris. On the other hand, a
            paste containing more than about 90 percent by weight
            dicalcium phosphate, based on the total weight of the paste,
            can become so viscous that it is difficult to apply to the
            teeth using conventional cleaning techniques. Thus, it is
            preferred that the paste contain between about 75 weight
            percent and 85 weight percent, based on the total weight of
            the paste, to provide a paste having sufficient polishing
            agent to effectively clean the teeth while maintaining a
            sufficiently low viscosity to permit ease of use.<br>
            <br>
            [0013] The balance of the formulation is water and
            optionally other ingredients that are typically used in a
            prophylactic dental paste, such as flavoring agents like oil
            of wintergreen, oil of peppermint, oil of spearmint, oil of
            sassafras, oil of anise and the like; sweetening agents such
            as saccharin, dextrose, levulose, sodium cyclamate and the
            like; binders such as water soluble salts of cellulose
            ethers such as sodium carboxymethyl cellulose and sodium
            carboxymethyl hydroxyethyl cellulose; natural gums such as
            gum arabic and the like; humectants such as glycols,
            glycerin, sorbitol and other polyhydric alcohols; and
            coloring agents. The prophylactic dental paste of the
            present invention can be used in a conventional manner to
            clean teeth professionally using conventional equipment and
            techniques. The optimum amount of paste, the degree of
            cleaning and polishing desired, the RDA of the paste and the
            like can be determined in accordance with conventional
            techniques.<br>
            <br>
            [0014] When teeth are cleaned professionally to remove
            plaque, tartar, pellicle and other dental debris and the
            enamel of the teeth is exposed, it is frequently desirable
            to treat the teeth with fluoride to inhibit caries
            formation. Accordingly, the paste can optionally contain a
            source of fluoride ion, such as monofluorophosphate and the
            like, to aid in this treatment. In addition, although
            Applicants do not wish to be bound by any particular theory,
            it is believed that the dicalcium phosphate used in the
            prophylactic dental paste of the present invention in
            contact with the teeth free of tartar, plaque and pellicle,
            aids in the remineralization of the tooth surface, an
            advantage not found with the prophylactic dental paste
            compositions of the prior art.<br>
            <br>
            DESCRIPTION OF THE PREFERRED EMBODIMENTS<br>
            <br>
            [0015] This invention is illustrated by but not limited to
            the following Examples wherein all percentages are by weight
            unless otherwise noted.<br>
            <br>
            EXAMPLE I<br>
            <br>
            [0016] A carrier gel is prepared by mixing the following
            ingredients in the indicated amounts:<br>
            <br>
            [0017] A series of prophylactic dental pastes are each
            prepared by combining 75 grams of the above carrier gel with
            175 grams of the following polishing agents: (1) chalk; (2)
            flour of pumice; (3) zirconium silicate; and (4) dicalcium
            phosphate dihydrate containing 0.6 percent tetrapotassium
            pyrophosphate and 2 percent trimagnesium phosphate
            stabilizers, and having an RDA of about 250.<br>
            <br>
            &nbsp;<br>
            <b> </b><b>US6372198</b><br>
            <br>
            [0003] The present invention relates generally to
            dentifrices, and more particularly to dentifrice
            compositions containing enhanced levels of minerals for
            mineralizing and remineralizing teeth, as well as various
            chemical compounds for promoting beneficial oral cavity
            health...<br>
            <br>
            DETAILED DESCRIPTION OF THE INVENTION<br>
            <br>
            [0078] The present invention is primarily directed to
            dentifrice compositions, and particularly those dentifrice
            compositions containing enhanced levels of minerals for
            mineralizing and remineralizing teeth, as well as various
            chemical compounds for promoting beneficial oral cavity
            health.<br>
            <br>
            [0079] In accordance with one aspect of the present
            invention, not only are enhanced levels of water soluble
            calcium salts and phosphate salts employed, but divalent
            metals, such as magnesium, strontium, tin, and zinc, are
            optionally employed as well. These divalent metals aid in
            the aforementioned mineralization and remineralization
            processes.<br>
            <br>
            [0080] Water-soluble calcium salts and compounds suitable
            for practicing the present invention are, by way of a
            non-limiting example, calcium chloride, calcium bromide,
            calcium nitrate, calcium acetate, calcium gluconate, calcium
            benzoate, calcium glycerophosphate, calcium formate, calcium
            fumarate, calcium lactate, calcium butyrate and calcium
            isobutyrate, calcium malate, calcium maleate, calcium
            propionate, or mixtures of water-soluble calcium compounds.
            In the compositions of the invention for the
            mineralization/remineralization of human dental enamel, the
            calicum ions are preferably present in a range from about at
            least 18 mmol/L to about 1.5 mol/L.<br>
            <br>
            [0081] Water-soluble inorganic phosphate salts and compounds
            suitable for practicing to the present invention are, by way
            of a non-limiting example, alkali salts and ammonium salts
            of orthophosphoric acid, such as potassium, sodium or
            ammonium orthophosphate, monopotassium phosphate,
            dipotassium phosphate, tripotassium phosphate, monosodium
            phosphate, disodium phosphate and trisodium phosphate. The
            concentration of the phosphate ions is preferably about at
            least 18 mmol/L to about 1.5 mol/L.<br>
            <br>
            [0082] If desired, water-soluble salts yielding both calcium
            and phosphate ions, such as monobasic-calcium
            orthophosphate, may be employed.<br>
            <br>
            [0083] With respect to the stabilizing divalent metal
            compound, it is also possible to employ any water-soluble,
            non-toxic divalent metal compound which will stabilize the
            calcium and phosphate ions so that they do not rapidly or
            prematurely precipitate before diffusing into the teeth. In
            practice, however, it has been found that at least one
            member selected from the group consisting of magnesium,
            strontium, tin, and zinc, with magnesium being preferred,
            are the most effective in stabilizing the system.<br>
            <br>
            [0084] Suitable magnesium compounds are, by way of a
            non-limiting example, magnesium acetate, magnesium ammonium
            sulfate, magnesium benzoate, magnesium bromide, magnesium
            borate, magnesium citrate, magnesium chloride, magnesium
            gluconate, magnesium glycerophosphate, magnesium hydroxide,
            magnesium iodide, magnesium oxide, magnesium propionate,
            magnesium D-lactate, magnesium DL-lactate, magnesium
            orthophosphate, magnesium phenolsulfonate, magnesium
            pyrophosphate, magnesium sulfate, magnesium nitrate, and
            magnesium tartrate.<br>
            [0085] Suitable strontium compounds are, by way of a
            non-limiting example, strontium acetate, strontium ammonium
            sulfate, strontium benzoate, strontium bromide, strontium
            borate, strontium caprylate, strontium carbonate, strontium
            citrate, strontium chloride, strontium gluconate, strontium
            glycerophosphate, strontium hydroxide, strontium iodide,
            strontium oxide, strontium propionate, strontium D-lactate,
            strontium DL-lactate, strontium pyrophosphate, strontium
            sulfate, strontium nitrate, and strontium tartrate.<br>
            <br>
            [0086] Suitable tin compounds are, by way of a non-limiting
            example, stannous acetate, stannous ammonium sulfate,
            stannous benzoate, stannous bromide, stannous borate,
            stannous carbonate, stannous citrate, stannous chloride,
            stannous gluconate, stannous glycerophosphate, stannous
            hydroxide, stannous iodide, stannous oxide, stannous
            propionate, stannous D-lactate, stannous DL-lactate,
            stannous orthophosphate, stannous <br>
            pyrophosphate, stannous sulfate, stannous nitrate, and
            stannous tartrate.<br>
            <br>
            [0087] Suitable zinc compounds are, by way of a non-limiting
            example, zinc acetate, zinc ammonium sulfate, zinc benzoate,
            zinc bromide, zinc borate, zinc citrate, zinc chloride, zinc
            gluconate, zinc glycerophosphate, zinc hydroxide, zinc
            iodide, zinc oxide, zinc propionate, zinc D-lactate, zinc
            DL-lactate, zinc pyrophosphate, zinc sulfate, zinc nitrate,
            and zinc tartrate. Preferred zinc compounds are zinc
            acetate, zinc chloride, zinc sulfate, and zinc nitrate...<br>
            <br>
            [0093] In the case of two separate components, the pH of a
            component of such toothpaste or gel comprised of the active
            cationic or anionic ingredients each has a pH of more than
            about 3. The mixture of the two portions which is placed in
            the mouth, however, must have a pH of from 4.5 to about 7.0,
            preferably from about 5.0 to about 7.0, more preferably from
            about 5.0 to about 5.75. The pHs of the cationic portion and
            the anionic portion can be adjusted so long as the above pH
            parameters are not exceeded...<br>
            <br>
            [0100] In accordance with another aspect of the present
            invention, trace minerals, such as selenium and bromine,
            that are believed to have beneficial effects on the overall
            health of the oral cavity are also preferably employed in
            the dentifrice composition of the present invention.
            Although these trace minerals may be added to the dentifrice
            composition of the present invention from various chemical
            suppliers, it is preferred to use mineral water from a
            natural source, such as a spring. Examples of such
            naturally-occurring springs are located in the southeastern
            portion of Michigan, for example in the Mount Clemens area,
            and have been identified as having some of the highest, if
            not the highest, levels of naturally-occurring minerals, as
            well as trace minerals, of any springs in the world.
            Although the exact mechanisms of the health benefits have
            not been thoroughly explained, it is generally recognized
            that several different types of trace minerals, such as
            selenium and bromine, have been identified as having
            potentially beneficial effects on overall health, and
            specifically on the health of the oral cavity, either acting
            alone or in concert with other minerals, vitamins, and/or
            enzymes.<br>
            <br>
            EXAMPLE I<br>
            INGREDIENT&nbsp; AMOUNT (grains/gallon)<br>
            <br>
            Ferrous carbonate&nbsp; &lt;0.13<br>
            Ferrous sulfide&nbsp; &lt;0.16<br>
            Lithium chloride&nbsp; 9.3<br>
            Magnesium carbonate&nbsp; &lt;0.085<br>
            Magnesium bromide&nbsp; 1600<br>
            Magnesium chloride&nbsp; 850<br>
            Magnesium iodide&nbsp; 0.77<br>
            Magnesium sulfate&nbsp; 70<br>
            Potassium chloride&nbsp; 160<br>
            Potassium sulfate&nbsp; 102<br>
            Rubidium&nbsp; 0.26<br>
            Sodium carbonate&nbsp; &lt;0.11<br>
            Sodium diborate&nbsp; 12.5<br>
            Sodium chloride&nbsp; 4500<br>
            Sodium selenite&nbsp; &lt;0.013<br>
            Sodium silicate&nbsp; 0.28<br>
            Sodium sulfite&nbsp; 0.37<br>
            Sodium sulfate&nbsp; 83<br>
            Sodium tellurite&nbsp; &lt;0.11<br>
            Strontium sulfate&nbsp; 28<br>
            Sulfur&nbsp; 80<br>
            <br>
            [0106] Coenzyme Q10 (also known as Co Q10, Q10, vitamin Q10,
            ubiquinone, or ubidecarenone) is a benzoquinone compound
            synthesized naturally in the human body. The "Q" and the
            "10" in the name refer to the quinone chemical group and the
            10 isoprenyl chemical subunits, respectively, that are part
            of this compound's structure. The term "coenzyme" denotes it
            as an organic (contains carbon atoms), nonprotein molecule
            necessary for the proper functioning of its protein partner
            (an enzyme or enzyme complex). Coenzyme Q10 is used by the
            cells of the body in a process known variously as aerobic
            respiration, aerobic metabolism, oxidative metabolism, or
            cell respiration. Through this process, energy for cell
            growth and maintenance is created inside cells in
            compartments called mitochondria. Coenzyme Q10 is also used
            by the body as an endogenous antioxidant. An antioxidant is
            a substance that protects cells from free radicals, which
            are highly reactive chemicals, often containing oxygen
            atoms, capable of damaging important cellular molecules such
            as DNA and lipids.<br>
            <br>
            [0107] It has recently been suggested that oral and/or
            intravenous administration of coenzyme Q10 may be beneficial
            in the treatment of various diseases, including periodontal
            disease. In certain clinical studies, it has been observed
            that the oral administration, for example, in the form of
            pills, capsules, and powders, of coenzyme Q10 has alleviated
            the symptoms of periodontal disease, including inflammation,
            swelling, and bleeding of the gum tissues.<br>
            <br>
            [0108] Accordingly, in accordance with a preferred
            embodiment of the present invention, the dentifrice
            composition of the present invention preferably contains an
            amount of coenzyme Q10. It is believed that the coenzyme
            Q10, when present in sufficient amounts, will have a
            therapeutic effect on the soft tissues surrounding, adjacent
            to, or in proximity to, the tooth structure (e.g., gum
            tissues) and thus aid in the prevention and treatment of
            various periodontal diseases. The form of the coenzyme Q10,
            for example, powder or liquid, is not thought to be
            critical.<br>
            <br>
            [0109] By way of a non-limiting example, a dentifrice
            composition, in accordance with one aspect of the present
            invention, is presented below<br>
            <br>
            EXAMPLE II<br>
            <br>
            AMOUNT INGREDIENT&nbsp; (WEIGHT PERCENTAGE)<br>
            <br>
            Deionized water&nbsp; 130&nbsp; ml (16.26)<br>
            Mineral water&nbsp; 40&nbsp; ml (5.0)<br>
            Sodium saccharin&nbsp; 0.7&nbsp; g (0.086)<br>
            Methylparaben&nbsp; 1.3&nbsp; g (0.16)<br>
            Sodium carboxymethylcellulose (CMC)&nbsp; 2.2&nbsp; g (0.28)<br>
            Sorbitol (70 vol. %)&nbsp; 200&nbsp; ml (25.0)<br>
            Glycerine (97 vol. %)&nbsp; 45&nbsp; ml (5.625)<br>
            Dicalcium phosphate dihydrate&nbsp; 330&nbsp; g (41.25)<br>
            Dicalcium phosphate anhydrous&nbsp; 25&nbsp; g (3.125)<br>
            Carageenan (marine colloids)&nbsp; 10&nbsp; g (1.25)<br>
            Sodium monofluorophosphate (optional)&nbsp; 0.79&nbsp; g
            (0.1)<br>
            Coenzyme Q10 (optional)&nbsp; 2.4&nbsp; g (0.31)<br>
            Sodium lauryl sulfate&nbsp; 13&nbsp; g (1.625)<br>
            Sodium sulfoacetate (optional)&nbsp; 23&nbsp; g (2.87)<br>
            Wintergreen flavoring&nbsp; 0.6&nbsp; ml (0.075)<br>
            Cinnamon flavoring&nbsp; 4&nbsp; ml (0.5)<br>
            <br>
            [0110] As previously noted, the dentifrice composition of
            the present invention is then formed into a suitable paste,
            gel, powder, or liquid, for use by a consumer. The consumer
            then places an appropriate amount (e.g., 2.0-2.5 g of the
            dentifrice per application, preferably three applications
            per day) of the dentifrice composition of the present
            invention on a toothbrush and proceeds to brush in a normal
            manner, whereupon the key ingredients of the dentifrice
            composition of the present invention, i.e., the calcium ions
            and phosphate ions, aided by the optional magnesium, contact
            the teeth and act in manner to cause the mineralization and
            remineralization of various surfaces and subsurfaces of the
            teeth, as previously described. The other optional
            ingredients of the dentifrice composition of the present
            invention, i.e., the various trace minerals such as selenium
            and bromine, as well as the coenzyme Q10, act to aid in the
            overall health of the oral cavity, especially the gum
            tissues. If the level of the coenzyme Q10 needs to be raised
            in order to have a therapeutic effect, additional amounts of
            coenzyme Q10 may be added to the dentifrice composition of
            the present invention. Additionally, because coenzyme Q10
            may have a tendency to cause the dentifrice composition to
            take on a slightly orange color, whitening agents, such as
            titanium dioxide, may be employed to restore a whiter
            appearance to the dentifrice composition.<br>
            <br>
            &nbsp;&nbsp; <br>
            <b> </b><b>US2005089481</b><br>
            <br>
            SUMMARY OF THE INVENTION<br>
            <br>
            [0012] The present inventors made wholeheartedly
            investigations in order to solve the above problems, and as
            the result, they found out the method to obtain the
            excellent composition for the caries prevention. That is, in
            the composition comprising (a) the casein
            phosphopeptide-amorphous calcium phosphate complex (CPP-ACP)
            and/or the casein phosphopeptide-amorphous calcium fluoride
            phosphate complex (CPP-ACFP), (b) a sodium
            carboxymethylcellulose, (c) a viscosity regulator, and (d)
            water, when the sodium carboxymethylcellulose having a
            specific etherification degree was used, the composition for
            the caries prevention, which has the effects for efficiently
            suppressing the demineralization and promoting the
            remineralization, and the excellent stability in keeping for
            a long time, was obtained. Then, the present invention was
            completed.<br>
            <br>
            [0013] In a first aspect of the present invention,
            composition for the oral cavity to prevent the caries
            comprises (a) 1 to 30% by weight of the casein
            phosphopeptide-amorphous calcium phosphate complex (CPP-ACP)
            and/or the casein phosphopeptide-amorphous calcium fluoride
            phosphate complex (CPP-ACFP), (b) 0.01 to 10% by weight of
            the sodium carboxymethylcellulose, having the etherification
            degree of 0.7 to 1.0, (c) 0.5 to 40% by weight of the
            viscosity regulator, and (d) a residual amount of water.
            This composition is used by coating on the tooth. In a
            second aspect of the present invention, a composition for
            oral cavity to prevent a caries comprises (a) 1 to 30% by
            weight of the casein phosphopeptide-amorphous calcium
            phosphate comply (CCP-ACP) and/or the casein
            phosphopeptide-amorphous calcium fluoride phosphate complex
            (CCP-ACFP), (b) 0.01 to 10% by weight of the sodium
            carboxymethylcellulose having the etherification degree of
            0.7 to 1.0, (c) 0.5 to 40% by weight of the viscosity
            regulator, (e) 0.01 to 5.0% by weight of the fluoride
            compound, and (d) a residual amount of water, and being used
            by applying on a tooth. In a third aspect of the present
            invention, the fluoride compound is at least one selected
            from the group consisting of sodium fluoride, stannous
            fluoride, sodium monofluoro phosphate in the composition for
            oral cavity to prevent a caries according to the second
            aspect of the present invention.<br>
            <br>
            [0014] Hereinafter, the composition for the caries
            prevention of the present invention will be explained. (a)
            The casein phosphopeptide-amorphous calcium phosphate
            complex (CPP-ACP) and/or the casein phosphopeptide-amorphous
            calcium fluoride phosphate complex (CPP-ACFP) are not
            especially limited, if it is approved as foods or in
            dentistry. For example, the material prepared by the method
            of mixing calcium, an inorganic phosphoric acid, and
            fluoride if necessary with phosphopeptide, filtrating the
            mixed material, and drying, is preferably used in respect of
            the composition and crystallinity (refer to published
            Japanese translation of PTC international publication for
            patent application 2002-500626).<br>
            <br>
            [0015] At this time, the blending amount of the casein
            phosphopeptide-amorphous calcium phosphate complex (CPP-ACP)
            and/or the casein phosphopeptide-amorphous calcium fluoride
            phosphate complex (CPP-ACFP) (a) is 1 to 30% by weight of
            the whole composition, preferably 1 to 10% by weight
            especially. If said amount is less than 1% by weight, the
            supplying of calcium and phosphorus is not sufficient, so
            that the prevention effect of the caries can not be
            obtained. If said amount exceeds 30% by weight, the
            viscosity of the composition becomes too high.<br>
            <br>
            [0016] The etherification degree of the sodium
            carboxymethylcellulose (b), which is blended to obtain
            stability in keeping for a long time, is 0.7 to 1.0,
            preferably 0.85 to 0.95 especially. Because, if the
            etherification degree is less than 0.7, the blending effect
            can not be obtained, and if said amount exceeds 1.0, the
            sodium carboxymethylcellulose is easily influenced by
            calcium existing in the CPP-ACP and/or the CPP-ACFP, so that
            the preservation property becomes to be insufficient, since
            an insoluble precipitate is generated or said sodium
            carboxymethylcellulose is gelled.<br>
            <br>
            [0017] The blending amount of the sodium
            carboxymethylcellulose having the etherification degree of
            0.7 to 1.0 is 0.01 to 10% by weight of the whole
            composition, preferably 1 to 5% by weight especially. If
            said amount is less than 0.01% by weight, the viscosity of
            the composition is low and it easily flows with saliva at
            the time of the applying on the tooth. Therefore, the
            prevention effect of the caries can not be obtained. If said
            amount exceeds 10% by weight, the viscosity of the
            composition is high and it can not easily spread at the time
            of the applying on the tooth, and the sense of use is also
            bad.<br>
            <br>
            [0018] In the composition for the caries prevention of the
            present invention, it is necessary to use (c) the viscosity
            regulator, in order to use the composition by applying on
            the tooth and to obtain the prevention effect of the caries
            by (a) the casein phosphopeptide-amorphous calcium phosphate
            complex (CPP-ACP) and/or the casein phosphopeptide-amorphous
            calcium fluoride phosphate complex (CPP-ACFP) being stayed
            in the oral cavity. As for (c) the viscosity regulator, for
            example, a natural material, such as gum guaiac, carob bean
            gum, Tara gum, tamarind seed gum, gum arabic, tragacanth
            gum, karaya gum, carrageenan, xanthan gum, gellan gum,
            curdlan, chitin, chitosan or chitosamine, an organic
            synthetic material, such as glycerin, propylene glycol,
            sodium alginate, propylene glycol ester alginate, sodium
            starch glycolate, sodium starch phosphate ester, sodium
            polyacrylate or polyvinyl pyrrolidone, or an inorganic
            synthetic material, such as calcium carbonate, calcium
            silicate, a silica fine powder, amorphous hydrous silica or
            hydrophobic silica, can be used...<br>
            <br>
            [0021] Since the composition for the caries prevention of
            the present invention is directly coated on the tooth, pH is
            adjusted in the range of 5.5 to 9.5 preferably. Although the
            method for keeping said range is not limited especially, for
            example, an aqueous solution of phosphate, which is one of
            the constitution components of the CPP-ACP and the CPP-ACFP,
            or phosphate salt is added to adjust the pH preferably...<br>
            <br>
            DETAILED DESCRIPTION OF PREFERRED EMBODIMENT<br>
            <br>
            Blending of the demineralization liquid (pH 4.8)<br>
            lactic acid: 0.1 mol/L<br>
            calcium chloride: 1.5 m.mol/L<br>
            potassium dihydrogen phosphate: 0.9 m.mol/L<br>
            sodium carboxymethylcellulose (cellogen HE-1500F, made by
            Daiichi Kogyo Seiyaku Co., Ltd.) 1% by weight<br>
            <br>
            [0043] Clearly from Table 3, it was identified that the
            composition for the caries prevention being excellent in the
            caries prevention and the stability in keeping for a long
            time, could be obtained, by selecting the specific sodium
            carboxymethylcellulose having the specific etherification
            degree and blending said sodium carboxymethylcellulose with
            the composition for the caries prevention containing the
            CPP-ACP and/or CPP-ACFP.<br>
            <br>
            [0044] The composition for the caries prevention of the
            present invention contains the CPP-ACP and/or CPP-ACFP and
            is blended with sodium carboxymethylcellulose having the
            etherification degree of 0.7 to 1.0, so that it has
            promoting effect of the remineralization and excellent
            stability in keeping for a long time. Therefore, said
            composition has the great value for contributing to dental
            medicine.<br>
            <br>
            <br>
            <b>US2008152598</b><br>
            <b> </b><br>
            DETAILED DESCRIPTION OF THE INVENTION<br>
            <br>
            [0066] In various embodiments, the present invention
            involves employing oral compositions for the stabilization,
            recalcification and remineralization of dental enamel and
            dentin and protection of teeth against tooth caries. The
            invention relates to the use of the calcium form of zeolite,
            water-soluble phosphate salts and matrix proteins of teeth
            for pH adjustment in the mouth and simultaneous building of
            calcium and phosphate ions from the oral solution into tooth
            enamel and dentin in the presence of tooth matrix proteins
            to stabilize the crystal structure of calcium hydroxyapatite
            in tooth enamel and dentin.<br>
            <br>
            [0067] As used herein, the term "dental matrix protein" is
            defined as structural and/or adhesive and include those of
            enamel. Examples of the matrix proteins of the invention are
            collagen, elastin, ameloblastin, sheathlin, However, the
            term may also include amelogenins, praline-rich
            non-amelogenins, tuftelin, tuft proteins, serum proteins and
            other proteins. The terms "matrix proteins", "dental matrix
            proteins", "enamel matrix proteins" and "matrix proteins of
            the teeth" are used interchangeably throughout the
            specification.<br>
            <br>
            [0068] Dentin is defined herein as the substance between the
            enamel or cementum and the pulp chamber. It is secreted by
            the odontoblasts of the dental pulp. An odontoblast is a
            cell involved in dentinogenesis, which is the creation of
            dentin, the substance under tooth enamel. The odontoblasts
            secrete dentin throughout life, which may be an attempt to
            compensate for natural wearing down of the enamel. These
            cells are responsible for producing the calcified dental
            matrix. The dental matrix protein is one of the dental
            noncollagenous matrix proteins that has been implicated in
            regulation of mineralization.<br>
            <br>
            [0069] Since the calcium ions are bound in the
            microcrystalline particles of inorganic carriers (zeolite),
            they are not active until "free" from the zeolite crystal
            framework. Hence it follows, that although the
            concentrations of calcium and phosphate ions in the oral
            composition are favorable (or more than favorable) for total
            remineralization, the speed of remineralization is
            controlled by the rates of release of calcium ions from the
            zeolite microcrystals during the exchange of calcium ions
            from the zeolite with other ions from the solution. The
            calcium ions released from zeolite microcrystals are
            incorporated, together with equivalent quantity of phosphate
            ions into the dental enamel and dentin, and remineralize
            them. If the composition contains dental matrix proteins,
            the same improves the above mentioned processes by its
            action as the precursor for the transformation of the
            "unripe" calcium hydroxyapatite into the "ripe" calcium
            hydroxyapatite. "Ripe" calcium hydroxyapatite is more stable
            than "unripe" calcium hydroxyapatite. The components of
            calcium hydroxyapatite; calcium ions, phosphate ions and
            dental matrix protein integrally construct the dental enamel
            and/or dentin by a self-organized process (restitutio ad
            integrum).<br>
            <br>
            [0070] In one aspect, the invention can be in the form of a
            toothpaste. In other aspects the oral composition may be in
            the form of chewing gum, gel, mouth rinse, candy, lozenge,
            film, transbuccal patch and other preparations which can be
            kept in the mouth cavity.<br>
            <br>
            [0071] In various embodiments of the oral composition, the
            extract and/or the oil of the medicinal herb milfoil may be
            present in the amounts from about 0.01 to about 0.025 wt %,
            as a mild anti-inflammatory agent.<br>
            <br>
            [0072] Although the essential role of the calcium form of
            zeolite in the oral composition for the stabilization,
            recalcification and remineralization of dental enamel
            (OKSRCD) based on this invention is supplying active calcium
            ions, the calcium form of zeolite has also another crucial
            role in the control and maintenance of optimal pH for the
            stabilization and remineralization of dental enamel and
            dentin. Table 1 shows the pH values of the liquid phases of
            the suspensions containing 1 g of the calcium form of
            zeolite (types I, II and III) in 10, 100 and 1000 ml of
            demineralized water.<br>
            [0000]<br>
            <br>
            The data in Table 1 shows that in all cases the starting pH
            of the demineralized water, i.e., 4.8 increased after
            addition of the calcium form of zeolite. <br>
            For a constant concentration of suspension, expressed as the
            volume of water in which 1 g of zeolite is suspended, pH
            decreases in the sequence: pH(type I)=7-9.2&gt;pH(type
            II)=6-8.2&gt;pH(type III)=4.92-7.6. Hence, with the increase
            of the molar ratio Si/Al in the framework structure of
            zeolite, i.e., Si/Al(type D&lt;Si/Al(type II)&lt;Si/Al(type
            III). As shown in table 1, for a given type of zeolite, pH
            depends on the concentration of suspension, so that using
            calcium form of different types of zeolites (having Si/Al in
            the range from 1 to 10) in the suspensions containing 1 g of
            zeolite in 10, 100 and 1000 ml of water, the suspensions
            having pH in the range from about 5 to 9 can be obtained...<br>
            &nbsp;<br>
            1. Mixing together water suspensions of a calcium form of
            zeolite and water solution of phosphate ions [e.g., addition
            of (Na,H)-phosphate salts into a water suspension of zeolite
            and/or addition of calcium form of zeolite into water
            solution of phosphate] considerably changes the pH of the
            mixture (see Table 3) relative to the water suspension of a
            calcium form of zeolite (see Table 1) and water solution of
            (Na,H)-phosphate (see Table 2) alone.<br>
            <br>
            2. Although the presence of a calcium form of zeolite
            considerably influences the pH value of mixtures (calcium
            form of zeolite suspended in phosphate solution; see Tables
            1-3), equilibrium pH value is determined by the type and
            concentration of the dissolved phosphate ions, but is not
            influenced by the type of zeolite and its content in the
            investigated range (0.1-10 wt. %; see Table 3 and FIG. 1)<br>
            <br>
            3. pH of the suspension of the calcium form of zeolite(s) in
            the water solution(s) of Na3PO4 does not change
            significantly with the increase of concentrations of
            PO4&lt;3-&gt; ions in the concentration range from about
            0.0001.5 mol dm&lt;-3 &gt; to about mol 0.0008 mol dm&lt;-3
            &gt; (equilibrium pH is from about 8.12 to about 8.5 in the
            concentration range of PO4&lt;3-&gt; ions; see FIG. 1). At
            concentrations of PO4&lt;3-&gt; ions higher than 0.0008 mol
            dm&lt;-3&gt; , pH increases with their increasing
            concentration and reaches the maximum pH value of about 11.7
            for concentrations of PO4&lt;-&gt; ions higher than 0.0167
            mol dm&lt;-3&gt; .<br>
            <br>
            4. pH of the suspension of the calcium form of zeolite(s) in
            the water solution(s) of Na2HPO4 changes little with the
            change of concentration of HPO4&lt;-&gt; ions; pH does
            change from about 7.80 to 8.11 when the concentration of
            HPO4&lt;-&gt; ions increased 0.00014 mol dm&lt;-3 &gt; to
            0.167 mol dm&lt;-3 &gt; (see FIG. 1).<br>
            <br>
            5. pH of the suspension of the calcium form of zeolite(s) in
            the water solution(s) of NaH2PO4 is approximately constant
            (about 7.7) for low concentrations of H2PO4&lt;-&gt; ions
            (from about 0.00017 mol dm&lt;-3 &gt; to about 0.0008 mol
            dm&lt;-3&gt; ), and progressively decreases with the
            increased concentration of H2PO4&lt;-&gt; for the
            concentration of H2PO4&lt;-&gt; higher than 0.0008 mol
            dm&lt;-3 &gt; and reaches the pH value of about 6.4 at
            concentrations of H2PO4&lt;-&gt; ions of about 0.17 mol
            dm&lt;-3 &gt; (see Table 3 and FIG. 1).<br>
            <br>
            [0080] The optimal pH (7.5-8) can be achieved by mixing a
            calcium form of zeolite (0.1-10 wt. %, regardless of the
            type) with 0.00015 mol dm&lt;-3 &gt; to about 0.0008 mol
            dm&lt;-3 &gt; solution of Na3PO4, or with 0.00014 mol
            dm&lt;-3 &gt; to 0.167 mol dm&lt;-3 &gt; solution of
            Na2HPO4, or with 0.00017 mol dm&lt;-3 &gt; to about 0.0008
            mol dm&lt;-3 &gt; solution of NaH2PO4. As shown in FIG. 1,
            pH values higher than 8 can be obtained only with Na3PO4 for
            the concentrations of PO4&lt;3-&gt; ions higher than 0.0008
            mol dm&lt;-3&gt; . At the same time, these results show that
            pH remains approximately constant when the systems
            containing PO4&lt;3-&gt; and H2PO4&lt;-&gt; are diluted by a
            factor of 5, and when the system containing HPO4&lt;2-&gt;
            ions is diluted by a factor of 1200.<br>
            <br>
            &nbsp;[0083] In order to prove the conclusion resulted from
            the investigation of the influence of pH on the stability of
            teeth, samples of teeth were treated with solutions prepared
            in the following way: (i) solution (L-Ca)o was prepared by a
            centrifugal separation of the solid phase (calcium form of
            zeolite of type I) from the suspension (1 g of the calcium
            form of zeolite in the 100 ml demineralized water; pH 8.01),
            stirred for 24 hours at room temperature and; (ii) solution
            (L-Na)o was prepared by a centrifugal separation of the
            solid phase (sodium form of zeolite of type I) from the
            suspension (1 g of the sodium form of zeolite in the 100 ml
            demineralized water; pH=10.5), stirred for 24 hours at room
            temperature. The solution (L-Ca)0 contained 0.01 mg
            Ca&lt;2+&gt; ions/cm&lt;3 &gt; (see Table 4) as a
            consequence of equilibrium of the process of substitution of
            H&lt;+&gt; ions from the water according to the equation:<br>
            [0000]<br>
            CaZ+2H2O&lt;=&gt;H2Z+Ca&lt;2+&gt; +2OH&lt;-&gt; (1)<br>
            <br>
            The results presented in Table 4 show the concentrations of
            calcium in alkaline solutions (L-Ca)1-(L-Ca)4 are
            approximately 1440 times lower than in the acidic solutions
            K1-K4, and that the concentrations of calcium in the
            alkaline solutions (L-Na)5-(L-Na)7 are approximately 5600
            times lower than in the acidic solutions K5-K7, after
            contact with the samples of teeth. This means that the
            decalcification in the alkaline solutions L-Ca and L-Na has
            been reduced more than 3 three orders of magnitude (at
            pH=8.01) or more (at pH=10.5) relative to decalcification in
            the acidic solutions K (pH=3.5). Although the greater effect
            of stabilization at a higher pH value (solution (L-Na)0;
            pH=10.5) was expected, the reduction of the concentration of
            calcium in the solution (L-Ca)0 from the starting value of
            0.01 mg/cm&lt;3 &gt; to approximately 0.0026 mg/dm&lt;3 &gt;
            clearly indicates that about 75% of calcium ions from the
            solution (L-Ca)0 was incorporated in the dental enamel
            during treatment. The alkaline environment established by
            the presence of the calcium form of zeolite not only
            significantly lowers the process of decalcification, but
            also stimulates the process of calcification.<br>
            <br>
            [0085] In order to prove the process of (re)calcification
            during treatment and to separate the influence of
            stabilization of dental enamel in the alkali environment
            from the influence of (re)calcification on the lowering of
            demineralization in the acidic medium, samples of teeth were
            been divided into two approximately equal parts, and
            thereafter the samples were treated as follows:<br>
            <br>
            The concentrations of calcium ions in the solutions after
            decalcification in the acidic medium are shown in Table 5.
            The designations A1-A3 correspond to the solutions obtained
            after decalcification of the teeth from the series A. The
            designations B1-B3 correspond to the solutions obtained
            after decalcification of the teeth from the series B. The
            designations A1-(Ca)-A3-(Ca) correspond to the solutions
            obtained after decalcification of the teeth from the series
            A, which were previously treated with the suspension
            containing 1 g of the calcium form of zeolite of type I in
            100 ml of demineralized water. The designations
            B1-(Na)-B3-(Na) correspond to the solutions obtained after
            decalcification of the teeth from the series B, which were
            previously treated with the suspension contained 1 g of the
            sodium form of zeolite of type I in 100 ml of demineralized
            water. The meaning of X+ is the percentage of the
            concentration of calcium ions in alkaline solution relative
            to the concentration of calcium ions in the corresponding
            acidic solution, e.g., X+=75% means that the concentration
            of calcium ions in alkaline solution is 75 of the
            concentration of calcium ions in the acidic solution, or in
            the other words, that the concentration of calcium ions in
            the alkaline solution is 25% (=100-X+) lower than in the
            corresponding acidic solution.<br>
            <br>
            [0086] The concentrations of calcium in the solutions
            A-(Ca)n and B-(Na)n are 9-25 lower than in the solutions An
            and Bn. However, the average lowering in the concentration
            of calcium ions in the solutions A-(Ca)n is about 19.5%,
            relative to the concentrations of calcium ions in the
            solutions An, while the average lowering in the
            concentration of calcium ions in the solutions B-(Na)n is
            about 6.4% relative to the concentrations of calcium ions in
            the solutions Bn. Hence one can conclude that the increased
            level of stabilization of teeth in the suspension of calcium
            forms of zeolite in comparison with the suspension of sodium
            form of zeolite is caused by the incorporation of calcium
            from the calcium form of zeolite into the dental enamel
            (calcification) during the treatment...<br>
            <br>
            [0088] It is important to emphasize that the rate of
            remineralization and the amount of deposited hydroxyapatite
            can be adjusted with the concentrations of phosphate and
            calcium form of zeolite in the suspension. It is especially
            important that the excess of one of the components (calcium
            or phosphate ions) does not change the chemical composition
            of deposited hydroxyapatite, i.e., that the amount of
            deposited hydroxyapatite is determined by the concentration
            of component that is in deficit (i.e., by the concentration
            of calcium ions in the mentioned case).<br>
            [0089] Based on the presented results, we conclude that the
            decreased dissolution of tooth enamel and dentin
            (demineralization, expressed as the concentration of calcium
            and/or phosphate ions), of teeth treated with the oral
            composition, relative to the untreated teeth, can be
            ascribed to the stabilization of mineral portion of tooth
            (enamel and dentin) by the activity of an excess of
            OH&lt;-&gt; ions in the mildly alkaline environment and by
            simultaneous incorporation of calcium and phosphorus from
            the oral composition into the enamel and dentin
            (remineralization). Since demineralization is a time
            dependent process and demineralization and
            (re)remineralization are parallel processes, it can be
            assumed that the time of treatment of teeth with the oral
            composition significantly influences effects of
            stabilization, (re)calcification and (re)mineralization of
            teeth.<br>
            <br>
            [0090] The results of testing of an influence of the time of
            treatment of teeth with the oral composition according to
            the invention are shown on FIG. 4. Depending on the
            cumulative time of treatment (10-300 minutes), the stability
            of dental enamel and dentin increases from 7 to 29% with
            respect to the untreated teeth (see FIG. 4). The results in
            FIG. 4 show that the value S % increases with treatment
            time; S % reached the maximum value (&gt;23%) in
            approximately 60 minutes, and further treatment does not
            have a significant effect. Therefore, one can conclude that
            the reduction of demineralization after treatment with oral
            composition is caused by deposition of hydroxyapatite on the
            surface of tooth enamel (remineralization), and by
            stabilization of the newly formed enamel under optimal pH
            conditions. It was also shown that an addition of enamel
            matrix protein in the oral composition increases the rate of
            remineralization, and at the same time increases the tooth
            stability 30-50% relative to the oral composition without
            enamel matrix protein.<br>
            <br>
            EXAMPLE 1<br>
            <br>
            [0091] Enamel matrix protein (EMP) is a component of
            mineralized tissues such as bone, dentin, cementum and
            calcified gristly. Enamel matrix protein is a significant
            component of the extracellular bone matrix and has been
            suggested to constitute approximately 8% of all
            non-collagenous proteins found in bone and cementum. Enamel
            matrix protein was originally isolated from the bovine
            cortical bone (powder) as a 23-kDa glycopeptide with high
            sialic acid content, as described in separate reports in
            Biochim. Biophys. Acta. 1965 101:327-35. Shortly modified
            protocol: Purification of enamel matrix protein isolated
            from bone powder was achieved by ion exchange chromatography
            on a DEAE-cellulose column. The eluting buffer for isolation
            of enamel matrix protein was 50 mM of sodium acetate
            containing 7 M urea and 0.5% (wt/vol) Triton X-100 at pH
            6.0. After digestion of bone powder with 7 M urea overnight
            (o/n) aliquots of 10 ml was dialysis against PBS o/n and
            lyophilized. Powder was resuspended in 0.05 M potassium
            acetate buffer pH 5.0. After equilibration of the DEAE
            columns by washing with a buffer, samples of the fractions
            were applied in a 0.05 M-acetate buffer, pH 5-0. Elution
            with a flow rate of about 10 ml/hr was carried out either
            with a linear gradient of 0.0-1.0 M NaCl in 0.05 M-acetate
            buffer, pH 5.0. One-minute fractions were collected during a
            total run time of 60 min, respectively. Fractions were
            collected between 0.6 to 0.9 M of NaCl of linear gradient
            and then dialysis against PBS o/n at +40C and lyophilized.
            The final product contains 1.32*10&lt;-4&gt; -0.1 wt. % of
            enamel matrix proteins. Enamel matrix protein in these
            examples was upregulated process of dentin mineralization
            after 7 days of therapy by our composition.<br>
            The term "upregulated" as used herein refers to the process
            by which the number of components increases in response to
            external variables...<br>
            <br>
            When the invention is used in the form of toothpaste, in
            accordance with the invention, the components are present in
            the following amounts:<br>
            [0000]<br>
            <br>
            1. Calcium form of zeolite:&nbsp; 0.1-10&nbsp; wt. %<br>
            2. Phosphate ions:&nbsp; 0.00132-2&nbsp; wt. %<br>
            3. Matrix proteins:&nbsp; 1.32 * 10&lt;-4&gt; -0.1&nbsp; wt.
            %<br>
            &nbsp;&nbsp;&nbsp; <br>
            <br>
            <b>US2008050407</b><br>
            <b> </b><br>
            SUMMARY<br>
            <br>
            [0004] The present disclosure relates to oral care products
            for the improved mineralization/remineralization of teeth of
            a consumer. In an embodiment, the present disclosure
            provides an oral product comprising a calcium salt, a
            phosphate salt, a sodium salt and a potassium salt. For
            example, the molar ratio of the sodium salt to the potassium
            salt can, in an embodiment, range from about 3 to about 4.<br>
            <br>
            DETAILED DESCRIPTION<br>
            <br>
            [0052] The present disclosure relates to oral care products
            for the improved mineralization/remineralization of teeth of
            consumer. In a general embodiment, the present disclosure
            provides an oral product comprising a calcium salt, a
            phosphate salt, a sodium salt and a potassium salt. The
            molar ratio of the sodium salt to the potassium salt can
            range be any suitable range such as, for example, from about
            3 to about 4. The phosphate salt and the sodium/potassium
            salt can originate from the same or different compounds.<br>
            <br>
            [0053] Stimulated saliva can promote mineralization through
            the addition of calcium, phosphate and buffer ions. Oral
            products such as confections and chewing gum can be designed
            with technologies that offer an effective portable and great
            tasting means to significantly enhance this baseline
            salivary mineralization rate. In embodiments, the present
            disclosures provides oral care products that promote a
            sustained high level release of ions like calcium,
            phosphate, sodium and potassium salts for an extended period
            time in the oral cavity. These ions in turn interact to
            precipitate amorphous "apatitic-like" calcium-phosphate
            (CaP) crystals which are sufficient in size to diffuse
            through a pellicle or plaque layer and lesion surface zone
            of teeth. Over time, and repeated use, these CaP crystals
            accumulate and transform to enamel-like structures that
            reconstitute the subsurface mineral matrix.<br>
            <br>
            [0054] It has been surprisingly discovered that the use of a
            combination sodium and potassium salts in an oral product
            containing a calcium salt, acts to promote upon placement of
            this composition in an oral cavity for mastication or
            consumption, for release and precipitation of the calcium,
            potassium, and phosphate ions present therein the oral
            cavity, and thus also acts to promote the subsequent
            remineralization of the teeth exposed thereto. In
            particular, this disclosure relates to the use of a sodium
            salt to potassium salt molar ratio (Na/K) of about 3.0 to
            about 4.0 in oral products. For example, this ratio is
            designed to act as a phosphate buffer system to maintain a
            physiological pH=7.4@37[deg.] C., a favorable
            remineralization environment.<br>
            <br>
            [0055] In an embodiment, the total amount of the sodium salt
            and the potassium salt comprises from about 0.01% to about
            10% by weight of the oral product. In another embodiment,
            the total amount of the sodium salt and the potassium salt
            comprises from about 6.0% to about 8.0% by weight of the
            oral product.<br>
            <br>
            [0056] Without being held to any particular theory, it is
            generally believed that, upon initial placement of the
            product in the oral cavity, calcium, phosphate, sodium and
            potassium ions are released yielding a Ca/P molar ratio of
            about 1.50 to about 2.0, preferably from about 1.50 to 1.70.
            Thus, a precipitate of potassium-substituted amorphous
            apatite can form, adhere to oral surfaces, and rapidly
            transform to enamel-like crystal layer. During acid
            challenge caused by lactic acid from oral plaque bacteria,
            dissolution of the precipitated potassium-substituted
            amorphous apatite layer re-establishes favorable
            remineralization conditions by releasing calcium and
            phosphate ions near the enamel surface of teeth.
            Surprisingly, the disclosure offers an opportunity for
            remineralization without the employment of acids to oral
            products through its unique buffer system by employing a
            molar ratio of sodium to potassium of about 3.0 to about
            4.0.<br>
            <br>
            [0057] In an embodiment, a suitable calcium salt such as,
            for example, a partially soluble calcium salt such as
            calcium citrate, is able to deliver a sustained high level
            of calcium ions from an oral product to the saliva. In
            another embodiment, a blend of soluble sodium phosphate
            dibasic and potassium-phosphate monobasic is encapsulated in
            polyvinylacetate (PVAc) (e.g. high molecular weight) to
            provide a sustained, high level delivery of phosphate ions
            (PO4) from gum to the saliva.<br>
            <br>
            [0058] The oral products of the present disclosure includes,
            but are not limited to, chewing gums, candies/confections,
            gels, toothpastes, foams, oral rinses and/or dentifrices.
            Compounds that release calcium, phosphate, potassium or
            sodium ions may be selected from a number of commercially
            available compounds, and other compounds that are recognized
            as food additives in other contexts. All such additives
            encompassed herein are intended to be non-toxic. For the
            purpose of this disclosure, the term "non-toxic" is intended
            to conform with accepted and established definitions of
            safety, such as described by the designation "generally
            accepted as safe" by the Food and Drug Administration. Also,
            encompassed in this definition are those compounds that have
            been added to food for some time and which are recognized as
            safe under conditions of their intended use. The additives
            of the disclosure, including calcium salts, are sufficiently
            non-toxic for oral use at the intended levels on a regular
            basis, and are preferably stable for a desired shelf life<br>
            <br>
            [0059] Calcium Salts<br>
            <br>
            [0060] Although different calcium salts may be employed for
            mineralization/remineralization of teeth, typical calcium
            salts include, but are not limited to, the calcium salts of
            sulfates (e.g., calcium sulfate, anhydrous calcium sulfate,
            calcium sulfate hemihydrate, calcium sulfate dihydrate),
            gluconates, (borogluconate), glycerophosphates,
            polyphosphates, lactates (lactate-gluconate, lactobionate),
            malates, citrates, tartrates, fumarates, malonates,
            nitrates, acetates, ascorbates, benzoates, bisulfites,
            carbonates, chlorides, diglutamates, disodiums,
            ferrocyanides, formates, fumarates, guanylates, sulfites,
            hydroxides, inosinates, propionates, peroxides, silicates,
            sorbates, sulfites, and succinates, as well as calcium
            oxide, calcium panthothenate, calcium 5'-ribonucleotides and
            the like, alone or in any combination. The calcium salts
            employed may be monoprotic, diprotic or triprotic.<br>
            <br>
            [0061] Potassium Salts<br>
            <br>
            [0062] Although different potassium salts may be employed
            for mineralization/remineralization of teeth, typical
            potassium salts include, but are not limited to potassium
            acetates, potassium adipates, potassium aluminium silicates,
            potassium ascorbates, potassium benzoates, potassium
            bicarbonates, potassium bisulfites, potassium bromates,
            potassium carbonates, potassium chlorides, potassium
            citrates, potassium ferrocyanides, potassium fumarates,
            potassium gluconatse potassium hydrogen sulfites, potassium
            hydroxide, potassium lactates, potassium malates, potassium
            metabisulfites, potassium nitrates, potassium nitrites,
            potassium phosphates, potassium propionates, potassium
            sodium tartrates, potassium sorbates, potassium sulfates,
            potassium sulfites, potassium tartrates and the like, alone
            or in combination. The potassium salts employed may be
            monoprotic, diprotic or triprotic.<br>
            <br>
            [0063] Sodium Salts<br>
            <br>
            [0064] A variety of sodium salts may be employed for
            mineralization/remineralization of teeth, typical sodium
            salts include, but are not limited to sodium acetates,
            sodium adipates, sodium aluminum phosphates, sodium
            ascorbates, sodium benzoates, sodium bicarbonates, sodium
            bisulfites, sodium carbonates, sodium citrates, sodium
            dehydroacetates, sodium erythorbates, sodium erythorbins,
            sodium ethyl para-hydroxybenzoates, sodium formates, sodium
            fumarates, sodium gluconates, sodium hydrogen acetates,
            sodium chlorides, sodium hydroxides, sodium lactates, sodium
            malates, sodium metabisulfites, sodium methyl
            para-hydroxybenzoates, sodium nitrates, sodium nitrites,
            sodium orthophenyl phenols, sodium propionates, sodium
            propyl para-hydroxybenzoates, sodium sorbates, sodium
            stearoyl lactylates, sodium succinates, sodium sulfites,
            sodium tartrates, sodium tetraborates, soda ash (Na2CO3),
            chile saltpeter (NaNO3), monosodium glutamate (MSG), di-,
            tri-, and tetra-sodium phosphates, and the like, alone or in
            any combination. The most common source of sodium is sodium
            chloride, but it occurs in and may be derived from many
            other minerals such as soda niter, cryolite, amphibole,
            zeolite, etc. The sodium salts employed may be monoprotic,
            diprotic or triprotic.<br>
            <br>
            [0065] Salt Separation: Encapsulation, Agglomeration
            Physical &amp; Coatings<br>
            <br>
            [0066] In an embodiment, the potassium and sodium salts
            employed are encapsulated or coated with a barrier layer, in
            order for example to limit, or substantially prevent the
            salts from interacting with one or more of the ingredients
            employed in an oral product. Physical modifications of the
            potassium and sodium salts by encapsulation with another
            substrate may increase or delay their release by modifying
            the solubility or dissolution rates of the salts. For
            example, the potassium and sodium salts may be coated with
            silicon dioxide. Still further, the potassium and sodium
            salts may be encapsulated (e.g. co-encapsulated) together
            with polyvinylacetate (PVAc). Typically, the amount of PVAc
            present in the encapsulation matrix is at least about 10% by
            weight, about 30% by weight, or about 60% by weight or more,
            the concentration potassium and sodium salts falling within
            a range of about 0.01% to about 80%, or about 20% to about
            70%, or about 30% to about 60% based on the total weight of
            the encapsulation matrix.<br>
            <br>
            [0067] Any standard technique which gives full or partial
            encapsulation of the salts can be used. These techniques
            include, but are not limited to, spray drying, spray
            chilling, fluid-bed coating, extrusion, coextrusion,
            inclusion, granulation, roll compaction and coacervation.
            These encapsulation techniques, which give full or partial
            encapsulation of the salts can be used individually or in
            combination in a single step process or multiple step
            process. For example, the salts may be spray-dried, followed
            by fluid-bed coating of the resultant powder.<br>
            <br>
            [0068] The encapsulation techniques of the potassium and
            sodium salts here described are standard coating techniques
            and generally give varying degrees of coating, from partial
            to full coating, depending on the coating composition used
            in the process. Also, the coating compositions may be
            susceptible to water permeation of varying degrees.
            Generally, coating compositions having high organic
            solubility, good film forming properties and low water
            solubility give better delayed release of the salts. Such
            compositions include, but are not limited to, acrylic
            polymers and copolymers, carboxyvinyl polymer, polyamides,
            polysterene, polyvinyl acetate, polyvinyl acetate phthalate,
            polyvinylpyrrolidone and waxes. Although all of these
            materials may be used for encapsulation of the salts,
            typically only food-grade materials should be considered.<br>
            <br>
            [0069] The polymers used for encapsulation of the sodium
            phosphate and potassium phosphate salts can have any
            suitable molecular weight. In an embodiment, the polymer(s)
            used for encapsulation of the sodium phosphate and potassium
            phosphate salts have a molecular weight of about 1.5*10&lt;3
            &gt; g/mol. The polymer(s) used for encapsulation of the
            sodium phosphate and potassium phosphate salts can have a
            molecular weight of about 80*10&lt;3 &gt; g/mol. The
            polymer(s) used for encapsulation of the sodium phosphate
            and potassium phosphate salts can also have a molecular
            weight of about 80 to about 100*10&lt;3 &gt; g/mol.
            Alternatively, the polymer(s) used for encapsulation of the
            sodium phosphate and potassium phosphate salts can have a
            molecular weight of about 150*10&lt;3 &gt; g/mol.<br>
            <br>
            [0070] Two standard food-grade coating materials that are
            good film formers but are not water soluble are shellac and
            zein. Others which are more water soluble, but are good film
            formers are materials like agar, alginates, a wide variety
            of derivatives like ethyl cellulose, methyl cellulose,
            sodium hydroxymethyl cellulose, and hydroxypropylcellulose,
            dextrin, gelatin, starches, and modified starches. These
            ingredients which are generally approved for food use give a
            fast release when used as an encapsulant for the salts. In
            an embodiment, acacia or maltodextrin is used to encapsulate
            the salts. In still another embodiment, PVAc is used to
            encapsulate the salts.<br>
            <br>
            [0071] The amount of coating or encapsulating material on
            the salts may also control the length of time of release
            from oral products. Generally, the higher the level of
            water-insoluble coating and the lower amount of salts, the
            slower the release of the salt during mastication. Also, the
            higher the usage level of a water-soluble coating, the
            slower the release rate. In an embodiment, to obtain the
            desired salt release to blend with a oral product's flavor
            release, the encapsulant is typically a minimum of about
            1.0% by weight of the coated salts. For example, the
            encapsulant is a minimum 1.0% by weight of the encapsulation
            matrix.<br>
            <br>
            [0072] Another method of giving a modified release of the
            salts is through the process of agglomeration of the salts
            with an agglomerating agent which partially coats the
            potassium and sodium salts. This method includes the step of
            mixing the salt and an agglomerating agent with a small
            amount of water or solvent. The mixture is prepared in such
            a way as to have individual wet particles in contact with
            each other so that a partial coating can be applied. After
            the water or solvent is removed, the mixture is ground and
            used as a powdered, coated product.<br>
            <br>
            [0073] Materials that can be used as agglomerating agents
            are the same as those used in encapsulation procedures
            mentioned previously. However, since the coating is only a
            partial encapsulation, and the potassium and sodium salts
            can be slightly water soluble, some agglomerating agents are
            more effective in modifying the release of the salts than
            others. Suitable agglomerating agents include, but are not
            limited to, organic polymers like acrylic polymers and
            copolymers, polyvinyl acetate (PVAc), polyvinylpyrolidone,
            waxes, shellac, and zein. Other agglomerating agents
            include, but are not limited to, agar, alginates, a wide
            range of cellulose derivatives like ethyl cellulose, methyl
            cellulose, sodium hydroxymethylcellulose,
            hydroxypropylmethyl cellulose, dextrin, gelatin, modified
            and unmodified starches, and vegetable gums like guar gum,
            locust bean gum, and carrageenan. Even though the
            agglomerated salts may be only partially coated, when the
            quantity of the coating is increased compared to the
            quantity of the salt, the release of the salt can be delayed
            longer during mastication. In an embodiment, the level of
            the agglomerating agent is at least 5% by weight of
            agglomeration matrix.<br>
            <br>
            [0074] The potassium salt and sodium salts may be coated
            together or separately. The salts may be coated in a
            two-step or multiple step process, either alone or in
            combination. The salts may be encapsulated with any of the
            materials described previously and then the encapsulated
            salts can be agglomerated as described previously to obtain
            an encapsulated/agglomerated molar ratio of sodium salt to
            potassium salt, for example, of about 3.5.<br>
            <br>
            [0075] In another embodiment, the sodium salt and/or
            potassium salt may be absorbed onto another component which
            is porous and becomes entrapped in the matrix of the porous
            component. Common materials used for absorbing the salts
            include, but are not limited to, silicas, silicates,
            pharmasorb clay, spongelike beads or microbeads, amorphous
            sugars like spray-dried dextrose, sucrose, alditols,
            amorphous carbonates and hydroxides including aluminum and
            calcium lakes, vegetable gums and other spray dried
            materials. Insoluble materials will give the salts a delayed
            release while water soluble materials will give the salts a
            fast release from an oral product.<br>
            <br>
            [0076] Depending on the type of the absorbent material and
            how it is prepared, the amount of salts that can be loaded
            onto the absorbent will vary. Generally, materials like
            polymers or spongelike beads or microbeads, amorphous sugars
            and alditols and amorphous carbonates and hydroxides absorb
            an amount equal to about 10% to about 40% of the weight of
            the absorbent. Other materials like silicas and pharmasorb
            clays may be able to absorb about 20% to about 80% of the
            weight of the absorbent.<br>
            <br>
            [0077] The general procedure for absorbing the potassium
            and/or sodium salt onto an absorbent may be characterized as
            follows: an absorbent, like fumed silica powder, can be
            mixed in a powder blender and an aqueous solution of the
            slightly water soluble salts can be sprayed onto the powder
            as mixing continues. The aqueous solution can be about 1.0%
            by weight of the salts and higher solid levels may be used
            if temperatures of up to 90[deg.] C. are used. Generally,
            water is the solvent, but other solvents like alcohol can
            also be used if approved for food use. As the powder mixes,
            the liquid is sprayed onto the powder. Spraying is stopped
            before the mix becomes damp. The still free flowing powder
            is removed from the mixer and dried to remove the water or
            other solvent, then ground to a specific particle size.<br>
            <br>
            [0078] After the salt(s) is absorbed onto an absorbent or
            fixed onto an absorbent, the potassium salt and/or sodium
            salt can be coated by encapsulation, either or fully or
            partially, as described elsewhere herein. Alternatively,
            another form of encapsulation may be used, which is by
            entrapment of an ingredient by fiber extrusion or fiber
            spinning into a polymer.<br>
            <br>
            [0079] In view of the foregoing, it is to be noted that the
            four primary methods to obtain a controlled release of the
            remineralizing/mineralizing agents (e.g. salts) of the
            present disclosure are (1) encapsulation (either fully or
            partially), (2) agglomeration, (3) fixation or absorption,
            and (4) entrapment into a extruded compound. These four
            methods may be combined in any usable manner which
            physically modifies the release or dissolvability of the
            sodium and potassium salts included in this disclosure.<br>
            <br>
            [0080] Other methods of treating the sodium salt and/or
            potassium salt to modify or physically isolate the salts
            from other ingredients may also have some effect on their
            release rate, dissolvability or stability. In an embodiment,
            the potassium salt may be added to one layer of a
            multi-layered chewing gum composition, and the sodium salt
            may be added to a different layer of the multi-layered
            chewing gum composition, and the calcium salt may be added
            to another different layer of the chewing gum composition.<br>
            <br>
            [0081] In yet another embodiment, the potassium and sodium
            salts may be encapsulated and added to the liquid inside a
            liquid center oral product. The calcium salt may be added to
            the material surrounding the liquid center. The center fill
            of an oral product may comprise one or more carbohydrate
            syrups, glycerin, thickeners, flavors, acidulants, colors,
            sweeteners in conventional amounts. The ingredients are
            combined in a conventional manner. This method of delivery
            of the sodium, potassium, and calcium salts can allow for a
            smooth release rate, and can reduce or eliminate possible
            reactions of the salts prior to consumption thereby
            enhancing release, improving remineralization/mineralization
            and yield improved shelf stability.<br>
            <br>
            [0082] Another embodiment of isolating the potassium salt
            and/or sodium salt is to use them in a coating/panning of an
            oral product. For example, pellet or ball gum is prepared as
            conventional chewing gum, but formed into pellets that are
            pillow shaped, or formed into balls. The pellets/balls can
            then be sugar or polyol coated or panned by conventional
            techniques to make a unique coated chewing gum. Depending on
            the salts employed, they can be quite stable and slightly
            water soluble, making them easy additions to a hot sugar
            solution for sugar panning. The salts can also be added as a
            powder blended with other powders often used in some types
            of panning procedures.<br>
            <br>
            [0083] Conventional panning procedures generally coat with
            sucrose, but recent advances in panning have allowed the use
            of other carbohydrate materials to be used in the place of
            sucrose. Some of these components include, but are not
            limited to, dextrose, maltose, palatinose, xylitol,
            lactitol, hydrogenated isomaltulose and other alditols, or a
            combination thereof. These materials may be blended with
            panning modifiers including, but not limiting to, gum
            Arabic, maltodextrins, corn syrups, gelatin, cellulose type
            materials like carboxymethylcellulose (CMC), or
            hydroxymethylcellulose (HMC), starch and modified starches,
            vegetable gums like alginates, locust bean gum, gum Arabic,
            guar gum, and gum tragacanth, insoluble carbonates like
            calcium carbonate or magnesium carbonate or talc.<br>
            <br>
            [0084] Antitack agents may be added as panning modifiers
            which allow the use of a variety of carbohydrates and sugar
            alcohols to be used in the development of new panned or
            coated oral products. For example, the oral products can
            include, but are not limited to, chewing gums, candies,
            pressed tablets, mints, chewy candies, hard boiled candies,
            chocolates, nougats, gels, confectionery pastes, liquids and
            the like, alone or in any combination. Flavors may also be
            added with the coating and with the salts of the disclosure
            to yield unique product characteristics.<br>
            <br>
            [0085] In yet another embodiment, another type of coating
            may be employed to isolate the potassium salt and/or sodium
            salt from each other and other oral product ingredients.
            This technique is referred to as a film coating. For
            example, a film like shellac, Zein, or cellulose-type
            material is applied onto a product, including but not
            limiting to chewing gums, candies, pressed tablets, mints,
            chewy candies, hard boiled candies, chocolates, nougats,
            gels, confectionery pastes, liquids and the like, alone or
            in any combination, forming a thin film on the surface of
            the product. The film may be applied by mixing a polymer, a
            plasticizer and a solvent (pigments are optional) and
            spraying the mixture onto surface of another product,
            coating, or material. This may be accomplished in
            conventional type panning equipment, or in more advanced
            side-vented coating pans. When a solvent like alcohol is
            used, extra precautions are needed to prevent fires and
            explosions, and specialized equipment is used.<br>
            <br>
            [0086] Some film polymers can use water as the solvent in
            film coating. Recent advances in polymer research and in
            film coating technology eliminates the problems associated
            with applying solvents to a coating. These advances make it
            possible to apply aqueous films to a variety of finished
            products, including chewing gums, candies, and the like. As
            the potassium salt and/or sodium salt employed may be
            slightly water soluble, they can be added to this aqueous
            film solution and applied with the film to another product
            surface, coating, or material. The aqueous film, or even the
            alcohol solvent film, in which the salt or salts may be
            dispersed may also contain a flavor along with the polymer
            and plasticizer. By adding the salt or salts to the
            polymer/plasticizer/solvent system, either as an emulsion or
            solution, the salt or salts can be added with sweeteners or
            flavors to balance taste. The potassium salt and/or sodium
            salt can also be dissolved in the aqueous solvent and coated
            on the surface with the aqueous film.<br>
            <br>
            [0087] Oral Products<br>
            <br>
            [0088] The present disclosure is directed to various oral
            products, including for example chewing gums (e.g., tablet
            gums, pellet or dragee gums, stick gums, compressed gums,
            co-extruded layered gums, bubble gums, etc.), candies,
            confectioneries, chocolates, gels, confectionery pastes,
            toothpastes, mouth rinses and dentifrices.<br>
            <br>
            [0089] In one embodiment, the oral product of the present
            disclosure is a chewing gum. In another embodiment, the oral
            product is a co-extruded layered gum, wherein for example
            the gum comprises one layer which comprises the calcium salt
            and either: (i) one layer which comprises the
            co-encapsulated sodium salt and potassium salt having a
            molar ratio of approximately 3:5 respectively; or, (ii) two
            layers which comprise the sodium salt in one layer and the
            potassium salt in another layer having a molar ratio of
            approximately 3:5. For example, the layer comprising the
            calcium salt can be present (i.e. sandwiched) therebetween.
            In this way, the calcium, sodium and potassium salts are
            essentially encapsulated in the gum base, and thus premature
            contact of these salts are limited, and likely,
            substantially prevented...<br>
            <br>
            [0116] Chewing gum generally conveys oral care benefits. In
            addition to mechanical cleaning of the teeth provided by the
            chewing action, saliva stimulated by chewing, flavor and
            taste from the product conveys beneficial properties in
            reducing bad breath, neutralizing acid, and the like. Saliva
            also contains beneficial polypeptides and other components
            which may improve the oral environment. These include:
            antimicrobial proteins, such as lysozyme, lactoferrin,
            peroxidases, and histatins; inhibitors of spontaneous
            crystallization, such as statherin.<br>
            <br>
            <br>
            [0128] Methods of Mineralization or Remineralization<br>
            <br>
            [0129] In general, mineralization or remineralization of a
            tooth surface may be accomplished by administering an oral
            product of the disclosure using conditions and techniques
            known in the art. Regardless of the form of the oral
            products, it is desirable for its duration in the oral
            cavity, as well as the rate at which the calcium, potassium,
            and sodium salts are released from the oral product to be
            controlled so as to optimize the effectiveness of the
            product in mineralizing or remineralizing the tooth surface.<br>
            <br>
            [0130] For example, in the case of chewing gum,
            administration typically comprises chewing the gum for at
            least mi 5 to about 60 minutes, or 10 to about 30 minutes.
            Generally, a subject is encouraged to chew the gum for a
            certain period of time for a minimum of about 5 minutes,
            about 10 minutes, about 15 minutes, about 20 minutes or
            more.<br>
            <br>
            [0131] Without being bound to any particular theory, the
            inventor of the present disclosure believes that by
            employing a calcium salt with a molar blend of about 3.0 to
            about 4.0 of sodium salt and potassium salt offers optimum
            salt solubility and mineralization/remineralization effects.
            Further, in oral products that remain in the oral cavity for
            extended periods of time, this disclosure provides a
            stability and sustained release of high levels of calcium
            and phosphate ions over long periods of time. Still further,
            this disclosure offers mineralization/remineralization
            effects without the need of incorporating a food acid to
            stimulate release of the salts from an oral product and into
            the oral cavity of a consumer for
            mineralization/remineralization effects.<br>
            <br>
            EXAMPLES<br>
            <br>
            [0132] By way of example and not limitation, the following
            examples are illustrative of various embodiments of the
            present disclosure and further illustrate experimental
            testing conducted with the oral care products in accordance
            with embodiments of the present disclosure,<br>
            <br>
            [0131] Without being bound to any particular theory, the
            inventor of the present disclosure believes that by
            employing a calcium salt with a molar blend of about 3.0 to
            about 4.0 of sodium salt and potassium salt offers optimum
            salt solubility and mineralization/remineralization effects.
            Further, in oral products that remain in the oral cavity for
            extended periods of time, this disclosure provides a
            stability and sustained release of high levels of calcium
            and phosphate ions over long periods of time. Still further,
            this disclosure offers mineralization/remineralization
            effects without the need of incorporating a food acid to
            stimulate release of the salts from an oral product and into
            the oral cavity of a consumer for
            mineralization/remineralization effects.<br>
            <br>
            [0135] Treatment Cycle:<br>
            <br>
            [0136] Artificial saliva with active treatments (1 hr, 4*
            daily)<br>
            <br>
            TABLE 1<br>
            <br>
            Quantity Dissolved&nbsp; <br>
            <br>
            Reagents&nbsp; in 1 L&nbsp; Molarity<br>
            KCl&nbsp; 1.114 g&nbsp; K, Cl: 14.9 mM<br>
            &nbsp; CaCl2-2H2O&nbsp; 0.213 g&nbsp; Ca: 1.45 mM<br>
            &nbsp; KH2PO4&nbsp; 0.738 g&nbsp; PO4: 5.4 mM<br>
            &nbsp; NaCl&nbsp; 1.658 g&nbsp; Na, Cl: 6.5 mM<br>
            &nbsp; Porcine Muscin&nbsp; 2.200 g&nbsp; Ca: P = 0.27[3]
            and&nbsp; (viscosity)&nbsp;&nbsp;&nbsp; I.S. = 0.058<br>
            <br>
            [0142] Based on the data provided, one can make the
            following observations:<br>
            <br>
            No significant dose response was observed with Ca-lactate at
            500 and 1500 ppm respectively.<br>
            <br>
            The addition of phosphate salts (709 ppm) to a Ca-lactate
            (500 ppm) solutions provided significantly higher enamel
            rehardening over Ca-lactate alone (500 and 1500 ppm
            respectively). This indicated that phosphate addition was a
            key driver for remineralization.<br>
            <br>
            A molar blend of Na/K phosphate salts provided higher enamel
            rehardening over diammonium phosphate salts at equal
            phosphate ion concentration. This indicated that Na/K
            phosphate molar blend may be a better pH buffer over the
            ammonium ion.<br>
            <br>
            At equivalent calcium and phosphate ion concentrations,
            solutions with the citrate anion provided higher enamel
            rehardening over the lactate anion. It is hypothesized the
            triprotic citrate anion could potentially provide a
            mineralization/remineralization template through
            simultaneous adsorption to the tooth surface and
            sequestering of Ca ions. The lactate anion though is
            monoprotic and may not provide this templating effect.<br>
            <br>
            At equivalent mass percent (0.38%) in solution, Ca-citrate
            (21% Ca) provided higher enamel rehardening over Ca-lactate
            (13% Ca) through the addition of higher concentrations of Ca
            ions. This indicated that greater calcium addition was a key
            driver for mineralization/remineralization.<br>
            <br>
            EXAMPLE<br>
            <br>
            Oral Care Product Formulations<br>
            [0148]<br>
            <br>
            Chewing Gum Compositions:<br>
            <br>
            Ingredients (Weight %)&nbsp; Ex. 1&nbsp; Ex. 2&nbsp; Ex.
            3&nbsp; Ex. 4&nbsp; Ex. 5&nbsp; Ex. 6&nbsp; Ex. 7<br>
            Gum Base&nbsp; 33.23&nbsp; 30.60&nbsp; 31.10&nbsp;
            35.60&nbsp; 35.1&nbsp; 34.23&nbsp; 31.87<br>
            Sorbitol&nbsp; 41.12&nbsp; 39.00&nbsp; 35.00&nbsp;
            35.50&nbsp; 35.1&nbsp; 42.72&nbsp; 41.00<br>
            Calcium citrate&nbsp; 6.75&nbsp; 7.50&nbsp; 10.00&nbsp;
            8.50&nbsp; 4.50&nbsp; *&nbsp; 3.34<br>
            Calcium glycerophosphate&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *&nbsp; *&nbsp; 7.75&nbsp; 3.34<br>
            Encapsulated sodium phosphate (47%)&nbsp; 5.00&nbsp;
            7.50&nbsp; 10.00&nbsp; *&nbsp; *&nbsp; 6.00&nbsp; 7.00<br>
            and potassium phosphate (13%)<br>
            Encapsulated sodium phosphate (35%)&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 6.00&nbsp; 12.00&nbsp; *&nbsp; *<br>
            and potassium phosphate (15%)<br>
            Calcium carbonate&nbsp; 7.00&nbsp; 7.00&nbsp; 7.00&nbsp;
            7.00&nbsp; 5.00&nbsp; 4.00&nbsp; 8.50<br>
            Glycerin&nbsp; 4.00&nbsp; 5.50&nbsp; 4.00&nbsp; 4.50&nbsp;
            5.00&nbsp; 3.00&nbsp; 2.50<br>
            Encapsulated sweetener&nbsp; 0.75&nbsp; 0.75&nbsp;
            0.75&nbsp; 0.75&nbsp; 0.25&nbsp; 1.00&nbsp; 1.25<br>
            Flavor&nbsp; 1.30&nbsp; 1.30&nbsp; 1.30&nbsp; 1.30&nbsp;
            1.50&nbsp; 1.00&nbsp; 1.00<br>
            Menthol&nbsp; 0.45&nbsp; 0.45&nbsp; 0.45&nbsp; 0.45&nbsp;
            0.75&nbsp; *&nbsp; *<br>
            Color&nbsp; 0.15&nbsp; 0.15&nbsp; 0.15&nbsp; 0.15&nbsp;
            0.05&nbsp; 0.15&nbsp; 0.15<br>
            WS-23&nbsp; 0.15&nbsp; 0.15&nbsp; 0.15&nbsp; 0.15&nbsp;
            0.50&nbsp; *&nbsp; *<br>
            High intensity sweetener&nbsp; 0.10&nbsp; 0.10&nbsp;
            0.10&nbsp; 0.10&nbsp; 0.25&nbsp; 0.15&nbsp; 0.05<br>
            Total Weight %&nbsp; 100%&nbsp; 100%&nbsp; 100%&nbsp;
            100%&nbsp; 100%&nbsp; 100%&nbsp; 100%<br>
            [0149]<br>
            <br>
            TABLE 5<br>
            <br>
            Chewing Gum Compositions:<br>
            <br>
            Ingredients (Weight %)&nbsp; Ex. 8&nbsp; Ex. 9&nbsp; Ex.
            10&nbsp; Ex. 11&nbsp; Ex. 12&nbsp; Ex. 13<br>
            Sugar&nbsp; 50.50&nbsp; 32.30&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *<br>
            Xylitol&nbsp; *&nbsp; 32.30&nbsp; 63.60&nbsp; *&nbsp;
            *&nbsp; *<br>
            Sorbitol&nbsp; *&nbsp; *&nbsp; *&nbsp; 63.60&nbsp;
            40.90&nbsp; 20.00<br>
            Mannitol&nbsp; *&nbsp; *&nbsp; *&nbsp; *&nbsp; 12.00&nbsp;
            25.00<br>
            Gum Base&nbsp; 19.20&nbsp; 19.20&nbsp; 19.60&nbsp;
            19.60&nbsp; 25.50&nbsp; 30.00<br>
            Corn syrup&nbsp; 15.90&nbsp; 1.40&nbsp; *&nbsp; *&nbsp;
            *&nbsp; *<br>
            Glycerin&nbsp; 1.40&nbsp; 12.90&nbsp; 12.90&nbsp;
            12.90&nbsp; 5.60&nbsp; 8.00<br>
            Cooling Agent&nbsp; 0.20&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 0.50<br>
            Flavor&nbsp; 0.80&nbsp; 0.90&nbsp; 0.90&nbsp; 0.90&nbsp;
            1.00&nbsp; 1.50<br>
            Encapsulated sodium phosphate (47%)&nbsp; *&nbsp; *&nbsp;
            *&nbsp; *&nbsp; *&nbsp; 7.50<br>
            and potassium phosphate (13%)<br>
            Encapsulated Sodium Phosphate&nbsp; 3.00&nbsp; *&nbsp;
            3.00&nbsp; *&nbsp; 4.00&nbsp; *<br>
            Encapsulated Potassium Phosphate&nbsp; 3.00&nbsp; *&nbsp;
            *&nbsp; 3.00&nbsp; 4.00&nbsp; *<br>
            Encapsulated Calcium citrate&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 7.00&nbsp; *<br>
            Calcium Citrate&nbsp; 6.00&nbsp; 6.00&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 7.50<br>
            Total Weight %&nbsp; 100%&nbsp; 100%&nbsp; 100%&nbsp;
            100%&nbsp; 100%&nbsp; 100%<br>
            [0150]<br>
            <br>
            TABLE 6<br>
            <br>
            Coating Compositions<br>
            <br>
            Ingredients (Weight %)&nbsp; Ex. 14&nbsp; Ex. 15&nbsp; Ex.
            16&nbsp; Ex. 17&nbsp; Ex. 18&nbsp; Ex. 19<br>
            <br>
            Xylitol&nbsp; 90.00&nbsp; 90.00&nbsp; 87.74&nbsp; *&nbsp;
            *&nbsp; *<br>
            Maltitol&nbsp; *&nbsp; *&nbsp; *&nbsp; 80.10&nbsp;
            74.70&nbsp; 67.2<br>
            Maltitol Powder&nbsp; *&nbsp; *&nbsp; *&nbsp; 10.00&nbsp;
            15.00&nbsp; 20.00<br>
            Gum Arabic&nbsp; 4.00&nbsp; 5.00&nbsp; 7.00&nbsp; 8.50&nbsp;
            7.50&nbsp; 9.00<br>
            Flavor&nbsp; 0.50&nbsp; 0.50&nbsp; 0.66&nbsp; 0.70&nbsp;
            0.90&nbsp; 0.5<br>
            Titanium Dioxide&nbsp; 0.50&nbsp; 0.84&nbsp; -&nbsp;
            0.50&nbsp; 0.50&nbsp; 0.5<br>
            Talc&nbsp; 0.10&nbsp; 0.10&nbsp; 0.10&nbsp; 0.10&nbsp;
            0.10&nbsp; 0.2<br>
            Wax&nbsp; 0.10&nbsp; 0.10&nbsp; 0.10&nbsp; 0.10&nbsp;
            0.10&nbsp; 0.2<br>
            Color&nbsp; *&nbsp; *&nbsp; 1.40&nbsp; *&nbsp; 0.20&nbsp;
            0.40<br>
            Encapsulated sodium phosphate (47%)&nbsp; 4.80&nbsp; *&nbsp;
            *&nbsp; *&nbsp; *&nbsp; *<br>
            and potassium phosphate (13%)<br>
            Encapsulated Sodium Phosphate&nbsp; *&nbsp; *&nbsp;
            3.00&nbsp; *&nbsp; *&nbsp; *<br>
            Encapsulated Potassium Phosphate&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 3.00&nbsp; *&nbsp; *<br>
            Encapsulated Calcium citrate&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 1.00&nbsp; *<br>
            Sodium Phosphate&nbsp; *&nbsp; *&nbsp; *&nbsp; *&nbsp;
            *&nbsp; 2.00<br>
            Calcium Citrate&nbsp; *&nbsp; 4.00&nbsp; *&nbsp; *&nbsp;
            *&nbsp; *<br>
            Total Dry Weight %&nbsp; 100%&nbsp; 100%&nbsp; 100%&nbsp;
            100%&nbsp; 100%&nbsp; 100%<br>
            [0151]<br>
            <br>
            TABLE 7<br>
            <br>
            Hard Candy Compositions<br>
            <br>
            Ingredients (Weight %)&nbsp; Ex. 20&nbsp; Ex. 21&nbsp; Ex.
            22&nbsp; Ex. 23&nbsp; Ex. 24<br>
            Corn Syrup&nbsp; 37.00&nbsp; *&nbsp; *&nbsp; 45.3&nbsp; *<br>
            Sugar&nbsp; 46.50&nbsp; *&nbsp; *&nbsp; 45.0&nbsp; *<br>
            Polyalcohol&nbsp; *&nbsp; 86.30&nbsp; 80.00&nbsp; *&nbsp;
            92.8<br>
            Flavor&nbsp; 1.00&nbsp; 3.00&nbsp; 2.00&nbsp; 5.0&nbsp; 3.5<br>
            Color&nbsp; 0.50&nbsp; 0.50&nbsp; 1.00&nbsp; 0.5&nbsp; 0.4<br>
            Encapsulated sodium and potassium&nbsp; 7.50&nbsp;
            5.00&nbsp; 8.50&nbsp; *&nbsp; 3.00<br>
            phosphate (50% sodium phosphate<br>
            and 10% potassium phosphate)<br>
            Calcium Citrate&nbsp; 7.50&nbsp; 5.00&nbsp; 8.50&nbsp;
            4.00&nbsp; *<br>
            High Intensity Sweetener&nbsp; *&nbsp; 0.20&nbsp; *&nbsp;
            0.20&nbsp; 0.3<br>
            Total Dry Weight %&nbsp; 100%&nbsp; 100%&nbsp; 100%&nbsp;
            100%&nbsp; 100%<br>
            [0152]<br>
            <br>
            TABLE 8<br>
            <br>
            Pressed Mint Compositions<br>
            <br>
            Ingredients (Weight %)&nbsp; EX. 25&nbsp; EX. 26&nbsp; EX.
            27&nbsp; EX. 28&nbsp; EX. 29<br>
            Sorbitol&nbsp; 82.85&nbsp; 93.85&nbsp; 87.85&nbsp;
            96.85&nbsp; 94.85<br>
            Flavor&nbsp; 1.00&nbsp; 1.00&nbsp; 1.00&nbsp; 1.00&nbsp;
            1.00<br>
            Mg Stearate&nbsp; 0.95&nbsp; 0.95&nbsp; 0.95&nbsp;
            0.95&nbsp; 0.95<br>
            High Intensity Sweetener&nbsp; 0.20&nbsp; 0.20&nbsp;
            0.20&nbsp; 0.20&nbsp; 0.20<br>
            Encapsulated sodium and potassium&nbsp; 7.50&nbsp;
            2.00&nbsp; 5.00&nbsp; *&nbsp; 1.00<br>
            phosphate (50% sodium phosphate<br>
            and 10% potassium phosphate)<br>
            Calcium Citrate&nbsp; 7.50&nbsp; 2.00&nbsp; 5.00&nbsp;
            1.00&nbsp; 2.00<br>
            Total Dry Weight %&nbsp; 100%&nbsp; 100%&nbsp; 100%&nbsp;
            100%&nbsp; 100%<br>
            [0153]<br>
            <br>
            TABLE 9<br>
            <br>
            Oral Rinse Composition<br>
            <br>
            &nbsp; Ingredients (Weight %)&nbsp; Ex. 30&nbsp; Ex.
            31&nbsp; Ex. 32<br>
            <br>
            &nbsp; Calcium citrate&nbsp; 10.00&nbsp; *&nbsp; *<br>
            &nbsp; Sodium phosphate and&nbsp; *&nbsp;&nbsp; 8.00&nbsp; *<br>
            &nbsp; potassium phosphate in a&nbsp; molar ratio of 3:4<br>
            &nbsp; Chlorhexidene gluconate&nbsp; *&nbsp; *&nbsp;&nbsp;
            0.12%<br>
            &nbsp; Ethanol&nbsp; 11.60&nbsp; 11.60&nbsp; 11.60<br>
            &nbsp; Sodium saccharin&nbsp;&nbsp; 0.15&nbsp;&nbsp;
            0.15&nbsp;&nbsp; 0.15<br>
            &nbsp; FD&amp;C Blue No. 1&nbsp;&nbsp; 0.001&nbsp;&nbsp;
            0.001&nbsp;&nbsp; 0.001<br>
            &nbsp; Peppermint oil&nbsp;&nbsp; 0.50&nbsp;&nbsp;
            0.50&nbsp;&nbsp; 0.50<br>
            &nbsp; Glycerin&nbsp; 10.00&nbsp; 10.00&nbsp; 10.00<br>
            &nbsp; Tween&nbsp; 50.00&nbsp; 50.00&nbsp; 50.00<br>
            &nbsp; Water&nbsp; 17.74&nbsp; 19.74&nbsp; 27.63<br>
            &nbsp; Total Weight %&nbsp; 100% &lt; &gt;&nbsp;&nbsp; 100%
            &lt; &gt;&nbsp;&nbsp; 100% &lt; &gt;<br>
            <br>
            [0154] Example 33: Examples 30 and 31 are kept in separate
            chambers of an oral mouthrinse composition and upon
            dispensing the mouthrinse they are released into the oral
            cavity of a consumer simultaneously.<br>
            <br>
            [0155] Example 34: Examples 30, 31 and 32 are kept in
            separate chambers of an oral mouthrinse composition and upon
            dispensing the mouthrinse they are released into the oral
            cavity of a consumer simultaneously.<br>
            <br>
            [0156] Example 35: Example 30 is used a liquid center in a
            multilayered chewing gum composition with the chewing gum of
            Example 4 and the coating composition of Example 15.<br>
            &nbsp;&nbsp;&nbsp; <br>
            &nbsp;&nbsp;&nbsp; <br>
            <b>WO2011031606 (A2)</b><br>
            <b> </b><b>DENTAL PROPHYLACTIC PASTE</b><br>
            <b> </b><br>
            The inventors of the present invention have discovered that
            remineralization properties can be achieved while providing
            improved handability by controlling the ratio of the
            moisture retention agent, water, and silicate matrix to the
            total amount of calcium and phosphate salts and when
            present, fluoride containing compounds. In particular, it is
            desirable that the silicate matrix and a total amount of the
            calcium and phosphate in the paste be present in a ratio
            that ranges from about 0.25:1 to 0.75:1. In a preferred
            embodiment, the amount of sodium silicate and methyl
            salicylate and a total amount of the calcium and phosphate
            salts and fluoride containing compounds in the prophy paste
            are present in a ratio ranging from about 0.15 to 0.3:1.<br>
            <br>
            Further, it is also desirable for the moisture retention
            agent and a total amount of the calcium and phosphate salts
            in the paste be present in a ratio ranging from about 1.5:1
            to 5.5:1. In a preferred embodiment, the ratio of the
            silicate matrix to the total amount of the calcium and
            phosphate in the paste is about 0.3:1. In one embodiment,
            the water and a total amount of the calcium and phosphate
            salts in the paste are present in a ratio from about 0.4:1.
            In further embodiments, the amount water and a total amount
            of the calcium and phosphate salts and fluoride containing
            compound in the prophy paste are present in a ratio ranging
            from about 0.1 :1 to 0.3:1 , with a ratio of about 0.2:1
            being somewhat more preferred. The prophy may also include
            abrasive agents. Suitable abrasive agents include amorphous
            aluminum silicate, also commonly known as pumice, fused
            sodium potassium aluminum silicate, also commonly know as
            perilite, diatomaceous earth, and combinations thereof. When
            present, the amount of abrasive agent generally ranges from
            about 24 to 48 weight percent, based on the total weight of
            the prophy paste, and in particular from about 26 to 44
            weight percent, and more particularly from about 28 to 42
            weight percent. Preferably, the ratio of abrasive agent to
            the total amount of calcium and phosphate salts and fluoride
            in the paste ranges from about 1.5:1 to 3.5:1 , with a ratio
            ranging from about 1.5:1 to 3:1 being somewhat more
            preferred, and a ratio of 2:1 to 3:1 , being even more
            preferred.<br>
            <br>
            In one embodiment, the present invention provides a dental
            prophylactic paste having low splattering and
            remineralization properties comprising from about 3 to 6
            weight percent of a phosphate salt, from about 2 to 12
            weight percent of a calcium salt; from about 0.02 to 12
            weight percent of a fluoride containing compound, from about
            1 to 8 weight percent of a combination of an alkali silicate
            and a salicylate, from about 0.02 to 2 weight percent of
            sodium carboxymethyl cellulose, from about 36 to 42 weight
            percent glycerin, from about 2 to 6 percent water, and from
            about 24 to 48 weight percent of an abrasive agent. <br>
            <br>
            <br>
            While not wishing to be bound by theory, it believed that
            the calcium, phosphate, and fluoride ions diffuse through
            the tooth surface to remineralize the demineralized tooth
            enamel. In one embodiment, the prophy paste is applied to a
            patient's tooth enamel using a rapidly rotating rubber cup
            or cup brush during a routine dental professional cleaning.
            While the length of contact time between the paste and tooth
            surface is not critical, it is desirable for the time to be
            great enough to allow the calcium, phosphate, and when
            present, fluoride ions, to remineralize the demineralized
            portions of the tooth. Generally, it is desirable for the
            prophy paste to remain in contact with the tooth surface for
            at least 10 seconds prior rinsing.<br>
            <br>
            Suitable water-soluble calcium compounds include calcium
            chloride, calcium bromide, calcium nitrate, calcium acetate,
            calcium gluconate, calcium benzoate, calcium
            glycerophosphate, calcium formate, calcium fumarate, calcium
            lactate, calcium butyrate and calcium isobutyrate, calcium
            malate, calcium maleate, calcium propionate, calcium
            valerate or mixtures of water-soluble calcium compounds. In
            a preferred embodiment, the water-soluble calcium compound
            comprises calcium malate. Typically, the concentration of
            the water-soluble calcium compound in the prophy paste is
            from about 1 to 15 weight percent, based on the total weight
            of the composition, and in particular, from about 2 to 12
            weight percent. In a preferred embodiment, the amount of the
            water- soluble calcium compound is from about 6 to 10 weight
            percent.<br>
            <br>
            Suitable water-soluble inorganic phosphates within the scope
            of the present invention are, for example, alkali salts and
            ammonium salts of orthophosphoric acid, such as potassium,
            sodium or ammonium orthophosphate, monopotassium phosphate,
            dipotassium phosphate, tripotassium phosphate, monosodium
            phosphate, disodium phosphate and trisodium phosphate and
            tricalcium phosphate. In a preferred<br>
            embodiment, the water-soluble phosphate compound comprises
            disodium hydrogen phosphate or tricalcium phosphate.
            Typically, the concentration of the water-soluble phosphate
            compound in the prophy paste is from about 1 to 15 weight
            percent, based on the total weight of the composition, and
            in particular, from about 2 to 12 weight percent. In a
            preferred embodiment, the amount of the water-soluble
            phosphate compound is from about 3 to 8 weight percent.<br>
            <br>
            In order to effect remineralization of the dental enamel, an
            effective amount of the desired cations and anions must be
            employed in the oral cavity. Preferably, the concentration
            of the calcium ions in the mouth during application of the
            prophy paste is at least about 2 milligram/gram, and more
            preferably more than about 15 milligrams/grams. Preferably,
            the concentration of the phosphate ions in the mouth during
            application of the prophy paste is at least about 2
            milligram/gram, and more preferably more than about 5
            milligrams/grams. Preferably, the concentration of the
            fluoride ions in the mouth during application of the prophy
            paste is at least about 2 milligram/gram, and more
            preferably more than about 10 milligrams/grams.<br>
            In addition to the remineralization properties discussed
            above, prophy pastes in accordance with the present
            invention also exhibits excellent handability in relation to
            the manufacturing process as well as use by the end user. In
            particular, the prophy paste demonstrates little to no
            splattering during the step of loading the paste into the
            cup of the applicator tip as well as when the paste is
            applied to the teeth of the dental patient.<br>
            <br>
            The desirable handability properties of the inventive prophy
            pastes are due in part to the combination of the silicate
            matrix, water, and moisture retention agent.<br>
            <br>
            Further, it has been discovered that by selecting the
            appropriate ratio of the remineralization components (e.g.,
            calcium, phosphate, fluoride) to the silicate matrix
            components, moisture retention agent, and water, prophy
            pastes having remineralization properties as well as
            improved handability can be achieved. Further the desirable
            handability / splatter control properties are achieved
            within the scope of the inventive prophy paste when the
            combination ratios of remineralization components to
            silicate matrix is about 3 to about 5.5 to 1 ,
            remineralization components to moisture retention agents is
            about 0.4 to about 0.6 to 1 and remineralization components
            to water is about 3 to about 13 to 1 with the ratio of 6 to
            about 10 to 1 being preferred.<br>
            <br>
            Alkali metal silicates that can be used in the present
            invention includes sodium silicate and potassium silicate,
            and combinations thereof. The alkali metal silicate is
            typically present in an amount ranging from about 2 to 10
            weight percent, based on the total weight of the
            composition, and in particular, from about 3 to 6 weight
            percent. Salicylates that can be used in accordance with the
            present invention include methyl salicylate, also commonly
            known as sweet birch oil or oil of wintergreen.<br>
            <br>
            In a preferred embodiment, the silicate matrix comprises a
            combination of sodium silicate, methyl salicylate and sodium
            carboxymethycellulose. In this<br>
            embodiment, the sodium silicate and methyl salicylate
            together form the silicate matrix of the composition in the
            ratios of sodium silicate 2.0 to 6.0 to methyl salicylate
            0.1 to 1.2 parts.<br>
            <br>
            Glycerin is a preferred moisture retention agent.<br>
            <br>
            <br>
            TABLE 1<br>
            Sample 1 : Course Grit<br>
            Ingredient Name (% w/w)<br>
            Purified Water 1.40<br>
            Glycerin 37.00<br>
            Calcium Malate 8.00<br>
            Sodium MFP 9.40<br>
            Sodium Phosphate Dibasic 5.00<br>
            Sodium Silicate 5.00<br>
            Methyl Salicylate 0.80<br>
            Pumice 0 6.25<br>
            Pumice FF 25.0<br>
            Flavorant 0.90<br>
            Sodium Carboxymethyl Cellulose 0.05<br>
            Sodium Saccharin 0.04<br>
            Monosodium Phosphate 0.16<br>
            Red 40 1 %/Glycerin 1.00<br>
            Total 100 TABLE 2<br>
            Sample 2: Medium Grit<br>
            Ingredient Name I (% w/w)<br>
            Purified Water 1.65<br>
            Glycerin 37.00<br>
            Calcium Malate 8.00<br>
            Sodium MFP 9.40<br>
            Sodium Phosphate Dibasic 5.00<br>
            Sodium Silicate 5.00<br>
            Methyl Salicylate 0.80<br>
            Pumice FF 31.00<br>
            Flavorant 0.90<br>
            Socium Carboxymethyl Cellulose 0.05<br>
            Sodium Saccharin 0.04<br>
            Monosodium Phosphate 0.16<br>
            Blue #1/Blue #2/Glycerin 1.00<br>
            Total i 100<br>
            <br>
            <br>
            <b>US2008247973</b><br>
            <b> </b><br>
            [0010] The present invention relates to oral care
            compositions comprising selected surface-active
            organophosphate compounds to provide protection of teeth
            from erosion caused by the action of chemicals, such as
            harsh abrasives and acids. The surface-active
            organophosphate compounds are substantive to teeth, the
            phosphate groups binding the calcium in teeth and thus
            preventing loss of calcium from dissolution when contacted
            with acids.&nbsp; <br>
            <br>
            ...Examples of suitable agents include alkyl and alkyl
            (poly)alkoxy phosphates such as lauryl phosphate (tradenames
            MAP 230K and MAP 230T from Croda); PPG5 ceteareth-10
            phosphate (available from Croda under the tradename
            Crodaphos SG); Laureth-1phosphate (tradenames MAP L210 from
            Rhodia, Phosten HLP-1 from Nikkol Chemical or Sunmaep L from
            Sunjin); Laureth-3 phosphate (tradenames MAP L130 from
            Rhodia or Foamphos L-3 from Alzo or Emphiphos DF 1326 from
            Huntsman Chemical); Laureth-9 phosphate (tradename Foamphos
            L-9 from Alzo); Trilaureth-4 phosphate (tradenames Hostaphat
            KL 340D from Clariant or TLP-4 from Nikkol Chemical); C12-18
            PEG 9 phosphate (tradename Crafol AP261 from Cognis); Sodium
            dilaureth-10 phosphate (tradename DLP-10 from Nikkol
            Chemical). Particularly preferred agents are polymeric, for
            example those containing repeating alkoxy groups as the
            polymeric portion, in particular 3 or more ethoxy, propoxy
            isopropoxy or butoxy groups.<br>
            [0027] Additional suitable polymeric organophosphate agents
            include dextran phosphate, polyglucoside phosphate, alkyl
            polyglucoside phosphate, polyglyceryl phosphate, alkyl
            polyglyceryl phosphate, polyether phosphates and alkoxylated
            polyol phosphates. Some specific examples are PEG phosphate,
            PPG phosphate, alkyl PPG phosphate, PEG/PPG phosphate, alkyl
            PEG/PPG phosphate, PEG/PPG/PEG phosphate, dipropylene glycol
            phosphate, PEG glyceryl phosphate, PBG (polybutylene glycol)
            phosphate, PEG cyclodextrin phosphate, PEG sorbitan
            phosphate, PEG alkyl sorbitan phosphate, and PEG methyl
            glucoside phosphate.<br>
            <br>
            [0028] Suitable non-polymeric phosphates include alkyl mono
            glyceride phosphate, alkyl sorbitan phosphate, alkyl methyl
            glucoside phosphate, alkyl sucrose phosphates.<br>
            <br>
            [0030] The amount of organophosphate agent required is an
            effective amount to provide the protection from erosion due
            to acid or abrasive challenges. Preferably, the protection
            will last for at least about an hour after use of the
            composition. An effective amount of organophosphate agent
            will typically be from about 0.01% to about 35%, preferably
            from about 0.035% to about 20%, more preferably from about
            0.035% to about 10%, and most preferably from about 0.035%
            to about 5%, by weight of the total oral composition.<br>
            <br>
            [0036] The present compositions may comprise a metal ion
            source that provides stannous ions, zinc ions, copper ions,
            or mixtures thereof as antimicrobial agent. The metal ion
            source can be a soluble or a sparingly soluble compound of
            stannous, zinc, or copper with inorganic or organic counter
            ions. Examples include the fluoride, chloride,
            chlorofluoride, acetate, hexafluorozirconate, sulfate,
            tartrate, gluconate, citrate, malate, glycinate,
            pyrophosphate, metaphosphate, oxalate, phosphate, carbonate
            salts and oxides of stannous, zinc, and copper.<br>
            <br>
            [0037] Stannous, zinc and copper ions have been found to
            help in the reduction of gingivitis, plaque, sensitivity,
            and improved breath benefits. An effective amount is defined
            as from at least about 50 ppm to about 20,000 ppm metal ion
            of the total composition, preferably from about 500 ppm to
            about 15,000 ppm. More preferably, metal ions are present in
            an amount from about 3,000 ppm to about 13,000 ppm and even
            more preferably from about 5,000 ppm to about 10,000 ppm.
            This is the total amount of metal ions (stannous, zinc,
            copper and mixtures thereof) for delivery to the tooth
            surface.<br>
            <br>
            [0038] Dentifrices containing stannous salts, particularly
            stannous fluoride and stannous chloride, are described in
            U.S. Pat. No. 5,004,597 to Majeti et al. Other descriptions
            of stannous salts are found in U.S. Pat. No. 5,578,293
            issued to Prencipe et al. and in U.S. Pat. No. 5,281,410
            issued to Lukacovic et al. In addition to the stannous ion
            source, other ingredients needed to stabilize the stannous
            may also be included, such as the ingredients described in
            Majeti et al. and Prencipe et al.<br>
            <br>
            [0039] The preferred stannous salts are stannous fluoride
            and stannous chloride dihydrate. Other suitable stannous
            salts include stannous acetate, stannous tartrate and sodium
            stannous citrate. Examples of suitable zinc ion sources are
            zinc oxide, zinc sulfate, zinc chloride, zinc citrate, zinc
            lactate, zinc gluconate, zinc malate, zinc tartrate, zinc
            carbonate, zinc phosphate, and other salts listed in U.S.
            Pat. No. 4,022,880. Zinc citrate and zinc lactate are
            particularly preferred. Examples of suitable copper ion
            sources are listed in U.S. Pat. No. 5,534,243. The combined
            metal ion source(s) will be present in an amount of from
            about 0.05% to about 11%, by weight of the final
            composition. Preferably, the metal ion sources are present
            in an amount of from about 0.5 to about 7%, more preferably
            from about 1% to about 5%. Preferably, the stannous salts
            may be present in an amount of from about 0.1 to about 7%,
            more preferably from about 1% to about 5%, and most
            preferably from about 1.5% to about 3% by weight of the
            total composition. The amount of zinc or copper salts used
            in the present invention ranges from about 0.01 to about 5%,
            preferably from about 0.05 to about 4%, more preferably from
            about 0.1 to about 3.0%....<br>
            <br>
            Anticalculus Agent<br>
            <br>
            [0041] The present compositions may optionally include an
            anticalculus agent, such as a pyrophosphate salt as a source
            of pyrophosphate ion. The pyrophosphate salts useful in the
            present compositions include the mono-, di- and tetraalkali
            metal pyrophosphate salts and mixtures thereof. Disodium
            dihydrogen pyrophosphate (Na2H2P2O7), sodium acid
            pyrophosphate, tetrasodium pyrophosphate (Na4P2O7), and
            tetrapotassium pyrophosphate (K4P2O7) in their unhydrated as
            well as hydrated forms are the preferred species. In
            compositions of the present invention, the pyrophosphate
            salt may be present in one of three ways: predominately
            dissolved, predominately undissolved, or a mixture of
            dissolved and undissolved pyrophosphate.<br>
            [0042] Compositions comprising predominately dissolved
            pyrophosphate refer to compositions where at least one
            pyrophosphate ion source is in an amount sufficient to
            provide at least about 0.025% free pyrophosphate ions. The
            amount of free pyrophosphate ions may be from about 1% to
            about 15%, from about 1.5% to about 10% in one embodiment,
            and from about 2% to about 6% in another embodiment. Free
            pyrophosphate ions may be present in a variety of protonated
            states depending on the pH of the composition.<br>
            <br>
            [0043] Compositions comprising predominately undissolved
            pyrophosphate refer to compositions containing no more than
            about 20% of the total pyrophosphate salt dissolved in the
            composition, preferably less than about 10% of the total
            pyrophosphate dissolved in the composition. Tetrasodium
            pyrophosphate salt is a preferred pyrophosphate salt in
            these compositions. Tetrasodium pyrophosphate may be the
            anhydrous salt form or the decahydrate form, or any other
            species stable in solid form in the dentifrice compositions.
            The salt is in its solid particle form, which may be its
            crystalline and/or amorphous state, with the particle size
            of the salt preferably being small enough to be
            aesthetically acceptable and readily soluble during use. The
            amount of pyrophosphate salt useful in making these
            compositions is any tartar control effective amount,
            generally from about 1.5% to about 15%, preferably from
            about 2% to about 10%, and most preferably from about 3% to
            about 8%, by weight of the dentifrice composition.<br>
            <br>
            [0045] The pyrophosphate salts are described in more detail
            in Kirk-Othmer Encyclopedia of Chemical Technology, Third
            Edition, Volume 17, Wiley-Interscience Publishers (1982).<br>
            <br>
            [0046] Optional agents to be used in place of or in
            combination with the pyrophosphate salt include such known
            materials as longer chain (3 or more) polyphosphates
            including tripolyphosphate, tetrapolyphosphate and
            hexametaphosphate; synthetic anionic polymers, including
            polyacrylates and copolymers of maleic anhydride or acid and
            methyl vinyl ether (e.g., Gantrez), as described, for
            example, in U.S. Pat. No. 4,627,977, to Gaffar et al. as
            well as, e.g., polyamino propane sulfonic acid (AMPS),
            diphosphonates (e.g., EHDP; AHP), polypeptides (such as
            polyaspartic and polyglutamic acids), and mixtures thereof.<br>
            <br>
            Other Active Agents<br>
            <br>
            [0047] Still another active agent that may be included in
            the present compositions is a tooth bleaching active
            selected from the group consisting of peroxides, perborates,
            percarbonates, peroxyacids, persulfates, and combinations
            thereof. Suitable peroxide compounds include hydrogen
            peroxide, urea peroxide, calcium peroxide, sodium peroxide,
            zinc peroxide and mixtures thereof. A preferred percarbonate
            is sodium percarbonate. Preferred persulfates are <b>oxones</b>.<br>
            <br>
            [0048] Preferred peroxide sources for use in dentifrice
            formulations are calcium peroxide and urea peroxide.
            Hydrogen peroxide and urea peroxide are preferred for use in
            mouthrinse formulations. The following amounts represent the
            amount of peroxide raw material, although the peroxide
            source may contain ingredients other than the peroxide raw
            material. The present composition may contain from about
            0.01% to about 30%, preferably from about 0.1% to about 10%,
            and more preferably from about 0.5% to about 5% of a
            peroxide source, by weight of the composition.<br>
            <br>
            [0049] In addition to whitening, the peroxide also provides
            other benefits to the oral cavity. It has long been
            recognized that hydrogen peroxide and other
            peroxygen-compounds are effective in curative and/or
            prophylactic treatments with respect to caries, dental
            plaque, gingivitis, periodontitis, mouth odor, recurrent
            aphthous ulcers, denture irritations, orthodontic appliance
            lesions, postextraction and postperiodontal surgery,
            traumatic oral lesions and mucosal infections, herpetic
            stomatitis and the like. Peroxide-containing agents in the
            oral cavity exert a chemomechanical action generating
            thousands of tiny oxygen bubbles produced by interaction
            with tissue and salivary enzymes. The swishing action of a
            mouthrinse enhances this inherent chemomechanical action.
            Such action has been recommended for delivery of other
            agents into infected gingival crevices. Peroxide mouthrinses
            thus prevent colonization and multiplication of anaerobic
            bacteria known to be associated with periodontal disease.<br>
            <br>
            [0050] Another optional active agent that may be added to
            the present compositions is a dentinal desensitizing agent
            to control hypersensitivity, such as salts of potassium,
            calcium, strontium and tin including nitrate, chloride,
            fluoride, phosphates, pyrophosphate, polyphosphate, citrate,
            oxalate and sulfate.<br>
            <br>
            Tooth Substantive Agent<br>
            <br>
            [0051] The present invention may include a tooth substantive
            agent such as polymeric surface active agents (PMSA's),
            which are polyelectrolytes, more specifically anionic
            polymers. The PMSA's contain anionic groups, e.g.,
            phosphate, phosphonate, carboxy, or mixtures thereof, and
            thus, have the capability to interact with cationic or
            positively charged entities. The "mineral" descriptor is
            intended to convey that the surface activity or
            substantivity of the polymer is toward mineral surfaces such
            as calcium phosphate minerals in teeth.<br>
            <br>
            [0052] PMSA's are useful in the present compositions because
            of their stain prevention benefit. It is believed the PMSA's
            provide a stain prevention benefit because of their
            reactivity or substantivity to mineral surfaces, resulting
            in desorption of portions of undesirable adsorbed pellicle
            proteins, in particular those associated with binding color
            bodies that stain teeth, calculus development and attraction
            of undesirable microbial species. The retention of these
            PMSA's on teeth can also prevent stains from accruing due to
            disruption of binding sites of color bodies on tooth
            surfaces.<br>
            <br>
            [0053] The ability of PMSA's to bind stain promoting
            ingredients of oral care products, for example, stannous
            ions and cationic antimicrobials, is also believed to be
            helpful. The PMSA will also provide tooth surface
            conditioning effects which produce desirable effects on
            surface thermodynamic properties and surface film
            properties, which impart improved clean feel aesthetics both
            during and most importantly, following rinsing or brushing.
            Many of these polymeric agents are also known or expected to
            provide tartar control benefits when applied in oral
            compositions, hence providing improvement in both the
            appearance of teeth and their tactile impression to
            consumers.<br>
            <br>
            [0054] Suitable examples of such polymers are
            polyelectrolytes such as condensed phosphorylated polymers;
            polyphosphonates; copolymers of phosphate- or
            phosphonate-containing monomers or polymers with other
            monomers such as ethylenically unsaturated monomers and
            amino acids or with other polymers such as proteins,
            polypeptides, polysaccharides, poly(acrylate),
            poly(acrylamide), poly(methacrylate), poly(ethacrylate),
            poly(hydroxyalkylmethacrylate), poly(vinyl alcohol),
            poly(maleic anhydride), poly(maleate) poly(amide),
            poly(ethylene amine), poly(ethylene glycol), poly(propylene
            glycol), poly(vinyl acetate) and poly(vinyl benzyl
            chloride); polycarboxylates and carboxy-substituted
            polymers; and mixtures thereof. Suitable polymeric mineral
            surface active agents include the carboxy-substituted
            alcohol polymers described in U.S. Pat. Nos. 5,292,501;
            5,213,789, 5,093,170; 5,009,882; and 4,939,284; all to
            Degenhardt et al. and the diphosphonate-derivatized polymers
            in U.S. Pat. No. 5,011,913 to Benedict et al. the synthetic
            anionic polymers including polyacrylates and copolymers of
            maleic anhydride or acid and methyl vinyl ether (e.g.,
            Gantrez), as described, for example, in U.S. Pat. No.
            4,627,977, to Gaffar et al. A preferred polymer is
            diphosphonate modified polyacrylic acid. Polymers with
            activity must have sufficient surface binding propensity to
            desorb pellicle proteins and remain affixed to enamel
            surfaces. For tooth surfaces, polymers with end or side
            chain phosphate or phosphonate functions are preferred
            although other polymers with mineral binding activity may
            prove effective depending upon adsorption affinity.<br>
            <br>
            [0055] Additional examples of suitable phosphonate
            containing polymeric mineral surface active agents include
            the geminal diphosphonate polymers disclosed as anticalculus
            agents in U.S. Pat. No. 4,877,603 to Degenhardt et al.
            phosphonate group containing copolymers disclosed in U.S.
            Pat. No. 4,749,758 to Dursch et al. and in GB 1,290,724
            (both assigned to Hoechst) suitable for use in detergent and
            cleaning compositions; and the copolymers and cotelomers
            disclosed as useful for applications including scale and
            corrosion inhibition, coatings, cements and ion-exchange
            resins in U.S. Pat. No. 5,980,776 to Zakikhani et al. and
            U.S. Pat. No. 6,071,434 to Davis et al. Additional polymers
            include the water-soluble copolymers of vinylphosphonic acid
            and acrylic acid and salts thereof disclosed in GB 1,290,724
            wherein the copolymers contain from about 10% to about 90%
            by weight vinylphosphonic acid and from about 90% to about
            10% by weight acrylic acid, more particularly wherein the
            copolymers have a weight ratio of vinylphosphonic acid to
            acrylic acid of 70% vinylphosphonic acid to 30% acrylic
            acid; 50% vinylphosphonic acid to 50% acrylic acid; or 30%
            vinylphosphonic acid to 70% acrylic acid. Other suitable
            polymers include the water soluble polymers disclosed by
            Zakikhani and Davis prepared by copolymerizing diphosphonate
            or polyphosphonate monomers having one or more unsaturated
            C-C bonds (e.g., vinylidene-1,1-diphosphonic acid and
            2-(hydroxyphosphinyl)ethylidene-1,1-diphosphonic acid), with
            at least one further compound having unsaturated C-C bonds
            (e.g., acrylate and methacrylate monomers). Suitable
            polymers include the diphosphonate/acrylate polymers
            supplied by Rhodia under the designation ITC 1087 (Average
            MW 3000-60,000) and Polymer 1154 (Average MW 6000-55,000).<br>
            <br>
            [0056] A preferred PMSA is a polyphosphate. A polyphosphate
            is generally understood to consist of two or more phosphate
            molecules arranged primarily in a linear configuration,
            although some cyclic derivatives may be present. Although
            pyrophosphates (n=2) are technically polyphosphates, the
            polyphosphates desired are those having around three or more
            phosphate groups so that surface adsorption at effective
            concentrations produces sufficient non-bound phosphate
            functions, which enhance the anionic surface charge as well
            as hydrophilic character of the surfaces. The inorganic
            polyphosphate salts desired include tripolyphosphate,
            tetrapolyphosphate and hexametaphosphate, among others.
            Polyphosphates larger than tetrapolyphosphate usually occur
            as amorphous glassy materials. Preferred in this invention
            are the linear polyphosphates having the formula:<br>
            [0000]<br>
            XO(XPO3)nX<br>
            <br>
            [0000] wherein X is sodium, potassium or ammonium and n
            averages from about 3 to about 125. Preferred polyphosphates
            are those having n averaging from about 6 to about 21, such
            as those commercially known as Sodaphos (n 6), Hexaphos (n
            13), and Glass H (n 21) and manufactured by FMC Corporation
            and Astaris. These polyphosphates may be used alone or in
            combination. Polyphosphates are susceptible to hydrolysis in
            high water formulations at acid pH, particularly below pH 5.
            Thus it is preferred to use longer-chain polyphosphates, in
            particular Glass H with an average chain length of about 21.
            It is believed such longer-chain polyphosphates when
            undergoing hydrolysis produce shorter-chain polyphosphates
            which are still effective to deposit onto teeth and provide
            a stain preventive benefit.<br>
            <br>
            [0057] Other polyphosphorylated compounds may be used in
            addition to or instead of the polyphosphate, in particular
            polyphosphorylated inositol compounds such as phytic acid,
            myo-inositol pentakis(dihydrogen phosphate); myo-inositol
            tetrakis(dihydrogen phosphate), myo-inositol
            trikis(dihydrogen phosphate), and an alkali metal, alkaline
            earth metal or ammonium salt thereof. Preferred herein is
            phytic acid, also known as myo-inositol 1,2,3,4,5,6-hexakis
            (dihydrogen phosphate) or inositol hexaphosphoric acid, and
            its alkali metal, alkaline earth metal or ammonium salts.
            Herein, the term "phytate" includes phytic acid and its
            salts as well as the other polyphosphorylated inositol
            compounds.<br>
            <br>
            [0058] The amount of tooth substantive agent will typically
            be from about 0.1% to about 35% by weight of the total oral
            composition. In dentifrice formulations, the amount is
            preferably from about 2% to about 30%, more preferably from
            about 5% to about 25%, and most preferably from about 6% to
            about 20%. In mouthrinse compositions, the amount of tooth
            substantive agent is preferably from about 0.1% to 5% and
            more preferably from about 0.5% to about 3%.<br>
            <br>
            [0059] In addition to creating the surface modifying
            effects, the tooth substantive agent may also function to
            solubilize insoluble salts. For example, Glass H has been
            found to solubilize insoluble stannous salts. Thus, in
            compositions containing stannous fluoride for example, Glass
            H contributes to decreasing the stain promoting effect of
            stannous.<br>
            <br>
            Chelating Agents<br>
            <br>
            [0060] Another optional agent is a chelating agent, also
            called sequestrants, such as gluconic acid, tartaric acid,
            citric acid and pharmaceutically-acceptable salts thereof.
            Chelating agents are able to complex calcium found in the
            cell walls of the bacteria. Chelating agents can also
            disrupt plaque by removing calcium from the calcium bridges
            which help hold this biomass intact. However, it is not
            desired to use a chelating agent which has an affinity for
            calcium that is too high, as this may result in tooth
            demineralization, which is contrary to the objects and
            intentions of the present invention. Suitable chelating
            agents will generally have a calcium binding constant of
            about 10&lt;1 &gt; to 10&lt;5 &gt; to provide improved
            cleaning with reduced plaque and calculus formation.
            Chelating agents also have the ability to complex with
            metallic ions and thus aid in preventing their adverse
            effects on the stability or appearance of products.
            Chelation of ions, such as iron or copper, helps retard
            oxidative deterioration of finished products.<br>
            <br>
            [0061] Examples of suitable chelating agents are sodium or
            potassium gluconate and citrate; citric acid/alkali metal
            citrate combination; disodium tartrate; dipotassium
            tartrate; sodium potassium tartrate; sodium hydrogen
            tartrate; potassium hydrogen tartrate; sodium, potassium or
            ammonium polyphosphates and mixtures thereof. The chelating
            agent may be used from about 0.1% to about 2.5%, preferably
            from about 0.5% to about 2.5% and more preferably from about
            1.0% to about 2.5%.<br>
            <br>
            TABLE 2<br>
            Toothpaste Formulations<br>
            <br>
            Ingredients&nbsp; A&nbsp; B&nbsp; C&nbsp; D&nbsp; E&nbsp;
            F&nbsp; G&nbsp; H&nbsp; I&nbsp; J&nbsp; K<br>
            USP Water&nbsp; 11.0&nbsp; 11&nbsp; 11.0&nbsp; 11.0&nbsp;
            11.0&nbsp; 11.0&nbsp; 11.0&nbsp; 11.0&nbsp; 11.0&nbsp;
            11.0&nbsp; 11.0<br>
            Silica, dental type&nbsp; 15.0&nbsp; 15.0&nbsp; 15.0&nbsp;
            15.0&nbsp; 15.0&nbsp; 15.0&nbsp; 15.0&nbsp; 15.0&nbsp;
            15.0&nbsp; 15.0&nbsp; 15.0<br>
            NaF USP&nbsp; 0.243&nbsp; 0.243&nbsp; 0.243&nbsp;
            0.243&nbsp; 0.243&nbsp; 0.243&nbsp; 0.243&nbsp; 0.243&nbsp;
            0.243&nbsp; 0.243&nbsp; 0.243<br>
            MAP L210&lt;5&gt;&nbsp;&nbsp; -&nbsp; 5.0&nbsp; -&nbsp;
            -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; 5.0&nbsp; -<br>
            Foamphos L-3&lt;3&gt;&nbsp;&nbsp; -&nbsp; -&nbsp;
            5.0&nbsp;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -&nbsp; -&nbsp; -<br>
            Foamphos L-9&lt;7&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp;
            5.0&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -<br>
            DLP-10&lt;8&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp;
            5.0&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -<br>
            KL340D&lt;6&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -&nbsp;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; 5.0<br>
            MAP 230K&lt;2&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -&nbsp; -&nbsp; 5.0&nbsp; 5.0&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -<br>
            Crodaphos SG&lt;4&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -&nbsp; -&nbsp; -&nbsp; -&nbsp; 5.0&nbsp; -&nbsp; -&nbsp; -<br>
            MAP 230T&lt;9&gt;&nbsp;&nbsp; -&nbsp; -&nbsp; -&nbsp;
            -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; 5.0&nbsp; -&nbsp; -<br>
            Sodium saccharin&nbsp; 0.13&nbsp; 0.13&nbsp; 0.13&nbsp;
            0.13&nbsp; 0.13&nbsp; 0.13&nbsp; 0.13&nbsp; 0.13&nbsp;
            0.13&nbsp; 0.13&nbsp; 0.13<br>
            NaOH (50% soln)&nbsp; 0.5&nbsp; 0.5&nbsp; 1.0&nbsp;
            0.5&nbsp; 1.0&nbsp; 1.0&nbsp; 1.0&nbsp; 1.0&nbsp; 1.0&nbsp;
            0.5&nbsp; 1.0<br>
            CMC sodium&nbsp; 0.75&nbsp; 0.75&nbsp; 0.75&nbsp; 0.75&nbsp;
            0.75&nbsp; 0.75&nbsp; 0.75&nbsp; 0.75&nbsp; 0.75&nbsp;
            0.75&nbsp; 0.75<br>
            Titanium dioxide&nbsp; 0.25&nbsp; 0.25&nbsp; 0.25&nbsp;
            0.25&nbsp; 0.25&nbsp; 0.25&nbsp; 0.25&nbsp; 0.25&nbsp;
            0.25&nbsp; 0.25&nbsp; 0.25<br>
            Carbomer 956&nbsp; 0.30&nbsp; 0.30&nbsp; 0.30&nbsp;
            0.30&nbsp; 0.30&nbsp; 0.30&nbsp; 0.30&nbsp; 0.30&nbsp;
            0.30&nbsp; 0.30&nbsp; 0.30<br>
            Flavor&nbsp; 0.80&nbsp; 0.80&nbsp; 0.80&nbsp; 0.80&nbsp;
            0.80&nbsp; 0.80&nbsp; 0.80&nbsp; 0.80&nbsp; 0.80&nbsp;
            0.80&nbsp; 0.80<br>
            Na lauryl sulfate&nbsp; 4.0&nbsp; 4.0&nbsp; -&nbsp; -&nbsp;
            -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -<br>
            (28% soln)<br>
            Cocamidopropyl&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp; -&nbsp;
            3.3&nbsp; -&nbsp; -&nbsp; -&nbsp; 3.3&nbsp; -<br>
            Betaine (30% soln.)<br>
            Sorbitol solution&nbsp; 67.0&nbsp; 62.0&nbsp; 66.0&nbsp;
            66.0&nbsp; 66.0&nbsp; 62.7&nbsp; 66.0&nbsp; 66.0&nbsp;
            66.0&nbsp; 62.7&nbsp; 66.0<br>
            FD&amp;C Blue #1&nbsp; 0.05&nbsp; 0.05&nbsp; 0.05&nbsp;
            0.05&nbsp; 0.05&nbsp; 0.05&nbsp; 0.05&nbsp; 0.05&nbsp;
            0.05&nbsp; 0.05&nbsp; 0.05<br>
            Total&nbsp; 100&nbsp; 100&nbsp; 100&nbsp; 100&nbsp;
            100&nbsp; 100&nbsp; 100&nbsp; 100&nbsp; 100&nbsp; 100&nbsp;
            100<br>
            <br>
            &lt;2&gt; Potassium C12/13 phosphate supplied by Croda<br>
            &lt;3&gt; Laureth-3 phosphate supplied by Alzo, neutralized
            with base such as NaOH<br>
            &lt;4&gt; PPG5 Ceteareth-10 phosphate supplied by Croda,
            neutralized with base such as NaOH<br>
            &lt;5&gt; Laureth-1 phosphate supplied by Rhodia,
            neutralized with NaOH<br>
            &lt;6&gt; Trilaureth-4 phosphate supplied by Clariant<br>
            &lt;7&gt; Laureth-9 phosphate supplied by Alzo, neutralized
            with base such as NaOH<br>
            &lt;8&gt; Sodium diLaureth-10 phosphate supplied by Nikkol
            Chemical<br>
            &lt;9&gt; Triethanolamine C12/13 phosphate supplied by Croda<br>
            [0000]<br>
            &nbsp;&nbsp;&nbsp;&nbsp; <br>
            <b>CALCIUM PEROXYPHOSPHATES AND USE THEREOF IN DENTAL
              COMPOSITIONS&nbsp; </b><br>
            <b> </b><b>US2011142768</b><br>
            <b> </b><br>
            BACKGROUND OF THE INVENTION<br>
            <br>
            [0003] A tooth is comprised of an outer hard enamel
            protective layer and an inner dentin layer. The outer enamel
            layer is naturally either opaque white or slightly off-white
            in color. It is composed of apatite mineral crystals that
            are somewhat porous. Without being bound by theory, it is
            believed that the porous nature of the enamel layer permits
            staining agents and discoloring substances to permeate into
            the enamel and discolor a tooth.<br>
            <br>
            [0004] Dentin, the inner bony part of the tooth, contains
            thousands of microscopic tubules. On the crown end of the
            tooth, the dentin tubule ends are normally sealed by the
            enamel. These dentin tubules pass all the way through the
            dentin from the enamel-sealed crown end to the pulp chamber.
            On the root end of the tooth, these tubules are also sealed
            by a bony material called cementum. However, if either the
            enamel-sealed crown ends or the cementum-sealed root ends of
            the dentin tubules become exposed, fluid easily travels
            through the tubules, causing hypersensitivity and/or pain.
            Undesirable exposure of dentin tubules may result from
            mechanical abrasion, caries, chemical treatment (e.g.,
            whitening agents), and other factors.<br>
            <br>
            [0005] Plaques are a major cause of both dental decay and
            inflammatory periodontal disease. These plaques can contain
            250 or more separate microbial species. They use sugars and
            other fermentable carbohydrates to produce acids, which
            cause demineralization of the tooth surface, and polymers,
            with which the microbial organisms bind themselves to the
            tooth surface... <br>
            <br>
            SUMMARY OF THE INVENTION<br>
            <br>
            [0014] The present invention is directed to calcium
            peroxyphosphate compounds and methods for the preparation of
            these compounds. The present invention is also directed to
            dental compositions comprising calcium peroxyphosphate
            compounds and methods for using such compositions that
            combine tooth whitening/stain removal with remineralization
            to hinder and/or prevent degradation of the tooth structure,
            normally associated with whitening.<br>
            <br>
            [0015] In one embodiment, therefore, the present invention
            is a calcium peroxyphosphate compound or a hydrate or a
            peroxyhydrate thereof. In another embodiment, the compound
            further comprises hydrogen ions and/or hydroxide ions.<br>
            <br>
            [0016] In another embodiment, the calcium peroxyphosphate
            compound is a calcium peroxymonophosphate or calcium
            diperoxymonophosphate having Formula (I):...<br>
            <br>
            DETAILED DESCRIPTION OF THE INVENTION<br>
            <br>
            [0024] Calcium peroxyphosphates represent a class of
            compounds capable of releasing active oxygen, calcium ions,
            and phosphate ions from a single molecule. Such compounds
            provide both whitening and remineralizing components for
            oral use. In particular, without being bound by theory, it
            is believed that as active oxygen removes tooth stains and
            leaves behind a void, the calcium and phosphate ions that
            are in close proximity and released from the same parent
            molecule precipitate to form tooth mineral (i.e., calcium
            phosphate) and repair the void by such remineralization.
            Such calcium peroxyphosphates should be provided in
            sufficient concentration in the oral environment to effect
            the desired whitening and remineralizing of teeth without
            toxicity or other undesirable effects. Such compositions may
            additionally contain a source of fluoride ions to enhance
            further remineralization. In this manner, compositions of
            the present invention advantageously achieve both whitening
            and remineralization of teeth.<br>
            <br>
            [0025] Exemplary calcium peroxyphosphate compounds of the
            present invention include calcium peroxyphosphates, which
            embrace calcium peroxymonophosphates, calcium
            peroxydiphosphates, calcium peroxytriphosphates, etc. Other
            exemplary compounds of the present invention also include
            calcium diperoxyphosphates, which embrace calcium
            diperoxymonopho sphates, calcium diperoxydipho sphates,
            calcium diperoxytriphosphates, etc. Overall, compounds of
            the present invention include the calcium salts of phosphate
            monomers, dimers, and polymers, provided that at least one
            of the phosphate structural units is oxidized to a
            peroxyphosphate group (e.g., PO5&lt;-3&gt;), comprising one
            peroxy substituent, or to a diperoxyphosphate group (e.g.,
            PO6 &lt;-3&gt;), comprising two peroxy substituents. These
            peroxyphosphate and diperoxyphosphate groups may also be in
            their respective hydrogen or dihydrogen forms. Thus, calcium
            peroxyphosphates and calcium diperoxyphosphates include
            calcium compounds having hydrogen peroxyphosphate groups
            (HPO5&lt;-2&gt;), dihydrogen peroxyphosphate
            (H2PO5&lt;-1&gt;), hydrogen diperoxyphosphate groups
            (HPO6&lt;-2&gt;), and/or dihydrogen diperoxyphosphate groups
            (H2PO6&lt;-1&gt;). Furthermore, the calcium peroxyphosphate
            and calcium diperoxyphosphate compounds of the present
            invention may also include hydroxyl (OH&lt;-&gt;) groups
            that, in addition to the negatively charged peroxyphosphate
            and peroxydiphosphate groups (whether or not in their
            hydrogen forms) must be charge-balanced by the positive
            oxidation state of calcium.<br>
            <br>
            [0026] Other exemplary compounds of the present invention
            include calcium peroxymonopho sphates, calcium peroxydipho
            sphates, calcium diperoxymonopho sphates, and calcium
            diperoxydiphosphates. Preferred are calcium
            peroxymonophosphate or calcium diperoxymonophosphate
            compounds having Formula (I):<br>
            <br>
            [0000]<br>
            CaqHx(PHOS)y(OH), (I)<br>
            <br>
            [0027] wherein q is [1/2].(3y+z-x); x is from 0 to 8; y is
            an integer from 1 to 3; z is from 0 to 1; x&lt;3y; and PHOS
            is peroxymonophosphate having the formula PO5 or
            diperoxymonophosphate having the formula PO6, or calcium
            peroxydiphosphate or calcium diperoxydiphosphate compounds
            having Formula (II):<br>
            <br>
            [0000]<br>
            CaqHx(DIPHOS) (II)<br>
            <br>
            [0000] wherein q is [1/2].(4-x); x is from 0 to 3; and
            DIPHOS is peroxydiphosphate having the formula P2O8 or
            diperoxydiphosphate having the formula P2O9.<br>
            <br>
            [0028] Exemplary peroxymonophosphates of the above-defined
            Formula (I) include CaHPO5, Ca(H2PO5)2, Ca3(PO5)2,
            Ca4H(PO5)3, and Ca5(PO5)3OH. Exemplary peroxydiphosphates of
            the above-defined Formula (II) include CaH2(P2O8) and
            Ca2(P2O8).<br>
            <br>
            [0029] In one synthesis route in preparing calcium
            peroxymonophosphate compounds of the present invention, an
            initial step involves the preparation of
            peroxymonophosphoric acid. The synthesis of
            peroxymonophosphoric acid may be carried out as described,
            for example, by Schmidlin and Massini (Ber., 43, 1910, page
            1162) according to the reaction<br>
            <br>
            [0000]<br>
            P2O5+2H2O2+H2O-&gt;2H3PO5 (i)<br>
            <br>
            [0000] However, due to the inherent safety risk of the above
            highly exothermic reaction (1), improvements in this basic
            synthesis route to peroxymonophosphoric acid were developed
            and are described, for example, in Can. J. Chem. 81:156-160
            (2003) and U.S. Pat. Nos. 3,036,887 and 3,085,856.
            Alternative methods for preparing this acid are described,
            for example, by J. E. Such, "Peroxophosphoric Acid &amp;
            Peroxophosphates" in MELLOR'S COMPREHENSIVE TREATISE ON
            INORGANIC AND THEORETICAL CHEMISTRY, Vol. VIII (Supp III),
            Longmana, London (1971). These methods include (i) the
            hydrolysis of peroxydiphosphate in a strong acid solution,
            (ii) the reaction of H4P2O7 with aqueous hydrogen peroxide,
            and (iii) the anodic oxidation of PO4&lt;-3 &gt;or
            P2O7&lt;-4&gt;.<br>
            <br>
            [0030] Diperoxyphosphoric acid, H3PO6, a starting material
            in the preparation of calcium diperoxymonophosphate, is less
            well known than H3PO5. However, this peroxy acid may be
            prepared, for example, in a manner similar to that for
            preparation of H3PO5, namely by the action of hydrogen
            peroxide on either P2O5 or pyrophosphoryl chloride (PO3Cl4).
            In general, the use of a peroxygenated phosphoric acid
            starting material allows for the preparation of various
            types of calcium peroxyphosphate compounds described herein.<br>
            <br>
            [0031] Preferably, peroxymonophosphoric acid is prepared
            according to the above-noted reaction (1) in a
            water-immiscible liquid medium, such as carbon
            tetrachloride, that is inert to both the reactants and the
            reaction product under the conditions of use. The resulting
            peroxymonophosphoric acid may thereafter be separated from
            the organic diluent phase by, for example, decantation or
            equivalent methods. The recovered peroxymonophosphoric acid
            is then reacted with a calcium compound, preferably selected
            from the group consisting of calcium carbonate, calcium
            bicarbonate, calcium hydroxide, and mixtures thereof. The
            calcium compound may be added as a solid or a solution
            (e.g., an aqueous solution). The reaction between the peroxy
            acid and the calcium compound is preferably carried out at
            low temperature, preferably from about -10[deg.] C. to about
            20[deg.] C., to avoid excessive loss of active oxygen
            through decomposition. The calcium peroxymonophosphates
            generated from this reaction typically precipitate rapidly
            upon mixing of the reactants. When a solid calcium carbonate
            reactant is used, the rate of dissolution of this compound
            and the rate of evaporation of carbon dioxide both influence
            the rate of product precipitation.<br>
            <br>
            [0032] The solid product can be recovered from the liquid
            medium described above by separation methods that include,
            but are not limited to, evaporation, filtration, and
            freeze-drying. Product purity can be increased by
            recrystallization or fractional crystallization, with either
            of these methods preferably employing water or a mixture of
            water and a water-soluble organic solvent. Preferred organic
            solvents having some water solubility and that are
            appropriate for this purpose include saturated aliphatic
            ketones (e.g., acetone) and aliphatic alcohols (e.g.,
            methanol, ethanol, and glycerol). The various calcium
            peroxyphosphate compounds described herein (e.g., calcium
            peroxydiphosphates, and calcium diperoxydiphosphates) may be
            prepared following analogous procedures, using the
            appropriate starting peroxy acid.<br>
            <br>
            [0033] While the above-noted procedures may generate a
            single calcium peroxyphosphate compound, generally a mixture
            of compounds is obtained. For example, a mixture of the
            peroxygenated forms Ca(H2PO5)2 and CaHPO5 may be obtained in
            the preparation of calcium peroxymonophosphates. The
            procedures described above may also yield non-peroxygenated
            calcium phosphates such as mono- and di-calcium phosphates.
            Preferably, however, the peroxygenated forms will be
            present, in either the impure or purified reaction products
            described above, in an amount of at least about 10% by
            weight, and more preferably in an amount from about 10% to
            about 90% by weight, relative to the total amount of
            peroxygenated and non-peroxygenated calcium phosphates.
            Mixtures of calcium peroxyphosphates and calcium phosphates
            may be characterized according to their overall relative
            amounts of calcium, phosphate, and peroxide and/or according
            to other analytically identifiable criteria, in order to
            help assess the types and relative amounts of the calcium
            phosphate species present. In case a mixture of various
            calcium peroxyphosphates or a mixture of calcium
            peroxyphosphates and calcium phosphates is obtained, the
            molar average calcium to phosphate molar ratio (Ca/P ratio)
            of the various these calcium compounds ranges preferably
            from about 0.25 to about 1.67, depending on the relative
            amounts of calcium compounds and peroxymonophosphoric acid
            used in the reaction described above. Importantly, both the
            peroxygenated and non-peroxygenated calcium phosphates,
            obtained from the synthesis procedures described above, may
            also be incorporated into dental compositions or
            restoratives as described herein without the need to
            segregate the peroxygenated forms. It is also possible to
            employ precursors of calcium peroxyphosphates (e.g.,
            components comprising sources of calcium and peroxyphosphate
            that react to form the desired calcium peroxyphosphates) in
            these restorative compositions, for example in separate
            compositions that are mixed before or during use. In this
            manner, the calcium peroxyphosphate compound may be
            generated in situ within, and/or on the surfaces of, the
            teeth.<br>
            <br>
            [0034] Any of the calcium peroxyphosphates and calcium
            diperoxyphosphates described above may be in their
            respective hydrated or peroxyhydrated forms without
            adversely affecting their ability to release calcium ions,
            phosphate ions, and peroxide. As is known in the art,
            hydrated or peroxyhydrated forms refer to the parent
            molecules having one or more water molecules or hydrogen
            peroxide molecules, respectively, in their structures. Thus,
            as an example, a hydrated form of tricalcium
            peroxymonophosphate may be represented as Ca3(PO5)2.m H2O,
            indicating the association of "m" water molecules per
            molecule of calcium peroxymonophosphate. Likewise, a
            peroxyhydrated form of tricalcium peroxymonophosphate may be
            represented as Ca3(PO5)2.n H2O2, indicating the association
            of "n" hydrogen peroxide molecules per molecule of calcium
            peroxymonophosphate. Typically, "m" is an integer from 0 to
            5.<br>
            <br>
            [0035] Advantageously, when used in dental compositions the
            calcium peroxyphosphate compounds described above can
            readily provide both tooth whitening and remineralizing
            activity, as they comprise both peroxyphosphate ions and
            calcium ions in a single molecule of an ionic salt. Thus,
            these compounds are capable of releasing calcium ions,
            phosphate ions, and active oxygen simultaneously, in close
            proximity, and in amounts sufficient and effective for these
            purposes. By "active oxygen" is meant atomic oxygen (O) that
            may be generated by the decomposition or hydrolysis of
            peroxyphosphate ions. As illustrated below,
            peroxymonophosphate ion, for example, may decompose to yield
            phosphate and active oxygen according to the following
            reaction (2):<br>
            <br>
            [0000]<br>
            PO5&lt;-3&gt;-&gt;PO4&lt;-3&gt;+O (2)<br>
            <br>
            [0036] Alternatively, and generally to a lesser extent,
            peroxymonophosphate ion may react with water (i.e.,
            hydrolyze) to form hydrogen peroxide, which in turn degrades
            to form active oxygen, as illustrated in the following
            reactions (3):<br>
            <br>
            [0000]<br>
            PO5&lt;-3&gt;+H2O-&gt;PO4&lt;-3&gt;+H2O2H2O2-&gt;H2O+O (3)<br>
            <br>
            [0037] Without being bound by theory, it is believed that,
            as active oxygen is generated according to the reactions (2)
            and (3) above, a free perhydroxyl radical (HOO.) forms for
            brief periods of time sufficient to oxidize dental stains.
            At the same time, calcium ions and phosphate ions deposit or
            precipitate, as calcium orthophosphate, in the void left
            behind, thereby remineralizing the tooth, strengthening it,
            inhibiting its decay, and/or attenuating its sensitivity.
            Additionally, remineralization, effected by the calcium and
            phosphate sources, can decrease tooth porosity resulting
            from the stain removal process. This in turn may prevent or
            slow the re-formation of a new stain within the void and
            also prolong the whitening effect. Because the deposited
            calcium orthophosphate is itself white, remineralization may
            further enhance whitening. Also, the precipitation of
            calcium orthophosphate onto and/or into the tooth surface
            can close pores in enamel and plug dentin tubules (e.g., at
            root ends) to reduce or eliminate post-treatment tooth
            sensitivity. The accompanying reduced porosity and/or
            plugging of dentin tubules can also generally reduce tooth
            surface permeability and consequently minimize the undesired
            effect of peroxide diffusion into the tooth pulp.<br>
            <br>
            [0038] Associated with the present invention is the
            determination that sufficiently high concentrations of
            calcium ions and phosphate ions are particularly effective
            for tooth remineralization as a means to compensate for the
            reduction in tooth surface integrity that may result from
            whitening or bleaching with active oxygen, generated
            according to above-noted reactions (2) and/or (3).<br>
            <br>
            [0039] Compounds of the present invention typically
            decompose in aqueous media (e.g., upon exposure to saliva)
            to provide tooth whitening and remineralizing at combined
            effective amounts or concentrations of calcium ions,
            phosphate ions, and active oxygen. By "whitening and
            remineralizing at combined effective amounts" is meant that
            the amounts of calcium ion, phosphate ion, and active oxygen
            together are sufficient to whiten teeth and compensate,
            through precipitation (i.e., remineralization) of calcium
            phosphate, for some or all of the void that typically
            accompanies the whitening or stain removal process. The
            remineralization that is effected by compounds of the
            present invention also refers to the strengthening of
            pre-existing tooth weaknesses that are not associated with
            contemporaneous whitening or stain removal.<br>
            <br>
            [0040] Preferably, when used in dental compositions,
            compounds of the present invention are present, on an
            anhydrous basis, in the composition in an amount of at least
            about 1% and preferably from about 3% to about 32% by
            weight, to provide generally effective amounts of calcium
            ions, phosphate ions, and active oxygen to effect the dual
            purposes of tooth whitening and remineralization discussed
            above. Also additional sources of peroxide, calcium salts,
            and phosphate salts can be included... <br>
            <br>
            [0041] The decomposition of peroxymonophosphates according
            to reaction (2) above, which promotes the effects of tooth
            whitening and remineralization when used in dental
            compositions or restoratives, increases in rate with
            increasing pH, until a maximum decomposition rate is
            achieved in a pH range of 12-13. In order to inhibit
            decomposition prior to use, however, these compounds are
            preferably stabilized by maintaining them either at a
            neutral pH or at a slightly acidic pH and optionally in the
            presence of a stabilizer. While low pH favors the hydrolysis
            of peroxyphosphate according to reaction (3) above, it is
            believed that the extent of hydrolysis becomes appreciable
            only under strongly acidic conditions, which are easily
            avoided.<br>
            <br>
            [0042] Stabilizers for use in dental compositions comprising
            compounds of the present invention include chelating agents
            that can scavenge and inactivate trace metals that could
            otherwise catalyze the decomposition process. Suitable
            chelating agents are described, for example, in U.S. Pat.
            No. 6,221,341. Metals, such as iron, manganese, and copper,
            and their oxides are known in the art to promote the
            degradation of peroxide through Fenton-type reactions. This
            particular degradation mechanism is undesirable in that the
            hydroxyl free radical (HO.) is created and is not as
            effective as active oxygen generated according to reactions
            (2) and (3) above, in attacking chromogens that stain the
            teeth.<br>
            <br>
            [0043] Stabilizers therefore include, but are not limited
            to, pharmaceutically acceptable chelating agents such as the
            various amino carboxylate compounds that have the capacity
            to form metal-ligand complexes with one or more transition
            metal ions in solution. Such amino carboxylates include
            ethylenediaminetetraacetic acid (EDTA) and
            diethyltriaminepentaacetic (DTPA),
            1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
            (BAPTA), ethylene
            glycol-bis(2-aminoethyl)-N,N,N',N'-tetraacetic acid (EGTA),
            and other amino carboxylate compounds having one or multiple
            carboxylate groups. Any derivative salt form of these amino
            carboxylate chelating agents, for example the disodium salt
            form, may be also used, provided that some capacity remains
            for the chelating agent to complex with free transition
            metal ions present. Forms of these chelating agents other
            than salt forms are also effective and include the various
            ester, anhydride, and halogenated forms of these compounds.
            A preferred stabilizer is EDTA.<br>
            <br>
            [0044] As stated, calcium peroxyphosphate compounds of the
            present invention may be stabilized under neutral to
            slightly acidic pH conditions. When used in dental
            compositions, these compounds can be conveniently decomposed
            at the time of use to effect the beneficial release of (i)
            active oxygen for tooth whitening and (ii) calcium phosphate
            for tooth remineralization. Peroxyphosphate decomposition
            according to reaction (2) above is achieved, for example, by
            increasing pH or introducing activators such as catalytic
            amounts of trace metal ions into the calcium peroxyphosphate
            composition. A further advantage associated with effecting
            decomposition by increasing pH is the simultaneous
            promotion, at elevated pH, of the precipitation of calcium
            phosphate as tooth mineral. As described previously, calcium
            phosphate is a decomposition product of calcium
            peroxymonophosphates.<br>
            <br>
            [0045] Based on the above, a kit comprising two separate
            compositions represents a possible vehicle for employing
            compounds of the present invention, allowing for long-term
            storage of these compounds prior to use and activation of
            these compounds at the point of use. In such an embodiment,
            for example, the first composition may be a pH-control
            composition having an alkaline pH and the second composition
            may comprise a compound of the present invention. In this
            embodiment, an alkaline pH of the first composition refers
            to a pH value preferably above 8, and more preferably from
            about 8 to about 12, and even more preferably from about 9
            to about 11. The second composition comprising the calcium
            peroxyphosphate preferably has a neutral pH or a slightly
            acidic pH value (e.g., from about 3 to about 7).<br>
            <br>
            [0046] Alternatively, the first composition may comprise an
            activator (e.g., a transition metal ion such as
            Zn&lt;+2&gt;) to catalyze or accelerate the decomposition of
            calcium peroxyphosphate upon contact therewith prior to or
            during use. The first composition may also optionally
            comprise a soluble calcium salt to provide an additional
            source of calcium. Soluble calcium salts include, but are
            not limited to, calcium sulfate (e.g., plaster of paris),
            calcium chloride, calcium nitrate, calcium acetate, calcium
            bromide, calcium gluconate, calcium benzoate, calcium
            glycerophosphate, calcium formate, calcium fumarate, calcium
            lactate, calcium butyrate, calcium isobutyrate, calcium
            malate, calcium propionate, and calcium valerate. Preferred
            soluble calcium salts include calcium chloride, calcium
            nitrate, calcium sulfate, and calcium acetate. Calcium
            orthophosphates include, but are not limited to, amorphous
            calcium phosphate (ACP), amorphous calcium phosphate
            fluoride (ACPF), and amorphous calcium carbonate phosphate
            (ACCP), which are described, for example, in U.S. Pat. No.
            5,037,639.<br>
            <br>
            [0047] Upon increasing the pH of the second composition
            and/or activating it by combining or mixing it with the
            first pH-control composition having an alkaline pH and/or an
            activator, not only is active oxygen made available for
            whitening, but also the released calcium ions and phosphate
            ions are precipitated as calcium phosphate for
            remineralization. Another means of realizing the goals of
            long-term storage of compounds of the present invention and
            their activation upon use may be through the provision of a
            layered composition, with separate layers (e.g., gel layers)
            being maintained under separate conditions and/or having
            separate compositions as described above. A further
            alternative method of stabilizing a calcium peroxyphosphate
            compound prior to use is to maintain it as a solid (either
            crystalline or amorphous) or a solid suspended in an inert
            carrier, such as a polyol. The solid form can then be either
            dissolved in a composition comprising an aqueous carrier at
            the point of use or applied directed to the surfaces of the
            teeth. Yet another alternative for stabilization involves
            lyophilization of the calcium peroxymonophosphate, coupled
            with reconstitution prior to use.<br>
            <br>
            [0048] In the kit embodiment described previously,
            comprising two compositions, these compositions may be mixed
            or combined prior to application to the tooth surface, such
            that the combination/application steps are performed
            sequentially. In a preferred method of sequential
            application, for example, the compositions may be mixed and
            thereafter applied to the teeth in a tray and/or mouth
            guard. Alternatively, the compositions may be mixed on the
            teeth at the time of application (i.e., use) to the teeth in
            a simultaneous manner. Thus, simultaneous mixing and
            application includes methods wherein the first composition
            is applied onto the surface of the teeth (e.g., applying a
            solution with a cotton tip) and the second composition is
            then applied and combined with the applied first
            composition.<br>
            <br>
            [0049] Simultaneous mixing and application represents a
            preferred method of teeth whitening and remineralization,
            particularly when a first composition that comprises a
            soluble calcium salt is first applied to the surface of the
            teeth, allowing the applied calcium to diffuse into the
            teeth. After application of the first composition, a second
            composition comprising a compound of the present invention
            (i.e., a calcium peroxyphosphate) is thereafter applied to
            the teeth. In this manner, both within the teeth as well as
            on the surface of the teeth, active oxygen (obtained from
            the second composition) is generated for whitening or
            bleaching and the calcium ions (obtained from both
            compositions) and phosphate ions (obtained from the second
            composition) are activated for precipitation or
            remineralization as calcium phosphate tooth mineral.
            Preferably, the first composition is an aqueous solution. In
            another preferred embodiment, the second composition is in a
            gel form and is applied using a tray. In other embodiments,
            the calcium peroxyphosphate of the second composition may
            either be suspended as a solid in a non-aqueous medium or
            otherwise dissolved therein. In yet other embodiments, the
            second composition may comprise a peroxyphosphate and
            optionally a non-peroxygenated phosphate, such that the
            soluble calcium salt of the first composition reacts with
            the peroxyphosphate of the second composition to generate a
            calcium peroxyphosphate compound in situ. Without being
            bound by theory, it is believed that the calcium
            peroxymonophosphate compounds of the present invention,
            whether supplied in a single composition, in a kit
            comprising two or more compositions, or in the form of
            precursor components that are reacted at the point of use,
            can cause calcium orthophosphate (or tooth mineral) to
            precipitate, both on the surfaces of the dental tissues as
            well as in their interiors.<br>
            <br>
            [0050] Whether a single composition, or, as described above,
            two or more separate compositions are employed, the pH of
            the compositions of the present invention may be maintained
            or controlled using any pH-control agents and buffer systems
            known in the art to be suitable for oral compositions. For
            example, compositions for oral use may be adjusted and
            maintained at an alkaline pH, preferably at a pH from about
            8 to about 12, using hydroxide compounds (e.g., sodium
            hydroxide) and/or carbonate compounds (e.g., sodium
            carbonate). Likewise, compositions may be adjusted and
            maintained for stabilization purposes at approximately
            neutral or slightly acidic conditions, preferably at a pH
            from about 3 to about 7 using, for example, inorganic or
            organic acids including phosphoric acid, benzoic acid,
            and/or citric acid. Alternatively, dissolved carbon dioxide,
            for example in a carbonated solution under pressure, may
            also function as a pH-control agent as well as a carrier for
            calcium peroxymonophosphate compounds...<br>
            <br>
            EXAMPLE 1<br>
            Preparation of Calcium Peroxymonophosphate<br>
            <br>
            [0060] A 9.9 gram sample of phosphorus pentoxide powder was
            suspended in 68 g of carbon tetrachloride and cooled in an
            ice bath under vigorous stirring. To this suspension, 5.3 ml
            of 70% aqueous hydrogen peroxide was added dropwise at rate
            of 3 drops per second. The mixture was stirred for 3 hrs
            after the hydrogen peroxide addition. The mixture over time
            formed separate organic and aqueous peroxymonophosphoric
            acid layers. Five milliliters of the acid layer was obtained
            by decanting. To half of this inorganic concentrated
            peroxymonophosphoric acid, calcium carbonate slurry was
            added slowly in an ice bath and under stirring, until the pH
            of the solution was 1.7. This solution was then lyophilized.
            The resulting solid comprised calcium peroxymonophosphates
            with a Ca/P ratio of 0.28 and possibly additionally
            contained non-peroxygenated calcium phosphate compounds. The
            prepared calcium peroxymonophosphate had a distinct x-ray
            powder diffraction pattern, different from that
            corresponding to calcium phosphate. The d-space for 010 was
            in the range of 12.5 to 12.9 A, compared to 11.7 A
            corresponding to calcium phosphate. The calcium
            peroxymonophosphates also exhibited a peroxide IR peak of
            785 cm&lt;-1&gt;, which was absent from the corresponding
            calcium phosphates.<br>
            <br>
            EXAMPLE 2<br>
            <br>
            [0061] Calcium carbonate slurry was added slowly, under
            stirring, to the other half of the inorganic concentrated
            peroxymonophosphoric acid layer as described in the Example
            1, until the pH of solution was 3.5. This solution was then
            lyophilized. The solid comprised calcium
            peroxymonophosphates with a Ca/P ratio of 0.5 and possibly
            additionally contained non-peroxygenated calcium phosphate
            compounds. such as dicalcium phosphate dihydrate and
            monocalcium phosphate monohydrate. The prepared calcium
            peroxymonophosphate has a distinct x-ray powder diffraction
            pattern different from that corresponding to calcium
            phosphate. The d-space for 010 was 12 A, compared to 11.7 A
            for calcium phosphate. The calcium peroxymonophosphates also
            exhibited a peroxide IR peak of 785 cm&lt;-1&gt;, which was
            absent from the corresponding simple calcium phosphates.<br>
            <br>
            EXAMPLE 3<br>
            Alternate Preparation of Calcium Peroxymonophosphate<br>
            <br>
            [0062] Suspend 2.22 grams of calcium hydroxide in 50 ml of
            water. To this suspension, slowly add 2.28 grams of
            concentrated peroxymonophosphoric acid, to be prepared as
            described in Example 1, in order to precipitate calcium
            peroxymonophosphate. Filter the resulting slurry and wash it
            with distilled water. The solid to be recovered is a basic
            calcium peroxymonophosphate, possibly also containing one or
            more calcium phosphate compounds.<br>
            <br>
            EXAMPLE 4<br>
            Preparation of Calcium Peroxydiphosphate<br>
            <br>
            [0063] Dissolve 3.46 grams of potassium peroxydiphosphate in
            10 ml of water. To this solution, add 2.94 grams of calcium
            chloride dihydrate under stirring, in order to precipitate
            calcium peroxydiphosphate. Filter the resulting slurry and
            wash it with distilled water. The solid to be recovered
            contains calcium peroxydiphosphate.<br>
            <br>
            EXAMPLE 5<br>
            Preparation of Calcium Diperoxymonophosphate<br>
            <br>
            [0064] Prepare diperoxymonophosphoric acid by the action of
            hydrogen peroxide on pyrophosphoryl chloride. Maintain this
            inorganic diperoxymonophosphoric acid in an ice bath under
            stirring and slowly add a calcium carbonate slurry until the
            pH of the resulting solution is 3.3 and calcium
            diperoxymonophosphate precipitates. Filter the resulting
            slurry and then wash it with distilled water. The solid to
            be recovered contains calcium diperoxymonophosphates and
            possibly also contains one or more calcium phosphate
            compounds.<br>
            <br>
            <b>Dentifrice compositions&nbsp; </b><br>
            <b> </b><b>US4327079</b><br>
            <b> </b><br>
            According to the present invention, there is provided a
            dentifrice composition containing synthetic hydroxyapatite
            powder and being neutral or weakly alkaline.<br>
            <br>
            It has been found that the dentifrice composition of the
            present invention is very effective in fortifying a surface
            of a tooth, promoting remineralization of the surface of the
            tooth and eliminating plaque (a colony of bacteria).<br>
            <br>
            In general, a conventional dentifrice contains, as a
            tooth-cleaning and abrading agent, a mineral, such as
            colloidal silica, calcium phosphate, calcium carbonate,
            magnesium carbonate, etc. While these abrading agents are
            used to remove contaminants on teeth, it is essential that
            they do not harm the teeth.<br>
            <br>
            Since the dentifrice composition of the present invention
            contains a suitable amount of synthetic hydroxyapatite
            powder, plaque as well as substances contaminating teeth can
            be removed very effectively. We presume this is due to the
            fact that the synthetic hydroxyapatite has a hardness
            similar to that of the enamel portion of the tooth and it
            can impart an appropriate abrading effect on the enamel
            portion of the tooth in brushing the teeth. We further
            presume this is also due to the fact that the synthetic
            hydroxyapatite has a large surface area and an excellent
            absorptivity. We have further found that the synthetic
            hydroxyapatite powder has the effect of strengthening the
            coating on and remineralization the surface of the enamel of
            the tooth.<br>
            <br>
            In accordance with the present invention, there is further
            provided a dentifrice composition containing synthetic
            hydroxyapatite powder and, based on the weight of the
            composition, 0.1 to 20% by weight of NaCl and/or KCl and
            0.003 to 3% by weight of MgCl2.<br>
            <br>
            It has also been found that the presence of a mixture of
            NaCl and/or KCl with MgCl2 in a dentifrice composition
            containing synthetic hydroxyapatite powder can effectively
            promote the elimination of plaque from teeth and the
            fortification and remineralization of the surfaces of the
            teeth.<br>
            <br>
            More specifically, the latter dentifrice composition of the
            present invention can effectively deposit and coat crystals
            of hydroxyapatite on the surfaces of the teeth. We presume
            this is due to the fact that the solubility of
            hydroxyapatite in water is increased in the presence of the
            chlorides as specified above. More particularly, since
            hydroxyapatite is a salt which only slightly soluble in
            water, the ion products of ions such as [Ca@++ ], [HPO4@--
            ], etc. ionized in the dentifrice are small. This means that
            the ion products for promoting coating on the surfaces of
            the teeth, i.e. deposition of the crystals of hydroxyapatite
            on the surfaces of the teeth are small. However, if NaCl
            and/or KCl and MgCl2 are added to the dentifrice containing
            hydroxyapatite, it is presumed that the solubilities of
            Ca@++ and HPO4@-- are increased very much and the coating on
            the teeth is enhanced.<br>
            <br>
            In cases where the amounts of NaCl and/or KCl and MgCl2
            contained in the dentifrice composition of the present
            invention are smaller than those specified above, a
            sufficient coating effect cannot be obtained, while in cases
            where such amounts are larger than those specified above, it
            becomes difficult to give a comfortable feeling in the use
            of the dentifrice composition.<br>
            <br>
            To obtain a suitable abrading effect and desired plaque
            elimination, the average particle size of the hydroxyapatite
            powder is preferably about 2.mu. and the maximum particle
            size thereof is preferably 10.mu. or less.<br>
            <br>
            The dentifrice composition of the present invention may
            include various additives which are commonly employed in
            dentifrices and may further include, if desired, citric
            acid, lactic acid, acetic acid, pyrrolic acid, glutamine,
            proline, serine, glycine, etc.<br>
            <br>
            EXAMPLE 1<br>
            Tooth Paste<br>
            <br>
            Apatite Powder 13.2<br>
            Calcium phosphate 25.0<br>
            CMC sodium salt 0.3<br>
            Carrageenan 1.2<br>
            Glycerin 10.0<br>
            Solbitol 15.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.2<br>
            Sodium saccharinate<br>
            0.1<br>
            Silicon dioxide 2.0<br>
            Water 30.0<br>
            <br>
            EXAMPLE 2<br>
            Tooth Paste<br>
            <br>
            Apatite powder 7.2<br>
            Calcium phosphate 10.0<br>
            Calcium pyrophosphate 20.0<br>
            CMC Sodium salt 1.0<br>
            Sodium alginate 0.1<br>
            Glycerin 10.0<br>
            Solbitol 10.0 <br>
            Sodium lauryl sulfate 1.5<br>
            Sodium lauryl sarcosinate 0.5<br>
            Flavor 0.5<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.5<br>
            Sodium phosphate 1.0<br>
            Water 35.0<br>
            <br>
            EXAMPLE 3<br>
            Tooth Paste<br>
            <br>
            Apatite powder 22.3<br>
            Calcium pyrophosphate 10.0<br>
            CMC sodium salt 0.5<br>
            Carrageenan 0.6<br>
            Glycerin 20.0<br>
            Solbitol 10.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.0<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.0<br>
            Sodium phosphate 0.5<br>
            Water 30.0<br>
            <br>
            EXAMPLE 4<br>
            Tooth Paste<br>
            <br>
            Apatite powder 38.1<br>
            CMC sodium salt 1.0<br>
            Carrageenan 0.3<br>
            Glycerin 35.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.0<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.5<br>
            Water 20.0<br>
            <br>
            EXAMPLE 5<br>
            Tooth Powder<br>
            <br>
            Apatite powder 96.3<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.5<br>
            Sodium saccharinate0.2<br>
            <br>
            EXAMPLE 6<br>
            Tooth Powder<br>
            <br>
            Apatite powder 40.7<br>
            Calcium pyrophosphate 50.0<br>
            Silicon dioxide 5.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 2.0<br>
            Sodium saccharinate 0.3<br>
            <br>
            EXAMPLE 7<br>
            Wet Tooth Powder<br>
            <br>
            Apatite powder 65.38<br>
            Calcium phosphate 10.0<br>
            Solbitol 10.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.5<br>
            Calcium phosphate 1.0<br>
            Water 10.0<br>
            Sodium saccharinate 0.12<br>
            <br>
            EXAMPLE 11<br>
            Tooth Paste<br>
            <br>
            Apatite powder 10.0<br>
            Calcium phosphate 25.0<br>
            CMC sodium salt 0.3<br>
            Carrageenan 1.2<br>
            Glycerin 10.0<br>
            Solbitol 15.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.2<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.0<br>
            NaCl 0.27<br>
            MgCl2 0.01<br>
            Water 32.92<br>
            <br>
            EXAMPLE 12<br>
            Tooth Paste<br>
            <br>
            Apatite powder 5.0<br>
            Calcium phosphate 10.0<br>
            Calcium pyrophosphate 20.0<br>
            CMC sodium salt 1.0<br>
            Sodium alginate 0.1<br>
            Glycerin 10.0<br>
            Solbitol 10.0<br>
            Sodium lauryl sulfate 1.5<br>
            Sodium lauryl sarcosinate 0.5<br>
            Flavor 0.5<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.5<br>
            NaCl 3.0<br>
            MgCl2 0.2<br>
            Water 35.0<br>
            <br>
            EXAMPLE 13<br>
            <br>
            Tooth Paste<br>
            <br>
            Apatite powder 20.0<br>
            Calcium pyrophosphate 10.0<br>
            CMC sodium salt 0.5<br>
            Carrageenan 0.6<br>
            Glycerin 20.0<br>
            Solbitol 10.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.0<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.0<br>
            KCl 2.0<br>
            MgCl2 0.3<br>
            Sodium phosphate 0.5<br>
            Water 30.0<br>
            <br>
            EXAMPLE 14<br>
            Tooth Paste<br>
            <br>
            Apatite powder 35.0<br>
            CMC sodium salt 1.0<br>
            Carrageenan 0.3<br>
            Glycerin 35.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.0<br>
            Sodium saccharinate 0.1<br>
            Silicon dioxide 2.5<br>
            NaCl 2.0<br>
            MgCl2 0.1<br>
            KCl 1.0<br>
            Water 20.0<br>
            <br>
            EXAMPLE 15<br>
            <br>
            Tooth Powder<br>
            <br>
            Apatite powder 90.8<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.5<br>
            Sodium saccharinate 0.2<br>
            NaCl 5.0<br>
            MgCl2 0.5<br>
            <br>
            EXAMPLE 16<br>
            <br>
            Tooth Powder<br>
            <br>
            Apatite powder 38.0<br>
            Calcium pyrophosphate 50.0<br>
            Silicon dioxide 5.0<br>
            Sodium lauryl sulfate2.0<br>
            Flavor 2.0<br>
            Sodium saccharinate 0.3<br>
            NaCl 1.8<br>
            MgCl2 0.2<br>
            Potassium phosphate 0.7<br>
            <br>
            EXAMPLE 17<br>
            Wet Tooth Powder<br>
            <br>
            Apatite powder 63.0<br>
            Calcium phosphate 10.0<br>
            Solbitol 10.0<br>
            Sodium lauryl sulfate 2.0<br>
            Flavor 1.5<br>
            NaCl 3.3<br>
            MgCl2 0.08<br>
            Water 10.0<br>
            Sodium saccharinate 0.12<br>
            <br>
            EXAMPLE 18<br>
            <br>
            1 g of hydroxyapatite powder was introduced into 100 ml of
            37 DEG C. distilled water and NaCl and MgCl2 were added in
            various concentrations. The calcium ion concentrations of
            the respective solutions were measured and it was confirmed
            that the solubility of hydroxyapatite was increased by
            adding NaCl and MgCl2. The calcium ion concentrations 10
            days after the preparation of the solutions were as follows:<br>
            <br>
            NaCl concentration;<br>
            0 0.3 0.3 3.0 3.0 (%)<br>
            <br>
            MgCl2 concentration;<br>
            0 0.03 0.3 0.03 0.3 (%)<br>
            <br>
            Ca@++ concentration;<br>
            4.9 26.0 31.2 31.5 36.7 (ppm)<br>
            <br>
            EXAMPLE 19<br>
            <br>
            An adult's permanent tooth was sliced in two using a prisma
            adamantinum to prepare a section about 200 .mu.m thick. The
            enamel portion was removed to expose the dentin portion. A
            hydroxyapatite-saturated solution in distilled water
            containing 0.001% of MgCl2 and 0.9% of NaCl was passed over
            the so prepared section at a flow rate of 0.6 ml/min. The
            section was continuously observed using a polarization
            microscope and it was confirmed that all over the surfaces
            of the section were coated with analogous apatite crystals
            at a thickness of about 5 .mu.m.<br>
            <br>
            <b>DENTAL FORMULATION&nbsp; </b><br>
            <b> </b><b>WO9319728</b><br>
            <br>
            This invention concerns inhibiting tooth enamel
            demineralization.<br>
            <br>
            More specifically it relates to the use of a water soluble
            phosphate, particularly a<b> pyrophosphate or
              tripolyphosphate</b>, to inhibit demineralization while
            not negatively impacting remineralization. This provides a
            means for preventing or reducing dental caries.<br>
            <br>
            It has been found that certain water soluble phosphates
            exemplified by the alkali metal pyrophosphates and
            tripolyphosphates inhibit demineralization of enamel and
            they do not interfere with the remineralization phenomena of
            the fluoride ion in subsurface caries-like lesions. This
            finding makes it possible to provide an anti-caries dental
            preparation which <b>does not use fluoride.</b>..<br>
            <br>
            Specific Embodiments<br>
            <br>
            In the broadest embodiment, this invention utilizes certain
            phosphates as a means for inhibiting tooth enamel
            demineralization and thus reducing or preventing dental
            caries. It has been found that the presence of a orally
            acceptable water soluble phosphate is the critical factor,
            not the acid or salt form in which it is presented. Such a
            phosphate may be an orthophosphate, a pyrophosphate, a
            polyphosphate (chain phosphates) or a metaphosphate (cyclic
            phosphates). The preferred phosphates are pyrophosphate and
            tripolyposphate. So far as the ionic form of the phosphate
            is concerned, the acid form of each of these phosphates
            should not be used. That is acid phosphates such as Hop3010
            or H4P207 should not be used. But the partially neutralized
            forms may be used, though the fully neutralized forms are
            usually preferred.The salts of Group Ia alkali metals of
            periods 2, 3 and 4 are preferred, particularly the sodium
            and potassium forms and mixtures thereof. Most preferred is
            Nags3010 alone or mixtures of Na4P2O7 and K4P207.
            Notwithstanding this preference, several phosphate types and
            ionic forms may be incorporated into a single preparation.
            The phosphate may be anhydrous or hydrated.<br>
            <br>
            Many commercial sources sell suitable phosphate
            preparations. In particular sodium and potassium
            pyrophosphate and sodium tripolyphosphate are available from
            a number of companies. Or the salts may be custom prepared
            to define standards by a commercial source or by the one who
            is doing the formulation work by using published techniques
            and processes. Pure phosphate preparations meeting local
            regulatory requirements should be used in these dental
            preparations.<br>
            <br>
            Effective concentrations of phosphate will vary with the
            type of phosphate selected, its water solubility, the type
            of product (i.e., toothpastes, mouthwashes, chewing gums)
            and may be influenced by the nature and chemical or physical
            characteristics of the carrier and coformulated excipients.
            Some ingredients or formulations may have a higher available
            phosphate content. In any event, an effective amount is that
            amount which will reduce enamel demineralization to an
            extent that dental caries will be reduced in a statistically
            significant manner over a phosphate-free control which is
            also free of any other demineralization inhibiting agent or
            remineralizing agent.<br>
            <br>
            As a practical matter, though not intending to be bound by
            such lower limit, about 2% by weight, or more, of a
            phosphate ion should provide an effective anti-caries
            preparation when used incorporated into orally acceptable
            preparations and when used in a normal, routine fashion. A
            preferred baseline for toothpastes, gels and liquids is 5%
            by weight. As regards sodium tripolyphosphate
            concentrations, 5% wlw is a preferred amount. As for
            pyrophosphates, a preferred amount is about 1.8% tetrasodium
            pryophosphate and 4.0% tetrapotassium pyrophosphate. These
            amounts, when combined with the excipients normally used to
            confect pastes and gels, should provide sufficient available
            phosphate to inhibit enamel demineralization to a point
            where dental caries will be usefully reduced.Variations and
            refinements in the level of phosphates can be carried out as
            required or as appropriate to maximize the effectiveness of
            the phosphate in a given formulation.<br>
            <br>
            Phosphates may represent a higher percentage of the overall
            ingredient profile in dry formulations such as dental
            tablets, lozenges and chewing gums.<br>
            <br>
            These phosphates can be presented in any orally acceptable
            carrier. The only limitation is that the phosphate must be
            available to interact with tooth enamel and the formulation
            must not have any deleterious or untoward affects on the
            teeth or the oral cavity when used within approved
            guidelines.<br>
            <br>
            Many orally acceptable formulations are known in the dental
            arts.<br>
            <br>
            Broadly speaking, these include dentifrices (pastes, gels
            and liquids), tooth powders, mouth rinses, dental tablets,
            dental lozenges, and dental care chewing gums, for example.
            Three of the most preferred formulations are toothpastes,
            gels, and mouthwashes. These will be specifically
            illustrated below as of orally acceptable formulations
            contemplated in the use of this invention.<br>
            <br>
            Toothpastes, gels and liquid formulations may be prepared
            with conventional ingredients, keeping in mind that certain
            abrasives may not be compatible with certain water soluble
            phosphates. These potential limitations are detailed below.
            Aside from this one limitation, one can use pretty much any
            combination of dentally acceptable abrasive, humectant,
            detergent, sweetening agent, flavor, antimicrobial agent,
            coloring agent and pigment and the like. A preferred
            toothpaste or gel will contain about 5% of the pyrophosphate
            salt or tripolyphosphate salt, about 10 to 80% of a
            humectant, about 0.25 to 5% of a detergent, up to 2%
            sweetening and flavoring agents (in combination), coloring
            agents, binders and thickening agents, and water in amounts
            sufficient to make a stable, flowable paste or gel.<br>
            <br>
            The abrasive polishing material contemplated for use in the
            present invention can be any material which does not
            excessively abrade dentin. These include, for example,
            silicas including gels and precipitates, calcium
            pyrophosphate, calcium polymetaphosphate, insoluble sodium
            polymetaphosphate, hydrated alumina, and resinous abrasive
            materials such as particulate condensation products of urea
            and formaldehyde, and others such as disclosed by in U.S.
            Pat. No. 3,070,510 incorporated herein by reference.
            Mixtures of abrasives may also be used. Certain abrasives
            may not be compatible with the metioned phosphates. For
            example calcium carbonate, dicalcium orthophosphate
            dihydrate, and tricalcium phosphate are best avoided if the
            maximum effect of the water soluble phosphates are to be
            realized.<br>
            <br>
            Silica dental abrasives, of various types, can provide the
            unique benefits of exceptional dental cleaning and polishing
            performance without unduly abrading tooth enamel or dentin.
            Silica abrasive materials are also exceptionally compatible
            with many ionic materials including the phosphates which are
            the subject of this invention. For these reasons they are
            preferred for use herein.<br>
            <br>
            The silica abrasive polishing materials useful herein, as
            well as the other abrasives, generally have an average
            particle size ranging between about 0.1 and 30 microns,
            preferably 5 and 15 microns. The silica abrasive can be
            precipitated silica or silica gels such as the silica,
            xerogels described in U.S. Pat. No. 3,538,230 and U.S. Pat.
            No. 3,862,207, both incorporated herein by reference.
            Preferred are the silica xerogels marketed under the trade
            name "Syloid" by the W.R. Grace &amp; BR Company, Davison
            Chemical Division. Preferred precipitated silica materials
            include those marketed by the J.M. Huber Corporation under
            the trade name, "Zeodent." These silica abrasives are
            described in U.S.Pat. No. 4,340,583, incorporated herein by
            reference.<br>
            <br>
            The abrasive in the dentifrice compositions described herein
            is present at a level of from about 6% to about 70%,
            preferably from about 15% to about 25% when the dentifrice
            is a toothpaste. Higher levels, as high as 90%, may be used
            if the composition is a tooth powder...<br>
            <br>
            Water is also present in the toothpaste compositions of this
            invention. Water employed in the preparation of commercially
            suitable compositions should preferably be deionized and
            free of organic impurities. Water generally comprises from
            about 10% to 70%, preferably from about 20% to 40%, by
            weight of a toothpaste. These amounts of water include the
            free water which is added plus that which is introduced with
            other materials such as when sorbitol or other polyhydric
            alcohols which are manufactured as dilutions where water is
            the diluent...<br>
            <br>
            It is also desirable to include a humectant in a toothpaste
            to keep it from hardening. Suitable humectants include
            glycerin, sorbitol, and other edible polyhydric alcohols
            such as PEGs, at a level of from about 10% to about 70%.<br>
            <br>
            Antibacterial agents may be added to these pastes and gels
            (and mouthwashes). Any one of a number of antibacterial
            drugs or agents may be used. Triclosan,
            5-chloro-2-(2,4-dichlorpphenoxy)phenol, is one example. A
            group of useful antibacterials is the cationic antibacterial
            agent. Suitable cationic antibacterial agents for use in
            dentifrices include:<br>
            <br>
            (i) quaternary ammonium compounds, for instance those in
            which one or two of the subsistent on the quaternary
            nitrogen has between 8 and 20, preferably 10 and 18 carbon
            atoms and is preferably an alkyl group, which may optionally
            be interrupted by an amine, ester, oxygen, sulphur, or
            heterocyclic ring The remaining nitrogen substituents will
            have a lower number of carbon atoms, for instance between 1
            and 7, and are preferably alkyl, for instance methyl or
            ethyl, or benzyl. The anion will be an orally acceptable
            salt forming group.<br>
            <br>
            Examples of such compounds include benzalkonium chloride,
            dodceyl trimethyl ammonium chloride, benzyl dimethyl stearyl
            ammonium chloride, cetyl trimethyl ammonium bromide,
            benzethonium chloride Cdiisobutyl phenoxyethoxyethyl
            dimethylbenzyl ammonium chloride), and methyl benzethonium
            chloride;<br>
            ii) pyridinium and isoquinolinium compounds, exemplified by
            hexadecylpyridinium chloride, cetyl pyridinium chloride, and
            alkyl isoquinolinium bromide;<br>
            (iii) pyrimidine derivatives such as hexetidine (5-amino-1,3
            Bi(2-ethylhexylS5-methylhexahydropyrimidine);<br>
            (iv) aniline derivatives such as hexamidine isothionate
            (4,4'diamonding-a,w-diphenoxyhexane isothionate); ;<br>
            (v) bispyridine derivatives such as octenidine(N,N'[1,10-
            decanediyldi-1(4H)-pyridinyl-4-ylidine]b s(l-o ctanamine
            dihydrochloride); and<br>
            (vi) biguanides including:<br>
            (a) mono-biguanides such as p-chlorobenzyl biguanide and N'
            (4-chlorobenzyl)-N"-(2,4-dichlorobenzyl)biguanide.<br>
            <br>
            (b) bis-biguanides of the general formula (I):<br>
            EMI7.1<br>
            wherein:<br>
            A1 and A2 are independently a phenyl group optionally
            substituted by (C1,4)alkyl, (C1-4)alkoxy, nitro, halogen, C1
            l2)alkyl group, or (C4 12)alicylclic;<br>
            X1 and X2 are independently (C1 3)alkylene;<br>
            R and R1 are independently hydrogen, (C112)alkyl, or aryl(C
            6)alkyl;<br>
            Z1 and Z2 are independently 0 or 1;<br>
            Q is CH2, oxygen, sulfur, or aryl;<br>
            n in teach (CH2)n group is independently an integer from 1
            to 12 but the total of both n groups may not exceed 12;<br>
            aryl is phenyl, naphthyl or another aromatic ring; and
            orally acceptable acid addition salts thereof. Preferred
            compounds are chlorhexidine and alexidine.<br>
            <br>
            (c) poly(biguanides) such as polyhexamethylene biguanide
            hydrochloride.<br>
            <br>
            An effective amount of a antibacterial agent is in the range
            of about 0.005 to 10% weight/weight (w/w), preferably 0.005
            to 5%, more preferably 0.005 to 2.5% and most preferably
            1.0% w/w...<br>
            <br>
            Generally, on a weight basis, the mouthwashes of the
            invention comprise 0.5% to 5% of the phosphate, 5% to 30%
            (preferably 5% to 20%) ethyl alcohol, 0% to 25% (preferably
            3% to 20%) of a humectant, 0% to 25% (preferably 0.01% to
            2.0%) surfactant, 0% to 5% (preferably 0.005% to 0.3%)
            sweetening agent, 0% to 0.3% (preferably 0.03% to 0.3%)
            flavoring agent, about 0.1% of a preservative, pH adjusting
            agent as needed, and the balance water.<br>
            <br>
            The pH of a mouthwash and/or its pH in the mouth can be any
            pH which is safe for the mouth's hard and soft tissues.
            Generally the pH will be adjusted to about 3 to about 10,
            preferably from about 4 to about 8...<br>
            <br>
            Example 1<br>
            Toothpaste Formulation<br>
            A toothpaste can be prepared using the following ingredients
            and two different phosphates.<br>
            <br>
            Table 1 - Tube Formulations<br>
            Ingredient % W/W (triDolvDhos) % W/W (ovrophos)<br>
            PEG-8, FCC (PEG 400) 3.00 3.00<br>
            Xanthan Gum 0.700 0.6000<br>
            Sorbitol USP (70%) 29.9322 28.4761<br>
            Hydrated silicia (Zeofree 153) 8.000 7.000<br>
            Hydrated silicia (Zeofree 113)14.000 14.000<br>
            Sodium tripolyphosphate 5.000<br>
            Sodium pyrophosphate 1.810<br>
            Ptassium pyrophosphate 4.000<br>
            Sodium Hydroxide (50% solution) 0.900<br>
            Glycerin 10.000 10.000<br>
            Flavor 0.800 0.800<br>
            Sodium lauryl sulfate 1.150 1.150<br>
            Sodium saccharin 0.214 0.214<br>
            D &amp; Red * 30 Aluminum lake 0.025 0.025<br>
            FD &amp; Blue #1 (0.2%) 0.2478 0.2478<br>
            D &amp; Yellow *10 (0.2%) 0.2015 0.2015<br>
            Titanium dioxide 0.7235 0.7235<br>
            Sodium benzoate 0.100 0.100<br>
            Deionized water qs 100.00% qs 100.00%<br>
            In these two formulations, PEG-8 is a polyethylene glycol.
            It, along with the sorbitol and glycerin, is a humectant.
            Xanthan gum and the Zeofree 153 are binders and thickening
            agents. Three dyes are recited in this formulation as it is
            to be presented as a tri-colored product much like that sold
            under the Aquafresh brand name of SmithKline<br>
            Beehcam Consumer Brands.<br>
            <br>
            Because of the presence of pyrophosphates and
            tripolyphosphates, clear gel-like formulations cannot be
            prepared. But one can prepare gellike toothpastes, albeit
            opaque gels, by eliminating the three dyes from the
            foregoing formulations.<br>
            <br>
            Pump dispensers have gained favor with many toothpaste
            users.<br>
            <br>
            The following formulation can be used with a pump dispenser
            system.<br>
            <br>
            Table 2 - Pump Dispenser Formulation<br>
            Ingredient % WIW (trinolvnbos) % WIW (pyronbos)<br>
            PEG-8, FCC (PEG 400) 3.00 3.00 XanthanGum 0.700 0.6000<br>
            Sorbitol USP (70%) 29.609 28.253<br>
            Hydrated silicia (Zeofree 153) 8.000 7.000<br>
            Hydrated silica (Zeofree 113) 14.000 14.000<br>
            Sodium tripolyphosphate 5.000<br>
            Sodium pyrophosphate 1.810<br>
            Potassium pyrophosphate 4.000<br>
            Sodium Hydroxide (50it solution) 0.900<br>
            Glycerin 10.000 10.000<br>
            Flavor 0.800 0.800<br>
            Sodium lauryl sulfate 1.150 1.150<br>
            Sodium saccharin 0.214 0.214<br>
            D &amp; Red # 30 Aluminum lake 0.025 0.025<br>
            FD &amp; Blue #1 (0.2%) 0.2478 0.2478<br>
            D &amp; Yellow #10 (0.2%) 0.2015 0.2015<br>
            Titanium dioxide 0.9560 0.9560 Sodium benzoate 0.100 0.200<br>
            Purified Water qs 100.00% qs 100.00%<br>
            Example 2<br>
            Mouthwash Formulations<br>
            An anti-caries mouthwash employing the pyrophosphates of
            this invention is illustrated by the following formulation.<br>
            <br>
            Table 3 - Pvrophosphate-containing Mouthwash<br>
            Ingredients % W/W<br>
            Ethyl Alcohol, 190 proof 8.00<br>
            Glycerin, 99% U.S.P. 8.000<br>
            Sodium pyrophosphate 2.060<br>
            Potassium pyrophosphate 0.710<br>
            Flavor 0.200<br>
            Menthol 0.007<br>
            Cremophor RH-60 0.200<br>
            Pluronic F-108 (surfactant) 0.100<br>
            Pluronic F-127 (surfactant) 0.100<br>
            Benzoic acid 0.100<br>
            Sodium saccharin 0.060<br>
            FD &amp; #1 (0.2% solution) 0.140<br>
            FD &amp; yellow #5 (0.2% solution) 0.900<br>
            Phosphoric acid 25% solution<br>
            to adjust pH As needed<br>
            Deionized water qs 100.00%<br>
            These ingredients, expect the phosphoric acid and a small
            amount of the water are mixed together, the pH is adjusted
            to the desired figure, then the solution is brought to
            volume with water. This mouthwash may be packaged in any
            conventional bottle or container.<br>
            <br>
            A similar mouthwash, but using a tripolyphosphate, is
            prepared as per the following formulation.<br>
            <br>
            Table 4<br>
            Tripolvphosphate-containing Mouthwash Ingredients % W/W %W/W<br>
            Ethyl Alcohol, 190 proof 8.00<br>
            Glycerin, 99% U.S.P. 8.000<br>
            Sodium tripolyphosphate 0.50<br>
            Flavor 0.200<br>
            Menthol 0.007<br>
            Cremophor RH-60 0.200<br>
            Pluronic F-108 (surfactant) 0.100<br>
            Pluronic F-127 (surfactant) 0.100<br>
            Benzoic acid 0.100<br>
            Sodium saccharin 0.060<br>
            FD &amp; #1 (0.2% solution) 0.140<br>
            FD &amp; yellow #5 (0.2% solution)0.900<br>
            Phosphoric acid 25% solution<br>
            to adjust pH As needed<br>
            Deionized water qs 100.00%<br>
            Example 3<br>
            Method for Testing the Efficacv of Phosphates<br>
            The efficacy of these phosphates was determined using the
            following protocol:<br>
            Dentifrices (toothpastes) were prepared in plain color-coded
            tubes.<br>
            <br>
            All had the same base to which was added a tripolyphosphate,
            pyrophosphate, or one of these phosphates with NaF. The
            control was the dentifrice base. The following table gives
            the concentrations of actives in each formulation.<br>
            <br>
            Product Description<br>
            (Fluoride as NaF. 1100 ppm F-- where shown)<br>
            Sodium tripolyphosphate (5%) without F<br>
            Sodium/potassium pyrophosphate (1.8/4.0%) without F<br>
            Toothpaste base<br>
            Sodium tripolyphosphate with F<br>
            Sodium/potassium pyrophosphate with F<br>
            The identity of the products was withheld from the
            technician until all experiments were completely assessed
            and data assembled. All experiments were conducted with
            color-coded tubes and all experimental racks and tubes
            similarly coded to keep the operatives blind. The only
            partial breaking of the code was when it became necessary to
            instruct the operative which was the correct radiotracer to
            add in the "hot" experiments.<br>
            <br>
            The pH cycling (demineralization/remineralization) model for
            the in vitro study of fluoride-containing products and
            fluoride products containing anticalculus agents was that of
            Featherstone et al, Caries<br>
            Res. 1988; 22:337-341. This model has previously been shown
            to simulate results found by us in vivo around orthodontic
            brackets (O'Reilly and Featherstone, Am. J. Orthod. 1987;
            92:33-40). Each test cell consisted of ten human tooth
            crowns which were removed from the roots, cleaned and
            painted with acid resistant varnish to leave test windows as
            described in detail previously (Featherstone et al, Caries
            Res.<br>
            <br>
            1988; 22:337-341).<br>
            <br>
            The study was divided into "cold" legs and "hot" legs. The
            "cold" legs, with no radiotracer added, were used in order
            to determine whether the test anticalculus agents
            (pyrophosphate and tripolyphosphate) individually had a
            detrimental outcome on the net effect of
            demineralization/remineralization. In this case two windows,
            designated "upper" (towards occlusal) and "lower" (towards
            cervical) were placed on the enamel surface of each tooth
            crown. In the "hot" legs where 32p labelled potassium
            pyrophosphate or sodium tripolyphosphate was added, one
            window approximately 3 x 7 mm was placed on each test
            surface.<br>
            <br>
            The test regimen in each 24 hour period was as follows:<br>
            1. Demineralization. Teeth were immersed individually for 6
            hours daily at 37 OC in 40 mli of a buffer containing 0.075
            mol/L acetate, 2.0 mmol/L CaHP04 at pH 4.3.<br>
            <br>
            2. Product immersion. The crowns were removed from solution,
            thoroughly rinsed with double deionized water (DDW), and
            immersed individually in 4 mL of a 1:3 slurry of dentifrice
            (one of the test or placebo products, see below) in DDW, and
            stirred on an orbital shaker for 5 minutes. The slurries
            were made fresh daily within 30 minutes of immersion, and
            where appropriate, radiotracers were added and dispersed by
            vortexing. After the product immersion, the samples were
            again thoroughly washed in DDW and transferred to the
            remineralizing solution.<br>
            <br>
            3. Remineralization. Each tooth was then immersed
            individually for 17 hours at 37 "C in 20 mL of a
            mineralizing solution containing 1.5 mmol/L calcium, 0.9
            mmol/L phosphate, 150 mmoVL KCI (to maintain ionic
            strength), 20 mmol/L cacodylate to buffer to pH 7.0. This
            solution simulates the remineralizing phase (ten Cate and
            Duijsters, Caries Res.<br>
            <br>
            1982; 16:201-210) of the caries process (by salivary
            minerals).<br>
            <br>
            Duration of pH cvcling. The above pH cycling was repeated
            for 3 weeks, consisting of 14 cycling days and two weekend
            periods in mineralizing solution. The test scheme was
            designed to model, a total daily demineralization challenge
            of 6 hours, a once per day fluoride (or non fluoride)
            treatment, and 17 hours daily of repair (remineralization).<br>
            <br>
            Test Groups. The experiments were carried out in duplicate,
            one group of each pair using sodium tripolyphosphate and one
            using pyrophosphate salts The groups were designed to give
            four "cold" legs (A1, A2, B1, B2, below) which were assessed
            by cross-sectional microhardness testing (see below) to
            determine the degree of demineralization, and four identical
            "hot" legs (C1, C2, D1, D2) using radiolabeled sodium
            tripolyphosphate or pyrophosphate salts to determine the
            degree of penetration of the tripolyphosphate or
            pyrophosphate into the enamel during treatment with and
            without fluoride present. A fifth "cold" leg (E below)
            served as the baseline control and used a placebo dentifrice
            with no fluoride, no tripolyphosphate, and no pyrophosphate
            ions.<br>
            <br>
            A1. Demineralization/remineralization cycling as above with
            5 minutes daily immersion prior to remineralization in a 1:3
            slurry of a sodium tripolyphosphate/sodium fluoride
            dentifrice (4 mL of solution per tooth individually).<br>
            <br>
            A2. In the duplicate experiment a pyrophosphate salt/NaF
            dentifrice was used.<br>
            <br>
            B1. Demineralization/remineralization cycling with 5 minutes
            daily immersion prior to remineralization in a 1:3 slurry of
            an sodium tripolyphosphate non-fluoride dentifrice (sodium
            tripolyphosphate present as in A but with no added sodium
            fluoride) (4 mL of solution per tooth individually).<br>
            <br>
            B2. In the duplicate experiment pyrophosphate salts
            containing dentifrice without an added fluoride ion was
            similarly used.<br>
            <br>
            C1. Demineralization/remineralization cycling with 5 minutes
            daily immersion prior to remineralization in a 1:3 slurry of
            an sodium tripolyphosphate/sodium fluoride dentifrice (4 mL
            of solution per tooth individually). In this group the
            sodium tripolyphosphate slurry was labeled with 32P as
            sodium tripolyphosphate added as a radiotracer prior to
            immersion of the teeth.<br>
            <br>
            C2. In the duplicate experiment pyrophosphate salts were
            used and similarly radiolabeled with 32P as pyrophosphate
            salts.<br>
            <br>
            D1. Demineralization/remineralization cycling with 5 minutes
            daily immersion prior to remineralization in a 1:3 slurry of
            sodium tripolyphosphate (as in C, but with no added sodium
            fluoride) dentifrice (4 mL of solution per tooth
            individually) and with 32P labeled sodium tripolyphosphate
            added as described above.<br>
            <br>
            D2. In the duplicate experiment pyrophosphate salts were
            used, similarly radiolabeled.<br>
            <br>
            E. Demineralization/remineralization cycling with 5 minutes
            daily immersion prior to remineralization in a 1:3 slurry of
            a placebo dentifrice (no added sodium fluoride, no added
            sodium tripolyphosphate or pyrophosphate salts, 4 mL per
            tooth individually).<br>
            <br>
            All groups used freshly made treatment slurries daily.<br>
            <br>
            Demineralization and remineralization solutions were
            replaced weekly.<br>
            <br>
            Assessment Methodology<br>
            Chemical analvses: All demineralization and remineralization
            solutions were analyzed for fluoride ion by specific ion
            electrode before use. Each individual test tube was analyzed
            for F- after 7 and 14 days of cycling. Changes in F-
            solution were calculated by subtracting the starting values.<br>
            <br>
            Phvsical analvses: Groups A1, A2, B1, B2, and E were
            assessed by cross-sectional microhardness profiles, as
            described below. The duplicate radiotracer groups (C1, C2,
            D1, and D2) obviously could not be assessed in this manner.
            They were assessed by radiotracer counting as described
            separately below.<br>
            <br>
            At the end of the cycling period, teeth from groups A, B,
            and E were thoroughly rinsed in DDW, sectioned
            longitudinally through the center of the lesions produced,
            and embedded in epoxy resin with the cut face exposed as
            described in detail previously (ten Cate et al, Caries Res.<br>
            <br>
            1985: 19:335-341). After serially polishing the embedded
            teeth, each lesion was assessed by cross-sectional
            microhardness, according to the published methods in the
            references above. Indents were commenced at 25 pm from the
            anatomical surface and repeated at 25 pm intervals to a
            depth of 300 Fun, across the sectioned lesion and into the
            sound underlying enamel. This method has been shown to give
            results comparable with microradiography (White and
            Featherstone, Caries Res.<br>
            <br>
            1987; 21:502-512).<br>
            <br>
            The indentation lengths were converted as per our published
            formula to volume percent, mineral and mineral loss (AZ)
            values (jim x vol % mineral) were calculated using Simpson's
            rule for each profile, for each lesion on each tooth, as
            described previously (White and<br>
            Featherstone, Caries Res. 1987; 21:502-512). Mean values of
            AZ for each group were calculated, and mineral loss profiles
            were plotted as vol % mineral vs. depth from the outer
            surface.<br>
            <br>
            Radiotracer analvses: Teeth from groups C and D were
            thoroughly washed in DDW and the varnish was removed
            individually from each tooth by acetone. Eight stepwise
            abrasions were made for each sample using small preweighed
            circles of silicon carbide paper (600 grade) to remove
            layers approximately 5 jim thick Each sample was weighed,
            dissolved into a scintillation cocktail and the
            radioactivity counted in a Searle scintillation counter.<br>
            <br>
            Results for sodium tripolyphosphate and pyrophosphate salt
            products, with and without fluoride present, were compared.
            The amount of lesion formation was measured by the duplicate
            "cold" legs (A and B) described above as radiotracer
            material cannot be used in the other laboratories.<br>
            <br>
            Uptake of tripolyphosphate or pvrophosphate into caries-like
            lesions.<br>
            <br>
            This assay assessed the amount of uptake of sodium
            tripolyphosphate or pyrophosphate salts into preformed
            caries-like lesions in human enamel in vitro:<br>
            Test material: Human dental enamel from molars with caries
            free (by stereo microscope) buccal or lingual surfaces.
            Teeth were cleaned and prepared as described above for the
            pH cycling study.<br>
            <br>
            Artificial caries lesion formation: Artificial caries-like
            lesions were produced in one window (3 x 7 mm) on one enamel
            surface of molars prepared in our standard manner by
            immersion for 5 days in a pH 5.0 buffer (0.05 mol/L
            lactate), 50 percent saturated with hydroxyapatite, and with
            0.2% carbopol, as per the method of White (Caries Res. 1987:
            21:228-242). This system produced lesions approximately 100
            pm deep in 5 days.<br>
            <br>
            Immersion in tripolvuhosphate or pvrophosphate salts: Teeth
            with preformed caries-like lesions were individually
            immersed in 20m1 of a 1:3 slurry of sodium tripolyphosphate
            or pyrophosphate salts dentifrice with 32P labeled sodium
            tripolyphosphate or pyrophosphate salts added at similar
            concentration as used in the pH cycling experiments above.
            Groups of 10 teeth each were used. The first group was
            immersed for one hour and the second group for 4 hours for
            each of sodium tripolyphosphate and pyrophosphate salts. At
            the end of the immersion period the teeth were removed,
            rinsed in DDW and immediately air dried. They were assessed
            for radiotracer uptake using the abrasion method as
            described above.<br>
            <br>
            Table 6<br>
            Relative mineral loss, AZ (volume % x pm) as mean values<br>
            (SD = standard deviation) for each group for upper and lower<br>
            windows. Values are arranged in ascending order of AZ<br>
            values for the upper window.<br>
            <br>
            Test Group Product Description Mean AZ (vol % x pm)<br>
            Upper Window Lower Window<br>
            A2 PPir Toothpaste, with NaF3 292 (346) 318 (368)<br>
            A1 STPP2 toothpaste, with NaF 597 (425) 273 (638)<br>
            B1 STPP without NaF 1300 (814) 1996 (834)<br>
            B2 PPi without NaF 1399 (652) 2671 (1643)<br>
            E Placebo, no NaF, no<br>
            STPP,no PPi 3809 (584) 5069 (1092)<br>
            1 PPi means potassium pyrophosphate/sodium pyrophosphate
            (4.0%l1.81to)<br>
            2 STPP means sodium tripolyphosphate (5%).<br>
            <br>
            3 NaF at a concentration sufficient to give 1100 ppm F-.<br>
            <br>
            Both sodium tripolyphosphate and potassium/sodium
            pyrophosphate mix demonstrated significant reduction in
            caries as compared with the placebo, and approaching that
            demonstrated by the combination of these phosphates and NaF.<br>
            <br>
            ////////////////<br>
            <br>
            &nbsp;CHEWING GUM WITH DENTAL HEALTH BENEFITS EMPLOYING
            CALCIUM LACTATE&nbsp; <br>
            Description of WO0042861 (A1)<br>
            Translate this text into Tooltip<br>
            &gt; &nbsp;&nbsp;&nbsp; <br>
            Translate this text into<br>
            &nbsp;&nbsp;&nbsp; &nbsp;<br>
            <br>
            The EPO does not accept any responsibility for the accuracy
            of data and information originating from other authorities
            than the EPO; in particular, the EPO does not guarantee that
            they are complete, up-to-date or fit for specific purposes.<br>
            <br>
            SPECIFICATION<br>
            TITLE<br>
            "CHEWING GUM WITH DENTAL HEALTH BENEFITS<br>
            EMPLOYING CALCIUM LACTATE"<br>
            BACKGROUND OF THE INVENTION<br>
            The present invention relates generally to chewing gums.
            More specifically, the present invention relates to chewing
            gums that can provide dental benefits.<br>
            <br>
            Except for the common cold, dental caries (tooth decay) is
            the most prevalent human disorder. See, The Merck Manual,
            Sixteenth Edition, p. 2480. Even though, many steps have
            been taken to reduce dental caries and tooth decay, such as
            fluoridation and improved dental care, tooth decay continues
            to be a significant problem. This is especially true in the
            adult population; 80% of the tooth decay occurs in 20% of
            the population. See Featherstone, An Updated Understanding
            of the Mechanism of Dental Decay and its Prevention,
            Nutrition Quarterly, Vol. 14, No. 1,1990, pp. 5-11.<br>
            <br>
            To protect a normal tooth, a thin layer of dental enamel
            forms a protective coating over the tooth. This coating
            consists mainly of calcium, phosphate, and other ions in a
            hydroxyapatite-like structure. The enamel contains 2 to 5
            percent carbonate; this carbonate content makes the enamel
            susceptible to acid dissolution. See, Featherstone, id. at
            6.<br>
            <br>
            The interaction of three factors is believed to result in
            dental caries: a susceptible tooth surface; the proper
            microflora; and a suitable substrate for the microflora.
            Although several acidogenic micro-organisms that are present
            in the mouth can initiate carious lesions, Streptococcus
            mutans is believed to be the primary pathogen. See, The
            Merck<br>
            Manual, supra.<br>
            <br>
            It is known that foods containing fermentable carbohydrates
            can promote dental caries. Tooth decay begins when the
            Streptococcus mutans, that reside principally in the plaque
            that adheres to a tooth surface, metabolize the fermentable
            carbohydrates consumed by the host. During the metabolism of
            the fermentable carbohydrates by the bacteria, lactic acid
            and other organic acids are secreted as a by-product. These
            acids reduce the pH of the surrounding plaque/tooth
            environment.<br>
            <br>
            When the pH of the plaque/tooth environment drops below a
            critical level of 5.5 to 5.7, hydroxyapatite (calcium
            phosphate hydroxide, Cal0 (PO4) 6 (OH) 2), the key component
            of tooth enamel, begins to dissolve. This critical pH can
            change depending on the concentration of the key ions.
            Typically, the dissolution begins below the tooth's porous
            surface.<br>
            <br>
            With repeated acid attacks, caused by the further metabolism
            of fermentable carbohydrates by the bacteria, subsurface
            lesions expand. The body's natural remineralization
            mechanism, however, at this point, can still reverse the
            decay process.<br>
            <br>
            But, if the lesions expand to the point that the enamel
            surface breaks, a cavity is formed and the process is no
            longer reversible.<br>
            <br>
            The natural remineralization process involves, in part, the
            flow of saliva over the plaque. The saliva can raise the pH
            of the environment. Additionally, calcium and phosphate ions
            in the saliva precipitate out to replace the hydroxyapatite
            that was dissolved by the organic acids created during the
            metabolism of the fermentable carbohydrates.<br>
            <br>
            However, typically, this remineralization process only
            occurs at significant levels when the pH is above the
            critical level. Therefore, if the saliva does not
            sufficiently raise the pH, significant remineralization will
            not occur. But, the remineralization process may be enhanced
            by fluoride in the oral cavity that speeds up new crystal
            growth and makes a flurorapatite-like material that is
            precipitated on the surface of the crystals inside the
            caries lesion. See, Featherstone, id. at 7.<br>
            <br>
            A number of salts have been reported in certain experiments
            to counteract demineralization. One of the difficulties is
            providing a viable vehicle for delivering the salts. Still
            further, a number of safety issues are raised by some of the
            salts.<br>
            <br>
            Furthermore, sensory problems with respect to some of the
            salts prevent these salts from being taken on a regular
            basis by a patient to provide prophylactic benefits.<br>
            <br>
            U. S. Patent No. 5,378,171 discloses a sugar chewing gum
            with dental health benefits that includes calcium
            glycerophosphate.<br>
            <br>
            SUMMARY OF THE INVENTION<br>
            The present invention provides a composition and method for
            the remineralization of enamel. Pursuant to the present
            invention, sugar free chewing gum is provided that includes
            a therapeutically effective amount of calcium lactate.<br>
            <br>
            It has been found that calcium lactate counteracts the
            decaying process. Calcium lactate is believed to function by
            promoting remineralization of the tooth enamel caused by
            dental caries. Calcium lactate has been found to be an
            effective enamel remineralization agent that is acceptable
            from sensory and safety standpoints.<br>
            <br>
            Pursuant to the present invention, calcium lactate can be
            used in chewing gum.<br>
            <br>
            Chewing gum is an especially good vehicle for delivering
            calcium lactate because it can deliver the ingredient over
            prolonged periods of time. Additionally, chewing gum can be
            conveniently used almost anywhere, at anytime, as opposed to
            a rinse or dentifrices.<br>
            <br>
            To this end, a method for remineralizing enamel is provided
            comprising the step of providing a chewing gum that includes
            a therapeutically effective amount of calcium lactate.<br>
            <br>
            In an embodiment, two pieces of chewing gum are chewed at a
            time.<br>
            <br>
            In an embodiment of the method, the gum is chewed at least
            twice a day.<br>
            <br>
            In an embodiment of the method, the chewing gum produces a
            calcium ion concentration in the saliva of the mouth of the
            chewer of at least 200 ppm.<br>
            <br>
            In an embodiment of the method, the gum is chewed for at
            least two minutes.<br>
            <br>
            The present invention also provides a chewing gum for
            reducing the generation of dental caries comprising a water
            insoluble base, water soluble portion and flavor, and
            calcium lactate.<br>
            <br>
            In an embodiment, the chewing gum is sugarless.<br>
            <br>
            In an embodiment, the chewing gum is wax-free.<br>
            <br>
            In an embodiment, the chewing gum is a low calorie chewing
            gum.<br>
            <br>
            In an embodiment, the chewing gum contains other therapeutic
            agents.<br>
            <br>
            In an embodiment, the chewing gum includes at least 40 mg of
            calcium lactate.<br>
            <br>
            In an embodiment, the chewing gum is in the form of a stick.<br>
            <br>
            In an embodiment, the chewing gum is in the form of a
            pellet.<br>
            <br>
            In an embodiment, the chewing gum includes an additional
            therapeutic agent.<br>
            <br>
            An advantage of the present invention is to provide a method
            for preventing, or reducing the risk of, dental caries of
            the remineralization of enamel.<br>
            <br>
            Another advantage of the present invention is to treat
            dental caries.<br>
            <br>
            Additionally, an advantage of the present invention is to
            provide a chewing gum that can be used to improve dental
            health.<br>
            <br>
            Further, an advantage of the present invention is to provide
            a chewing gum that does not have the sensory drawbacks of
            other sources of calcium.<br>
            <br>
            Moreover, an advantage of the present invention is to
            provide an easy and enjoyable way to improve dental health.<br>
            <br>
            Still further, an advantage of the present invention is to
            provide a composition and method for delivering a
            therapeutic agent over a prolonged period of time to the
            oral region.<br>
            <br>
            Additional features and advantages of the present invention
            are described in, and will be apparent from, the detailed
            description of the presently preferred embodiments.<br>
            <br>
            DETAII, ED DESCRIPTION OF THE<br>
            PRESENTLY PREFERRED EMBODIMENTS<br>
            The present invention provides a method and composition for
            remineralizing tooth enamel and thereby preventing and/or
            treating dental caries. Pursuant to the present invention, a
            chewing gum is provided that includes a therapeutically
            effective amount of calcium lactate. The chewing gum of the
            present invention, by including a therapeutically effective
            amount of calcium lactate, can improve dental health when
            chewed.<br>
            <br>
            Calcium lactate is believed to function by the
            remineralization of tooth enamel.<br>
            <br>
            Calcium lactate when provided in a chewing gum can produce a
            calcium ion concentration in the saliva during chewing which
            is effective to remineralized carious lesions in teeth. For
            example, it has been found that 80 mg of calcium lactate in
            chewing gum will produce saliva calcium levels greater than
            500 parts per million, this level has been shown to
            remineralize teeth.<br>
            <br>
            It is believed that the calcium ion concentration in the
            saliva should be above 200 ppm in order to initiate the
            remineralization process. Preferably the calcium ion
            concentration should be above 350 ppm and most preferably
            above 500 ppm. These levels should be provided for at least
            one minute, preferably more than two minutes, and most
            preferably more than four minutes upon chewing the gum.<br>
            <br>
            It has been found that these levels can be accomplished by
            the inclusion of at least 40 mg, preferably at least 60 mg
            and most preferably at least 80 mg of calcium lactate in a
            piece of chewing gum. In some cases, it may be desirable to
            divide the prescribed dosage among two or more smaller
            pieces of gum which are intended to be chewed together.<br>
            <br>
            In another embodiment of the invention, a method for the
            remineralization of carious lesions in teeth is provided
            that comprises providing a sugarless chewing gum comprising
            calcium lactate. The gum is chewed for at least two minutes
            (preferably at least 5 minutes and most preferably at least
            20 minutes) whereby the calcium is released by the gum in a
            quantity sufficient to produce a calcium concentration which
            is effective to remineralized the carious lesions. This
            treatment is repeated at least twice, preferably at least
            three times, and most preferably at least five times daily
            until the lesion has been remineralized.<br>
            <br>
            The chewing gum composition may be any chewing gum formula
            and most preferably a sugarless formulation. Such formulas
            typically contain a major amount of a sugar alcohol bulking
            agent, a substantial portion of gum base, minor amounts of
            syrups, softeners, flavors, color and high intensity
            sweeteners. Low calorie gums which contain reduced levels of
            sugar alcohols and increased levels of base and/or low
            calorie or calorie-free bulking agents are also anticipated.
            The product may be formed into tabs, sticks, chunks or
            coated pellets. A piece size of 1 to 4 grams is preferred.
            As previously mentioned, with smaller pieces sizes, it may
            be desirable to split the calcium lactate dosage between two
            or more pieces to reduce the concentration for improved
            sensory acceptability.<br>
            <br>
            Chewing gum generally consists of a water insoluble gum
            base, a water soluble portion, and flavors. The water
            soluble portion dissipates with a portion of the flavor over
            a period of time during chewing. The gum base portion is
            retained in the mouth throughout the chew.<br>
            <br>
            The insoluble gum base generally comprises elastomers,
            resins, fats and oils, softeners, and inorganic fillers. The
            gum base may or may not include wax. The insoluble gum base
            can constitute approximately 5 to about 95 percent, by
            weight, of the chewing gum, more commonly, the gum base
            comprises 10 to about 50 percent of the gum, and in some
            preferred embodiments, 20 to about 35 percent, by weight, of
            the chewing gum.<br>
            <br>
            In an embodiment, the chewing gum base of the present
            invention contains about 20 to about 60 weight percent
            synthetic elastomer, 0 to about 30 weight percent natural
            elastomer, about 5 to about 55 weight percent elastomer
            plasticizer, about 4 to about 35 weight percent filler,
            about 5 to about 35 weight percent softener, and optional
            minor amounts (about one percent or less) of miscellaneous
            ingredients such as colorants, antioxidants, etc.<br>
            <br>
            Synthetic elastomers may include, but are not limited to,
            polyisobutylene with<br>
            GPC weight average molecular weight of about 10,000 to about
            95,000, isobutyleneisoprene copolymer (butyl elastomer),
            styrene-butadiene copolymers having styrenebutadiene ratios
            of about 1: 3 to about 3: 1, polyvinyl acetate having GPC
            weight average molecular weight of about 2,000 to about
            90,000, polyisoprene, polyethylene, vinyl acetate-vinyl
            laurate copolymer having vinyl laurate content of about 5 to
            about 50 percent by weight of the copolymer, and
            combinations thereof.<br>
            <br>
            Preferred ranges are, for polyisobutylene, 50,000 to 80,000
            GPC weight average molecular weight, for styrene-butadiene,
            1: 1 to 1: 3 bound styrene-butadiene, for polyvinyl acetate,
            10,000 to 65,000 GPC weight average molecular weight with
            the higher molecular weight polyvinyl acetates typically
            used in bubble gum base, and for vinyl acetate-vinyl
            laurate, vinyl laurate content of 10-45 percent.<br>
            <br>
            Natural elastomers may include natural rubber such as smoked
            or liquid latex and guayule as well as natural gums such as
            jelutong, lechi caspi, perillo, sorva, massaranduba balata,
            massaranduba chocolate, nispero, rosindinha, chicle, gutta
            hang kang, and combinations thereof. The preferred synthetic
            elastomer and natural elastomer concentrations vary
            depending on whether the chewing gum in which the base is
            used is abhesive or conventional, bubble gum or regular gum,
            as discussed below. Preferred natural elastomers include
            jelutong, chicle, sorva and massaranduba balata.<br>
            <br>
            Elastomer plasticizers may include, but are not limited to,
            natural rosin esters such as glycerol esters of partially
            hydrogenated rosin, glycerol esters polymerized rosin,
            glycerol esters of partially dimerized rosin, glycerol
            esters of rosin, pentaerythritol esters of partially
            hydrogenated rosin, methyl and partially hydrogenated methyl
            esters of rosin, pentaerythritol esters of rosin; synthetics
            such as terpene resins derived from alphapinene,
            beta-pinene, and/or d-limonene; and any suitable
            combinations of the foregoing. the preferred elastomer
            plasticizers will also vary depending on the specific
            application, and on the type of elastomer which is used.<br>
            <br>
            Fillers/texturizers may include magnesium and calcium
            carbonate, ground limestone, silicate types such as
            magnesium and aluminum silicate, clay, alumina, talc,
            titanium oxide, mono-, di-and tri-calcium phosphate,
            cellulose polymers, such as wood, and combinations thereof.<br>
            <br>
            Softeners/emulsifiers may include tallow, hydrogenated
            tallow, hydrogenated and partially hydrogenated vegetable
            oils, cocoa butter, glycerol monostearate, glycerol
            triacetate, lecithin, mono-, di-and triglycerides,
            acetylated monoglycerides, fatty acids (e. g. stearic,
            palmitic, oleic and linoleic acids), and combinations
            thereof.<br>
            <br>
            Colorants and whiteners may include FD &amp; C-type dyes and
            lakes, fruit and vegetable extracts, titanium dioxide, and
            combinations thereof.<br>
            <br>
            The base may or may not include wax. An example of a
            wax-free gum base is disclosed in U. S. Patent No.
            5,286,500, the disclosure of which is incorporated herein by
            reference.<br>
            <br>
            In addition to a water insoluble gum base portion, a typical
            chewing gum composition includes a water soluble bulk
            portion and one or more flavoring agents. The water soluble
            portion can include bulk sweeteners, high intensity
            sweeteners, flavoring agents, softeners, emulsifiers,
            colors, acidulants, fillers, antioxidants, and other
            components that provide desired attributes.<br>
            <br>
            Softeners are added to the chewing gum in order to optimize
            the chewability and mouth feel of the gum. The softeners,
            which are also known as plasticizers and plasticizing
            agents, generally constitute between approximately 0.5 to
            about 15% by weight of the chewing gum. The softeners may
            include glycerin, lecithin, and combinations thereof.
            Aqueous sweetener solutions such as those containing
            sorbitol, hydrogenated starch hydrolysates, corn syrup and
            combinations thereof, may also be used as softeners and
            binding agents in chewing gum.<br>
            <br>
            Bulk sweeteners include both sugar and sugarless components.
            Bulk sweeteners typically constitute 5 to about 95% by
            weight of the chewing gum, more typically, 20 to 80% by
            weight, and more commonly, 30 to 60% by weight of the gum.<br>
            <br>
            Sugar sweeteners generally include saccharide-containing
            components commonly known in the chewing gum art, including,
            but not limited to, sucrose, dextrose, maltose, dextrin,
            dried invert sugar, fructose, levulose, galactose, corn
            syrup solids, and the like, alone or in combination.<br>
            <br>
            Sugarless sweeteners include, but are not limited to, sugar
            alcohols such as sorbitol, mannitol, xylitol, hydrogenated
            starch hydrolysates, maltitol, and the like, alone or in
            combination.<br>
            <br>
            High intensity artificial sweeteners can also be used, alone
            or in combination with the above. Preferred sweeteners
            include, but are not limited to sucralose, aspartame, salts
            of acesulfame, alitame, saccharin and its salts, cyclamic
            acid and its salts, glycyrrhizin, dihydrochalcones,
            thaumatin, monellin, and the like, alone or in combination.
            In order to provide longer lasting sweetness and flavor
            perception, it may be desirable to encapsulate or otherwise
            control the release of at least a portion of the artificial
            sweetener. Such techniques as wet granulation, wax
            granulation, spray drying, spray chilling, fluid bed
            coating, coacervation, and fiber extension may be used to
            achieve the desired release characteristics.<br>
            <br>
            Usage level of the artificial sweetener will vary greatly
            and will depend on such factors as potency of the sweetener,
            rate of release, desired sweetness of the product, level and
            type of flavor used and cost considerations. Thus, the
            active level of artificial sweetener may vary from 0.02 to
            about 8%. When carriers used for encapsulation are included,
            the usage level of the encapsulated sweetener will be
            proportionately higher.<br>
            <br>
            Combinations of sugar and/or sugarless sweeteners may be
            used in chewing gum.<br>
            <br>
            Additionally, the softener may also provide additional
            sweetness such as with aqueous sugar or alditol solutions.<br>
            <br>
            If a low calorie gum is desired, a low caloric bulking agent
            can be used. Example of low caloric bulking agents include:
            polydextrose; Raftilose, Raftilin;<br>
            Fructooligosaccharides (NutraFlora); Palatinose
            oligosaccharide; Guar Gum Hydrolysate (Sun Fiber); or
            indigestible dextrin (Fibersol). However, other low calorie
            bulking agents can be used.<br>
            <br>
            A variety of flavoring agents can be used. The flavor can be
            used in amounts of approximately 0.1 to about 15 weight
            percent of the gum, and preferably, 0.2 to 5%.<br>
            <br>
            Flavoring agents may include essential oils, synthetic
            flavors or mixtures thereof including, but not limited to,
            oils derived from plants and fruits such as citrus oils,
            fruit essences, peppermint oil, spearmint oil, other mint
            oils, clove oil, oil of wintergreen, anise and the like.
            Artificial flavoring agents and components may also be used.
            Natural and artificial flavoring agents may be combined in
            any sensorially acceptable fashion.<br>
            <br>
            Additional oral health ingredients may be added including
            but not limited to, antiplaque/anti-gingivitis agents (such
            as chlorhexidine, CPC, triclosan), pH control agents
            (including Urea and buffers,) other inorganic components for
            tarter or caries control (phosphates, fluoride) and
            biological agents (antibodies, enzymes). The only
            requirement is that the agents be safe and effective and
            that they do not react undesirably with each other such as
            may happen with phosphate salts.<br>
            <br>
            Preferably the calcium lactate is mixed into the chewing gum
            mass but it may also be added to a coating syrup or used as
            a dry charge in a coating process in the case of a coated
            chewing gum.<br>
            <br>
            The following examples, which as of this time have not been
            made, illustrate some embodiments of the invention. Of
            course, many others are possible.<br>
            <br>
            EXAMPLES 2 3 4<br>
            Gum Base 30.0% 32.60% 30.0% 70.0%<br>
            Sorbitol 40.0-25.4 10.4<br>
            Maltitol-30.00<br>
            Xylitol 0.5 15.00 30.0<br>
            Mannitol 7.0 5.00 2.0 2.0<br>
            Calcium Lactate 3.0 4.00 4.0 6.0<br>
            Aspartame 0.5-0.2 Acesulfame K-0.15 0.1<br>
            Sucralose-0.15-0.2<br>
            Alitame--0.1 Neotame---0.1<br>
            Sorbitol Solution 15.0-5.0 (70% solids)<br>
            HydrogenatedStarch-9.00-5.0<br>
            Hydrolysate Syrup (85% solids)<br>
            Glycerin 3.0 3.00 2.0 5.0<br>
            Color-0.10 0.2 0.3<br>
            Flavor 1.0 1. 00 1.0 1.0<br>
            (Spearmint) (Cinnamon) (Peppermint) (Wintergreen)<br>
            Total 100% 100% 100% 100%<br>
            Form 3g stick 3g stick 2g tab lg tab<br>
            EXAMPLES<br>
            7 8 9 10<br>
            Gum Base 25.0% 35.00% 35.0% 30.0%<br>
            Sorbitol 31.9-35.0 39.50%<br>
            Polydextrose-40.88<br>
            Xylitol 15.0-5.0 5.00<br>
            Mannitol 5.0 5.00 5.0 4.00<br>
            Calcium Lactate 3.0 2.00 4.0 4.00<br>
            Aspartame 0.5 0.50 0.3 0.50<br>
            Chlorhexidine-0.17<br>
            Triclosan-0.25<br>
            Urea 3.5--0.50<br>
            S. Mutans Monclonal---0.50<br>
            Antibodies<br>
            Glycerin 5.0 5.00 5.0 15.00<br>
            Hydrogenated Starch 10.0 10.00 9.9<br>
            Hydrolysate Syrup (85% solids)<br>
            Color 0.1 0.20 0.1 0.15<br>
            Flavor 1.0 1. 00 0.7 0.85<br>
            (Sweet Fruit) (Peppermint) (Menthol) (Spearmint)<br>
            Total 100.0% 100.00% 100.0% 100.00%<br>
            Form 3g stick 3g stick lg pellet 3g stick<br>
            center<br>
            Notes on Examples:<br>
            Examples 4 and 8 are low caloric chewing gums.<br>
            ////////////////<br>
            &nbsp;&nbsp;&nbsp; <br>
            &nbsp;&nbsp;&nbsp;&nbsp; Oral and dental care product&nbsp;
            <br>
            Description of US2007154411 <br>
            <br>
            [0030] Protein hydrolysates mean for the purposes of the
            present invention degradation products of proteins such as,
            for example, collagen, elastin, casein, keratin, almond,
            potato, wheat, rice and soybean protein which are obtained
            by acidic, alkaline and/or enzymatic hydrolysis of the
            proteins themselves or their degradation products such as,
            for example, gelatin. Suitable for the enzymatic degradation
            are all enzymes having hydrolytic activity, such as, for
            example, alkaline proteases. Further suitable enzymes and
            enzymatic hydrolysis methods are described for example in K.
            Drauz and H. Waldmann, Enzyme Catalysis in Organic
            Synthesis, VCH-Verlag, Weinheim 1975. In the degradation,
            the proteins are split into smaller subunits, and the
            degradation may proceed via the stages of polypeptides to
            oligopeptides and on to the individual amino acids. Protein
            hydrolysates with little degradation include for example the
            gelatin which is preferred for the purposes of the present
            invention and which may have molecular masses in the range
            from 15 000 to 250 000 D. Gelatin is a polypeptide which is
            obtained principally by hydrolysis of collagen under acidic
            (type A gelatin) or alkaline (type B gelatin) conditions.
            The gel strength of the gelatin is proportional to its
            molecular weight, i.e. gelatin which has been hydrolyzed to
            a greater extent yields a solution of lower viscosity. The
            gel strength of gelatin is indicated in Bloom numbers. The
            polymer size is greatly reduced in the enzymatic cleavage of
            gelatin, leading to very low Bloom numbers.<br>
            [0036] For the preparation of the composite material,
            reference is expressly made to the disclosure in WO 01/01930
            A1.<br>
            &nbsp;lower when the chosen calcination temperature is
            higher and the chosen duration of calcination is longer.
            Slightly calcined aluminas differ from pure [gamma]-Al2O3 by
            the agglomerates being less hard, the specific area being
            larger and the pore volumes being larger.<br>
            &nbsp;<br>
            [0055] Examples of water-insoluble metaphosphates of the
            invention are in particular sodium metaphosphate, calcium
            phosphate such as, for example, tricalcium phosphate,
            calcium hydrogen phosphate, calcium hydrogen phosphate
            dihydrate and calcium pyrophosphate.<br>
            <br>
            [0056] A further possibility according to the invention is
            to employ magnesium carbonate, magnesium hydrogen phosphate,
            trimagnesium phosphate or sodium hydrogen carbonate as
            polishing agents, especially mixed with other polishing
            agents.<br>
            <br>
            [0057] A further polishing agent which is suitable for use
            in the oral and dental hygiene products of the invention is
            calcium phosphate dihydrate (CaHPO4*2H2O). Calcium phosphate
            dihydrate occurs naturally as brushite and is obtainable
            commercially in suitable particle sizes of from 1 to 50
            [mu]m as polishing agent.<br>
            <br>
            [0062] The remineralization-promoting component in the
            products of the invention promotes the remineralization of
            the enamel and the sealing of dental lesions and is selected
            from fluorides, microparticulate phosphate salts of calcium
            such as, for example, calcium glycerol phosphate, calcium
            hydrogen phosphate, hydroxyapatite, fluoroapatite, F-doped
            hydroxyapatite, dicalcium phosphate dihydrate and calcium
            fluoride. However, magnesium salts such as, for example,
            magnesium sulfate, magnesium fluoride or magnesium
            monofluorophosphate also have remineralizing effects.<br>
            <br>
            [0063] In a preferred embodiment of the invention, a
            magnesium salt is employed as remineralization-promoting
            agent.<br>
            <br>
            &nbsp;<br>
            Tartar Inhibitors<br>
            <br>
            [0105] Tartar comprises mineral deposits which are very
            similar to natural enamel. In order to inhibit tartar
            formation, substances which intervene specifically in
            crystal nucleation and prevent nuclei which are already
            present from growing further are added to the dental
            cleaning compositions of the invention. Examples thereof are
            condensed phosphates which are preferably chosen from the
            group of tripolyphosphates, of pyrophosphates, of
            trimetaphosphates or mixtures thereof. They are employed in
            the form of their alkali metal or ammonium salts, preferably
            in the form of their sodium or potassium salts. Aqueous
            solutions of these phosphates typically have an alkaline
            reaction, so that the pH of the dental hygiene products of
            the invention is adjusted where appropriate to values of
            7.5-9 by adding acid. Examples of acids which can be used in
            this connection are citric acid, phosphoric acid or acidic
            salts, e.g. NaH2PO4. The desired pH of the dental hygiene
            product can, however, also be adjusted by adding acidic
            salts of the condensed phosphates, e.g. K2H2P2O7.<br>
            <br>
            [0106] It is also possible to employ according to the
            invention mixtures of various condensed phosphates and/or
            hydrated salts of the condensed phosphates. Tartar
            inhibitors are normally employed in amounts of 0.1-5% by
            weight, preferably 0.1-3% by weight and in particular 0.1-2%
            by weight in the products of the invention.<br>
            <br>
            [0107] Further suitable tartar inhibitors are
            organophosphonates such as
            1-azacycloheptane-2,2-diphosphonate (Na salt),
            1-hydroxyethane-1,1-diphosphonate (Na salt) and zinc
            citrate.<br>
            <br>
            &nbsp;Active Substances to Counter Hypersensitive Teeth<br>
            <br>
            [0108] The products of the invention preferably further
            comprise active substances to counter hypersensitive teeth,
            they are selected from potassium and strontium salts such as
            potassium chloride, potassium sulfate, potassium
            bicarbonate, potassium citrate, potassium acetate, potassium
            nitrate, strontium chloride, strontium nitrate, strontium
            citrate, strontium acetate and strontium lactate and
            eugenol.<br>
            <br>
            [0109] The eugenol may be present mixed with aromatic oils
            in the oral and dental hygiene products. It is preferably
            present in the compositions in the <br>
            form of clove bud oil.<br>
            <br>
            [0110] The oral and dental hygiene products of the invention
            preferably comprise at least 0.5% by weight of potassium or
            strontium ions in the form of a dissolved salt and at least
            0.01% by weight of eugenol in pure form or in the form of
            the clove bud oil...<br>
            <br>
            &nbsp;&nbsp;&nbsp; <br>
            <b>US2006079467&nbsp;&nbsp; </b><br>
            <b> </b><b>Formulation of dual eicosanoid system and
              cytokine system inhibitors for use in the prevention and
              treatment of oral diseases and conditions&nbsp; </b><br>
            <b> </b>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<br>
            FIELD OF THE INVENTION<br>
            <br>
            [0002] This invention relates generally to a novel
            composition of matter comprised of a mixture of a blend of
            two specific classes of compounds-Free-B-Ring flavonoids and
            flavans-which target the eicosanoid and cytokine pathways
            for use in the prevention and treatment of diseases and
            conditions of the mouth, teeth and gums. <br>
            <br>
            BACKGROUND OF THE INVENTION<br>
            <br>
            [0003] Periodontal disease is a combination of inflammation
            and infection of some or all of the tooth support structures
            (gingiva, cementum, periodontal ligament, alveolar bone and
            other tissues surrounding the teeth). Gingivitis (gums) and
            periodontitis (gums and bone) are the two main forms of
            periodontal disease. According to National Oral Information
            distributed by the National Institute of Dental and
            Craniofacial Research, an estimated 80 percent of American
            adults currently have some form of periodontal disease.
            Periodontal disease is initiated when a pellicle forms on a
            clean tooth or teeth. This pellicle attracts aerobic
            gram-positive bacteria (mostly actinomyces and
            streptococci), which adhere to the tooth forming plaque.
            Within days the plaque thickens, the underlying bacteria run
            out of oxygen and anaerobic motile rods and spirochetes
            begin to populate the subgingival area. Endotoxins released
            by the anaerobic bacteria cause inflammation, gum tissue
            destruction and even bone loss. There are four primary
            stages of periodontal disease that can be characterized as
            indicated below. The destructive impact of periodontal
            disease goes beyond dental hygiene and health, in that
            microscopic lesions resulting from periodontal disease have
            been found in the liver, kidneys, and brain of some affected
            persons.<br>
            <br>
            Four Stages of Periodontal Disease<br>
            <br>
            Grade 1&nbsp; Inflammation<br>
            <br>
            Grade 2&nbsp; Inflammation, edema, gingival bleeding upon
            probing<br>
            <br>
            Grade 3&nbsp; Inflammation, edema, gingival bleeding upon
            probing, pustular<br>
            <br>
            &nbsp; discharge - slight to moderate bone loss<br>
            <br>
            Grade 4&nbsp; Inflammation, edema, gingival bleeding upon
            probing, pustular<br>
            <br>
            &nbsp; discharge, mobility - severe bone loss<br>
            <br>
            [0004] The inflammation resulting from periodontal disease
            is mainly related to two biological systems:-the eicosanoid
            system and the cytokine system. The release and metabolism
            of arachidonic acid (AA) from the cell membrane results in
            the generation of pro-inflammatory metabolites by several
            different pathways. Two of the most important pathways to
            inflammation are mediated by the enzymes lipoxygenase (LOX)
            and cyclooxygenase (COX). These are parallel pathways that
            result in the generation of leukotrienes and prostaglandins,
            respectively, which play important roles in the initiation
            and progression of the inflammatory response. These
            vasoactive compounds are chemotaxins, which both promote
            infiltration of inflammatory cells into gum tissue and serve
            to prolong the inflammatory response that may lead to bone
            loss. Consequently, the enzymes responsible for generating
            these mediators of inflammation can be targeted to develop
            therapeutic agents to prevent and treat diseases and
            conditions related to the mouth, teeth and gums.<br>
            <br>
            [0005] The cytokine system is a very potent force in
            homeostasis when activation of the network is local and the
            cytokines act vicinally in surface-bound or diffusible form.
            But when cytokine production is sustained and/or systemic,
            cytokines contribute to the signs, symptoms, and pathology
            of inflammatory, infectious, autoimmune, and malignant
            diseases. TNF-[alpha] is a potent pleiotropic cytokine
            produced by macrophages, neutrophiles, fibroblasts,
            keratinocytes, NK cells T and B cell and tumor cells.
            IL-1[beta], together with TNF-[alpha], plays a central role
            in inflammatory responses. Administration of antagonists,
            such as IL-1ra (IL-1 receptor antagonist), soluble fragment
            of IL-1 receptor, or monoclonal antibodies to TNF-[alpha]
            and soluble TNF receptor, all block various acute and
            chronic responses in animal models of inflammatory diseases.
            Nuclear factor kappa B (NF[kappa]B) is a transcription
            factor that controls gene expression of interleukin-1 beta
            (IL-1[beta]), tumor necrosis factor-alpha (TNF[alpha]),
            interleukin-6 (IL-6) and many other proteins. Some of these
            antagonists are beginning to be utilized as
            anti-inflammatory agents in diseases such as sepsis,
            periodontal diseases and rheumatoid arthritis. (Dinarello
            (2004) Curr Opin Pharmacol. 4:378-385). Anti-TNF-[alpha]
            antibodies were not only found to induce striking remissions
            in rheumatoid arthritis, but also to reduce tissue
            inflammation in Crohn's disease, an inflammatory bowel
            disease (Maini and Feldmann. (2002) Arthritis Res. 4 Suppl
            2: S22-8).<br>
            <br>
            [0006] Periodontal ligament (PDL) cells exhibit
            osteoblast-like features and are capable of differentiating
            into cells of either cementogenic or osteogenic lineage.
            These cells are crucial for the maintenance of the integrity
            and regeneration of the periodontium (Somerman et al. (1990)
            Arch Oral Biol. 35: 241-47; Pitaru et al. (1994) J
            Periodontal Res. 29:81-94). Chronic infections in the
            periodontium, initiated by bacterial colonization, induce
            synthesis of pro-inflammatory cytokines, which can
            potentially affect PDL cell phenotype and function. These
            cytokines not only activate and recruit immune cells to the
            site of infection (Le and Vilcek (1987) J. Immunol. 139:
            3330; Kunkel et al (1994) Ann. N.Y. Acad. Sci. 730:134), but
            also induce loss of supporting bone and ligamentous
            attachment (Pitaru et al. (1994) J Periodontal Res.
            29:81-94). TNF[alpha], for example, has been shown to
            modulate the PDL cell osteoblast-like phenotype and
            functions (Agarwal et al. (1998) Infect. Immun. 66:932-937).
            Additionally, TNF[alpha] and IL-1[beta] change the
            phenotypic characteristics of osteoblasts by down-regulation
            of alkaline phosphatase (Kuroki et al. (1994) Rheumatology
            33:224) and by the modulation of collagen, collagenase,
            proteoglycan, and prostaglandin syntheses (Agarwal et al.
            (1998) Infect. Immun. 66:932-937).<br>
            <br>
            [0007] In the isolated PDL cells, IL-1[beta] induces
            phenotypic changes (Agarwal et al. (1998) Infect. Immun.
            66:932-937). PDL cells from healthy periodontium do not
            recognize bacterial lipopolysaccharide (LPS) nor do they
            elicit pro-inflammatory cytokines in response to LPS.
            Following IL-1[beta] treatment, PDL cells lose their
            osteoblast-like characteristics while assuming a new
            LPS-responsive phenotype. Thus, IL-1[beta] is an important
            regulator of PDL cell function and directs these cells to
            participate actively in an immune response during
            infections. IL-1[beta] stimulates bone resorption and
            inhibits bone formation (Stashenko et al. (1987) J Bone
            Miner Res. 2:559-65; Nguyen et al. (1991) Lymphokine
            Cytokine Res. 10:15-21; Tatakis (1993) J Periodontol (1991)
            64:416-31). In addition, IL-1[beta] synergizes the
            bone-resorptive actions of TNF-[alpha] (Bertolini et al.
            (1986) Nature 319:516-18; van der Pluijm et al. (1991)
            Endocrinology 129:1596). Another important activity of
            IL-1[beta] in the pathological process of periodontitis is
            to induce the production of matrix metalloproteinases (MMPs)
            (Havemose-Poulsen and Holmstrup (1997) Crit. Rev. Oral.
            Biol. Med 8:217). IL-1[beta] gives rise to an elevated level
            of procollagenase in both gingival fibroblasts and PDL cells
            (Meikle et al. (1989) J Periodontal Res. 24:207-13; Lark et
            al. (1990) Connect Tissue Res. 25:49-65; Tewari et al.
            (1994) Arch Oral Biol. 39 657-64). In addition, IL-1[beta]
            stimulates plasminogen activator in gingival fibroblasts,
            resulting in the generation of plasmin, which is an
            activator of several matrix metalloproteinases (Mochan et
            al. (1988) J Periodontal Res. 23:28-32). Furthermore,
            Stashenko and co-workers reported a positive correlation
            between IL-1[beta] levels in gingival tissues and recent
            attachment loss (Stashenko et al. (1991) J Clin Periodontol
            18:548-54).<br>
            <br>
            [0008] TNF[alpha] is another key mediator of immune and
            inflammatory responses and has been found in measurable
            quantities in the areas of active periodontal inflammation
            (Rossomando et al. (1990) Arch Oral Biol. 35:431-34;
            Stashenko et al. (1991) J Clin Periodontol 18:548-54).
            TNF[alpha] changes the osteoblastic features of PDL cells
            (Quintero et al. (1995) J. Dent. Res.74:1802). This is
            substantiated by their ability to express other
            pro-inflammatory cytokines, such as IL-1[beta], IL-6, and
            IL-8, in response to LPS. TNF[alpha] induces the secretion
            of collagenase by fibroblasts, resorption of cartilage and
            bone, and has been implicated in the destruction of
            periodontal tissue in periodontitis (Elias et al. (1987) J.
            Immunol. 138:3812; Meikle et al. (1989) J Periodontal Res.
            24:207-13; Chaudhary et al. (1992) Endocrinology 130:2528).
            In resting macrophages, TNF[alpha] induces the synthesis of
            IL-1[beta] and prostaglandin E2. TNF-[alpha] also activates
            osteoclasts and thus induces bone resorption. TNF-[alpha]
            has synergistic effects with the bone-resorptive actions of
            IL-1[beta] ((van der Pluijm et al. (1991) Endocrinology
            129:1596; Bertolini et al. (1986) Nature 319:516-8; Johnson
            et al. (1989) Endocrinology 124:1424).<br>
            <br>
            [0009] In inflammatory periodontal lesions, a variety of
            cell types-such as T-cells, macrophages, endothelial cells,
            and fibroblasts-were shown to have increased IL-6 expression
            at both the mRNA and protein levels (Kono et al. (1991 ) J.
            Immunol. 146:1812; Matsuki et al (1992) Immunology 76:42-47;
            Fujihashi et al. (1993) Am. J. Pathol. 142:1239; Yarnazaki
            et al. (1994) J Oral Pathol Med. 23:347-53). Since IL-6 is
            of particular importance in human B cell responses, it has
            been speculated that the expansion of B-cells/plasma cells
            seen in periodontitis lesions may result from an increased
            production of IL-6 at diseased sites (Fujihashi et al (1993)
            J Periodontol 64:400-406). Additionally, IL-6 plays an
            important role in the local regulation of bone turnover
            (Lowik et al. (1989) Biochem Biophys Res Commun.
            162:1546-52; Ishimi et al. (1990) J. Immunol. 145:3297;
            Kurihara et al. (1990) J. Immunol. 144:4226) and appears to
            be essential for bone loss caused by estrogen deficiency
            (Horowitz (1993) J Bone Miner Res. 8:1163-71). In vitro
            studies also demonstrated that simultaneous treatment of
            mouse osteoblastic cells and bone marrow cells with IL-6 and
            soluble IL-6 receptor strikingly induced osteoclast
            formation (Tamura et al. (1993) PNAS 90:11924) .
            Furthermore, it was also suggested that IL-6 may act as an
            autocrine and/or paracrine factor in bone resorption in
            pathologic states by stimulating the formation of
            osteoclasts and the activation of osteoclastic bone
            resorption (Ohsaki et al. (1992) Endocrinology 131: 2229).
            These findings imply the involvement of IL-6 in the
            pathogenesis of periodontal tissue destruction in
            periodontitis.<br>
            <br>
            [0010] Inhibition of the COX enzyme is the mechanism of
            action attributed to most non-steroidal anti-inflammatory
            drugs (NSAIDS). There are two distinct isoforms of the COX
            enzyme (COX-1 and COX-2), which share approximately 60%
            sequence homology, but differ in expression profiles and
            function. COX-1 is a constitutive form of the enzyme that
            has been linked to the production of physiologically
            important prostaglandins, which help regulate normal
            physiological functions, such as platelet aggregation,
            protection of cell function in the stomach and maintenance
            of normal kidney function. (Dannhardt and Kiefer (2001) Eur.
            J. Med. Chem. 36:109-26). The second isoform, COX-2, is a
            form of the enzyme that is inducible by pro-inflammatory
            cytokines, such as interleukin-1[beta] D(IL-1[beta]) and
            other growth factors. (Herschmann (1994) Cancer Metastasis
            Rev. 134:241-56; Xie et al. (1992) Drugs Dev. Res.
            25:249-65). This isoform catalyzes the production of
            prostaglandin E2 (PGE2) from arachidonic acid (AA).
            Inhibition of COX is responsible for the anti-inflammatory
            activity of conventional NSAIDs.<br>
            <br>
            [0011] Inhibitors that demonstrate dual specificity for COX
            and LOX would have the obvious benefit of inhibiting
            multiple pathways of arachidonic acid metabolism. Such
            inhibitors would block the inflammatory effects of
            prostaglandins (PG), as well as, those of multiple
            leukotrienes (LT) by limiting their production. This
            includes the vasodilation, vasopermeability and chemotactic
            effects of PGE2, LTB4, LTD4 and LTE4, also known as the slow
            reacting substance of anaphalaxis. Of these, LTB4 has the
            most potent chemotactic and chemokinetic effects. (Moore
            (1985) in Prostanoids: pharmacololical physiological and
            clinical relevance, Cambridge University Press, N.Y., pp.
            229-230).<br>
            <br>
            [0012] Because the mechanism of action of COX inhibitors
            overlaps that of most conventional NSAID's, COX inhibitors
            are used to treat many of the same symptoms, including pain
            and swelling associated with inflammation in transient
            conditions and chronic diseases in which inflammation plays
            a critical role. However, most of the known NSAIDs are not
            suitable for periodontal diseases due to their poor
            solubility and bioavailability.<br>
            <br>
            ...Applicant is unaware of any reports of a formulation
            combining Free-B-Ring-Flavonoids and flavans as the primary
            biologically active components targeting the eicosanoid and
            cytokine pathways for the treatment of oral diseases and
            conditions.<br>
            <br>
            [0014] Flavonoids or bioflavonoids are a widely distributed
            group of natural products, which have been reported to have
            antibacterial, anti-inflammatory, antiallergic,
            antimutagenic, antiviral, antineoplastic, anti-thrombic and
            vasodilatory activity. The structural unit common to this
            group of compounds includes two benzene rings on either side
            of a 3-carbon ring as illustrated by the following general
            structural formula:<br>
            EMI1.0<br>
            Various combinations of hydroxyl groups, sugars, oxygen and
            methyl groups attached to this general three ring structure
            create the various classes of flavonoids, which include
            flavanols, flavones, flavan-3-ols (catechins), anthocyanins
            and isoflavones.<br>
            <br>
            [0015] Free-B-Ring flavones and flavonols are a specific
            class of flavonoids, which have no substituent groups on the
            aromatic B ring (referred to herein as Free-B-Ring
            flavonoids), as illustrated by the following general
            structure:<br>
            EMI2.0<br>
            <br>
            &nbsp;<br>
            [0020] Free-B-Ring flavonoids are relatively rare. Out of
            9,396 flavonoids synthesized or isolated from natural
            sources, only 231 Free-B-Ring flavonoids are known (The
            Combined Chemical Dictionary, Chapman &amp; Hall/CRC,
            Version 5:1 June 2001). Free-B-Ring flavonoids have been
            reported to have diverse biological activity... <br>
            <br>
            [0022] The Chinese medicinal plant, Scuttellaria baicalensis
            contains significant amounts of Free-B-Ring flavonoids,
            including baicalein, baicalin, wogonin and baicalenoside.
            Traditionally, this plant has been used to treat a number of
            conditions including clearing away heat, purging fire,
            dampness-warm and summer fever syndromes; polydipsia
            resulting from high fever; carbuncle, sores and other
            pyogenic skin infections; upper respiratory infections, such
            as acute tonsillitis, laryngopharyngitis and scarlet fever;
            viral hepatitis; nephritis; pelvitis; dysentery; hematemesis
            and epistaxis. This plant has also traditionally been used
            to prevent miscarriage. (Encyclopedia of Chinese Traditional
            Medicine, ShangHai Science and Technology Press, ShangHai,
            China, 1998). Clinically Scutellaria is now used to treat
            conditions such as pediatric pneumonia, pediatric bacterial
            diarrhea, viral hepatitis, acute gallbladder inflammation,
            hypertension, topical acute inflammation, resulting from
            cuts and surgery, bronchial asthma and upper respiratory
            infections. (Encyclopedia of Chinese Traditional Medicine,
            ShangHai Science and Technology Press, ShangHai, China,
            1998). The pharmacological efficacy of Scuttellaria roots
            for treating bronchial asthma is reportedly related to the
            presence of Free-B-Ring flavonoids and their suppression of
            eotaxin associated recruitment of eosinophils. (Nakajima et
            al. (2001) Planta Med. 67(2):132-135).<br>
            <br>
            [0023] To date, a number of naturally occurring Free-B-Ring
            flavonoids have been commercialized for varying uses. For
            example, liposome formulations of Scutellaria extracts have
            been utilized for skin care (U.S. Pat. Nos. 5,643,598;
            5,443,983). Baicalin has been used for preventing cancer,
            due to its inhibitory effects on oncogenes (U.S. Pat. No.
            6,290,995). Baicalin and other compounds have been used as
            antiviral, antibacterial and immunomodulating agents (U.S.
            Pat. No. 6,083,921 and WO98/42363) and as natural
            anti-oxidants (WO98/49256 and Poland Pub. No. 9,849,256).
            Flavonoids formulates with terpenoids have been used as
            inhibitors of surface-bound glusosyltransferase for treating
            and inhibiting dental caries (US#20040057908). Japanese Pat.
            No. 63027435 describes the extraction, and enrichment of
            baicalein and Japanese Pat. No. 61050921 describes the
            purification of baicalin.<br>
            <br>
            [0024] U.S. application Ser. No. 10/091,362, filed Mar. 1,
            2002, entitled "Identification of Free-B-Ring Flavonoids as
            Potent COX-2 Inhibitors," and U.S. application Ser. No.
            10/427,746, filed Jul. 22, 2003, entitled "Formulation of a
            Mixture of Free-B-Ring Flavonoids and Flavans as a
            Therapeutic Agent" disclose a method for inhibiting the
            cyclooxygenase enzyme COX-2 by administering a composition
            comprising a Free-B-Ring flavonoid or a composition
            containing a mixture of Free-B-Ring flavonoids to a host in
            need thereof. This is the first report of a link between
            Free-B-Ring flavonoids and COX-2 inhibitory activity. These
            applications are specifically incorporated herein by
            reference in their entirety.<br>
            <br>
            [0031] Catechin is a flavan, found primarily in green tea,
            having the following structure:<br>
            EMI4.0<br>
            Catechin works both alone and in conjunction with other
            flavonoids found in tea, and has both antiviral and
            antioxidant activity. Catechin has been shown to be
            effective in the treatment of viral hepatitis. It also
            appears to prevent oxidative damage to the heart, kidney,
            lungs and spleen and has been shown to inhibit the growth of
            stomach cancer cells...<br>
            <br>
            &nbsp;[0033] Acacia is a genus of leguminous trees and
            shrubs. The genus Acacia includes more than 1000 species
            belonging to the family of Leguminosae and the subfamily of
            Mimosoideae. Acacias are distributed worldwide in tropical
            and subtropical areas of Central and South America, Africa,
            parts of Asia, as well as, Australia, which has the largest
            number of endemic species. To date, approximately 330
            compounds have been isolated from various Acacia species.
            Flavonoids are the major class of compounds isolated from
            Acacias. Approximately 180 different flavonoids have been
            identified, 111 of which are flavans. Terpenoids are second
            largest class of compounds isolated from species of the
            Acacia genus, with 48 compounds having been identified.
            Other classes of compounds isolated from Acacia include,
            alkaloids (28), amino acids/peptides (20), tannins (16),
            carbohydrates (15), oxygen heterocycles (15) and aliphatic
            compounds (10). (Buckingham, The Combined Chemical
            Dictionary, Chapman &amp; Hall CRC, version 5:2, December
            2001)...<br>
            <br>
            [0035] The Uncaria genus, includes 34 species many of which
            are well known as medicinal plants. Uncaria plants have been
            utilized by different cultures for treatment of wounds, and
            ulcers, fevers, headaches, gastrointestinal illnesses and
            microbial/gungal infections. Uncaria plants contain
            significant amounts of catechin and other flavones. Other
            components that have been reported in Uncaria genus include
            alkaloids, terpenes, quinovic acid glycosides, coumarins,
            and flavonoids. Uncaria gambir is a species common in
            Malaysia, Singapore, India and other South East Asian
            countries. Catechins are major components in the whole plant
            of Uncaria gambir.<br>
            <br>
            SUMMARY OF THE INVENTION<br>
            <br>
            [0036] The present invention includes methods that are
            effective in simultaneously inhibiting both the eicosanoid
            system and the cytokine system for use in the prevention and
            treatment of diseases and conditions related to the mouth,
            teeth and gums. The method for the simultaneous dual
            modulation of both the eicosanoid system and the cytokine
            system is comprised of administering, systemically or
            locally, a composition comprised of a mixture of Free-B-Ring
            flavonoids and flavans synthesized and/or isolated from a
            single plant or multiple plants to a host in need thereof.
            This composition of matter is referred to herein as UP676.
            The efficacy and safety of this method is demonstrated with
            purified enzymes, in different cell lines, in multiple
            animal models and eventually in a human clinical study. The
            ratio of the Free-B-Ring flavonoids to flavans in the
            composition is in the range of 99.9:0.1 of Free-B-Ring
            flavonoids:flavans to 0.1:99.9 Free-B-Ring
            flavonoids:flavans. In specific embodiments of the present
            invention, the ratio of Free-B-Ring flavonoids to flavans is
            selected from the group consisting of approximately 90:10,
            80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80 and 10:90.
            In a preferred embodiment of this invention, the ratio of
            Free-B-Ring flavonoids:flavans in the composition of matter
            is 80:20. In a preferred embodiment, the Free-B-Ring
            flavonoids are isolated from a plant or plants in the
            Scutellariagenus of plants and the flavans are isolated from
            a plant or plants in the Acacia or Uncaaria genus of plants.<br>
            <br>
            [0037] The present invention also includes methods for the
            prevention and treatment of diseases and conditions of the
            mouth, teeth and gums. The method for preventing and
            treating said diseases and conditions of the mouth, teeth
            and gums is comprised of administering, systemically or
            topically, to a host in need thereof an effective amount of
            a composition comprising a mixture of Free-B-Ring flavonoids
            and flavans synthesized and/or isolated from a single plant
            or multiple plants and a pharmaceutically acceptable
            carrier. The ratio of the Free-B-Ring flavonoids to flavans
            in the composition is in the range of 99.9:0.1 of
            Free-B-Ring flavonoids:flavans to 0.1:99.9 Free-B-Ring
            flavonoids:flavans. In specific embodiments of the present
            invention, the ratio of Free-B-Ring flavonoids to flavans is
            selected from the group consisting of approximately 90:10,
            80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80 and 10:90.
            In a preferred embodiment of this invention, the ratio of
            Free-B-Ring flavonoids:flavans in the composition of matter
            is 80:20. In a preferred embodiment, the Free-B-Ring
            flavonoids are isolated from a plant or plants in the
            Scutellaria genus of plants and the flavans are isolated
            from a plant or plants in the Acacia or Uncaria genus of
            plants...<br>
            <br>
            [0044] The Free-B-Ring flavonoids of this invention may be
            obtained by synthetic methods or extracted from the family
            of plants including, but not limited to Annonaceae,
            Asteraceae, Bignioniaceae, Combretaceae, Compositae,
            Euphorbiaceae, Labiatae, Lauranceae, Leguminosae, Moraceae,
            Pinaceae, Pteridaceae, Sinopteridaceae, Ulmaceae and
            Zingiberacea. The Free-B-Ring flavonoids can be extracted,
            concentrated, and purified from the following genus of high
            plants, including but not limited to Demos, Achyrocline,
            Oroxylum, Buchenavia, Anaphalis, Cotula, Gnaphalium,
            Helichrysum, Centaurea, Eupatoriuin, Baccharis, Sapium,
            Scutellaria, Molsa, Colebrookea, Stachys, Origanum,
            Ziziphora, Lindera, Actiniodaphne, Acacia, Derris,
            Glycyrrhiza, Millettia, Pongamia, Tephrosia, Artocarpus,
            Ficus, Pityrogramma, Notholaena, Pinus, Ulmus and Alpinia.<br>
            <br>
            [0051] The flavans of this invention may be obtained from a
            plant or plants selected from the genus of Acacia or
            Uncaria. In a preferred embodiment, the plant is selected
            from the group consisting of Acacia catechu, Acacia
            concinna, Acacia farinesiana, Acacia Senegal, Acacia
            speciosa, Acacia arabica, A. caesia, A. pennata, A. sinuata.
            A. mearnsii, A. picnantha, A. dealbata, A. auriculiformis,
            A. holoserecia and A. mangium; and Uncaria gambir, Uncaria
            lanosa, Uncaria hirsute, Uncaria africana, Uncaria
            elliptica, Uncaria orientalis, Uncaria attenuate, Uncaria
            acida, Uncaria homomalla, Uncaria sessilifructus, Uncaria
            sterrophylla, Uncaria bernaysii, Uncaria sinensis, Uncaria
            callophylla, Uncaria rhychophylla, Uncaria tomeentosa,
            Uncaria longiflora, Uncaria hirsute, Uncaria cordata, and
            Uncaria borneensis.<br>
            <br>
            ...The combination of Free-B-Ring-flavonoids with flavans to
            produce the composition of matter referred to herein as
            UP676, offers a synergistic and potent modulator of both the
            eicosanoid system and the cytokine system that will help to
            control inflammation of the periodontal tissues, including
            inflammation in all four stages of periodontal disease.
            Additionally, due to the different biological availability,
            i.e. rate and percentage of biologically active compounds
            penetrating the epithelial cell membrane and the local
            concentrations of biologically active compounds in
            periodontal tissues, the combination of the two different
            type of compounds (higher polarity flavans vs. lower
            polarity Free-B-Ring flavonoids) offers both quick, on-site
            pain and acute-inflammatory relief by the biologically
            active flavans, as well as, longer lasting modulation of
            chronic inflammation in periodontal tissues by the
            biologically active Free-B-Ring flavonoids. Finally, in the
            preferred embodiment formulation of significant amounts of
            free-B-Ring flavonoids (80% by weight) with comparatively
            lower concentration of flavans (20% by weight), the more
            potent anti-oxidative flavans will function both as natural
            preservatives against oxidative degradation of the
            Free-B-Ring flavonoids and to neutralize and buffer the
            composition allowing delivery of the major active
            components-the Free-B-Ring flavonoids at the optimum pH and
            ionization conditions.<br>
            <br>
            DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT<br>
            <br>
            ...The Free-B-Ring flavonoids of this invention may be
            obtained by synthetic methods or may be isolated from the
            family of plants including, but not limited to Annonaceae,
            Asteraceae, Bignoniaceae, Combretaceae, Compositae,
            Euphorbiaceae, Labiatae, Lauranceae, Leguminosae, Moraceae,
            Pinaceae, Pteridaceae, Sinopteridaceae, Ulmaceae, and
            Zingiberacea. The Free-B-Ring flavonoids can be extracted,
            concentrated, and purified from the following genus of high
            plants, including but not limited to Desmos, Achyrocline,
            Oroxylum, Buchenavia, Anaphalis, Cotula, Gnaphalium,
            Helichrysum, Centaurea, Eupatorium, Baccharis, Sapium,
            Scutellaria, Molsa, Colebrookea, Stachys, Origanum,
            Ziziphora, Lindera, Actinodaphne, Acacia, Derris,
            Glycyrrhiza, Millettia, Pongamia, Tephrosia, Artocarpus,
            Ficus, Pityrogramma, Notholaena, Pinus, Ulmus and Alpinia.
            The flavonoids can be found in different parts of plants,
            including but not limited to stems, stem barks, twigs,
            tubers, roots, root barks, young shoots, seeds, rhizomes,
            flowers and other reproductive organs, leaves and other
            aerial parts.<br>
            <br>
            [0111] Methods for the isolation and purification of
            Free-B-Ring flavonoids are described in U.S. application
            Ser. No. 10/091,362, filed Mar. 1, 2002, entitled
            "Identification of Free-B-Ring Flavonoids as Potent Cox-2
            Inhibitors," and U.S. application Ser. No. 10/469,275, filed
            Aug. 27, 2003, entitled "Identification of Free-B-Ring
            Flavonoids as Potent Cox-2 Inhibitors," each of which is
            incorporated herein by reference in its entirety.<br>
            <br>
            [0112] The flavans that can be used in accordance with the
            method of this invention include compounds illustrated by
            the general structure set forth above. The flavans of this
            invention are isolated from a plant or plants selected from
            the Acacia or Uncaria genus of plants. In a preferred
            embodiment, the plant is selected from the group consisting
            of Acacia catechu (A. catechu), A. concinna, A. farnesiana,
            A. Senegal, A. speciosa, A. arabica, A. caesia, A. pennata,
            A. sinuata. A. mearnsii, A. picnantha, A. dealbata, A.
            auriculiformis, A. holoserecia and A. mangium; or Uncaria
            gambir, Uncaria lanosa, Uncaria hirsute, Uncaria africana,
            Uncaria elliptica, Uncaria orientalis, Uncaria attenuate,
            Uncaria acida, Uncaria homomalla, Uncaria sessilifructuts,
            Uncaria sterrophylla, Uncaria bernaysii, Uncaria sinensis,
            Uncaria callophylla, Uncaria rhychophylla, Uncaria
            tomentosa, Uncaria longiflora, Uncaria hirsute, Uncaria
            cordata, and Uncaria borneensis. The flavans can be found in
            different parts of plants, including but not limited to
            stems, stem barks, trunks, trunk barks, twigs, tubers,
            roots, root barks, young shoots, seeds, rhizomes, flowers
            and other reproductive organs, leaves and other aerial
            parts.<br>
            <br>
            [0113] Methods for the isolation and purification of flavans
            are described in U.S. application Ser. No. 10/104,477, filed
            Mar. 22, 2002, entitled "Isolation of a Dual Cox-2 and
            5-Lipoxygenase Inhibitor from Acacia," which is incorporated
            herein by reference in its entirety.<br>
            <br>
            EXAMPLES<br>
            <br>
            Example 1<br>
            <br>
            Preparation of Organic and Aqueous Extracts from Acacia and
            Scuttellaria Plants<br>
            <br>
            [0136] Plant material from Acacia catechu (L) Willd. barks,
            Scutellaria orthocalyx roots, Scutellaria baicalensis roots
            or Scutellaria lateriflora whole plant and various Oroxylum
            and Uncaria species was ground to a particle size of no
            larger than 2 mm. Dried ground plant material 60 g) was then
            transferred to an Erlenmeyer flask and
            methanol:dichloromethane (1: 1) (600mL) was added. The
            mixture was shaken for one hour, filtered and the biomass
            was extracted again with methanol: dichloromethane (1:1)
            (600 mL). The organic extracts were combined and evaporated
            under vacuum to provide the organic extract (see Table 1
            below). After organic extraction, the biomass was air dried
            and extracted once with ultra pure water (600 mL). The
            aqueous solution was filtered and freeze-dried to provide
            the aqueous extract (see Table 1 below).<br>
            <br>
            TABLE 1<br>
            Yield of Organic and Aqueous Extracts from Plant Species<br>
            Plant Source&nbsp; Plant Part&nbsp; Organic Extract&nbsp;
            Aqueous Extract<br>
            Acacia catechu&nbsp; barks&nbsp; 27.2 g&nbsp; 10.8 g<br>
            Scutellaria orthocalyx&nbsp; roots&nbsp; 4.04 g&nbsp; 8.95 g<br>
            Scutellaria baicalensis&nbsp; roots&nbsp; 9.18 g&nbsp; 7.18
            g<br>
            Scutellaria lateriflora&nbsp; whole plant&nbsp; 6.54 g&nbsp;
            4.08 g<br>
            Oroxylum indicum&nbsp; seeds&nbsp; 6.58 g&nbsp; 4.04 g<br>
            Uncaria hirsuta&nbsp; arerial parts&nbsp; 2.41 g&nbsp; 0.90
            g<br>
            Uncaria sinensis&nbsp; arerial parts&nbsp; 3.94 g&nbsp; 1.81
            g<br>
            Uncaria tomentosa&nbsp; bark&nbsp; 6.47 g&nbsp; 2.31 g<br>
            <br>
            Example 2<br>
            Inhibition of COX-2 and COX-1 Peroxidase Activity by Plant
            Extracts from A. catechu, Various Scutellaria Species and
            Other Plants<br>
            <br>
            TABLE 2<br>
            Inhibition of COX-2 Peroxidase Activity by Various Species<br>
            Inhibition of COX-2&nbsp; Inhibition of COX-2<br>
            Plant Source&nbsp; by organic extract&nbsp; by aqueous
            extract<br>
            Acacia catechu (bark)&nbsp; 75%&nbsp; 30%<br>
            Scutellaria orthocalyx (root)&nbsp; 55%&nbsp; 77%<br>
            Scutellaria baicalensis (root)&nbsp; 75%&nbsp; 0%<br>
            <br>
            <br>
            TABLE 3<br>
            IC50 Values of Organic Extracts for Human and Ovine COX-2
            and COX-1<br>
            IC50 Human&nbsp; IC50 Ovine&nbsp; IC50 Ovine<br>
            COX-2&nbsp; COX-2&nbsp; COX-1<br>
            Plant Source&nbsp; ([mu]g/mL)&nbsp; ([mu]g/mL)&nbsp;
            ([mu]g/mL)<br>
            Acacia catechu (bark)&nbsp;&nbsp; 3&nbsp; 6.25&nbsp; 2.5<br>
            Scutellaria orthocalyx (root)&nbsp; Not tested&nbsp;
            10&nbsp; 10<br>
            Scutellaria baicalensis (root)&nbsp; 30&nbsp; 20&nbsp; 20<br>
            Scutellaria lateriflora (whole&nbsp; 20&nbsp; 30&nbsp; 80<br>
            plant)<br>
            Uncaria sinensis (whole&nbsp; Not tested&nbsp; 2.2&nbsp;
            72.0<br>
            plant)<br>
            Oroxylum indicum (seeds)&nbsp; Not tested&nbsp; 2.48&nbsp;
            8.4<br>
            <br>
            <br>
            <br>
            TABLE 4<br>
            Inhibition of COX Enzyme Activity by Purified Free-B-Ring
            Flavonoids<br>
            Inhibition&nbsp; Inhibition<br>
            Free-B-Ring Flavonoids&nbsp; of COX-1&nbsp; of COX-2<br>
            Baicalin&nbsp; 95%&nbsp; 97%<br>
            Baicalein&nbsp; 107%&nbsp; 109%<br>
            5,6-Dihydroxy-7-methoxyflavone&nbsp; 75%&nbsp; 59%<br>
            7,8-Dihydroxyflavone&nbsp; 74%&nbsp; 63%<br>
            Wogonin&nbsp; 16%&nbsp; 12%<br>
            <br>
            Example 4<br>
            Inhibition of 5-Lipoxygenase by Catechin isolated from A.
            catechu<br>
            <br>
            TABLE 5<br>
            Free-B-Ring Flavonoid Content in Active Plant Extracts<br>
            %&nbsp; Weight&nbsp;&nbsp;&nbsp; Total amount&nbsp;
            Free-B-Ring Active&nbsp; of&nbsp; % Extractible&nbsp; of
            Free-B-Ring&nbsp; Flavonoids<br>
            Extracts&nbsp; Extract&nbsp; from BioMass&nbsp;
            Flavonoids&nbsp; in Extract<br>
            S. orthocalyx&nbsp; 8.95 g&nbsp; 14.9%&nbsp;&nbsp; 0.2
            mg&nbsp;&nbsp; 0.6%<br>
            (aqueousextract)<br>
            S. orthocalyx&nbsp; 3.43 g&nbsp; 5.7%&nbsp; 1.95
            mg&nbsp;&nbsp; 6.4% (organicextract)<br>
            S. baicalensis&nbsp; 7.18 g&nbsp; 12.0%&nbsp; 0.03 mg&nbsp;
            0.07% (aqueous extract)<br>
            S. baicalensis&nbsp; 9.18 g&nbsp; 15.3%&nbsp; 20.3 mg&nbsp;
            35.5% (organic extract)<br>
            <br>
            TABLE 6<br>
            Catechin Content in Active Plant Extracts<br>
            Active Extracts from&nbsp; Weight of&nbsp; %
            Extractible&nbsp; % Flavans<br>
            bark of A. catechu&nbsp; Extract&nbsp; from BioMass&nbsp; in
            Extract<br>
            Aqueous Extract&nbsp; 10.8 g&nbsp; 18.0%&nbsp; 0.998%<br>
            Organic Extract&nbsp; 27.2 g&nbsp; 45.3%&nbsp; 30.37%<br>
            <br>
            Example 7<br>
            Preparation of a Standardized Extract from A. catechu<br>
            <br>
            [0146] A. catechu (500 mg of ground root) was extracted
            twice with 25 mL (2*25 mL) of the following solvent systems.
            (1) 100% water, (2) 80:20 water:methanol, (3) 60:40
            water:methanol, (4) 40:60 water:methanol, (5) 20:80
            water:methanol, (6) 100% methanol, (7) 80:20 methanol:THF,
            (8) 60:40 methanol:THF. The two extracts from each
            individual extraction were combined concentrated and dried
            under low vacuum. The identification of the chemical
            components in each extract was achieved by HPLC using a
            PhotoDiode Array detector (HPLC/PDA) and a 250 mm*4.6 mm C18
            column. The chemical components were quantified based on
            retention time and PDA data using catechin and epicatechin
            as standards. The results are set forth in Table 7. As shown
            in Table 7, the flavan extract generated from solvent
            extraction with 80% methanol/water provided the highest
            concentration of flavan components.<br>
            <br>
            TABLE 7<br>
            Solvents for Generating Standardized Flavan Extracts from A.
            catechu<br>
            Extraction&nbsp; Weight of&nbsp; % Extractible&nbsp; Total
            amount&nbsp; % Catechins<br>
            Solvent&nbsp; Extract&nbsp; from BioMass&nbsp; of
            Catechins&nbsp; in Extract<br>
            100% water&nbsp; 292.8 mg&nbsp; 58.56%&nbsp; 13 mg&nbsp;
            12.02%<br>
            water:methanol&nbsp; 282.9 mg&nbsp; 56.58%&nbsp; 13 mg&nbsp;
            11.19%<br>
            (80:20) water:methanol&nbsp; 287.6 mg&nbsp; 57.52%&nbsp; 15
            mg&nbsp; 13.54%<br>
            (60:40) water:methanol&nbsp; 264.8 mg&nbsp; 52.96%&nbsp; 19
            mg&nbsp; 13.70%<br>
            (40:60) water:methanol&nbsp; 222.8 mg&nbsp; 44.56%&nbsp; 15
            mg&nbsp; 14.83%<br>
            (20:80)100% methanol&nbsp; 215.0 mg&nbsp; 43.00%&nbsp; 15
            mg&nbsp; 12.73%<br>
            methanol:THF&nbsp; 264.4 mg&nbsp; 52.88%&nbsp; 11 mg&nbsp;
            8.81%<br>
            (80:20) methanol:THF&nbsp; 259.9 mg&nbsp; 51.98%&nbsp; 15
            mg&nbsp; 9.05%<br>
            (60:40)<br>
            <br>
            [0147] A standardized extract was obtained from whole plant
            of Uncaria gambir by extracting the biomass with
            alcohol/water solvent. The flavan content in the
            standardized extract from Uncaria gambir were quantified
            using the same method. The results are set forth in Table 8.
            The flavans were quantified based on retention time and PDA
            data using catechin as standards.<br>
            <br>
            [0148] Higher purity material can be obtained by
            recrystallization of extracts having a catechin content of
            between 8%-15% using an alcohol/water and/or aqueous
            solvents as the recrystallization solvent. It may be
            necessary to decolorize prior to recrystallization by adding
            active charcoal or other decolorization agent to a heated
            saturated solution of the extract. The high purity catechins
            then crystallized upon cooling of the heated saturated
            solution. The crystals were then filtered to remove solvent,
            dried and ground into a fine powder. Recrystallization can
            be repeated as necessary to achieve the desired level of
            purity (60%-100% of catechin flavans).<br>
            <br>
            Example 8<br>
            <br>
            Preparation of Standardized Free-B-Ring Flavonoid Extracts
            from various Scutellaria species<br>
            <br>
            [0149] S. orthocalyx (500 mg of ground root) was extracted
            twice with 25 mL of the following solvent systems. (1) 100%
            water, (2) 80:20 water:methanol, (3) 60:40 water:methanol,
            (4) 40:60 water:methanol, (5) 20:80 water:methanol, (6) 100%
            methanol, (7) 80:20 methanol:THF, (8) 60:40 methanol:THF.
            The extracts were combined, concentrated and dried under low
            vacuum. Identification of chemical components in each
            extract was performed by HPLC using a PhotoDiode Array
            detector (HPLC/PDA) and a 250 mm*4.6 mm C18 column. The
            chemical components were quantified based on retention time
            and PDA data using baicalein, baicalin, scutellarein, and
            wogonin as standards. The results are set forth in Table 9.<br>
            <br>
            TABLE 9<br>
            <br>
            Quantification of Free-B-Ring Flavonoids Extracted from S.
            orthocalyx<br>
            Total&nbsp; % Flavo-Extraction&nbsp; Weight of&nbsp; %
            Extractible&nbsp; amount of&nbsp; noids<br>
            Solvent&nbsp; Extract&nbsp; from BioMass&nbsp;
            Flavonoids&nbsp; in Extract<br>
            <br>
            100% water&nbsp;&nbsp; 96 mg&nbsp; 19.2%&nbsp; 0.02 mg&nbsp;
            0.20%<br>
            Water:methanol&nbsp; 138.3 mg&nbsp; 27.7%&nbsp; 0.38
            mg&nbsp; 0.38%<br>
            (80:20)<br>
            Water:methanol&nbsp; 169.5 mg&nbsp; 33.9%&nbsp; 0.78
            mg&nbsp; 8.39%<br>
            (60:40)<br>
            Water:methanol&nbsp; 142.2 mg&nbsp; 28.4%&nbsp; 1.14
            mg&nbsp; 11.26%<br>
            (40:60)<br>
            Water:methanol&nbsp; 104.5 mg&nbsp; 20.9%&nbsp; 0.94
            mg&nbsp; 7.99%<br>
            (20:80)<br>
            100% methanol&nbsp;&nbsp; 57.5 mg&nbsp; 11.5%&nbsp; 0.99
            mg&nbsp; 10.42%<br>
            methanol:THF&nbsp;&nbsp; 59.6 mg&nbsp; 11.9%&nbsp; 0.89
            mg&nbsp; 8.76%<br>
            (80:20)<br>
            methanol:THF&nbsp;&nbsp; 58.8 mg&nbsp; 11.8%&nbsp; 1.10
            mg&nbsp; 10.71%<br>
            (60:40)<br>
            <br>
            [0150] S. baicalensis (1000 mg of ground root) was extracted
            twice using 50 mL of a mixture of methanol and water as
            follows: (1) 100% water, (2) 70:30 water:methanol, (3) 50:50
            water:methanol, (4) 30:70 water:methanol, (5) 100% methanol.
            The extracts were combined, concentrated and dried under low
            vacuum. Identification of the chemical components was
            performed by HPLC using a PhotoDiode Array detector
            (HPLC/PDA), and a 250 mm*4.6 mm C18 column. The chemical
            components in each extract were quantified based on
            retention time and PDA data using baicalein, baicalin,
            scutellarein, and wogonin standards. The results are set
            forth in Table 10.<br>
            <br>
            TABLE 10<br>
            Quantification of Free-B-Ring Flavonoids Extracted from S.
            baicalensis<br>
            Total&nbsp; % Flavo-Extraction&nbsp; Weight of&nbsp; %
            Extractible&nbsp; amount of&nbsp; noids<br>
            Solvent&nbsp; Extract&nbsp; from BioMass&nbsp;
            Flavonoids&nbsp; in Extract<br>
            100% water&nbsp; 277.5 mg&nbsp; 27.8%&nbsp;&nbsp; 1 mg&nbsp;
            0.09%<br>
            Water:methanol&nbsp; 338.6 mg&nbsp; 33.9%&nbsp; 1.19
            mg&nbsp; 11.48%<br>
            (70:30)<br>
            Water:methanol&nbsp; 304.3 mg&nbsp; 30.4%&nbsp; 1.99
            mg&nbsp; 18.93%<br>
            (50:50)<br>
            Water:methanol&nbsp; 293.9 mg&nbsp; 29.4%&nbsp; 2.29
            mg&nbsp; 19.61%<br>
            (30:70)<br>
            100% methanol&nbsp; 204.2 mg&nbsp; 20.4%&nbsp; 2.73 mg&nbsp;
            24.51%<br>
            <br>
            [0151] Higher purity Free-B-Ring flavonoids can be obtained
            by recrystallization of extracts having a Free-B-Ring
            flavonoid content of between 8-15% using alcohol/water as a
            recrystallization solvent. It may be necessary to decolorize
            prior to recrystallization by adding active charcoal or
            other decolorization agent to a heated saturated solution of
            the extract. The Free-B-Ring flavonoids crystallized upon
            cooling. The crystals were filtered, dried and ground into a
            fine powder. Recrystallization can be repeated as necessary
            to achieve the desired level of purity (60%-100% of
            Free-B-Ring flavonoids).<br>
            <br>
            Example 9<br>
            Preparation of a Formulation with a Standardized Free-B-Ring
            Flavonoid Extract from the Roots of S. baicalensis and a
            Standardized Flavan Extract from the Bark of A. catechu<br>
            <br>
            [0152] A novel composition of matter, referred to herein as
            UP676 was formulated using two standardized extracts
            isolated from Acacia and Scutellaria, respectively, together
            with one or more excipients. A general example for preparing
            such a composition is set forth below. The Acacia extract
            used in this example contained &gt;80% total flavans, as
            catechin and epicatechin, and the Scutellaria extract
            contained &gt;80% Free-B-Ring flavonoids, which was
            primarily baicalin. The Scutellaria extract also contained
            other minor amounts of Free-B-Ring flavonoids as set forth
            in Table 11. One or more excipients/preservatives was also
            added to the composition of matter. The ratio of flavans and
            Free-B-Ring flavonoids can be adjusted based on the
            indications and the specific requirements with respect to
            inhibition of COX vs. LO, requirements of skin penetration,
            and potency requirements of the product, such as duration of
            potency required, etc. The quantity of the excipients can be
            adjusted based on the actual active content of each
            ingredient. A blending table for each individual batch of
            product must be generated based on the product specification
            and QC results for individual batch of ingredients.
            Additional amounts of active ingredients in the range of
            2-5% are recommended to meet the product specification.<br>
            <br>
            [0153] S. baicalensis root extract (38.5 kg) (lot #
            RM052302-01) having a Free-B-Ring flavonoid content of 82.2%
            (baicalin); Acacia catechu bark extract (6.9 kg) (lot #
            RM052902-01) with total flavan content of 80.4%; and
            excipient (5.0 kg of Candex) were combined to provide a
            UP676 formulation (50.4 kg) having a blending ratio of 85:15
            by weight of the active Free-B-Ring flavonoids and flavans.
            Table 11 provides the quantification of the active
            Free-B-Ring flavonoids and flavans of this specific batch of
            UP676 (Lot#G 1702-COX-2), deternined using the methods
            provided in Examples 6 and 8. With reference to Table 11,
            this specific batch of UP676 contains 86% total active
            ingredients, including 75.7% Free-B-Ring flavonoids and
            10.3% flavans. FIG. 10 illustrates the HPLC chromatogram of
            a representative UP676 sample, which had a blending ratio of
            80:20 by weight of the active Free-B-Ring flavonoids and
            flavans.<br>
            <br>
            TABLE 11<br>
            Free-B-Ring Flavonoid and Flavan Content of a UP676
            Formulation<br>
            Active Components&nbsp; % Content<br>
            1.&nbsp; Flavonoids<br>
            &nbsp; a.&nbsp; Baicalin&nbsp; 62.5%<br>
            &nbsp; b.&nbsp; Minor Flavonoids<br>
            &nbsp; i.&nbsp; Wogonin-7-glucuronide&nbsp; 6.7%<br>
            &nbsp; ii.&nbsp; Oroxylin A 7-glucuronide&nbsp; 2.0%<br>
            &nbsp; iii.&nbsp; Baicalein&nbsp; 1.5%<br>
            &nbsp; iv.&nbsp; Wogonin&nbsp; 1.1%<br>
            &nbsp; v.&nbsp; Chrysin-7-glucuronide&nbsp; 0.8%<br>
            &nbsp; vi.&nbsp; 5-Methyl-wogonin-7-glucuronide&nbsp; 0.5%<br>
            &nbsp; vii.&nbsp; Scutellarin&nbsp; 0.3%<br>
            &nbsp; viii.&nbsp; Norwogonin&nbsp; 0.3%<br>
            &nbsp; ix.&nbsp; Chrysin&nbsp; &lt;0.2%<br>
            &nbsp; x.&nbsp; Oroxylin A&nbsp; &lt;0.2%<br>
            &nbsp; c.&nbsp; Total Free-B-ring Flavonoids&nbsp; 75.7%<br>
            2.&nbsp; Flavans<br>
            &nbsp; a.&nbsp; Catechin&nbsp; 9.9%<br>
            &nbsp; b.&nbsp; Epicatechin&nbsp; 0.4%<br>
            &nbsp; c.&nbsp; Subtotal Flavans&nbsp; 10.3%<br>
            3.&nbsp; Total Active Ingredients&nbsp;&nbsp; 86%<br>
            <br>
            [0154] Using the same approach, the following batches of
            UP676 were prepared using a combination of a standardized
            Free-B-Ring flavonoid extract from S. baicalensis roots and
            a standardized flavan extract from Acacia catechu bark
            having a blending ratio of 12:88 and 15:85, respectively.<br>
            [0155] S. baicalensis root extract (58.0 g) (lot #
            RM021203-01) having a Free-B-Ring flavonoid content of 87.9%
            (as baicalin) and Acacia catechu bark extract (442.0 g) (lot
            # RM050603-01) with total flavan content of 84.9% were
            blended to provide a UP676 composition (500 g, lot#QJ205-19)
            having a blending ratio of 12:88 by weight. Utilizing the
            methods provided in Examples 6 and 8, the Free-B-Ring
            flavonoid content of (baicalin) was 9.65% and flavan content
            (total catechin and epicatechin) was 73.2% in this specific
            batch of UP676 (lot#QJ205-19).<br>
            [0156] S. baicalensis root extract (300 g) (lot #
            RM060403-01) having a Free-B-Ring flavonoid content of 82.9%
            (as baicalin) and Acacia catechu bark extract (1700 g) (lot
            # RM050603-01) with total flavan content of 90.8% were
            blended to provide a UP676 composition (2000 g, lot#A1904)
            having a blending ratio of 15:85 by weight. Utilizing the
            methods provided in Examples 6 and 8, the Free-B-Ring
            flavonoid content (baicalin) was 15.6% and flavan content
            (total catechin and epicatechin) was 75.0% in this specific
            batch of UP676 (lot#A1904).<br>
            <br>
            Example 14<br>
            Formulation of the UP676 Composition into a Cream<br>
            <br>
            [0164] UP676 (0.5% by weight of UP676) (lot#A1904 as
            described in Example 9) was formulated as a cream as
            illustrated in the following procedure and in Table 13.<br>
            <br>
            [0165] UP676 (Lot#A1904) was dissolved in water at room
            temperature and homogenized with a blender until it was
            fully dispersed in solution (approximately 5 minutes). At
            room temperature and without stirring or agitating the
            solution, Ultrez-21 carbomer was added by sprinkling onto
            the surface of the solution and allowing it to fully wet (no
            white areas visible) and fall into the solution. With gentle
            stirring, the solution was then heated to 40[deg.] C. and
            glycerin was added (Part A). The mixture was then stirred
            for an additional 5 minutes. The remaining components (Part
            B) were weighed and heated to 40[deg.] C. while mixing. At
            40[deg.] C., the remaining components (Part B) were added to
            Part A and the resulting composition was mixed well until
            homogenous (approximately 5 minutes). The emulsion was
            cooled to 30[deg.] C. and the pH was adjusted to
            approximately 5.5 (5.3 to 5.7) by titrating with neutralizer
            while stirring with a stir bar and/or spatula. The emulsion
            became highly viscous due to neutralization-induced
            conformational change of the carbomer. The emulsion
            eventually achieved a suitable viscosity for an emulsion
            cream. The emulsion cream was then mixed until uniform after
            which it was poured into a clean storage vessel and stored
            at 2[deg.] C. to 8[deg.] C. for one month.<br>
            <br>
            TABLE 13<br>
            Ingredient list for a 0.5% UP676 Cream<br>
            Phase&nbsp; Ingredient&nbsp; % (w/w)&nbsp; Weight (g)<br>
            Aqueous&nbsp; Water, Purified&nbsp; 85.00&nbsp; 1275.0<br>
            &nbsp; UP676 (Lot#A1904)&nbsp; 0.50&nbsp; 7.5<br>
            &nbsp; Ultrez 21 Carbomer&nbsp; 0.50&nbsp; 7.5<br>
            &nbsp; Glycerin&nbsp; 8.00&nbsp; 120.0<br>
            Oil&nbsp; PEG-7 Glyceryl Cocoate&nbsp; 3.00&nbsp; 45.0<br>
            &nbsp; Caprylic/Capric Triglyceride&nbsp; 2.67&nbsp; 40.0<br>
            PH&nbsp; Sodium Hydroxide (18% w/v),&nbsp; 0.00&nbsp; 0.0<br>
            Neutralizer&nbsp; Molecular Biology Grade&nbsp;&nbsp;&nbsp;
            <br>
            SUM&nbsp; 7 Ingredients&nbsp; 99.7&nbsp; 1495.0<br>
            <br>
            Example 15<br>
            Evaluation of the Stability of Catechin in Solution<br>
            <br>
            [0166] Pure catechin was dissolved in 70% MeOH in water to a
            final concentration of 0.05% (W/V) after mixing with the
            solutions detailed below. A total of 6 different conditions
            (not including control solution) were chosen for this
            stability investigation at 45[deg.] C. Aqueous K2HPO4 (0.5
            M) or KH2PO4 (0.5 M) was utilized to make buffered solutions
            at pH 5 or 8, respectively. H2O2, SnCl2, FeCl3 or EDTA was
            added to the catechin solution to a concentration of 0.6%
            H2O2, or 0.05% SnCl2, or 0.05% FeCl3 or 0.05% EDTA,
            respectively. All seven solutions were stored in sealed
            bottles at 45[deg.] C. Each sample was tested for catechin
            content by HPLC as described in the Example 6 at day 0, 1,
            3, 6, 8, 10, 13, 20, and 28. The results are set forth in
            FIG. 15.<br>
            <br>
            [0167] The following preservatives: BHA, BHT, diammonium
            citrate (DAC), H2O2, propyl gallate (PG), sodium gluconate
            (SG), and sodium bisulfate/metabisulfite (SBS), were added
            into a buffered (pH 7.5) 0.05% catechin MeOH/H2O solution to
            yield a concentration of 0.05%. All eight solutions were
            stored in sealed bottles at 45[deg.] C. Each sample was
            tested by HPLC as described in Example 6 for catechin
            content at day 0, 1, 3, 6, 8, 10, 13, 20, and 28. The
            results are set forth in FIG. 16.<br>
            <br>
            &nbsp; <br>
            <b>WO2007038683</b><br>
            <b> </b><b>CALCIUM BINDING PEPTIDES&nbsp; </b><br>
            <b> </b><br>
            [0004] BACKGROUND<br>
            <br>
            [0005] [0002] Compounds that bind specifically to calcified
            surfaces include small fluorescent molecules such as
            tetracycline, calcein, and alizarin, and large
            calcium-binding proteins such as dentin phosphoprotein (DPP,
            often referred to as phosphophoryn) and amelogenin. DPP is
            one of the major noncollagenous proteins found in the dentin
            extracellular matrix and has long been implicated in the
            nucleation of hydroxyapatite (HA) during dentin
            mineralization (Lee 1980; Lussi 1988; Veis 1998; Hao 2004).
            Human DPP is derived from proteolytic cleavage of dentin
            sialophosphoprotein (DSPP). Human DPP is a highly flexible
            (Cross 2005), highly phosphorylated (Lee 1980) protein
            consisting primarily of a large number of Asp-Ser-Ser amino
            acid repeats (Gu 2000). The biochemical characteristics of
            DPP have been extensively investigated. These investigations
            have revealed that immobilized DPP causes marked increases
            in the rate of hydroxyapatite nucleation, though this effect
            is not seen with DPP in solution or with dephosphorylated
            DPP. In addition, high concentrations of DPP have been shown
            to inhibit HA crystal growth (Lussi 1988; Veis 1998; Saito
            2000).<br>
            <br>
            [0006] SUMMARY<br>
            <br>
            [0007] [0003] In certain embodiments, a composition is
            provided that includes one or more calcium binding peptides.
            These calcium binding peptides comprise the three amino acid
            repeat sequence (X-Y-Z)n, wherein X is aspartic acid,
            glutamic acid, asparagine, alanine or glutamine, Y and Z
            alanine, serine, threonine, phosphoserine, or
            phosphothreonine, and n is a number from 1 and 40, and
            wherein said calcium binding peptides bind calcium
            phosphate. In certain of these embodiments, the calcium
            binding peptides comprise about 1 to about 40 three amino
            acid repeats (i.e., n=1-40), and have a length from about 3
            to about 120 amino acids. In certain of these embodiments, n
            is a number from 2 to 8. In certain embodiments, X is
            aspartic acid and Y and Z are serine. In certain of these
            embodiments, the calcium binding peptides may have the amino
            acid sequence set forth in any of SEQ ID NOs:12-15.<br>
            <br>
            [0023] DETAILED DESCRIPTION<br>
            <br>
            [0025] Abbreviations<br>
            <br>
            [0026] [0024] The following abbreviations are used herein:
            BE, basal enamel; CE, cortical enamel; CL, carious lesion;
            CLSM, confocal laser scanning microscopy; CPD, circumpulpal
            dentin; D, dentin; DEJ, dentin-enamel junction; DPP, dentin
            phosphoprotein; E, enamel; DSPP, dentin sialophosphoprotein;
            HA, hydroxyapatite; MD, mantle dentin; MIC, minimum
            inhibitory concentration; P, pulp cavity wall; PB,
            periodontal bone; SEM, scanning electron microscopy; RTD,
            root tip dentin; [lambda], excitation wavelength.<br>
            <br>
            [0027] [0025] Amino acids are abbreviated using the standard
            system set forth below.<br>
            <br>
            [0028] Amino acid One letter Three letter abbreviation
            abbreviation<br>
            [0029] Alanine A Ala<br>
            [0030] Arginine R Arg<br>
            [0031] Asparagine N Asn<br>
            [0032] Aspartic acid D Asp<br>
            [0033] Cysteine C Cys<br>
            [0034] Glutamic acid E GIu<br>
            [0035] Glutamine Q GIn<br>
            [0036] Glycine G GIy<br>
            [0037] Histidine H His lsoleucine I Ne<br>
            [0038] Leucine L Leu<br>
            [0039] Lysine K Lys<br>
            [0040] Methionine M Met<br>
            [0041] Phenylalanine F Phe<br>
            [0042] Phosphoserine SP Sep<br>
            [0043] Proline P Pro<br>
            [0044] Serine S Ser<br>
            [0045] Threonine T Thr<br>
            [0046] Tryptophan W Trp<br>
            [0047] Tyrosine Y Tyr<br>
            [0048] Valine V VaI Unless indicated otherwise by a "D"
            prefix, e.g., D-AIa, the stereochemistry of the alpha-carbon
            of the amino acids and aminoacyl residues in peptides
            described herein is the natural or "L" configuration.<br>
            <br>
            [0049] Calcium binding peptides<br>
            <br>
            [0050] [0026] Compounds currently available for the direct
            remineralization of decalcified tissues consist mainly of
            various formulations of free or protein-bound calcium
            phosphate and/or sodium fluoride. Enhancement of
            calcification in biological tissues is generally achieved by
            manipulating cell signaling in bone and tooth precursor
            cells, or by increasing the global calcium concentration
            using calcium-fortified foods, dietary supplements, or other
            treatments rich in free or protein-bound calcium. Previous
            studies have described a formulation that recruits calcium
            phosphate to the tooth surface to enhance remineralization
            (see U.S. Pat. No. 6,780,844). However, enhancement of
            calcification by directly and specifically targeting calcium
            to surfaces has not been demonstrated. [0027] Disclosed
            herein are a series of small calcium binding peptides made
            up of variations of the Asp-Ser-Ser motif found in DPP.
            These peptides have been shown to bind tightly and
            specifically to calcium phosphate surfaces. In addition,
            these peptides have been shown to recruit calcium phosphate
            to such surfaces and to serve as binding moieties for the
            attachment of fluorescent labels to calcified surfaces
            regardless of their phosphorylation state. [0028] The
            peptides disclosed herein, referred to generally as DSS
            peptides, are composed of various numbers and/or
            combinations of the three amino acid Asp-Ser-Ser motif of
            DPP or variations thereof. Examples of three amino acid
            repeats that may be utilized include, but are not limited
            to, Asp-Ser-Ser (DSS, SEQ. ID NO. 1 ), Glu-Ser-Ser (ESS,
            SEQ. ID NO. 2), Asp-Thr-Thr (DTT, SEQ. ID NO. 3),
            Glu-Thr-Thr (ETT, SEQ. ID NO. 4), Asn-Ser-Ser (NSS, SEQ. ID
            NO. 5), Asn-Thr-Thr (NTT, SEQ. ID NO. 6), Gln-Ser-Ser (QSS,
            SEQ. ID NO. 7), Gln-Thr- Thr (QTT, SEQ. ID NO. 8), and
            variations thereof. Alternatively or in addition to these
            repeat sequences, the peptides disclosed herein may Include
            minor variations of these repeats, including but not limited
            to Asp-Ser-Thr (DST, SEQ. ID NO. 9), Asp-Ala-Ala (DAA, SEQ.
            ID NO. 10), or Ala-Ser-Thr (AST, SEQ. ID NO. 11 ). One or
            more amino acid residues within a three amino acid repeat
            may be chemically modified. For example, the peptides may
            contain one or more Ser or Thr residues in which a hydroxyl
            group has been modified by the addition of a phosphate
            group. The peptides may vary in length from three to greater
            than fifty amino acids.<br>
            <br>
            [0051] [0029] The binding affinity of the peptides disclosed
            herein for calcified surfaces may be controlled by altering
            the composition and number of repeats. For example,
            inclusion of one or more Asp-Ser-Ser (SEQ. ID NO. 1 )
            repeats will increase the binding affinity of the peptide,
            because this sequence exhibits the highest affinity of any
            of the repeats tested. The binding affinity of the peptide
            may also be increased by increasing the number of three
            amino acid repeats. Peptides containing more than six
            repeats generally exhibit greater binding affinity than
            those with fewer repeats. In certain embodiments, the
            peptides disclosed herein may have a binding affinity (KA)
            for hydroxyapatite of greater than 15,000 M&lt;"1&gt;. In
            certain embodiments, this binding affinity may be greater
            than 50,000 M&lt;"1&gt;, in other embodiments greater than
            100,000 M&lt;"1&gt;, in other embodiments greater than
            200,000 M&lt;'1&gt;, and in other embodiments greater than
            300,00O M&lt;"1&gt;. [0030] In certain embodiments, the
            peptides may contain one or more additional amino acids that
            are not part of a three amino acid repeat sequence. For
            example, in certain embodiments, the repeat portion of the
            peptide may be fused to an amino acid sequence having an
            additional functionality, such as for example an
            antimicrobial peptide sequence such as the 2c-4, PL135, or
            b-34 peptide sequences. In certain of these embodiments, the
            repeat portion of the peptide may be fused to the additional
            amino acid sequence via a linker sequence, such as for
            example a triglycine sequence. [0031] In certain
            embodiments, the peptides disclosed herein comprise the
            sequence (X-Y-Z)n, wherein X is an amino acid selected from
            aspartic acid, glutamic acid, asparagine, alanine and
            glutamine, Y and Z are amino acids selected from alanine,
            serine, threonine, phosphoserine, phosphothreonine, and
            their derivatives, and n is a number between 1 and 20. In
            certain embodiments, n is between 1 and 15, in other
            embodiments, n is between 1 and 10, and in certain
            embodiments n is between 3 and 8.<br>
            <br>
            [0052] [0032] The calcium binding peptides disclosed herein
            have been shown to induce calcium phosphate crystal growth
            on demineralized enamel and on both demineralized and
            nondemineralized dentin, depending on treatment conditions.
            Likewise, the peptides have been shown to induce
            remineralization of bone. Thus, in certain embodiments,
            compositions comprising the calcium binding peptides
            disclosed herein may be used to enhance mineralization by
            recruiting free-floating calcium phosphate particles to
            calcified surfaces. These peptides may bind to calcified
            surfaces and/or free-floating calcium phosphate aggregates.
            Concurrent binding of calcified surfaces and free-floating
            aggregates results in increased calcium phosphate
            concentration near the calcified surface, which leads to
            enhanced remineralization of the surface. By modulating the
            size and binding affinity of the peptides, it is possible to
            alter the amount of calcium bound to the surface. In certain
            embodiments, remineralization of teeth results in complete
            or partial occlusion of dentinal tubules.<br>
            &nbsp;<br>
            [0087] 2005), these results suggest that DSS peptides may be
            used to target kidney stones in diagnostic or therapeutic
            applications, and that they may be able to modulate the
            growth of kidney stones.<br>
            <br>
            <br>
            US6602490<br>
            <br>
            SUMMARY OF THE INVENTION<br>
            <br>
            [0006] The principal and secondary objects of the inventions
            are to provide a dental hygiene preparation that can
            effectively remove plaque and food debris from teeth, braces
            and prosthetic devices, remineralize tooth enamel over long
            periods between meals and avoid the toxicity of fluoridation
            compounds so that it can be effectively used by elderly or
            handicapped persons as well as those persons affected by
            mouth ulcers and irritations.<br>
            <br>
            [0007] These and other valuable objects are achieved by the
            preparation that uses in solution, a sequestrant such as
            Potassium Citrate, a chelating agent such as Dissodium
            Edetate and a nonfermentable sweetener such as Xylitol in
            combination with an emulsifying, wetting and solubizing
            agent such as Polysorbate. The preparation also contains
            Calcium Ascorbate as antioxidant as well as flavoring agents
            such as Spearmint and Peppermint. <b>The preparation does
              not contain any effective amount of Sodium Fluoride,
              Sodium monoflurophosphate, Stanous Fluoride or any other
              source of Fluoride.</b><br>
            <br>
            DESCRIPTION OF THE PREFERRED EMBODIMENT OF THE INVENTION<br>
            <br>
            [0008] The dental hygiene preparation according to the
            invention includes a sequestran such as Sodium
            Tripolyphospate, Sorbitol, Sodium Citrate and, preferably,
            Potassium Citrate in a proportion of approximately 0.0013 to
            0.032 percent per weight;<br>
            <br>
            [0009] a saturated solution of Disodium Edetate in
            proportion of approximately 0.0003 to 0.04 percent per
            volume;<br>
            <br>
            [0010] Xylitol in a proportion of approximately 0.008 to
            0.08 percent per weight;<br>
            <br>
            [0011] one or more emulsifying, wetting and solubizing agent
            such as Polysorbate in a proportion of approximately 0.0132
            to 0.32 percent per volume, and Poloxamer in a proportion of
            0.0013 to 0.0317 percent per weight; and<br>
            <br>
            [0012] an antioxidant, preferably Calcium Ascorbate
            Dihydrate in a proportion of approximately 0.003 to 0.02
            percent per weight.<br>
            <br>
            [0013] The preparation also, preferably, includes an
            additional sweetener such as Aspartane and Sodium Saccharin
            Dihydrate in a proportion of approximately 0.026 to 0.66
            percent per weight, as well as some flavoring agent such as
            Spearmint and Peppermint. Natural glycerin is preferably
            added as a humectant, plasticizer and tonicity agent. A
            small amount of alcohol and a coloring agent may also be
            included.<br>
            <br>
            [0014] The preparation does not contain any effective amount
            of Fluoride compound that could provide free Fluoride as a
            caries-preventive agent.<br>
            <br>
            [0015] The composition of a preferred example of the dental
            hygiene preparation is provided in Table 1.<br>
            <br>
            &nbsp; TABLE 1<br>
            <br>
            &nbsp; Water (purified)&nbsp; 3.785&nbsp; l (one gallon)<br>
            &nbsp; Ethanol 200 Proof U.S.P./N.F.&nbsp; 15&nbsp; ml<br>
            &nbsp; Rectified F.C.C. Oil of Spearmint&nbsp; 2&nbsp; ml<br>
            &nbsp; Natural F.C.C. Oil of Peppermint&nbsp; 2&nbsp; ml<br>
            &nbsp; DL-Menthol Crystal U.S.P./N.F.&nbsp; 400&nbsp; mg<br>
            &nbsp; (Crystals are Mixed into the alcohol&nbsp; solution).<br>
            &nbsp; Calcium Ascorbate Dihydrate F.C.C.&nbsp; 400&nbsp;
            mg&nbsp; (Powder is mixed into the water).<br>
            &nbsp; Potassium Citrate F.C.C. (Granules are&nbsp;
            400&nbsp; mg&nbsp; mixed into water).<br>
            &nbsp; Polysorbate 20 U.S.P./N.F.&nbsp; 3&nbsp; ml<br>
            &nbsp; Poloxamer 338 U.S.P./N.F.&nbsp; 400&nbsp; mg<br>
            &nbsp; Natural Glycerin U.S./N.F.&nbsp; 6&nbsp; ml<br>
            &nbsp; Xylitol F.C.C.&nbsp; 1.33&nbsp; g<br>
            &nbsp; Disodium Edetate U.S.P./N.F. (100 mg of&nbsp;
            1.25&nbsp; ml<br>
            &nbsp; this powder is mixed in 10 ml of warm&nbsp; purified
            water to obtain a saturated&nbsp; solution and 1.25 ml of
            this saturated&nbsp; solution is mixed into the main
            solution&nbsp; of other ingredients).<br>
            &nbsp; Aspartane (Nutrasweet) U.S.P./N.F.&nbsp; 2.6&nbsp; g<br>
            &nbsp; Blue Coloring F.D. &amp; C. #1&nbsp; 1&nbsp; drop
            (about 0.13 ml)<br>
            &nbsp; Sodium Carbonate, Anhydrous U.S.P./N.F.&nbsp; to
            adjust pH to 7.0<br>
            <br>
            [0016] In the example, <b>Xylitol, derived from the cell
              walls of plants, as been proven to inhibit the growth of
              bacteria, in particular Strep Mutans</b>, the main
            bacteria responsible for dental caries. Contrary to
            Fluoride, Xylitol can be safely ingested. Potassium Citrate
            is preferred as a sequestrant due to its solubizing and
            pH-stablilizing properties.<br>
            <br>
            [0017] The preparation in the example was obtained according
            to the following steps:<br>
            <br>
            [0018] Heating the water to approximately 66 degrees Celsius
            (150[deg.] F.);<br>
            <br>
            [0019] Dissolving the oil of Spearmint, oil of Peppermint,
            Menthol and Glycerin in the Ethanol, and stirring the
            mixture into the heated water. The Polysorbate 20, Poloxamer
            338 and Potassium Citrate were then sequentially dissolved
            into the heated water. Next, the Disodium Edetate solution
            was added within a range of 200 mg to 800 mg, i.e., from 2
            to 8 mg of pure Disodium. After letting the preparation cool
            to approximately 49 degrees Celsius (120[deg.] F.), the
            Xylitol was added. After letting the preparation cool to
            approximately 43 degrees Celsius (110[deg.] F.), the
            approximately 38 degrees Celsius (100[deg.] F.), the blue
            coloring agent is added.<br>
            <br>
            [0020] The pH was then adjusted to 7.0 with Sodium
            Carbonate.<br>
            <br>
            [0021] It should be noted that the preparation was
            continuously stirred during the entire process. Finally, the
            preparation was filtered through a 616-20 paper.<br>
            <br>
            [0022] Before bottling for commerical distribution, the
            preparation is passed through an ultra-violet disinfection
            unit then further filtered through a 5 micron filter prior
            to bottling.<br>
            <br>
            <br>
            <b> PROCESSES AND COMPOSITIONS FOR REMINERALIZATION OF
              DENTAL ENAMEL&nbsp; </b><br>
            <b> </b><b>GB1452125</b><br>
            <b> </b><br>
            It is well known in the dental art that dental caries begins
            as a subsurface demineralization ("white spot") of the
            dental enamel and that remineralization may be of importance
            in retarding or arresting dental caries. U.S. Patent
            3,679,360, July 25, 1972, to Rubin et al., discloses a
            method, the purpose of which is to deposit calcium phosphate
            from a gel medium onto the surface of a tooth. But this
            method of remineralizing has several disadvantages.
            Remineralization occurs only on the surface of the tooth
            whereas the initial cause of dental caries is subsurface
            demineralization. The surface on which apatite growth is
            desired must be prepared (as by roughening), and the tooth
            and coatings must be covered by a suitable cap for several
            days while the mineralization of the tooth surface occurs.<br>
            <br>
            The disadvantages of the method disclosed in the Rubin et
            al. patent are overcome by the present invention which
            provides for subsurface remineralization rather than surface
            remineralization. Since dental caries begins as a subsurface
            demineralization of the dental enamel, subsurface
            remineralization arrests and repairs the carious lesion
            before any permanent structural damage to the tooth occurs.
            The present invention does not require preparation of the
            enamel surface, capping of the tooth, or removal of decay
            products. Further, the present invention may be conveniently
            practiced by the public without substantially changing their
            dental care habits.<br>
            <br>
            The present invention provides an oral treatment pack
            comprising as components adapted for sequential application
            (in either order) to dental tissue:<br>
            <br>
            (A) a first component which comprises application in
            water-soluble form, which cation is capable of forming an
            insoluble precipitate; and<br>
            <br>
            (B) a second component which comprises an anion in
            water-soluble form, which anion is capable of forming with
            said cation an insoluble precipitate adapted to remineralize
            subsurface dental enamel, wherein one or both of the
            components contains a flavouring agents, the components
            being compatible with the oral environment and being such as
            to have a pH from 3 to 10 solution.<br>
            <br>
            Concentrations of cationic and anionic solutions for use as
            the components of the invention may generally be from 0.005%
            to 10% (or the limit of solubility of the salt), with from
            0.05 % to 5 % being preferred.<br>
            <br>
            (These percentages are by weight). More than one cation may
            be employed in the cationic solution. Similarly, more than
            one anion may be employed in the anionic solution.<br>
            <br>
            The application of the oral treatment pack of the invention
            involves:<br>
            <br>
            (1) applying one of the components to the surface of a tooth
            having a demineralized subsurface for a period of time
            sufficient to allow the said ion of<br>
            that component to diffuse into the demineralized subsurface,
            and thereafter<br>
            <br>
            (2) applying the other component to the surface of the tooth
            whereby the said ion of that other component is diffused
            into the demineralized subsurface and the said insoluble
            precipitate is thereby formed.<br>
            <br>
            The remineralizing precipitate formed is less susceptible to
            demineralization than original enamel if heavy metal cations
            and fluoride anions are employed.<br>
            <br>
            There is a-visible effect on "white spots" after as few as
            eight sequential applications, and it is contemplated that
            several sequential applications will be employed to achieve
            the most beneficial results.<br>
            <br>
            The present invention involves the discovery that subsurface
            dental enamel may be remineralized by the sequential
            application of certain soluble salts yielding ions which
            will react to form a remineralizing precipitate.<br>
            <br>
            The sequential application consists of two steps which may
            be performed in either order, although the following order
            is slightly preferred. In the first step, one com- ponent is
            placed in contact with the tooth surface nearest to the
            demineralized subsurface. This, first component preferably
            contains the stated cations, and they diffuse through the
            tooth surface to its demineralized subsurface.<br>
            <br>
            In the second step, the other component containing the
            stated anions is placed in contact with the tooth surface
            nearest the demineralized subsurface. The anions diffuse
            through the tooth surface to the demineralized subsurface
            where they come in contact with the cations previously
            deposited and form a precipitate which is bound to the tooth
            structure. As a result, the tooth's subsurface is
            remineralized.<br>
            <br>
            Concentrations of the salt solutions are generally from
            0.005 % to 10% or the limit of solubility of the salt, as
            stated above.<br>
            <br>
            Excess salt can be present, if desired. Con centrations from
            about 0.05O to about 5 0/s are preferred. The
            concentrations of the soluble salts containing the desired
            anions are essentially the same as those for the
            watersoluble salts containing the desired cations.<br>
            <br>
            If the remineralization contemplated by this invention is
            carried out in the presence of e:ther a heavy metal ion or
            fluoride ion, the remineralized enamel is more resistant to
            demineralization than was the original enamel.<br>
            <br>
            If both ions are present, the remineralized enamel is even
            more resistant to demineralization. The concentration of
            salt containing heavy metal ion and fluoride ion in their
            respective solutions may be from 0.005% to 10%, in
            accordance with the limits given above, but from 0.005% to
            0.1:d is preferred.<br>
            <br>
            Examples of suitable heavy metal ions are barium, lanthanum,
            manganese, lead, tin, zinc, indium, zirconium, iron,
            titanium, vanadium, and cadmium. Indium is preferred.<br>
            <br>
            In the most preferred embodiment of the present invention,
            the remineralizing cationic solution contains from about
            0.005 % to about 10%, preferably about 1%, of a soluble
            calcium salt yielding calcium ions and from about 0.005% to
            about 10%, preferably from about 0.005% to 0.1% of a soluble
            indium salt yielding indium ions. The remineralizing anionic
            solution contains from about 0.005% to about 10%, preferably
            about 1%, of soluble phosphate salt yielding phosphate ions
            and from about 0.005% to about 10%, preferably from about
            0.005% to about 0.1% of a soluble fluoride salt yielding
            fluoride ions.<br>
            <br>
            The resulting precipitate is a calcium phosphate or
            hydroxylapatite, the natural constituent of tooth enamel,
            with incorporated indium and fluoride ions. Not only does
            this process result in remineralized enamel, but the
            remineralized enamel is more resistant to subsequent
            demineralization than was the original enamel.<br>
            <br>
            Soluble fluoride and indium salts which are suitable for use
            in solutions of the present invention include, but are not
            limited to,&nbsp; indium chloride, indium sulfate, and
            indium nitrate. Suitable salts for other desired cations and
            anions would be obvious to one skilled in the art<br>
            The anions which give desirable insoluble precipitates
            include phosphate, C,--C1, fatty acyl groups, fluoride,
            fluorophosphate, silica fluoride, molybdate, sulfate,
            tungstate, ,,8 hydroxyquinolate, tartrate, sorbate, C,;Ci8
            alkyl sulfonates, carbonates, iodates, etc.<br>
            <br>
            Mixtures of these anions are desirable.<br>
            <br>
            Cations which give desirable insoluble precipitates are
            calcium, zinc, indium, rare earth metals, magnesium,
            manganese, cadmium, aluminum, barium, lanthanum, zirconium,
            strontium, cesium, etc. Mixtures of these cations are
            desirable.<br>
            &nbsp;<br>
            EXAMPLE I<br>
            <br>
            Cationic Mouthwash<br>
            Ingredient % by wight<br>
            Indium trichloride (2.89%<br>
            solution in H2O) 1.000<br>
            Bolic acid, U.S.P. 0.075<br>
            Glacial acetic acid, A.C.S. <br>
            0.200 NaOH (10 , solution in H O) 0.400<br>
            &nbsp;<br>
            Anionic Mouth Rinse<br>
            Ingredient % by weight<br>
            &nbsp;<br>
            Disodium phosphate 0.847<br>
            Boric acid, U.S.P. 0.075<br>
            Distilled water 81.210%<br>
            <br>
            EXAMPLE II<br>
            <br>
            Anionic Dentifrice<br>
            Ingredient  by weight<br>
            Disodium phosphate 3.820<br>
            Abrasive (precipitated silicagel) 19.000<br>
            &nbsp;<br>
            Cationic Dentifrice<br>
            Ingredient e,,') by weight<br>
            Calcium chloride 5.000<br>
            Indium trichloride (2.89% solution in H2O) 6.000<br>
            <br>
            EXAMPLE IV <br>
            <br>
            Toothp owder<br>
            Cationic Portion<br>
            Ingredient o, by weight<br>
            Indium trichloride 0.0289<br>
            Sodium citrate 1.50<br>
            <br>
            Anionic Portion<br>
            Ingredient % by weight<br>
            Disodium phosphate 3.82<br>
            Sodium citrate 1.50<br>
            &nbsp;<br>
            EXAMPLE V<br>
            <br>
            Chewing Gum<br>
            Cationic Portion<br>
            Ingredient % by weight<br>
            &nbsp;<br>
            InCI, 0.0289 CaCl2 5.00<br>
            Citric acid 1.00<br>
            &nbsp;Anionic Portion<br>
            Ingredient o by weight<br>
            Gum base<br>
            30 parts Estergum<br>
            45 parts Coumarone resin<br>
            15 parts dry Latex<br>
            10 parts Paraffin wax<br>
            (M.P.=180 F.) 30.00<br>
            &nbsp;<br>
            Na2HPO4 3.82<br>
            Citric acid 1.00<br>
            Flavor balance<br>
            &nbsp;<br>
            The concentration of the combination of the calcium and
            indium salts and the combinations of the phosphate and
            fluoride salts in the human mouth in use are respectively
            about 2% and about 1%.<br>
            <br>
            As an Example of the use of the oral treatment packs of the
            Examples a subject rinses his mouth with the cationic
            mouthwash of Example I and then rinses his mouth with the
            anionic mouthwash of Example I. Each rinse is performed for
            about 30 seconds.<br>
            <br>
            <b>US4397837</b><br>
            <b> </b><br>
            It has also already been proposed to add compounds
            containing calcium ions and phosphate ions to dental
            cosmetics which are used topically, and thus to achieve a
            remineralization of the dental enamel. In this way, however,
            no more satisfactory results, that is to say adequate
            remineralization of the dental enamel by the incorporation
            of calcium ions and phosphate ions, were achievable than in
            the case of using water-insoluble calcium phosphates, for
            example dicalcium phosphate, which has also already been
            described (British Patent Specification No. 1,102,024), for
            example in chewing gum. This is presumably due to the fact
            that as a result of the low solubility in water of these
            calcium phosphates and of the consequent inadequate
            dissociation, calcium ions and phosphate ions are not
            available in sufficient amount to effect satisfactory
            incorporation of these ions into the demineralized dental
            enamel.<br>
            <br>
            British Patent Specification No. 1,090,340 describes a
            process for the re-hardening of dental enamel which is
            characterized in that a supersaturated solution of an
            apatite material, which is stabilized with an isotonic
            sodium chloride solution, is produced in the presence of
            teeth by reaction of a mixture of a water-soluble calcium
            salt, a water-soluble phosphate salt and a water-soluble
            fluoride salt. This material is intended to be incorporated
            into the demineralized dental enamel. In this process, no
            real absorption of calcium ions, phosphate ions and fluoride
            ions by the dental enamel occurs, and hence no
            remineralization of the softened dental enamel, a deposit of
            fluorohydroxyapatite being merely produced on the surface of
            the dental enamel. In addition, the requisite presence of
            sodium chloride presents considerable problems in the
            manufacture of a dental&nbsp;&nbsp; <br>
            &nbsp;<br>
            As calcium compound it is in principle possible to employ,
            in the preparations of the invention, all water-soluble
            toxicologically harmless calcium compounds. A compound is
            considered to be water-soluble when at least 0.25 gram
            thereof dissolves in 100 ml of H2 O at 20 DEG C.<br>
            <br>
            Suitable water-soluble calcium compounds are, for example,
            calcium chloride, calcium nitrate, calcium acetate, calcium
            gluconate, calcium benzoate, calcium citrate, calcium
            formate, calcium fumarate, calcium lactate, calcium butyrate
            and calcium isobutyrate, calcium malate, calcium maleate,
            calcium propionate, calcium valerate or mixtures of
            water-soluble calcium compounds. In the compositions of the
            invention for the remineralization of human dental enamel,
            at least about 50 ppm of calcium ions should be present; the
            upper limit is about 35,000 ppm of calcium ions.<br>
            <br>
            Suitable water-soluble inorganic phosphates within the scope
            of the present invention are, for example, the alkali salts
            and ammonium salts of orthophosphoric acid, such as
            potassium, sodium or ammonium orthophosphate, water-soluble
            alkali metaphosphates or alkali polyphosphates or mixtures
            of these substances.<br>
            <br>
            Particular water-soluble organic phosphates are sugar esters
            of orthophosphoric acid and esters of phosphoric acid and
            polyhydric alcohols. As examples there may be mentioned
            fructose phosphate, sorbitol phosphate, glucose phosphate,
            sucrose phosphate, glycerophosphate, mannitol phosphate and
            inositol phosphate and their water-soluble salts. The
            concentration of the PO4 ions is preferably about 50 to
            40,000 ppm; solubility in water is defined as in the case of
            the calcium compounds.<br>
            <br>
            Toothpaste<br>
            A B<br>
            <br>
            Calcium chloride.2 H2 O 1.80 --<br>
            Disodium hydrogen phosphate -- 1.00<br>
            Phytic acid -- 0.35<br>
            <br>
            EXAMPLE 2<br>
            <br>
            Two pastes A and B were prepared, of which paste A consists
            of a customary paste base and contains a calcium compound.
            In contrast, paste B, which contains water-soluble
            phosphates, is in the form of a transparent gel. The teeth
            are first cleaned with paste A and subsequently with paste
            B.<br>
            <br>
            Toothpaste A:<br>
            Calcium gluconate 5.60 % by weight<br>
            Water 32.80 "<br>
            <br>
            Toothpaste B, in the form of a gel:<br>
            Sodium glycerophosphate 0.85<br>
            Potassium dihydrogen phosphate 0.50 <br>
            Disodium hydrogen phosphate 0.70 "<br>
            Precipitated silica 21.00<br>
            Water 13.12<br>
            Calcium chloride, anhydrous<br>
            1.10 KH2 PO4<br>
            0.01 Na2 HPO4.2 H2 O<br>
            <br>
            <br>
            EXAMPLE 4<br>
            <br>
            A two-layer (I and II) chewing gum was produced as follows
            (data in % by weight):<br>
            <br>
            1.82 of Ca Cl2.2H2 O and <br>
            (II) a mixture of 0.65 of Na2 HPO4.2H2 O, 0.55 of KH2 PO4
            and 0.82 of sodium glycerophosphate,<br>
            &nbsp;&nbsp; <br>
            EXAMPLE 5<br>
            <br>
            13.00% by weight of gum arabic<br>
            13.00 gelatin<br>
            (I) 49.94% by weight of or<br>
            (II) 51.47% by weight of water,<br>
            <br>
            were incorporated, in (I) 2.50% by weight of calcium
            gluconate, and in II<br>
            0.32% by weight of Na2 HPO4,<br>
            0.35% by weight of KH2 PO4 and<br>
            0.30% by weight of sodium glycerophosphate<br>
          </div>
          <br>
          <hr size="2" width="100%"><br>
        </div>
      </blockquote>
      <div align="center"><img alt="" src="0logo.gif" height="82"
          width="124"><br>
        <br>
      </div>
      <div style="text-align: center;"><b>Your Support Maintains this
          Service -- </b><b><br>
        </b> <b><br>
        </b> <b>BUY</b><b><br>
        </b> <b><br>
        </b> <big><b>The</b><b> Rex Research Civilization Kit </b></big><b><br>
        </b> <b><br>
        </b> <b>... It's Your Best Bet &amp; Investment in Sustainable
          Humanity on Earth ... </b><b><br>
        </b><b> Ensure &amp; Enhance Your Survival &amp; Genome
          Transmission ...</b><b> </b><b><br>
        </b> <b>Everything @ rexresearch.com on a Data DVD ! </b><b><br>
        </b> <b><br>
        </b> <b><a href="order.htm"
            ">ORDER PAGE</a></b><b><br>
        </b> </div>
      <b> </b><b><br>
      </b><b> </b>
      <hr style="width: 62%; height: 2px;">
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script>
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script></div>
  </body>
</html>
